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The poultry red mite Dermanyssus gallinae (De Geer) is a blood feeding ectoparasite 
that infests many bird species. Economically it is the most important parasite 
affecting egg-laying hens. The aim of this study was to identify vaccine candidate 
proteins from D. gallinae using a number of approaches. 
 
An immunisation trial was conducted using four protein fractions derived from  
D. gallinae. The fractions were injected into hens and immunoglobulin Y was 
purified from the yolk of eggs laid by the hens. An in vitro feeding assay in which 
mites were fed these antibodies showed a significant increase (p = 0.013) in mortality 
of mites fed with antibodies against a PBS-soluble fraction of D. gallinae. The PBS-
soluble proteins were then fractionated by anion exchange chromatography into three 
fractions, which were then used to immunise hens. One fraction produced antibodies 
that caused the greatest percentage mortality of mites, based on the results from a 
single feeding assay.  
 
To identify further potential vaccine antigens, three expressed sequence tag (EST) 
databases were produced. A complementary DNA (cDNA) library was prepared 
from a mixed gender and life stage population and 46 contigs were identified with 
significant homology to proteins from other organisms. A second database was 
generated using a suppression subtractive hybridisation approach and 133 “fed mite 
enriched” contigs identified with significant homology to proteins in either the NCBI 
non-redundant (nr) protein, KEGG databases or had a domain predicted by 
InterProScan. The most abundant proteins in this database were vitellogenin and 
GP80, a precursor molecule of vitellogenin. Roche 454 sequencing technology was 
used to generate an EST database of 13,363 contigs, of which 26 % had significant 
homology to a protein in the NCBI nr protein database. The majority of contigs  
(45 %) were classified as Cellular Processes and Signalling proteins. Illumina Solexa 
sequencing technology was also used to analyse the expression levels of genes in fed 
and starved mites. A total of 66 contigs were obtained with a significant and greater 
than three-fold change in expression level between the two groups. The contig with 




Paramyosin and tropomyosin have been used successfully to immunise hosts against 
other parasitic species. Tropomyosin had previously been characterised in  
D. gallinae. In this study paramyosin was characterised and recombinant versions of 
both proteins were used in an immunisation trial. Anti-tropomyosin (p < 0.001) and 
anti-paramyosin (p = 0.004) antibodies fed to mites in the in vitro feeding assay 
caused a significant increase in the mortality of the mites when compared to controls. 
 
An in vivo challenge was performed injecting three groups of hens with the PBS-
soluble native protein fraction, a recombinant protein cocktail, consisting of 
paramyosin, tropomyosin, cathepsin L, cathepsin D and histamine release factor, and 
an adjuvant only control, which were subjected to a challenge of D. gallinae. Each 
group consisted of three replicates based on weight. Western blot analysis of hen 
serum showed a significant increase (p < 0.05) in the titre of antibody from the hens 
immunised with the recombinant cocktail compared with controls. One of the 
replicates immunised with the PBS-soluble protein fraction showed a strong response 
but this was lacking in the other two replicates and no significant difference in IgY 
titre was found. No significant differences were found between the number of mites 
collected from the test or control groups following a large mite challenge.  
 
In conclusion the PBS-soluble protein fraction, paramyosin and tropomyosin have 
been shown to have potential as vaccine candidates based on in vitro studies. The 
bioinformatic analysis of D. gallinae has provided a large EST database and a list of 
66 proteins that had a significant difference in expression levels in fed and starved 













1.1 Poultry farming 
 
The rearing of domestic fowl is a huge industry worldwide. The scale of operation 
ranges from individuals who keep only a few free range hens to mass production by 
poultry farmers who keep hundreds of thousands of hens in battery cage, barnyard or 
free range systems where the eggs and meat produced are sold to supermarkets. The 
loss of production due to illness whether viral, bacterial or parasitic in nature is an 
important economic and welfare issue that needs to be continually addressed.  
 
In the United Kingdom there are 29.1 million laying hens, which makes the UK the 
sixth largest egg producer in Europe (British Egg Industry Council, 2008). The eggs 
are classified into two distinct categories depending on whether the hens are housed 
in either battery cages or non-caged systems. Non-caged systems can be classified as 
free range, barnyard housed or organic.  
 
Hens kept for meat or egg production are stocked at high densities, which can 
exacerbate the spread of disease throughout a flock. Each of the housing systems 
(discussed in 1.2) can be infested with the poultry red mite, Dermanyssus gallinae, 
and the levels of mites present are related to increases in hen mortality (Arkle et al., 
2006). Prevalence studies in England have shown that D. gallinae infestations are 
higher in the barnyard system than in battery cages (Fiddes et al., 2005). Historically, 
chemicals have been used to control D. gallinae. However, since the deregulation of 
some of the most effective chemicals that cause a build up of toxic residues in food 
products (Hamscher et al., 2003), an alternative control method is required. In 2005, 
the estimated cost incurred by D. gallinae to the European Union was 130 million 




1.2 Dermanyssus gallinae 
 
Dermanyssus gallinae (de Geer, 1778) is a haematophagous ectoparasite that infests 
many bird species worldwide. It is also known as the poultry red mite due to its 
preference for feeding on poultry and the red colouration of its body after feeding. 
Figure 1.1 is a photograph of an adult mite. 
 
Figure 1.1. Adult D. gallinae after a blood meal. 
 
All of the systems for poultry farming as described in 1.3 have problems with  
D. gallinae infestation. From an economic point of view it is one of the most 
important ectoparasites affecting egg-laying hens in many countries worldwide 
(Chauve, 1998). A survey carried out in Northern England revealed that 87.5 % of 
the 17 farms surveyed were infested with D. gallinae. Infestation was confirmed by 
setting traps near the hens and counting the number of mites collected after seven 
days (Guy et al., 2004). A similar survey in Sweden revealed that 67 % of the 21 
farms that responded had D. gallinae infestation in backyard flocks. Infestation was 
confirmed by inspections, sampling and interviewing the farmers (Hoglund et al., 
1995). As described in 1.2.3 D. gallinae affects the egg-laying potential of the hens 
due to blood loss and irritability. However, the main cause of economic egg loss due 
to mite infestation is cosmetic in nature. In a battery cage farm, when eggs are laid, 
they roll out of the cage onto a conveyer belt, where they cast a shadow. The mites 
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make use of this darkened area to hide. When the conveyer belt is activated the eggs 
roll backwards slightly and crush the blood-engorged mites thereby forming a blood 
spot on the eggs. Eggs with these blood spots cannot be sold on cosmetic grounds 
and have to be washed. After the eggs have been washed they are downgraded in 
quality and therefore value.  
 
D. gallinae rests during the day in any dark place, collecting in cracks and crevices 
provided by nest boxes or machinery in the poultry housing. Mites infest hens during 
the night and feed for approximately 90 minutes. They then retreat to the dark hiding 
places to digest the blood meal after which they moult, reproduce and lay eggs. 
Experiments conducted to study the longevity of D. gallinae found that the mites can 
live for at least eight months in natural conditions in a poultry house that has been 
depopulated of hens. During the experiment, which ran for nine months over the 
winter to the beginning of summer, the temperature ranged from -10 C to 32.7 C. 
The mite population dramatically decreased in June (month eight), when the 
temperature was at its highest, to 56 mites from hundreds observed at the end of 
April. No mites were found during a careful search of the poultry house at the end of 
July (month nine) and since only a few dead mites were found in the hen house at 
this time it was concluded that the mites had migrated in search of a blood meal 
(Kirkwood, 1963). The effects of temperature and humidity on oviposition, moulting 
and longevity of D. gallinae from a Swedish poultry farm were tested. Mites were 
collected from a poultry farm and exposed to a range of temperatures from -20 C to 
65 C in multi-well plates for 41 weeks. D. gallinae can survive in locations where 
the temperature is moderate, between 5 C and 45 C with female mites laying the 
greatest number of eggs at 25 C but do not tolerate temperature extremes, below  
-20 C and above 45 C. Mites were also exposed to a range of relative humidity from 
30 % to 90 %. The highest number of eggs were laid at a relative humidity of 70 % 
(Nordenfors et al., 1999). These conditions are optimal for a mite to mature from an 
egg to a sexually mature adult in the shortest period of time. The ability of  
D. gallinae to survive for such long periods without a bloodmeal makes the  
de-infestation of barns and cages a problem that needs to be addressed before a new 
flock can be introduced. This is especially important in a commercial environment 
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where rapid turnover is a priority. In a more general study it was suggested that a 
minimum period of four weeks was required between housing separate flocks to 
allow the mite population to decrease to a manageable level (Beugnet et al., 1997).  
 
D. gallinae have been found in poultry units all around the world (Kim et al., 2007; 
Roy & Chauve, 2009). Studies have been carried out in European countries to assess 
and control the populations of D. gallinae in poultry houses. In France massive 
infestations are common, where D. gallinae populations that are resistant to 
pyrethroid acaricides have been reported. The experiments were carried out in vitro, 
where mites were incubated for 24 hours on filter paper soaked in the chemical. The 
resistance detected in mites to these acaricides was reported to be similar to the 
resistance that developed in tick species, in particular Rhipicephalus (Boophilus) 
microplus (Beugnet et al., 1997). Surveys in Sweden, followed by visits to the farms 
were carried out to assess the prevalence of D. gallinae in the different housing 
systems. After inspection it was found that only 4 % of cage systems were infested, 
whereas as many as 67 % of backyard flocks and 33 % of barn or deep litter flocks 
were infested. The percentages for the backyard and barn or deep litter systems were 
much higher on inspection than was reported by farmers that responded to the 
survey, which stated that 19 % of backyard flocks and 21 % of barn or deep litter 
flocks were infested with mites. This suggested that either the situation had changed 
between the survey and the inspection or that the poultry workers could not identify 




By morphology, Dermanyssus gallinae is described as a member of the Phylum 
Arthropoda, Class Arachnida, Order Acari, Sub-order Mesostigmata and Family 
Dermanyssidae. After reclassification of the original 56 members of the genus 
Dermanyssus, 23 members remain. D. gallinae is widely distributed and has been 




Another mite that parasitizes hens is Ornithonyssus sylviarum (Northern Fowl Mite 
[NFM]) of the sub-order Mesostigmata and family Macronyssidae. The NFM is also 
a haematophagous ectoparasite of birds; however it spends its entire lifecycle on its 
host, which is most commonly poultry (Owen et al., 2009). 
 
Studies were conducted to assess the phylogenetic relationship between populations 
of D. gallinae in Italy, France and the UK. The mitochondrial cytochrome oxidase I 
gene was sequenced from each of the populations sampled in the different countries. 
It was found that there was a high rate of nucleotide substitution in the gene between 
mite populations. When aligned, 51.5 % of the nucleotide sequence was conserved 
throughout the cytochrome oxidase I gene. The amino acid sequences were between  
70 % and 87.9 % conserved within the samples from each country (Marangi et al., 
2009a). This suggested that the majority of the non-conserved nucleotide sites were  
silent mutations. Genetic differences between D. gallinae populations throughout 
Europe and the rest of the world could result in naturally resistant strains of the mite 
to any possible vaccine.  
 
1.2.2 Life cycle 
 
The life cycle of D. gallinae has previously been described (Chauve, 1998; Wood, 
1917). In brief, from egg to egg the entire life cycle can take as little as seven days. 
The six-legged larva will emerge from an egg laid three days previously. Within a 
day the larva will moult into an eight-legged protonymph. The protonymph takes its 
first blood meal and moults into a deutonymph within a day. The deutonymph feeds 
again and moults into an adult, which can then mate. After mating, the female feeds 
and starts to deposit eggs within 12 hours (Bruneau et al., 2001; Chauve, 1998). The 
female mite‟s laying life span is five to eight weeks, during which it can lay up to 
five clutches of about eight eggs (Meyer-Kuhling et al., 2007). In optimal conditions 
the mite population in a poultry house can double every six days (Maurer & 





Figure 1.2. Life cycle of D. gallinae. 
 
1.2.3 Clinical signs 
 
Since D. gallinae is a haematophagous parasite, the main symptom in infested hens 
is anaemia. Due to the extremely high population of mites that can infest poultry 
houses, the hens can lose a large volume of blood per night. A single female mite has 
the ability to ingest an average blood meal of 204 µg (Sikes & Chamberlain, 1954) 
and in heavy infestations there may be as many as 200,000 mites infesting a single 
hen (Kilpinen et al., 2005). An obvious sign of anaemia in hens is loss of colour of 
the wattle and comb, which become pale pink instead of red. 
 
Other clinical signs of heavily infested hens are changes in behaviour. At night the 
mites emerge from their hiding places to feed on the hens. This infestation leads to 
an increase in self grooming and social feather pecking (Kilpinen et al., 2005). The 
discomfort and itching caused by the feeding mites can deprive the hens of sleep. 
The resulting agitation leads to an increase in bullying by pecking, which causes 

















In extreme cases, anaemia and stress due to behavioural changes can result in death. 
However, the main effect of these symptoms is reduced egg-laying potential of the 
hens, which is one of the sources of economic loss suffered by farmers. 
 
1.2.4 D. gallinae as a vector for disease 
 
Many parasitic species are vectors for the mechanical and cyclical transmission of 
other pathogens, such as viruses and bacteria. D. gallinae has been shown to carry 
bacterium and therefore could be a vector in the mechanical transmission of several 
diseases that affect poultry. D. gallinae was collected from three farms on which the 
poultry had been diagnosed with hen erysipelas. Erysipelas is caused by the 
bacterium Erysipelothrix rhusiopathiae, which infects a number of vertebrate species 
including hens, pigs and humans. It causes an acute septicaemia in hens that can lead 
to death over a short period of time. The bacterium was present inside mites on all of 
the farms and was also found on the surface of the mites on one of the farms (Chirico 
et al., 2003). However, attempts to transmit the bacterium from infected D.gallinae 
to uninfected hens has not been successful (Brannstrom et al., 2010). 
 
Salmonella spp. are important bacteria that infect but are non-pathogenic in poultry. 
Salmonella spp. can be passed on to humans though consumption of contaminated 
products such as eggs and undercooked meat and can cause diarrhoea, stomach 
cramps, vomiting and fever in humans. In severe cases dehydration may occur which 
can be life-threatening if not treated. D. gallinae is a reservoir for Salmonella, and is 
capable of passing the bacterium from hen to hen (Moro et al., 2007). Through the 
control of D. gallinae the spread of Salmonella spp. may be reduced.  
 
1.2.5 Host specificity  
 
The preferred host for D. gallinae is poultry. However, it will feed opportunistically 
on wild birds, domestic animals such as dogs and cats, and humans. Personnel 
working with birds or coming into close contact with them can develop severe 
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dermatitis even after short exposure to the parasite. A reaction to D. gallinae was 
found to be the responsible for two out of eight cases of pruritus during a study of 
human patients in Israel. In the first case, a group of seven male poultry workers 
reported seeing mites crawling over the eggs they were collecting. The second case 
was a young girl who had mites collected from her hair and from the wall next to her 
bed. An infested sparrow nest was found near her bedroom window (Rosen et al., 
2002). Ectoparasites identified as D. gallinae were found on two patients with skin 
lesions in a Canadian hospital. Pigeons, which have previously been identified as a 
host of the mites (Deoreo, 1958), were found to be nesting in large sheltered 
walkways used by the patients. Upon inspection, D. gallinae were found in the bird 
nests (Auger et al., 1979).  
 
A study carried out in four locations in Sweden has shown that there is a genetic 
difference between D. gallinae that infest poultry units and those that infest wild 
birds. In this study four mite genes were sequenced, three of which were genetically 
identical. The fourth gene, internal transcribed spacer (ITS) 1, was shown to have 
two genotypes. The mite populations collected from wild birds had one genotype and 
the mites collected from poultry units had the other. This genetic difference clearly 
shows that there are two subspecies of D. gallinae. It was thought that the wild bird 
nests would not serve as a reservoir for the mites from the poultry unit (Brannstrom 
et al., 2008) 
 
1.3 Poultry housing systems 
1.3.1 Battery cage system 
 
Battery cages house laying hens in a relatively small area to allow thousands of hens 
to be kept efficiently and away from predators in a poultry house. The floor of the 
cage is sloped allowing the eggs to roll to the front to be collected on a conveyor 
belt. Figure 1.3 is a photograph of a battery cage system. 
 
In the UK 58 % of laying hens were housed in battery cages in 2008 (British Egg 
Industry Council). In 1988 the European Union issued a Council Directive that laid 
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out minimum requirements for conventional battery cages. They were to give laying 
hens “at least 450 cm
2
 of cage area”. Feeding and water troughs should always be 




Figure 1.3. Battery cage system containing hens. The hens feed through the bars, which rub their 
feathers causing bald patches.   
 
This Council Directive was reassessed in 1999 when the distinction between 
enriched and unenriched caged systems (conventional battery cages) was introduced 
and the minimum requirements for housing laying hens were increased. The new 
Council Directive (European Union Council Directive, 88/166/EEC) changed two 
points of the existing legislation for unenriched cages. Firstly the minimum cage area 
per hen was increased to 550 cm
2
 and secondly the cage had to be fitted with “claw-
shortening devices” to prevent overgrown claws. Conventional cages were not 
allowed to be built from 1 January 2003 and have to be entirely replaced with 
enriched cages by 1 January 2012. Minimum specifications were also set out for 
enriched cages in this Directive. Each bird must have at least 750 cm
2
 of floor space 
of which 600 cm
2 
should be at least 20 cm high and the cage should be no smaller 
than 2000 cm
2
. Each cage must also have facilities that allow the hens to express 
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natural behaviour, namely nesting, roosting and pecking or scratching. To this end, a 
curtained nesting area, a roosting perch allowing at least 15 cm per hens and a litter 
or scratch pad must all be provided. On the management side the aisles between the 
rows of cages must be at least 90 cm wide and there must be at least 35 cm between 
the bottom of the cage and the floor (Council Directive, 1999/74/EC). The 
implementation required in this legislation, namely the increase in furniture around 
the cage, had a negative effect of increasing the number of hiding places for  
D. gallinae. This also made cleaning the cages more difficult, and in the long term 
larger mite populations would be able to hide during the cleaning effort. 
 
The environmental conditions in a poultry unit allow the growth of mite populations. 
In a battery cage unit there are many dark places away from the hens where the mites 
can hide. Due to the number of hens in a battery unit the temperature is maintained at 
about 25 C, which is an optimal temperature for mite population growth. 
 
In battery cage farming systems the lighting regimen is carefully monitored. Hens 
that have a higher photostimulation show increases in egg production whereas a 
reduction in length of light stimulation can delay or decrease production. Hens have 
extra-retinal photoreceptors located in the brain. These receptors are affected by red 
light that stimulates egg production. Hens exposed to blue or green light stimulation 
laid fewer larger eggs (Rozenboim et al., 1998). The length of the light period was 
chosen to mimic the length of days during summer so that the hens will lay eggs all 
year. The artificial lights used in poultry units are required to be kept dim to reduce 
the amount of pecking that can lead to injury (Prescott & Wathes, 1999). During a 
normal legal lighting regime, where there has to be at least eight hours of 
uninterrupted darkness, D. gallinae spends most of it‟s time off host. However a 
study was performed that changed this regime to create varying periods of light and 
darkness. The lighting regimes followed over a 12-week period were: group 1 had  
14 hours of light followed by 10 hours of darkness; group 2 had 20 hours of light 
followed by four hours of darkness; group 3 had four repeats of 3.5 hours of light 
followed by 2.5 hours of darkness; group 4 had 24 repeats of 15 minutes light 
followed by 45 minutes darkness. The mean number of eggs per hen, mean feed 
25 
 
intake and number of mites collected were measured. Groups 3 and 4 had the 
smallest number of mites recovered no mites were collected from group 3 and only a 
single mite was found in the group on the last week of the study in group 4. These 
groups also laid the most eggs on average (60 eggs from each group) but on average 
did not consume the largest mass of feed, 13 kg and 11 kg respectively, compared to 
12.5 kg consumed by group 1 and 15 kg consumed by group 2, who laid 59 and 56 
eggs respectively. The only group that had a legal light regime was group 1; the hens 
laid 59 eggs on average and ate 12.5 kg of feed. However the highest number of 
mites was collected from this group, 158 mites collected in total with 124 of these 
collected during week 12 (Stafford et al., 2006).  
 
1.3.2 Free range system 
 
Free range housing systems for laying hens differ from the battery cage system in 
that the hens are not restricted inside the house and can roam around outside the 
house. The housing is covered in deep litter, which mainly consists of sawdust, and 
the hens are given nest boxes where they can lay their eggs. To be called free range, 
the stocking density has to be fewer than 1000 hens per hectare (Farm Animal 
Welfare Council, Report on the welfare of laying hens, 
http://www.fawc.org.uk/reports/layhens/lhgretoc.htm).  
 
1.3.3 Barnyard system 
 
The barnyard system is very similar to the free range system except the hens are kept 
in a large barn but do not have access to a pasture on which to roam. In a survey 
conducted in England, it was observed that flocks of laying hens housed in barnyard 
systems were more heavily parasitized than flocks in free range and even battery 







The differences between organic and other non-caged egg production system include 
feed, animal welfare and medication. The hens are not caged, they cannot be fed 
animal by-products or genetically modified crops and the use of chemicals are 
limited (Zenner et al., 2003). Farmers are only allowed to treat flocks with antibiotics 
in cases of emergency. 
 
1.4 Control methods 
 
Control methods at present rely on the use of chemicals, for example Poultry Shield 
and ByeMite®, while hens are in the cages (described in 1.4.1). However the mites 
live in hard to reach places that cannot easily be cleaned. There are differing reports 
on the most heavily infested housing system; one paper suggests that  
D. gallinae can infest free range systems to a higher degree than battery cage systems 
(Arkle et al., 2006), whilst a survey of poultry farmers in another suggested that 
barnyard systems were more heavily infested than battery cage systems (Fiddes et 
al., 2005). Barnyard and free range housing systems have more places for mites to 
hide, and the hens are kept on the floor in these systems, which make the use of 
chemical sprays directed specifically at the mites more restrictive. Cages however 
can be cleaned and sprayed directly using steam jets. However, time is restricted in a 
commercial poultry unit, and it is not possible to de-infest entire barns before the 
next flock arrives, due to the losses that are accrued during down time where the 
hens are not producing eggs. 
 
1.4.1 Chemical control 
 
As previously stated D. gallinae lives in small, dark spaces that can be hard to reach, 
so cleaning of cages by spraying needs to be meticulous in order to be effective. 
Spraying of cages can be unidirectional, leaving large mite populations on untreated 
sections of the cage (personal observation). Due to the short-lasting action period of 
some of the chemicals used, they need to be directly applied to the mites to have any 
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effect. For example, Poultry Shield is a detergent-based treatment, which can be 
sprayed into crevices in the poultry cages that the mites hide in during the day. 
Poultry Shield penetrates the cuticle of the mite and the protective coating around the 
egg, causing dehydration and death. 
 
Historically, a number of chemical acaricides have been used to control D. gallinae, 
for example synthetic pyrethroid acaricides such as Permethrin, and 
organophosphates such as dichlorvos. These chemicals have been used successfully 
for many years to control parasite numbers, although parasites have now started to 
develop resistance, and their use has been discontinued (Beugnet et al., 1997). On 
farms which appeared to have problems with chemical resistance, between eight and 
40 times as much Permethrin was required to kill 50 % (LD50) of the mites 
compared with a control farm (Beugnet et al., 1997). In addition, these chemicals 
may be toxic to host animals, including humans (Nordenfors et al., 2001) and can 
contaminate the environment and food products destined for human consumption 
(Mulenga et al., 2000). For example, residue of Propuxur has been found in eggs at a 
level six times higher than the maximum permitted in the European Union 
(Hamscher et al., 2003).  
 
Ivomec® (Merck Sharp and Dohme S.A.), which contains ivermectin, of the 
macrocyclic lactone family of anthelmintics, has been tested to ascertain its possible 
use in the control of D. gallinae. A range of concentrations of Ivomec® were 
injected intra-abdominally or intra-muscularly into hens. Ivomec® injected at a dose 
of less than 0.6 mg kg
-1
 intra-abdominally or when injected intra-muscularly at any 
concentration had no visible effect on the mites, which could still lay viable eggs. 









the mites suffered paralyses, which 
lasted a maximum of 70 hours. However this is close to the dose that is toxic to 
experimental hens (Zeman, 1987).  
 
The chemical ByeMite®, developed by Bayer HealthCare (Animal Health Division), 
is an emulsifiable concentrate containing phoxim (50 %), an organophosphate. The 
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efficacy of the drug was assessed during a trial on two commercial poultry farms 
where hens were housed in battery cages. ByeMite® was used to treat one farm and 
the other was untreated. Traps were put out on eight occasions from the day before 
treatment until 49 days post-treatment. Efficacy, measured in terms of reduction in 
mite numbers on the treated farm when compared to the control farm, was 96 % on 
day three and 99.8 % by day 49 (Meyer-Kuhling et al., 2007). D. gallinae from two 
farms in Germany and France were tested in vitro with ByeMite® and a biological 
product Mite-Stop®, which was derived from seeds of the plant Azadirachta indica. 
ByeMite® was shown to be as effective as previously demonstrated, killing 96 % of 
the mites in the experiment from the French farm. The percentage mortality caused 
by ByeMite® when the mites were in contact with the drug for only four seconds 
dropped to 27.8 % with mites from the German farm and 30 % with mites from the 
French farm. Mite-Stop® caused 100 % mortality on the mites from the French farm 
and 84.5 % mortality on mites from the German farm (Abdel-Ghaffar et al., 2009). 
The ineffectiveness of ByeMite® results from survival of mites due to their ability to 
hide in the crevices around the battery cages during the short exposure time. 
 
1.4.2 Plant extracts 
 
In a study, D. gallinae were exposed to a panel of 56 essential oils and the mortality 
of mites was measured. When the essential oils, at a concentration of 0.35 mg cm
-2
, 
were used in a filter paper contact bioassay only two of the oils failed to cause a 
mortality of at least 89 %. When the concentration was reduced to 0.07 mg cm
-2
, 37 
of the oils caused a mortality of 50 %, 13 of which caused mortality in all the mites 
tested. Only two of the oils cade (Juniperus oxycedrus) and horseradish (Cocholearia 
armoracia) caused 100 % mortality when the concentration was reduced to  
0.04 mg cm
-2





highest percentage mortality of mites was 46 % with Lime dis 5F (Citrus 
aurantifolia) (Kim et al., 2004). Further studies carried out revealed that the oils had 
a greater effectiveness in closed containers suggesting that it was the vapour phase 




Other studies have been carried out to assess the acaricidal effects of essential oil 
plant extracts. Thyme (Thymus vulgaris) and cade were tested over a time course 
from 0 to 24 hours. At time zero the thyme caused an increase in mortality of about  
5 % and increased to 50 % by 2 hours. The cade caused a mortality of 50 % only 
after 24 hours (George et al., 2010a). Another essential oil used in an in vitro trial 
was manuka (Leptospermum scoparium). This caused a mortality of almost 100 % in 
juvenile mites and almost 90 % in adult mites 24 hours after exposure. However, the 
ovicidal mortality was less than 10 % (George et al., 2010b).  
 
Plant products that have acaricidal properties could be used to control D. gallinae in 
the short term. However, as discussed in relation to chemical control, resistance in 
mite populations could develop against plant-derived products as it has done against 
organophosphates. Plant derived products, which are a possible alternative to 
chemical control that may not have a withdrawal period, could be used in 
combination with vaccination to control D. gallinae.  
 
1.4.3 Current vaccination strategies 
 
At present there is no vaccine for the control of D. gallinae. Hens however are 
vaccinated against a variety of other diseases, as detailed in Table 1.1. 
 
Immunological control, involving the use of vaccination with protein antigens, would 
allow farmers to reduce the number of chemical treatments required to bring mite 
populations to a manageable level. A reduction in use of acaracides is desirable for 
several reasons; the build up of drug resistance will be slowed, there will be fewer 
potentially toxic residues in food products, and exposure to potentially harmful 






1.5 Avian immune system 
 
Studies of the avian immune system have contributed to critical discoveries in the 
field of immunology, not least of which was the separation of bursa of Fabricius 
derived (B) lymphocytes and Thymus derived (T) lymphocytes that comprise the 
adaptive arm of the immune response (Davison, 2003).  
 
The immune system of birds has a number of similarities to that of the mammalian 


























































































































































































































































































































































































































































































































































































































































































































































































































1.5.1 Innate immunity 
 
The avian and mammalian innate immune systems perform the same function and 
have many of the same processes in common. Mucosal tissues in both systems offer 
the first line of defence against pathogens. Two of the main mucosal tissues that are 
under constant pressure from pathogens are the gut and the respiratory tract. There 
are specific areas in both tissues that allow the interaction between parts of the innate 
immune system and adaptive immune system. These are the gut-associated lymphoid 
tissue and the bronchial-associated lymphoid tissue. Antigen presenting cells, such as 
dendritic cells, migrate to these tissues after they have been activated by pathogens. 
In the lymphoid tissues, the dendritic cells interact and stimulate T lymphocytes in an 
antigen specific immune response. 
 
The complement cascade is a series of serum based proteins that are sequentially 
activated in three ways. 1) The classical pathway is activated by antibody-antigen 
complexes. In mammals these antibodies are IgG and IgM, however in the avian 
immune system IgY, the functional equivalent of IgG, does not activate complement 
(Cova, 2005; Koch et al., 1982). Some of the proteins that are specific to the classical 
complement pathway have been characterised in hens suggesting that the pathway is 
present. 2) The lectin pathway is activated by lectin proteins binding pathogen 
associated molecular pattern (PAMP) receptors. 3) The alternative pathway is 
activated by natural molecules such as bacterial lipopolysaccharides, zymosan 
(yeast), fungi, viruses and aggregates of immunoglobulin. Only a single protein has 
been characterised in hens that forms part of this pathway, factor B (Kjalke et al., 
1993), but the presence of this protein would indicate that the pathway is present. 
The complement cascade opsonises pathogens for phagocytosis and forms a 
membrane attack complex (MAC) that integrates with cellular pathogen‟s 
membrane, allowing cell lysis. The proteins that are involved in both these processes 




1.5.2 Adaptive immunity 
 
The adaptive immune response is activated by parts of the innate immune response, 
which in turn focuses the innate response, making it more effective. This is the same 
in both birds and mammals. The adaptive immune response responds faster and with 
a greater specificity to re-infection by the same pathogen.  
 
The cellular immune response involves the activation of lymphocytes, namely 
thymus-derived (T) cells and bursa-derived (B) cells. T cells, which discriminate 
between self and non-self and are responsible for cell-mediated immunity, partially 
mature in the thymus in both the avian and mammalian immune systems. The 
maturation of B cells, which produce immunoglobulins, occurs in the bursa of 
Fabricius in the avian immune system, whereas this occurs in bone marrow in the 
mammalian immune system. The bursa of Fabricius is a spherical lymphoid organ 
situated near the hen‟s cloaca. It has been shown that the removal of the bursa at 
progressively later stages of development in chicks can preventing antibody class 
switching by B cells as well as blocking antibody production permanently (Davison, 
2003). It has been shown that the bursa is also involved in the immune response to 
local antigen around the cloaca (Rose, 1979). The bursa can pinocytose antigens 
across its epithelium like the Peyer‟s patch does in mammals.  
  
The lymphoid tissue is arranged in a totally different manner in birds than in 
mammals. There are no organs with the same structure as mammalian lymph nodes 
in birds. However there are tissues that have two compartments that separate and 
regulate the interaction of lymphocytes in the same way as mammalian lymph nodes. 
The precursors of both types of lymphocytes differentiate in the primary lymphoid 
tissue, which is bone marrow derived for both mammals and birds. B cells in birds 
differentiate further in the bursa and migrate to the lymphoid tissues whereas with 
mammals they interact with T cells and mature into plasma cells or memory cells. 
There are peripheral lymphoid tissue in birds, such as the spleen, which is the same 
in mammals. In birds there are other tissues that bring the lymphocytes together, such 
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as mural lymphoid nodes, aggregated nodules of the digestive tract and occlusion 
region, as well as many smaller solitary nodes scattered throughout the body.  
 
1.5.3 Avian antibody 
 
During this study, experiments were performed involving the injection of protein 
antigens into hens to generate an immune response. This was subsequently tested to 
ascertain if the immune response generated would protect hens from D. gallinae 
infestation. These experiments specifically investigated the antibody response that 
was monitored using Western blot analysis and an in vitro feeding assay (McDevitt 
et al., 2006; Wright et al., 2009).  
 
Antibodies are generated from four protein molecules, two heavy chain molecules 
and two light chain molecules, which form a Y shaped structure. The molecule has 
two fragment antigen binding (Fab) regions, which bind specific epitopes on antigens 
and a single fragment crystallisable (Fc) region. The Fab regions comprise of 
portions of the heavy and light chains. The Fc region is made from two heavy chains 
and recruits effector cells and molecules to destroy the pathogen bound to the Fab 
receptor (Abbas & Lichtman, 2005). The antibody response in mammals and in birds 
is T cell-dependent but antibodies are produced by B cells. There are three classes or 
isotypes of antibody that birds produce; IgM, IgY and IgA (Davison, 2003). 
Systemic IgM is the first class of antibody to be produced in both mammals and birds 
following antigen challenge. Class switching then occurs during which the mRNA of 
some the B cells is spliced so that a different antibody heavy chain and therefore a 
different antibody class, IgY or IgA, is translated and expressed. The light chains are 
not altered during antibody class switching. The Fab region remains the same after 
class switching but the Fc region at the end of the heavy chain changes. The other 
mammalian antibody classes, IgE and IgD, are not present in birds. It has been 
hypothesised that IgY is an evolutionary ancestor of the mammalian IgG and IgE 
(Warr et al., 1995). IgY and IgM are systemic antibodies, whereas IgA is a local 
antibody that can be found predominantly in mucus and secreted fluids (Abbas & 
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Lichtman, 2005). The only class of antibody in egg yolk is IgY, which  can be 
purified easily from the yolk in large quantities (Schade et al., 1994).  
 
After vaccination with a protein antigen, systemic antibodies are raised that can bind 
to, and impair the function of, the target protein. After mammalian antibodies bind to 
their target epitope the classical pathway of the complement cascade can be 
activated. However, IgY has a different Fc region to mammalian IgG that cannot 
activate the avian complement cascade (Cova, 2005). 
 
1.5.4 Vaccination  
 
Vaccination is the process by which the immune response is primed against an 
antigen. The antigen presented to the immune system can be an attenuated parasite, 
virus or bacterium, or a sub-unit vaccine such as a mix of native proteins or a 
recombinant protein. The experiments described in this thesis involved immunisation 
of hens firstly with a mix of native proteins extracted from the mite using the natural 
solubility and then charge of the proteins to fractionate. During the thesis this process 
was called the “pragmatic” approach to vaccine development, which was first 
described during the production of the vaccine TickGARD™ (Willadsen, 2004). A 
second series of experiments were performed where hens were immunised with 
recombinant proteins that have implied critical function and had either been 
employed in immunisation trials against other parasites or were identified in 
expressed sequence tag (EST) database, which was called the “genetic” or “rational” 
approach to vaccine development throughout this thesis.  
 
During a natural parasitic infestation the host is continually being exposed to 
antigens from the parasite. Exposed antigens are proteins that are processed or “seen” 
by the host‟s immune system (Willadsen & Kemp, 1988). An immune response 
generated against exposed antigens is an acquired or “natural” immune response. The 
acquired immune response may be protective thereby reducing the level of parasitism 
that the host is subjected to (Trager, 1939). A study was performed using hens and  
D. gallinae where no significant relationship was found between anti-mite IgY 
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antibody titre and mite population. However there was a significant relationship 
between the mite population and the mortality of the hens (Arkle et al., 2006). The 
exposed antigens from D. gallinae do not appear to generate an anti-mite immune 
response to moderate the exponential population growth, which can be observed in 
poultry houses during the mites‟ optimum growing conditions. However, naturally 
acquired immunity has been demonstrated in White leghorn hens against the NFM. 
The number of NFM infesting a population of hens has been shown to be inversely 
related to the number of mites that re-infested the same hens after the hens had 
moulted, which deprived the mites of suitable conditions for infestation, i.e. the hens 
that had an initially high mite count had fewer mites after re-infestation (DeVaney & 
Ziprin, 1980). A study conducted with NFM and hens proposed two hypotheses 
about the decline of NFM populations in hen flocks: 1) The local inflammatory 
response in the skin blocks the NFMs access to the blood and 2) the Major 
Histocompatibility Complex affects the intensity of the inflammation response. It 
was observed that on infested hens the NFM lives on the border of sites of 
inflammation caused by an immune response, migrating out from the initial point of 
infestation (Owen et al., 2009). Decreased contact between D. gallinae and their host 
could be a reason why there is little evidence to suggest that hens develop a natural 
immunity. The NFM lives solely on its host so it is in contact with the hens for 
longer than D. gallinae that only feeds for approximately one and a half hours before 
withdrawing to the hiding places where it progresses through the lifecycle. The 
inflammatory response in hens infested with D. gallinae would probably be less 
intense since the mite does not restrict its feeding sites to the border between 
inflamed and normal skin, as is the case for NFM, so can avoid areas of 
inflammation on the hen. When confined to a single location the hen could mount an 
inflammatory response, however a study conducted to measure the mRNA cytokine 
expression did not indicate that there was a particular immune response generated 
(Harrington et al., 2010). 
 
Antigens from a parasite that are not presented to the host immune system during a 
natural infestation, such as proteins from the mite‟s gut or intracellular proteins, are 
known as “concealed” antigens (Trimnell et al., 2002). Following injection of 
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concealed antigens into the host, the antibodies generated in response can bind to 
these proteins within a feeding parasite and block their normal function, leading to a 
reduction in population of the parasite (Knox et al., 2003). Vaccination of hens with 
a concealed protein antigen from D. gallinae could elicit a strong protective antibody 
response that would result in the reduction of the population size of the mites in the 
poultry house. 
 
The pragmatic approach to vaccine development has previously been explored with 
Psoroptes ovis, an ectoparasite of sheep. P. ovis feeds on the exudates produced by 
lesions caused by the presence of the mite (Van Den Broek & Huntley, 2003). 
Antibodies present in the exudates have been shown to be ingested by the mite. 
These antibodies are partially digested by enzymes in the gut (Pettit et al., 2000) but 
could still be functionally active and be able to bind to protein(s) in the gut of the 
mite. P. ovis mites were sequentially homogenised to produce distinct protein 
fractions. These protein fractions were then injected into sheep, which were 
subsequently challenged with live mites. The sheep immunised with the protein 
fraction that was soluble in a PBS with Tween-20 solution, showed a reduction in 
lesion size and mite numbers (Smith et al., 2002). Serum from that trial, along with 
serum from a subsequent trial (Smith & Pettit, 2004), was used to immunoscreen a  
P. ovis cDNA library to identify immunoreactive proteins that could be expressed in 
a recombinant form. Two proteins of interest were found; a catchin-like protein and a 
novel mu class glutathione S-transferase. Western blot analysis showed that 
antibodies were raised against the recombinant forms of these proteins in sheep but 
were not present in the sheep of the control group, which were injected with adjuvant 
only (Nisbet et al., 2008). These antibodies could bind to the gut proteins in the mite 
resulting in an anti-mite effect, which could impair feeding ability that would led to 
an increase in mortality or a decrease in reproductive capability. 
 
The pragmatic approach was also taken in the development of TickGARD™, which 
has been the only commercially available vaccine for ectoparasites to date. It is a 
very effective vaccine against a population of tropical cattle tick R. microplus. The 
vaccine impairs the ability of the tick to digest a bloodmeal, which results a 30% 
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reduction in the number of engorged ticks, a 30 % reduction in the weight of 
engorged ticks and an 80% reduction in the weight of eggs laid per gram of engorged 
female tick, which therefore reduced the number of ticks on pasture. When the 
measurements listed above were combined a total vaccine capability of 90 % was 
calculated (Willadsen et al., 1995). The protective antigen in TickGARD™ is Bm86, 
a glycoprotein attached to the membrane of digest cells that are part of the tick‟s gut 
wall. Bm86 is a “concealed” antigen since it is not detected by the host immune 
system during a tick infestation. Bm86 has an amino acid identity of between 85 % 
and 94 % between ticks of the same genus (Canales et al., 2008) and an amino acid 
identity of 34 % between Bm86 and a homologue in Haemaphysalis longicornis, a 
hard tick (Liao et al., 2007). The vaccine generates antibodies in the host against 
Bm86, which are ingested by R. microplus and bind to Bm86 a glycosolated protein. 
In mammalian blood, immunoglobulins such as IgG activate the complement 
cascade, resulting in formation of the membrane attack complex. This occurs in the 
gut of the tick where the complement cascade results in lysis of the digest cells the 
Bm86 protein is bound to, leading to an inhibition of bloodmeal digestion. This 
damage results in the reduction in reproduction capacity of ticks feeding on 
vaccinated cattle (Kemp et al., 1989; Rand et al., 1989; Willadsen et al., 1989).  
 
During the development of TickGARD™, R. microplus ticks were homogenised in a 
Tris buffer to create a crude protein extract. The homogenate was centrifuged, 
resulting in a water-soluble fraction and a water insoluble fraction. These two 
fractions were then injected into cattle that were challenged with ticks. The insoluble 
fraction, which contained the membrane or particle bound proteins, proved the most 
effective in increasing mortality of the ticks. The detergent Nonidet P-40 was then 
used to solubilise the membrane bound proteins. The cattle in the group injected with 
the high molecular weight proteins that were soluble in the detergent had the lowest 
number of ticks per animal. These high molecular weight proteins were then 
subjected to isoelectric focusing, and then gel permeation chromatography to further 
reduce the number of different proteins in each injection (Willadsen et al., 1988). 
Further purification involving affinity chromatography with a wheat germ lectin-
Sepharose column and gel filtration was performed. The protein that was the 
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effective antigen was named Bm86, a glycoprotein with a molecular weight of  
89 kDa (Willadsen et al., 1989). The recombinant form of the protein was used in the 
vaccines TickGARD™, which was licensed in Australia, and Gavac™, which is 
licensed in Cuba. Although Bm86-based vaccines are highly effective against  
R. microplus there is a strain of the tick that is resistant, Argentina strain A. This 
strain of R. microplus has a homologue of Bm86 called Bm95. Bm95 was used in an 
immunisation trial where cattle were challenged with two strains of tick, Argentina 
strain A and a susceptible strain of R. microplus Camcord. A reduction in tick burden 
was observed on the cattle in both vaccinated groups, the resistant strain was reduced 
by 58 % and the susceptible strain by 89 % (Garcia-Garcia et al., 2000).  
 
Potentially protective proteins have been used in immunisation trials against 
endoparasites. Although endoparasites such as the nematode Haemonchus contortus, 
and ectoparasites such as D. gallinae, parasitize their respective hosts in a very 
different way, there could still be similar proteins in both that elicit a protective 
immune response. H. contortus and D. gallinae are both parasites that require a 
blood meal to complete their life cycle. Concealed vaccine candidates that have been 
identified in endoparasties have the potential to be effective against D. gallinae.  
 
Studies using pragmatic fractionation identified a complex structure in the intestine 
of H. contortus to be Haemonchus galactose-containing glycoprotein complex  
(H-gal-GP) (Smith et al., 1994). Recombinant versions of all the proteins that form 
the H-gal-GP protein complex were injected into sheep, which were subsequently 
challenged with H. contortus larvae. Sheep were also injected with the native form of 
the complex purified from H. contortus. Antibodies were detected that recognised  
H-gal-GP were detected in both the native and recombinant groups, however only the 
group injected with the native form of the protein complex developed protective 
immunity to the nematode (Cachat et al., 2010).  
 
By comparison to the pragmatic approaches detailed above, the rational approach to 
vaccine development employs proteins that have either already been shown to elicit 
an immune response that causes an increase in mortality in a closely related species 
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or proteins that are perceived to perform a critical physiological function. It is hoped 
that D. gallinae will show a close protein homology to other species of mites and, 
especially, ticks. In the field of tick biology, immunisation studies have been 
performed that test the capacity of many protein antigens to generate a protective 
immune response. The tropical cattle tick R. microplus, which is the only 
ectoparasite for which a vaccine has been commercially developed, and D. gallinae 
are members of the same Superorder (Parasitiformes). Mite homologues of protective 
protein antigens discovered in ticks could be used to generate an immune response 
against D. gallinae.  
 
Gavac™ has been used in an immunisation trial using hens where antibodies raised 
were fed to D. gallinae. IgY purified from the yolk taken from eggs laid by the test 
group (injected with Gavac™), and from eggs laid by the control group (injected 
with the Montanide ISA 50V adjuvant only), were fed to D. gallinae in hen blood 
using an in vitro feeding assay. The mortality of the mites fed antibodies raised 
against Bm86 was not significantly different from the mortality of the mites fed 
antibodies from the control hens. This trial also measured the mortality of mites fed 
antibodies raised against a recombinant form of subolesin, a potential vaccine 
candidate identified in ticks (Galindo et al., 2009). There was a significant increase 
in the mortality of the mites fed antibodies raised against subolesin when compared 
to the control group. Western blot analysis confirmed that antibodies were generated 
against Bm86 but not against subolesin at the predicted molecular mass. However, 
there were bands representing higher molecular mass proteins that could have been 
subolesin multimers. Polymerase chain reaction using gene-specific primers for 
subolesin and Bm86 amplified two DNA fragments in the subolesin reaction but no 
products were amplified in the Bm86 reaction. The smaller of the two DNA 
fragments (150 base pairs (bp)) amplified using the subolesin primers aligned with 
murine akirin1, a nuclear factor involved in the innate immune response, with a score 
of 49 %. The larger of the fragments amplified (300 bp) aligned with subolesin in 
Amblyomma hebraeum, with a score of 31 % (Harrington et al., 2009a). The low 
homology and lack of antibody response against subolesin described above, and the 
inability to successfully clone either protein at Moredun Research Institute 
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(experiments conducted by Dr. K. Bartley and author (unpublished data)) suggests 
that these proteins are not present in D. gallinae. 
 
Although there are only a few vaccines that have recombinant proteins as the 
antigen, such as TickGARD™ and Gavac™, the method has been shown to be a 
viable alternative to the use of chemicals for the control of pathogenic organisms. 
Although there are only two vaccines commercially available against ticks, and they 
use the same recombinant antigen (Bm86), many proteins in a recombinant form 
have been studied to assess their capacity to generate a protective immune response. 
The salivary protein 64P from the tick R. appendiculatus has been identified as a 
potential vaccine candidate. 64P is a component of the tick‟s cement cone that is 
injected into the host to aid feeding by securing its mouthparts to the skin and is 
therefore an exposed antigen. Recombinant truncated versions of this protein were 
injected into guinea pigs, which were then challenged with ticks. Of the six truncated 
versions of the protein, three caused mortality of between 55.5 % and 70 % in ticks 
that were used to challenge guinea pigs (Trimnell et al., 2002).  
 
Histamine release factor (HRF) is a protein that has been identified in ticks that is 
expressed in a variety of their tissues. HRF was also identified in D. gallinae and a 
recombinant form of the protein was used to immunise hens. The antibodies 
generated were tested in the in vitro feeding assay, which resulted in a modest 
increase in mite mortality to 9.2 % in the test group from a percentage mortality of 
2.7 % when mites were fed control blood. Although the function of HRF in  
D. gallinae is unclear it could be employed in a vaccine as part of a cocktail of 
recombinant proteins since it seems to have an anti-mite effect (Bartley et al., 2009). 
 
At the start of this project the only non-ribosomal protein identified in D. gallinae 
and published on the National Centre for Biotechnological Information database was 
tropomyosin. Tropomyosin is structural component of the cell cytoskeleton, which 
was successfully cloned from D. gallinae using degenerate primers designed using 
sequences from ticks and other mite species (Nisbet et al., 2006a). It has been used in 
immunisation trials against the filarial nematode Acanthocheilonema viteae. Both a 
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recombinant and the native form of A. viteae tropomyosin have been used to 
immunise jirds, which are rodent-like mammals. After challenge the recombinant 
form of the protein proved as effective as the worm-derived native protein in 
reducing worm burden by 30 %. Therefore the immune response generated by the 
host was not derived from any post-translational modifications in the native form of 
the protein (Hartmann et al., 2006).  
 
Paramyosin is another protein of the cell cytoskeleton. It is a thick filament protein 
with a coiled-coil structure and is found only in invertebrates. Paramyosin has been 
demonstrated to elicit an immune response against Schistosoma mansoni (Zhang et 
al., 2006). Paramyosin has also been demonstrated to induce a protective response to  
S. japonicum in mice. Immunisation with 5 µg of native paramyosin extracted from  
S. japonicum reduced the worm burden of experimentally infected mice by up to  
86 % after a five week period when the mean number of worms in the control mice 
and vaccinated mice were counted. By use of Western blot the antibody response 
generated was shown to be very specific to the antigen (Ramirez et al., 1996).  
 
1.6 Aims and objectives 
 
The aim of this project was to identify potential protein antigens for use as a vaccine 
to protect against D. gallinae infestation in poultry.  
 
The first objective, employing the “pragmatic” approach to vaccine development, 
was to divide the proteome of D. gallinae into protein fractions and inject them into 
hens to generate antibodies. These antibodies would be tested in an in vitro feeding 
assay for their ability to generate a protective response. The most promising protein 
fraction would then be subdivided, injected into hens and re-tested in the feeding 
assay. This process would reduce the number of potential protein antigens that might 
be effective in increasing mite mortality with a view to identifying the most 




The second objective, employing the “rational” approach, was to sequence genes 
from a complete cDNA library and a subtractive cDNA library and create expressed 
sequence tag (EST) databases. Roche 454 sequencing technology would be 
employed to generate a large EST database from the complete cDNA library. This 
large database would then be used to identify small sequences generated by Solexa 
sequencing of mRNA from fed and starved mites. The Solexa sequencing technology 
would be used to compare the expression levels of genes in two populations of mites. 
Sanger sequencing would be utilised to generate a smaller EST database using the 
subtractive library to look for homologues of known vaccine candidates in  
D. gallinae. 
 
The third objective was to sequence the paramyosin gene from D. gallinae and use it 
together with the tropomyosin gene (Nisbet et al., 2006a) to produce recombinant 
proteins. Hens would then be injected with the recombinant proteins to generate 
antibodies, which would be tested in the feeding assay and by Western blotting.  
 
The fourth objective was to carry out an in vivo trial. The most promising protein 
fractions identified in objective one and a cocktail of five recombinant proteins, 
including paramyosin and tropomyosin, identified in objective three, would be used 
to immunise laying hens, which would then be challenged with live mites. The mite 
population infesting the hens and the quantities of antibody generated against these 









Chapter 2:  
 





The materials described in this chapter were generic. Specific materials for 
individual chapters are described in the materials and methods section of the relevant 
chapter 
 
2.1.1 Escherichia coli strains 
 
The E. coli strains used in the experiments were JM109 competent cells (Promega) 
and BL21-CodonPlus® (DE3)-RIL competent cells (Stratagene). 
 
2.1.2 Cloning Vectors  
 
The cloning vectors used in the experiments are listed in table 2.1. 
 
Table 2.1. Vectors used in this study. 
Vector     Size (bp)  Reference 
pGEM®-T     3015   Promega 
pET-22b(+)     5493   Novagen 




The stock concentration of all the primers was 100 pmol/μl. Primers were diluted to 
10 pmol/µl for use in PCR reactions. Table 2.2 lists the standard primers used in the 




Table 2.2. Primers used in this study. 
Name    Sequence     Tm ( C) 
pET-SUMO forward  5‟ AGATTCTTGTACGACGGTATTAG 3‟  57 
T7 reverse   5‟ TAGTTATTGCTCAGCGGTGG 3‟  58 
M13 reverse primer  5‟ AGCGGATAACAATTTCACACAGGA 3‟  48 
M13 forward primer  5‟ CGCCAGGGTTTTCCCAGTCACGAC 3‟  47 
Universal primer mix  5‟ AAGCAGTGGTATCAACGCAGAGT 3‟  61 
 
2.1.4 Growth Media 
 
The composition of bacterial growth media is listed in table 2.3. 
 
Table 2.3. Growth media used in this study. 
Name     Composition 
Luria Bertani (LB) medium  1% Bacto-tryptone, 0.5% Bacto-yeast, 1% 
NaCl 
LB agar    LB medium plus 1.5% Agar 




The secondary antibody used for Western blots was a rabbit anti-chicken IgY/HRP 
conjugate (Sigma). The secondary antibody used for immunolocalisation was a rabbit 
polyclonal anti-mouse IgG/HRP conjugate (DakoCytomation). The generation of 
IgY against D. gallinae proteins for in vitro analysis in the feeding assay is described 



























































































































































































































































































































































































































































































































































































































































































The restriction enzymes used during this study were Not1 and BamH1 (Promega). 
The DNA modification enzymes were shrimp alkaline phosphatase and T4 ligase 
(Promega). 
 
2.1.8 Molecular weight markers 
 
The marker set used in these experiments for protein gels was SeeBlue plus 2 
molecular mass markers (Invitrogen).  
 





The antibiotics used in this study are listed in table 2.5. 
 
Table 2.5. Antibiotics used in bacterial cultures to select for specific bacteria or plasmids. N/A 
indicates that the bacterium or plasmid does not have the gene to offer resistance.  
Antibiotic  Plasmid   Bacterium 
Ampicillin  pET-22b(+)   N/A 
Chloramphenicol  N/A    BL21-CodonPlus® (DE)-RIL 






The methods described in this section were generic. Methods specific for individual 
chapters are described in the materials and methods section of the relevant chapter. 
 
2.2.1 Determination of protein concentration using the Pierce BCA 
Protein Assay 
 
The concentrations of the bovine serum albumin (BSA) standards were 2 mg/ml,  
1.5 mg/ml, 1 mg/ml, 0.75 mg/ml, 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml and  
0.025 mg/ml.  The standards were dissolved in the same diluent as the samples. Each 
standard (25 µl) was pipetted into each of three wells of a 96 well polycarbonate 
microtitre plate (Stratagene). The samples were tested undiluted, at 1:10 or 1:20 
dilutions in the assay and 25 µl were added to each well in triplicate. 
 
Protein assay reagent A and Protein assay reagent B, form the Pierce kit were mixed 
in a ratio of 50:1. The detection mixture (200 µl) was added to each well. The plate 
was incubated in the dark for 30 min at 37 C. Optical densities were read at 562 nm 
and the program KC4 was used to calculate the protein concentration. 
  
2.2.2 Protein concentration estimation of the red mite urea-soluble 
fraction 
 
The 2-D Quant Kit (Amersham Biosciences) was used to quantify the concentration 
of the urea-soluble fraction. To six 1.5 ml tubes 0 µl, 10 µl, 20 µl, 30 µl, 40 µl and 
50 µl of 2 mg/ml BSA were added. Approximately 0.5–50 µg of protein sample were 
added to 1.5 ml tubes. The samples were tested undiluted and at a 1:5 dilution. The 
samples were run in duplicate. 
 
To each tube, 500 µl of precipitant were added. The tubes were vortexed and 
incubated for 2 min at room temperature (RT). To each tube, 500 µl of co-precipitant 
were added, the tubes were mixed by inversion and centrifuged for 5 min at  
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10,000 x g, and the supernatant was removed. The tubes were centrifuged briefly and 
the excess liquid was removed by pipette. Copper solution (100 µl) and dH2O  
(400 µl) were then added to each tube and mixed by vortexing. Working colour 
reagent was prepared by adding 100 parts of colour reagent A to 1 part of colour 
reagent B, and 1 ml was added to each tube. Tubes were mixed by inversion and 
incubated at RT for 20 min. The absorbance was then measured at 480 nm in a 
spectrophotometer. The absorbances of the standards were used to generate a 
standard curve from which the concentration of the sample was calculated. 
 
2.2.3 Polyacrylamide gel electrophoresis (PAGE) 
 
PAGE was used to separate proteins of different masses. To prepare a 13 µl sample 
for denaturation then electrophoresis, 5 µl of 4x NuPAGE® LDS Sample Buffer and 
2 µl of 10x NuPAGE® Reducing Agent (Invitrogen-NuPAGE®) were added to the 
sample. This was vortexed and then centrifuged at 10,000 x g briefly to collect the 
entire sample at the bottom of the tube. The tubes were incubated at 70 C in a 
waterbath for 10 min. 1x NuPAGE® SDS MES Running Buffer was prepared by 
adding 50 ml of 20x NuPAGE® MES Running Buffer to 950 ml of dH2O.  
 
A precast NuPAGE® Bis-Tris gel (Invitrogen) was opened and the wells rinsed with 
dH2O. The Xcell SureLock Mini-Cell was assembled. The Lower Buffer Chamber 
was filled with 600 ml of NuPAGE® SDS MES running buffer and the Upper Buffer 
Chamber was filled with 200 ml of NuPAGE® SDS MES running buffer containing  
500 µl of NuPAGE® Antioxidant.  
 
SeeBlue Plus2 markers (7 µl) were loaded into the first lane of the gel and 20 µl of 
the samples were loaded into the other lanes. The gel was run for 35 min at a 
constant 200 V.  
 
The gel was removed from its cassette and placed in a large weigh boat containing 
dH2O, and incubated at RT on an orbital rocker for 5 min. The dH2O was changed 
three times. SimplyBlue stain was added and the gel was incubated at RT on an 
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orbital rocker for 1 hr. The stain was then discarded and the gel was washed in dH2O, 
changing the water every 20 min for 1-2 h depending on how clear the background 
was. The gel was then photographed under white light. 
 
2.2.4 Antibody (IgY) extraction from egg yolks 
 
IgY was extracted from egg yolk using a modified method based on the IgY 
Eggstract kit (Promega). Eggs were collected six weeks after the initial injection and 
the yolks were separated from the egg white. The yolk was carefully rolled onto 
several layers of paper towel, to remove adhering egg white from the intact yolk sac. 
The egg yolk was then positioned near the edge of the paper towel and punctured to 
drain into a universal. Yolk (10 ml) was pipetted into a small Duran bottle. Three 
volumes of Precipitation Solution A were added at RT and the mixture was stirred 
for 5 min to precipitate the lipids, then centrifuged at 5311 x g for 25 min at 4°C. The 
supernatant was filtered through Whatman grade 1 chromatography paper to remove 
particulate matter. The volume of the filtrate was measured and transfered to a clean 
Duran bottle. A third of the filtrate volume of Precipitation Solution B was slowly 
added, with stirring, for 5 min to precipitate the IgY. The IgY was pelleted by 
centrifugation at 5311 x g for 25 min at 4°C. To resuspend, the pellet was incubated 
for 4 hrs on a rocker at RT in half the starting yolk volume of PBS. Working 
solutions of purified IgY were stored at -20°C.  
 
The concentration of IgY was determined using the nanodrop with an absorbance of 
280nm, using 1.33 as the extinction coefficient (i.e., A280/1.33 = concentration in 
mg/ml).  
 
2.2.5 Western Blots 
 
Western blots were prepared using the Invitrogen iBlot™ system to transfer proteins 
onto nitrocellulose membranes following the manufacturer‟s instructions. Briefly, a 
PAGE gel was prepared as described in 2.2.3. Instead of staining the gel it was 




The iBlot™ was assembled by placing the anode stack on the blotting surface. The 
gel was then placed onto the nitrocellulose membrane, which was at the top of the 
anode stack, and the blotting roller was used to remove any air bubbles from between 
the gel and the nitrocellulose membrane. A piece of filter paper pre-soaked in dH2O 
was placed on the gel and again any air bubbles were removed. The cathode stack 
was placed onto the filter paper and air bubbles were removed. The disposable 
sponge was placed in the lid of the iBlot™ with the metal contact at the top right 
corner.  
 
The transfer programme ran for 7 min. At the end of the run, the nitrocellulose 
membrane was removed and placed into dH2O. The nitrocellulose was incubated for  
2 hrs in Wash Buffer to block the membrane. The nitrocellulose was then incubated 
in the primary antibody overnight at 4 C on an orbital rocker.  
 
The primary antibody was decanted off and Wash Buffer was used to wash the 
nitrocellulose six times, changing the buffer every 20 min.  
 
The nitrocellulose was then incubated with the secondary antibody at RT for 2 hrs 
before it was decanted off and Wash Buffer was used to wash the nitrocellulose six 
times, changing the buffer every 20 min. 
 
DAB (Sigma) was used to visualise the bands present. One of each of the tablets was 
dissolved in 5 ml of dH2O. The nitrocellulose was incubated in the DAB until bands 
were detected and then nitrocellulose was rinsed with tap water to stop the reaction. 
 
2.2.6 In vitro Feeding Assay 
 
This method was based on a protocol described previously (McDevitt et al., 2006) 
and was modified as follows: The bases of 5 ml cryovial tubes (Nalgene) were cut 
off and smoothed down. Plastic pastettes, cut at the half way point of the bulb and 
approximately 2 cm up the stalk, were inverted and used as a blood reservoir and to 
53 
 
hold the chick skin in place. Figure 2.1 is a diagram of the apparatus used. 
Thoroughly washed skins from one-day-old chicks, that had been plucked and 
harvested previously and stored in 100 % ethanol at 4 C for two weeks, were cut into 
2 cm
2
 pieces and placed over the end of the tube with the external surface of the skin 
facing the mites. The skin was held in place by the blood reservoir. The filter paper, 
cut into strips 40 mm long and 5 mm wide, was used to gather mites and to place 




















Figure 2.1. In vitro feeding device for D. gallinae. Method modified from McDevitt et al. (2006). 
 
Extracted antibody was added to fresh heparinised chicken blood (36 USP-units 
heparin sodium salt /ml blood) and mixed by inversion. The ratios of antibody to 
blood are detailed in the relevant results chapters. Approximately 300 l of blood 
was then added to the blood reservoir and the chambers were incubated overnight at 
CryoTube 5ml (Nunc) 
Filter Paper 
Blood Reservoir 














Cap of CryoTube 
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40 C in darkness, at a relative humidity of 75 % for between 18 and 24 hr. Ten 
feeding chambers were assembled per treatment group, where the group was either 
testing antibody from hens vaccinated with mite protein extract or antibody from the 
adjuvant control group. The experiment was repeated three times for each antibody 
tested. If the mites had fed within the past 24 hr, i.e. had signs of fresh blood in their 
gut, they were placed into individual wells of a 96 well plate (Greiner bio-one). 
Figure 2.2 is a picture of two mites. Panel A has had a recent bloodmeal and panel B 
has been starved for four weeks. 
 
  
Figure 2.2. Two pictures of D. gallinae. Panel A has recently fed and panel B has been starved 




Fresh, live mites were collected and placed into a 1.5 ml tube, which was filled with 
Carnoy‟s fixative. The mites were incubated for 2 hr at RT. The fixative was 
decanted and 70 % ethanol was added then incubated for 1 hr at RT. The ethanol was 
removed and replaced with cooled molten 1 % agarose mixed by inversion, then 
centrifuged at 14,200 x g briefly to pellet the mites. After the agarose had cooled, the 




agarose plug was taken from the 1.5 ml tube and any excess agarose was trimmed 
off. Mite pellets were immersed in molten wax and a cassette was placed on top. 
Molten wax was poured into the cassette to hold the wax block firm. A microtome 
was used to cut the block into 5 µm sections. Sections were placed in warm water, to 
flatten and to allow easy mounting onto glass slides. The slides were then incubated 
at 40 C for 1 hr to dry. Once dry, the slides were de-waxed, using the following 
protocol; submerge in xylene of 5 min, submerge in fresh xylene for a further 5 min, 
submerge in 100 % ethanol for 5 min, submerge in 95 % ethanol for 5 min, submerge 
in 75 % ethanol for 5 min and then submerge in water for 5 min. After each stage, 
the excess solvent was shaken off thoroughly. The slides were then washed twice in 
TBS for 5 min. The natural peroxidases were denatured using 100 µl of 100 % 
methanol and 1 % hydrogen peroxidase. Normal goat serum (NGS) (100 µl) was 
used to block the slide, diluted 1:4 in TBS. The slides were incubated for 30 min at 
RT. 
 
Primary antibody (100 µl) (see results chapters for dilution details) was incubated on 
the slides overnight at 4 C. The slides were washed twice in TBS, for 5 min each 
time. The secondary antibody used was 100µl of rabbit anti-mouse Ig/HRP 
(DakoCytomation) at a 1:200 dilution, incubated at RT for 1 hr. The slides were 
washed twice in TBS, for 5 min each time, to remove excess secondary antibody. 
DAB solution was prepared in 5 ml of water and 100 µl was added to each slide and 
incubated for 10 min at RT. The slides were washed twice in TBS, then twice in 
dH2O, for 5 min each time. The slides were immersed in haematoxylin for 30 sec, 
rinsed with dH2O, immersed in Scottish tap water for 1 min, then rinsed in dH2O. 
The following protocol was used to dehydrate the slides; immerse in 75 % ethanol at 
RT for 5 min, immerse in 95 % ethanol at RT for 5 min, immerse in 100 % ethanol at 
RT for 5 min, immerse in xylene at RT for 5 min and finally immerse in xylene at 
RT for 5 min. The slides were kept in xylene to prevent them from drying out. DPX 





2.2.8 Polymerase Chain Reaction (PCR) 
 
Each PCR reaction was set up using 40 µl of water, 1 µl of 1 µmol forward primer,  
1 µl of 1 µmol reverse primer, 1 µl of 50x dNTPs, to a final concentration of  
0.25 mmol per dNTP, 5 µl of 10x buffer, 1 µl of template DNA and 1 µl of 
polymerase, with 5 u of activity, in a 0.5 ml PCR tube. The primers used are listed in 
the relevant results chapters.  
 
The programme run was determined by the annealing temperature (Tm), supplied by 
Eurofins MWG Operon, of the primers and the length of DNA to be amplified 
(extension time). A typical programme used was 94 C for 5 min, then 25 cycles of 
94 C for 30 sec, Tm-5 C for 30 sec and 72 C for extension time, and finally 72 C 
for 7 min. The samples were stored at 4 C until required. The Tm and extension 
times can be found in the Materials and Methods sections of results chapters 
 
2.2.9 Agarose Gel Electrophoresis 
 
GelRed solution (3x) (Biotium, Hayward, USA) (20 ml) and 6 ml of 10x TAE were 
added to 34 ml of dH2O in a 250 ml Duran bottle. A 1 % agarose gel was prepared 
by adding 0.6 g of agarose. The agarose suspension was melted in a microwave oven 
on full power for 1 min. The bottle was placed in a 50 C water bath to cool before it 
was poured into the electrophoresis tray.  
 
Once the gel had set, the tray was placed into a tank and filled with 1x TAE until the 
gel was fully covered. The gel was then loaded, leaving one lane for a DNA ladder. 
The sample (5 µl) was added to 1 µl of 6x DNA sample buffer. The gel was run 
using a constant voltage of 80 V for between 40 min and 1.5 hr. The gel was 





2.2.10 Transformation of E. coli 
 
A screw top polythene tube was placed on ice and left to chill for 5 min. Competent 
cells were thawed on ice. Plasmid or ligation reaction (2 µl) (= ca. 250 ng) and 50 µl 
of JM109 competent cells (Stratagene) or BL21-CodonPlus® (DE3)-RIL competent 
cells (Stratagene), stored at -80 C, were pipetted into the bottom of the chilled test 
tube. The tubes were left on ice for 30 min and then immersed in a 42 C water-bath 
for 50 sec to allow the cells to take up the plasmid. The tubes were placed on ice for 
2 min. The volume was made up to 1 ml using LBroth and incubated at 37 C with 
shaking, at 250 rpm for 1.5 hr. Cell suspensions (20 µl and 200 µl) were plated out 
onto agar plates. The plates were incubated at 37 C overnight.  
 
2.2.11 Plasmid purification using Wizard® Plus SV Minipreps DNA 
Purification System (Promega) 
 
The Wizard Plus SV Miniprep DNA purification system (Promega) was used to 
purify plasmids from bacterial cells.  
 
An overnight 10 ml liquid culture of transformed bacteria was centrifuged at  
1912 x g for 10 min. The supernatant was then decanted and the tubes left to stand 
upside down for 1 min on a paper towel to remove all excess fluid. Cell  
Re-suspension Solution (250 µl) was added to re-suspend the bacteria and to transfer 
the suspension to a 1.5 ml tube. Cell Lysis Solution (250 µl) was added and the 
suspension cleared quickly as the cells lysed. The 1.5 ml tube was inverted four 
times and then left to incubate for 5 min. Alkaline Protease Solution (10 µl) was 
added and left to incubate for 5 min to degrade proteins. Neutralisation Solution  
(350 µl) was added to stop the reaction, and the tube was inverted several times to 
mix the contents. The 1.5 ml tube was centrifuged at 14,200 x g for 5 min and the 
supernatant was retained.  
 
The supernatant was pipetted onto a Minicolumn. The Minicolumn was centrifuged 
at 14,200 x g for 1 min to allow the DNA to absorb to the column and the eluate was 
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discarded. Column Wash Solution (750 µl) was added to the Minicolumn, which was 
centrifuged for 1 min. The eluate was discarded. Column Wash Solution (250 µl) 
was added. The Minicolumn was centrifuged for 2 min and the eluate was again 
discarded before the minicolumn was centrifuged again at 14,200 x g for 1 min to 
dry the filter. The Minicolumn was placed in a fresh 1.5 ml tube and 50 µl of dH2O 
were added to the centre of the column to elute the DNA. The tube was centrifuged 
at 14,200 x g for 2 min. The plasmid DNA was stored at -20 C.  
 
2.2.12 Pouring agar plates  
 
LB agar (200 ml) was melted at 110 C and cooled to 50 C in a waterbath. 
Antibiotics were added and mixed into the molten agar, which was then poured into 
petri dishes. Plates were stored at 4 C until required. 
 
2.2.13 QIAquick PCR Purification kit (QIAGEN®) 
 
Five volumes of Buffer PB were added to one volume of PCR product. A QIAquick 
spin column was placed in a 2 ml collection tube. To bind DNA, the sample was 
decanted into the QIAquick column and centrifuged at 14,200 x g for 1 min. The 
flow-through was discarded and the column was replaced in the collection tube. The 
column was washed by adding 0.75 ml of Buffer PE to the column, which was 
centrifuged again at 14,200 x g. The flow-through was again discarded and the 
column was replaced in the collection tube and centrifuged at 14,200 x g. The 
column was then placed into a clean 1.5 ml tube. To elute the DNA, 30 µl of water 
were added carefully onto the centre of the column, which was then centrifuged for  
1 min at 14,200 x g. The purified PCR product was stored at -20 C until required. 
 
2.2.14 PCR clean up using Exonuclease 1 and Shrimp Alkaline 
Phosphatase (SAP) 
 
A Master Mix was prepared using of 135 µl of SAP dilution buffer, 100 µl of SAP 
and 15 µl of Exo 1 per plate. To each well, 2.5 µl of Master Mix was added. The 
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plates were run on a PCR machine using the following programme: 37 C for 40 min 
followed by 80 C for 15 min. 
 
2.2.15 QIAquick gel extraction kit (QIAGEN®) 
 
The DNA band was cut from the gel, placed in a clean 1.5 ml tube and weighed. 
Three volumes of Buffer QG were added per one volume of gel. The tube was 
incubated at 50 C for 10 min, vortexing every 2 min to dissolve the gel slice. One 
volume of isopropanol was added and the tube was inverted to mix. The sample was 
applied to a QIAquick spin column, centrifuged for 1 min at 14,200 x g and the flow-
through was discarded. Buffer QG (0.5 ml) was added to the column, which was then 
centrifuged at 14,200 x g for 1 min and the flow-through was discarded. Buffer PE 
(0.75 ml) was added to the column to wash, and the column was centrifuged at 
14,200 x g, discarding the flow-through. The QIAquick column was placed into a 
new 1.5 ml tube and 50 µl of dH2O was added to elute the DNA. The column was 
centrifuged for 1 min at 14,200 x g, and the sample was stored at -20 C until 
required. 
 
2.2.16 Sanger sequencing 
 
DNA samples were diluted to 8 ng/µl. DNA (5 µl) was added to 5 µl of 3.2 pmol/µl 
of primer in a 0.5 ml tube. Primers used are listed in the relevant results chapters. 
 
Samples were sent to the Eurofins MWG Operon for DNA sequencing.  
 
2.2.17 Matrix Assisted Laser Desorption/Ionization Time-of-Flight 
(MALDI-ToF) 
 
Protein bands were cut from SDS-PAGE gels under sterile conditions and placed in 
sterile 1.5 ml tubes. Gel pieces were washed three times in 400 µl 50 % acetonitrile 
in 25 mM ammonium bicarbonate (pH 8.0) for 15 min. The gel pieces were washed 




The gel pieces were covered with trypsin solution (10 µg/ml trypsin (Promega) in  
25 mM ammonium bicarbonate [pH 8.0]) and allowed to rehydrate for 10 min. After  
10 min, if all the solution was absorbed, a further 5 µl of trypsin were added. The 
samples were then incubated overnight at 37ºC. After incubation, 10 µl of 50 % 
acetonitrile (Rathburn, 5 % trifluroacetic acid (TFA) [Fluka]) were added and the 
sample was vortexed for 30 min.  
 
For MALDI analysis, 0.5 µl of supernatant was mixed with 0.5 µl of matrix solution  
(10 mg/ml -cyano-4-hydroxycinnamic acid in 50 % acetonitrile, 0.1 % TFA) and 
spotted onto the sample well of a MALDI sample plate. Pepmix 2 standards  
(1µl [Bruker Daltonics]) were mixed with 9 µl matrix solution, and 0.4 µl was 
spotted adjacent to each sample spot. Spots were allowed to dry completely before 
being analysed using the Ultraflex II MALDI-ToF-ToF mass spectrometer. Data for 
Peptide Mass Fingerprint (PMF) analysis was accumulated from 10x100 shot 
batches. Each sample was calibrated using the adjacent standard. Where required, 
further analysis was carried out by obtaining ion fragmentation on individual 
peptides (Mass Spectrometer/ Mass Spectrometer [MS/MS]). 
 
Data was processed using Flex analysis software and compiled into mass lists. 
Searches were performed using Mascot
TM
 software, searching the Uniprot and NCBI 
non-redundant protein databases. Mass tolerances were set at 50 ppm for PMF and 
0.5 Da for MS/MS data.  
 
2.2.18 Concentration of protein by centrifugation column (Ambion)  
 
Dilute protein was added to the upper chamber of the centrifugation column. The 
apparatus was centrifuged at 3000 x g for 5 min when the volume was reduced to 





2.2.19 Ligation of DNA into pET-22b(+), pGEM®-T or pET-SUMO plasmid 
 
A ligation reaction was set up with 75 ng of PCR product to be ligated with 25 ng of 
plasmid. T4 ligase (Promega) 2 u (1 µl) was added to 15 µl of PCR product, 4 µl of 
plasmid and 2 µl of 10x ligation buffer. The ligation was incubated for 3 hr at RT. 
 
Ligation into pGEM®-T vector (Promega) uses the A to T overhang. Approximately  
3 µl of DNA was ligated into 1 µl of vector (50 ng), 5 µl of 2x ligation buffer and  
1 µl of T4 ligase (2 Weiss units/µl) was added to a 1.5 ml tube. The ligation was 
incubated overnight at 4 C. 
 
The ligation of DNA into pET-SUMO vector was by A to T overhang. 
Approximately 150 ng of DNA (1 µl) was ligated into 50 ng (2 µl) of vector using  
2 u of T4 ligase (1 µl), 1µl of 10x buffer and 5 µl of water. The ligation was 
incubated at 15 C overnight. Ligations were stored at -20 C until required. 
 
2.2.20 Glycerol stock 
 
To store bacteria at -80 C, 0.5 ml of a bacterial culture was added to 0.5 ml of 
glycerol in a 1.5 ml tube and mixed by vortex.   
 
2.2.21 Silver stain of PAGE gels 
 
The SilverQuest™ kit (Invitrogen) was used to stain PAGE gels prepared with low 
quantities of protein. 
 
The kit was used as per manufacturer‟s instructions. Briefly, each gel was washed 
with 100 ml of dH2O for 10 ml on a rocker. The gel was then incubated for 20 min 
on a rocker in 100 ml of Fix (ethanol 40 ml, acetic acid 10 ml, dH2O 50 ml). The gel 
was washed in 100 ml of 30 % ethanol for 10 min, then incubated in 100 ml of 
Sensitize (ethanol 30 ml, Sensitizer 10 ml, dH2O 60 ml) for 10 min on a rocker. The 
gel was again washed in 30 % ethanol for 10 min on a rocker then in dH2O for a 
62 
 
further 10 min on a rocker. The gel was incubated in Stain (Stainer 1 ml, dH2O 
 99 ml) for 15 min on a rocker and then washed for less than a minute in 100 ml 
dH2O. The gel was incubated in Develop (Developer 10 ml, Developer enhancer  
1 drop, dH2O 90 ml) for 4-8 min until the required staining was achieved. The 
developing process was stopped by adding 10 ml of Stopper directly to the previous 
step and incubating for 10 min on a rocker. The gel was washed in 100 ml of dH2O 
for 10 min. 









Testing of antibodies raised against D. gallinae 





The pragmatic approach to vaccine development using a protein antigen is to 
fractionate all the proteins from the pathogen of interest into subsets based on a 
particular property, to inject these protein fractions into the host and then to test the 
protective effects of the immune response generated.  
 
This approach was used during the development of the vaccine TickGARD™ to 
great effect, as described in chapter 1. Cattle were immunised with crude extracts 
from the tick R. microplus that had been fractionated by differential centrifugation. 
This demonstrated that there was an antigen in the membrane or particle-bound 
fraction that generated a protective immune response in the immunised cattle, as 
there was a drop in tick numbers in cattle in the immunised group. The fractionation 
process was continued using detergents, followed by isoelectric focusing and finally 
gel permeation chromatography. The immune response generated by this group of 
proteins caused a range of effects on the ticks feeding on the immunised animals, 
including visible damage in an average of 96 % of the ticks in one group of cattle 
(Willadsen et al., 1988). Following affinity chromatography on a wheat germ lectin-
Sepharose column and SDS gel electrophoresis, the glycoprotein Bm86 was then 
identified as the protein responsible for eliciting the protective immune response 
(Willadsen et al., 1989). Immunisation trials conducted with a recombinant form of 
the protein found it to be just as effective as the native form (Willadsen et al., 1992). 
 
3.1.1 Immunisation study 
 
All the fractions and recombinant proteins involved in the development of 
TickGARD™ were tested in large in vivo trials, in which immunised cattle were 
exposed to ticks and various aspects of the ticks were monitored, including mortality 
and visible damage. In this chapter, studies will be described that have been carried 
out with laying hens immunised with D. gallinae antigens. The protective effects of 
the antibody response generated in these studies have been measured by use of an in 




D. gallinae proteins in these experiments were initially fractionated based on their 
solubility in solutions of PBS, Tween 20, Triton X100 and urea, and in a subsequent 
experiment by ion exchange chromatorgraphy. This method has been used previously 
to fractionate Psoroptes ovis mites for immunisation of sheep before the animals 
were challenged. That study demonstrated a reduction in lesion size and mite 
numbers in sheep immunised with saline-soluble and Tween 20-soluble mite extracts 
(Smith et al., 2002). The PBS-soluble protein fraction was then sub-fractionated by 
ion exchange and gel filtration chromatography. The final protein fractions, when 
injected into sheep, reduced the numbers of P. ovis by more than 15-fold and lesion 
area by more than four-fold. However, the PBS-soluble protein fraction was 
subsequently shown to contain many proteins (Smith & Pettit, 2004), making 
protective antigen identification difficult. 
 
In the present study, immunisations of hens with D. gallinae extracts were carried 
out at the Scottish Agricultural College (SAC) Auchincruive, and Moredun Research 
Institute. The purpose of these studies was to generate antibodies to be tested in the 
in vitro feeding assay to assess any increase in mite mortality caused by the immune 
response to one or more of the protein fractions.  
 
3.1.2 In vitro feeding assay 
 
In vitro feeding assays have been used in the study of many haematophagous 
parasites with a view to vaccine development, for example in hard ticks (Krober & 
Guerin, 2007). The D. gallinae in vitro feeding assay was modified from a feeding 
assay developed in a collaboration between Moredun Research Institute and SAC 
Auchincruive (McDevitt et al., 2006). The first D. gallinae feeding assay in vitro was 
described in 1971 (Kirkwood, 1971). During the assay development, mites were fed 
blood from a variety of birds such as quail and chickens, and mammals such as 
calves and rabbits, and the highest percentage of mites fed on quail blood.  
D. gallinae would not feed through mammalian skin or synthetic membranes and so 
skins from two week old quail were used as a feeding membrane (Kirkwood, 1971). 
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However, work more recently carried out in Moredun Research Institute (Wright et 
al., unpublished data), The Netherlands (Monique Mul, personal communication) and 
Newcastle (Harrington et al., 2009b) has suggested that synthetic membranes could 
be used as a feeding membrane. Previous work on feeding assays suggested that the 
mite feeding rates were highest through bird skins, so the skin from one day old 
chicks was used as the feeding membrane (Kirkwood, 1971; McDevitt et al., 2006). 
The assay has been used to propagate populations of D. gallinae in vitro (Bruneau et 
al., 2001) and to test antibodies raised against possible vaccine candidates (Bartley et 
al., 2009; Wright et al., 2009). 
 
The assay has enabled the preliminary testing of antibodies raised against D. gallinae 
proteins to identify potential vaccine candidates, before embarking on the more 
technically demanding and expensive process of in vivo challenge studies, described 
in chapter 6. While the latter will be required to validate any potential vaccine, the 
current in vitro studies will allow the rapid selection of effective vaccine candidates, 
and enable studies on their mode(s) of action. 
 
The assay has also been used to test the protection given by antibodies raised against 
two specific recombinant proteins from D. gallinae, tropomyosin and paramyosin, 
described in chapter 5. 
 
3.1.3 Aims of chapter 
 
The purpose of the work described in this chapter was to test the potential of native 
mite proteins to elicit a protective antibody response by testing the protective nature 




3.2.1 D. gallinae used in the experiments 
 
Mixed stage and gender D. gallinae were collected from a commercial egg 
production unit and stored in a 75 cm
2
 culture flask (Corning), with a vented cap. 
These mites were conditioned before use in the in vitro feeding assay by initial 
incubation at room temperature (~ 21 +/- 2 C) for 7 days, followed by storage at  
4 +/- 1 C  for 21 days (McDevitt et al., 2006).  
 
For antigen preparation: Within 4 hr of collection, mites were taken from the culture 
flask, snap frozen in liquid nitrogen and stored at -80 C. These mites were at 
different life stages, and the majority (> 60 %) of the mites were engorged. Engorged 
mites were used as they would have up regulated proteins for digestion, moulting and 
reproduction that may be potential vaccine candidates. 
 
3.2.2 Fractionation of D. gallinae proteins 
 
Frozen mites (1 g) were homogenised and extracted sequentially with: 1) phosphate 
buffered saline (PBS-soluble proteins), 2) PBS containing 0.1 % v/v Tween 20 
(membrane-associated proteins), 3) PBS containing 2 % v/v Triton X100 (integral 
membrane proteins) and 4) 10 M urea containing 2 M dithiothreitol ([DTT], 
insoluble proteins). Frozen mites were added to 10 ml of chilled PBS and 
homogenised using a mechanical homogeniser (Ultra-Turrax T25, IKA-
Labortechnik) for 30 sec, on the highest power setting, rested on ice for 1 min then 
homogenised for a further 30 sec. The homogenised mites were then centrifuged at 
25,000 x g for 20 min at 4 C. The supernatant (PBS extract) was stored at -80°C. 
The pellet was re-suspended in chilled PBS containing 0.1 % v/v Tween 20 and 
transferred to a Dounce homogeniser, homogenised then centrifuged as previously 
described. This process was repeated using a further aliquot of PBS containing 0.1 % 
v/v Tween 20. The supernatant was stored at -80°C. The pellet was resuspended in 
PBS containing 2 % v/v Triton X100 before centrifugation at 100,000 x g for 45 min 
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at 4 C. The supernatant was stored at -80°C. The pellet was re-suspended in 10 M 
urea and 2 M DTT and incubated at 37 C overnight. The tubes were then centrifuged 
at 100,000 x g for 20 min at room temperature (RT). A PAGE gel was prepared 
using an aliquot of each protein fraction. The supernatant was then stored at -80°C. 
 
3.2.3 Immunisation of hens with the four mite protein fractions 
 
Forty Lohmann Brown hens were obtained at 16 weeks of age and housed in a single 
room in ten floor pens in groups of four, under standard environmental and feeding 
conditions for four weeks prior to the study commencing. The hens began laying 
eggs at 19-20 weeks of age.  At 20 weeks of age, the hens were re-divided into  
10 groups of four on the basis of body weight (ensuring that the mean weights for 
each group were within a 100 g tolerance) and placed in floor pens under standard 
environmental and feeding conditions. Two pens were randomly assigned to each 
treatment. The hens from each treatment group were immunised with one of the four 
mite extracts or an adjuvant control. Each dose comprised 75 µg of mite protein at  
1 µg/µl (concentration was determined using the Pierce BCA protein assay for the 
PBS-soluble protein, membrane-associated protein and integral membrane protein 
fractions as described in 2.2.1 and the 2-D Quant Kit (Amersham Biosciences) was 
used to determine the concentration of the urea protein fraction), 200 µg of QuilA 
adjuvant (1 µl), and PBS in a final volume of 300 µl. Control immunisations 
consisted of 200 µg of QuilA adjuvant (1 µl) in PBS (299 µl). The injections were 
administered into alternate breast muscles of the hen one week after they had been 
assigned to groups. Following the primary injection, two booster injections were 
administered at two week intervals.  
 
Eggs were collected on week six (two weeks after the final boost) and the IgY 
antibody was extracted from the yolk as described in 2.2.4, to be used in Western 





The experiment was carried out in accordance with the Animals (Scientific 
Procedures) Act 1986. The experiment was ratified by the ethics committee at the 
Scottish Agricultural College in Auchincruive.  
 
3.2.4 Fractionation of PBS-soluble D. gallinae proteins using a Mono-Q 
anion exchange column 
 
The PBS-soluble proteins were further fractionated into three fractions based on 
anion affinity to a Mono-Q anion exchange column HR 5/5 (GE Healthcare 
Amersham). D. gallinae were homogenised in PBS using the first part of the 
technique described in 3.2.2. The PBS-soluble proteins were stored at -80 C until 
required. The protein to be fractionated was filtered through a 0.4 µm syringe filter 
and then diluted 1:4 with Mono-Q buffer A as described in 2.1.6 to reduce the salt 
content to 30 mM. Table 3.1 details the HPLC conditions in the fractionation 
process. 
 
PAGE gels were prepared as described in 2.2.8 using an aliquot of each of the 
protein fractions. The PAGE gels were developed using SilverQuest (Invitrogen), as 
described in 2.2.21. A Western blot as described in 2.2.5 was prepared using an 
aliquot from each protein fraction, and was probed with the antibodies raised against 
the PBS-soluble proteins generated as described in 3.2.3.  
 
The immunisation doses were prepared by pooling fractions A6 to A9 for group 1, 
fractions A10 to B10 for group 2, and fractions B9 to B4 for group 3. The proteins 
were concentrated, using 10 kDa cut-off centrifugation filters (Amicon Ultra-15, 
Millipore), and the concentration was measured using the BCA assay (Pierce), as 
described in 2.2.1. These fractions were stored at -80 C in 1.5 ml tubes. Groups 1 
and 2 had 75 µg of protein and group 3 had approximately 10 µg of protein per 
vaccination, due to low concentration of protein in the protein fractions collected 
from the Mono-Q column. All groups, including control, had a base of PBS and had 




Table 3.1. HPLC parameters used to fractionate the PBS-soluble proteins. 
Variable     Value 
Column     Mono-Q HR 5/5 
Flow rate     1 ml/min 
Column pressure limit   3 MPa 
Wavelength     280 nm 
Equilibration volume    5 column volumes (cv) 
Flow through tube type   18 mm 
Flow through fraction size   5 ml 
Empty loop volume    4 ml 
Start fractionation at     0 % Buffer B (As described in 2.1.6) 
End fractionation at    100 % Buffer B 
Elute fraction size    1 ml 
Length of gradient    20 ml 
Gradient delay     2 ml 
Wash with     5 cv 
Re-equilibrate with    5 cv 
 
3.2.5 Immunisation of hens with three PBS-soluble D. gallinae protein 
fractions 
 
Twelve ISA brown chickens (20 weeks old) were obtained and were randomly 
allocated into groups of three hens housed in floor pens under standard 
environmental and feeding conditions at Moredun Research Institute. The hens were 
injected with the three protein fractions, prepared as described in 3.2.4, on week zero 
and boosted on weeks two and four. The injections were administered into alternate 
breast muscles of the hens. The eggs from the hens were collected six weeks after 
primary injection, and the IgY antibodies were extracted using the method described 




The experiment was carried out in accordance with the Animals (Scientific 
Procedures) Act 1986. The experiment was ratified by the ethics committee at 
Moredun Research Institute.  
 
3.2.6 Western Blots: Primary and secondary antibodies 
 
Western blots were prepared using the method described in 2.2.5. The primary 
antibodies used in the Western blots were extracted from eggs collected six weeks 
after initial injection and extracted as described in 2.2.4. The IgY extracted was 
diluted 1:200 with Wash Buffer as described in 2.1.6. The secondary antibody was 
rabbit anti-chicken IgY horse radish peroxidase conjugate (Sigma), diluted 1:30,000 
in Wash Buffer before use.  
 
3.2.7 In vitro feeding assay and related statistics 
 
An in vitro feeding assay experiment was conducted to determine the best storage 
conditions for chick skins to be used in the assays. The skins tested were harvested 
from 1 day old chicks and were stored at -20 C for two weeks, preserved in a) 100 % 
ethanol or b) methanol then stored at 4 C for two weeks or c) harvested on the day of 
the assay. The in vitro feeding assay was set up detailed in 2.2.6. All the mites in 
each chamber were scored as either alive or dead and fed or not fed. Three in vitro 
feeding assay experiments were carried out as described in 2.2.6.  
 
The first assay tested antibodies raised against all four whole mite protein fractions 
and the control group as described in 3.2.3, at a dilution of one part antibody to 20 
parts heparinised blood. Differences in mite mortality over the whole experiment 
between the four mite protein fractions and the control were statistically analysed 
using a proportional hazards model (Collet 1994), adjusting for the inclusion of data 
from the three experiments. Differences in the mortality data for the first two days of 
the three experiments between the four mite protein fraction treatment groups and the 
control group were analysed using a general linear mixed model with binomial error 
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and logit link function, fitting treatment group as a fixed effect and experiment as a 
random effect.  
 
The second experiment used the antibodies raised against PBS-soluble and the 
control group where the dilution of antibody fed to the mites was changed from 1:20 
to 1:1 (antibody:blood). The statistical test used for analysis of the in vitro feeding 
assay using a higher concentration of antibody was a simple logistic regression 
model with logit link function. 
 
The third experiment used the antibodies raised against the three sub-fractions of the 
PBS-soluble protein fraction, as described in 3.2.5. The antibody preparation was 
diluted 1:1 with heparinised blood. The statistical test used to analyse this data was a 
simple logistic regression model with logit link function, which had been fitted using 
three replicates per group. 
 
Statistical analyses were carried out using Genstat (Genstat, 10
th
 edition, Lawes 




3.3.1 Initial immunisation using four protein fractions from D. gallinae  
3.3.1.1 Initial fractionation and immunisation with four protein fractions 
 
Figure 3.1 shows the protein profile of the sequential extraction of four protein 
fractions from D. gallinae, yielding a number of proteins with a broad range of 





Figure 3.1. A PAGE gel showing the protein profiles of the four protein fractions to be used in 
the initial immunisation study. Lane M: SeeBlue plus 2 protein markers (Invitrogen). Lane 1: PBS-
soluble proteins. Lane 2: Membrane-associated proteins. Lane 3: Integral membrane proteins. Lane 4: 










1 2 3 4 M 
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3.3.1.2 Initial immunisation seroconversion 
 
Figure 3.2 is a scan of a Western blot prepared with the four D. gallinae protein 
fractions and probed with the antibody, extracted from egg yolk, raised against each 
fraction, and the control antibodies as described in 3.2.3. As can be seen, antibodies 
were raised against proteins with a broad range of molecular masses (lanes 1-4). A 
small number of proteins were detected in the control blot (lanes 5-6), two of which 
were probably subunits of IgY (heavy chain ~ 65 kDa, light chain ~ 21 kDa), since 




Figure 3.2. Western blots of mite proteins probed with antibodies raised against the four  
D. gallinae protein fractions. Lane M: SeeBlue plus 2 protein markers (Invitrogen) Lane 1: PBS-
soluble proteins, probed with antibodies raised against PBS-soluble proteins. Lane 2: Membrane-
associated proteins, probed with antibodies raised against membrane-associated proteins. Lane 3: 
Integral membrane proteins, probed with antibodies raised against integral membrane proteins. Lane 
4: Urea-soluble proteins, probed with antibodies raised against urea-soluble proteins. Lane 5: PBS-
soluble proteins, probed with antibodies raised in the control group (adjuvant only). Lane 6: 
Membrane-associated proteins, probed with antibodies raised in the control group. Lane 7: Integral 
membrane proteins, probed with antibodies raised in the control group. Lane 8: Urea-soluble proteins, 
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3.3.2 Second immunisation with three fractions of the PBS-soluble 
proteins  
3.3.2.1 PBS-soluble protein fractions  
 
The graph in figure 3.3 shows the ultraviolet absorption profile (at 280 nm) against 
volume of the protein fractions eluted from the Mono-Q column. Fraction A1 
contains the unbound proteins, i.e. those of neutral charge under anion conditions, or 
proteins that did not bind due to a lack of free ions. Fractions A2 to B4 contained 
proteins that dissociated from the column at increasing NaCl concentrations. As can 
be seen, there was a large peak in absorbance in fractions A8 to A10. 
 
Figure 3.4 is a scan of a PAGE gel developed with silver stain, as described in 3.2.5, 








































































































































































































































































































































































































































Figure 3.4. A polyacrylamide gel showing the protein profiles of the sub fractionated PBS-
soluble proteins that were injected into hens. Lane M: SeeBlue plus 2 protein markers (Invitrogen). 
Lane 1: PBS protein fraction before Mono-Q column fractionation. Lane 2: Unbound fraction A1. 
Lane 3: Fraction A2. Lane 4: Fraction A3. Lane 5: Fraction A4. Lane 6: Fraction A5. Lane 7: Fraction 
A6. Lane 8: Fraction A7. Lane 9: Fraction A8. Lane 1: Fraction A9. Lane 11: Fraction A10. Lane 12: 
Fraction A11. Lane 13: Fraction A12. Lane 14: Fraction B12. Lane 15: Fraction B11. Lane 16: 
Fraction B10. Lane 17: Fraction B9. Lane 18: Fraction B8. Lane 19: Fraction B7. Lane 20: Fraction 
B6. Lane 21: Fraction B5. Lane 22: Fraction B4. Lane 23: Fraction B3. Lane 24: Fraction B2. 
*Molecular mass (kDa). 
 
Figure 3.5 is a scan of the Western blots prepared using the 23 protein fractions from 
the Mono-Q anion exchange column and probed with the antibodies generated 
against the unfractionated PBS-soluble protein fraction from the initial 
immunisation. The blot was developed using ECL and shows immunoreactive bands 
at a broad range of molecular masses from 188 kDa to ~28 kDa from fraction A5 to 
















Figure 3.5. A Western blot probing all 23 fractions eluted with antibodies raised against the 
PBS-soluble protein in the initial immunisation. Lane 1: protein applied to column. Lane 2: 
Fraction A1, unbound to column. Lane 3: Fraction A2. Lane 4: Fraction A3. Lane 5: Fraction A4. 
Lane 6: Fraction A5. Lane 7: Fraction A6. Lane 8: Fraction A7. Lane 9: Fraction A8. Lane 1: Fraction 
A9. Lane 11: Fraction A10. Lane 12: Fraction A11. Lane 13: Fraction A12. Lane 14: Fraction B12. 
Lane 15: Fraction B11. Lane 16: Fraction B10. Lane 17: Fraction B9. Lane 18: Fraction B8. Lane 19: 
Fraction B7. Lane 20: Fraction B6. Lane 21: Fraction B5. Lane 22: Fraction B4. Lane 23: Fraction B3. 
Lane 24: Fraction B2. *Molecular mass (kDa). 
 
3.3.2.2 Immunisation with sub-fraction of PBS-soluble proteins  
 
Hens had been immunised with four protein fractions based on anion exchange. The 
fractions pooled were: group 1 fractions A6 to A9, group 2 fractions A10 to B10 and 
group 3 fractions B9 to B4. Figure 3.6 is a scan of a Western blot prepared with  
PBS-soluble proteins and probed with the antibodies raised against the fractionated  
PBS-soluble protein fraction. The antibodies generated against the three pooled PBS-
soluble protein fractions, groups 1, 2 and 3 as described above, were used to probe 
the PBS-soluble protein fraction and then compared to a Western blot that probed the  
PBS-soluble protein fraction with antibodies generated in the experiment described 
in 3.2.3. 
















Figure 3.6. A scan of a Western blot prepared with the PBS-soluble protein fraction (prepared 
as described in 3.2.2) and probed with the antibodies raised against the three fractionated PBS-
soluble protein fractions. Lane M: SeeBlue plus 2 protein markers (Invitrogen). Lane 1: PBS-soluble 
proteins probed with antibodies generated against protein from group 1. Lane 2: PBS-soluble proteins 
probed with antibodies generated against protein from group 2. Lane 3: PBS-soluble proteins probed 
with antibodies generated against protein from group 3.  Lane 4: PBS-soluble proteins probed with 
antibodies generated against protein from the control group. Lane 5: PBS-soluble proteins probed with 
antibodies raised against the PBS-soluble protein fraction. *Molecular mass (kDa). 
 
3.3.3 In vitro feeding assay 
3.3.3.1 Preliminary testing 
 
This experiment was performed to test a variety of membranes through which the 
mites could feed during the in vitro feeding assays. The mites that fed through 
ethanol preserved skins had the highest percentage feeding and the second lowest 
percentage mortality as seen in table 3.2, which shows the percentages of mites that 
had or had not fed and were alive or dead. This suggested that the chick skins could 














Table 3.2. Percentages of mites that had or had not fed and that were alive or dead. 
Treatment Dead/Fed (%) Dead/Not Fed (%) Live/Fed (%) Live/Not Fed (%) 
Fresh 1.65 8.24 28.57 61.54 
Frozen 2.2 2.2 27.47 68.13 
Ethanol 1.67 4.34 31.78 62.21 
Methanol 6.73 5.29 14.42 73.56 
 
3.3.3.2 Testing antibodies raised against the four mite protein fractions 
 
There was an uncontrollable variability in the numbers of mites feeding in each 
chamber, which meant that various numbers of mites progressed into the mortality 
monitoring phase of the experiments. Table 3.3 shows the numbers of mites that fed 
in each group. Because the number of mites feeding was variable for different groups 
and experiments, mortality was expressed as a cumulative percentage to allow 
unbiased summary comparison between treatment groups and each experiment. 
However, while estimates will be unbiased, the power to test the effect of the four 
mite protein fractions will vary marginally with the total number of feeding mites per 
fraction over the three experiments. Figure 3.7 is a graph of the cumulative 
percentage mite mortality against time, which differed between the four groups 
injected with mite protein over the course of the experiment. The percentage 
mortality was highest when the mites were fed antibodies raised against the PBS-
soluble protein fraction, with cumulative percentage mortality (across three 
experimental repeats) of 16.4 % after 24 hr, compared to 10.9 % for the controls. The 
cumulative percentage mortality in the PBS-soluble treatment rose from 16.4 % to 
34.8 % after 14 days, whereas the cumulative percentage mortality in the control 
mites rose from 10.9 % to 27.3 % after 14 days. The proportional hazards model 
showed that there was a statistically significant difference in mortality rates between 
the five treatments (p = 0.043). Parameter estimates showed that the anti-PBS protein 
fraction antibodies caused the highest mean mortality compared to the control group, 
but that this difference was not statistically significant when taken over the course of 




Table 3.3. The number of feeding mites in each group for the three experiments. 
Group Experiment 1 Experiment 2 Experiment 3 
Control 98 24 43 
PBS-soluble 58 100 92 
Membrane-associated 57 72 61 
Integral membrane 104 24 28 
Insoluble 78 189 51 
 
Focusing on the data from the first two days of the experiment (figure 3.7), a 
difference was observed between the gradient, or mortality rates, of the PBS-soluble 
protein group and control group, with the rate for the PBS-soluble protein group 
being consistently greater than that for the control group. This, however, was not the 
case from day three onwards. The generalised linear mixed model showed that there 
was a significant difference in the mean mortality in the first two days between the 
five groups (p = 0.016). Parameter estimates showed that the anti-PBS-soluble 
protein fraction antibodies caused the highest mean mortality compared to the 





Figure 3.7. Cumulative percentage mortality of D. gallinae fed heparinised chicken blood 
enriched with antibodies raised against four mite protein fractions and adjuvant-only (control). 
Mortality was monitored daily over a 14 day period following feeding. Each point represents 
cumulative mean percentage mortality and is derived from data recorded in three independent 
experiments. The range of the Standard Error of the Mean over the 14 days were Control 0.55-6.18; 
PBS-soluble group 3.36-8.04; Membrane-associated group 1.80-6.22; Integral membrane group 0.93-
5.00; Insoluble group 2.54-3.96. 
 
3.3.3.3 Testing concentrated antibodies raised against PBS-soluble 
proteins  
 
The results described in this section were derived from an in vitro feeding assay.  A 
higher concentration of the antibodies generated against the PBS-soluble protein 
fraction, as described in 3.2.3, was mixed with fresh hen blood and fed to the mites. 
Table 3.4 shows the number of mites that fed in each experiment, as can be seen, 
there was not much variation in the numbers in the test group. The number of mites 
that fed in the control group varied to a higher degree. Figure 3.8 is a graph of the 
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Table 3.4. The number of feeding mites in each group for the three experiments. 
Group Experiment 1 Experiment 2 Experiment 3 
Control 68 53 43 
PBS-soluble 65 66 52 
 
 
Figure 3.8. A graph of the cumulative percentage mortality of D. gallinae fed antibodies raised 
against PBS-soluble protein fraction and antibodies raised against adjuvant only (control). 
Mortality was monitored daily over a five day period following feeding. Each point represents 
cumulative mean percentage mortality and is derived from data recorded in three independent 
experiments. Error bars show the standard error of the mean. 
 
The mortality of the mites fed antibodies from the PBS-soluble protein fraction 
group was higher than that of the controls. The titre of the antibody was increased in 
this experiment, compared to the initial experiment with all five groups. As can be 
seen, the mortality of the mites increased when the concentration of antibody 
increased in the test group but not the control group. From Figure 3.7, the mortality 
of the mites fed antibodies from the PBS-soluble group was 16.4 % after one day and 
increased to 20.8 % after five days, compared to 31 % to 39 % from day one to five 



































mortality of the control group in each experiment was roughly the same from 7.5 % 
after one day to 1.6 % after five days for the first experiment with a lower 
concentration of antibody and 7 % to 12 % for the second experiment with a higher 
concentration of antibody. The cumulative percentage mortality of the mites fed 
antibodies from the PBS-soluble fraction more than doubled in this experiment 
compared to those fed the same antibodies at a lower concentration in the previous 
experiment, as described in 3.3.3.2. A simple logistic regression model showed that 
there was a significant difference between the two groups after five days, with a  
p value of 0.017.  
 
3.3.3.4 Testing antibodies raised against three PBS-soluble protein 
fractions separated by ion exchange chromatography  
 
Figure 3.9 is a graph showing the percentage mortality of D. gallinae fed antibodies 
raised against the three pools of the PBS-soluble protein fractions after fractionation 
by Mono-Q column. As can be seen, the pooled protein fraction 1 caused the highest 
mortality in the mites. All the protein fractions caused a higher mortality in the mites 
than the controls. This data was collected from a single assay, as replication was 





Figure 3.9. A graph of the percentage mortality of D. gallinae fed antibodies raised against the 
fractionated PBS-soluble protein fraction and antibodies raised against adjuvant only (control). 
Mortality was monitored daily over a four day period following feeding. The data presented in this 
graph was collected from a single assay where each data point represented the percentage mortality of 
the fed mites for each group on each day. The number of mites fed in each group was variable: 
Control group had 12 fed mites, Group 1 had 57 fed mites, Group 2 had 27 fed mites and Group 3 had 
12 fed mites. The hens in Group 1 were injected with protein from fractions A6 to A9, Group 2 were 
injected with protein from fractions A10 to B10, Group 3 were injected with protein from fraction B9 
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The experiments described in this chapter demonstrate that when antibodies were 
raised against D. gallinae protein extracts and tested in an in vitro feeding assay, the 
antibodies raised against some of the mite proteins significantly increased the mite 
mortality in the test group when compared to the control group. These protective, 
anti-mite, antibodies were raised against proteins from the PBS-soluble protein 
fraction that have not yet been identified. During the first two days after feeding, the 
mean mortality of the mites from the PBS group was significantly higher (p = 0.013) 
than that of the control group (figure 3.7). This mortality may be attributable to 
antibodies directed towards a single antigen, or to multiple antigens, important to the 
normal functioning and viability of the mite. These antigens appear to be present 
predominantly in the PBS-soluble protein fraction, and these PBS-soluble proteins 
therefore represent a likely source of vaccine candidate(s) which require 
identification and characterisation.  
 
The increased mortality of fed mites was modest but it should be noted that during 
the development of TickGARD™, which was previously an effective commercial 
vaccine against ticks, the initial effects of vaccination with crude tick extracts were 
also comparatively modest. As the protein component of the vaccine was reduced in 
complexity, the efficacy increased up to 40 % (Johnston et al., 1986), and to 90 % by 
use of either pure native or recombinant Bm86 (Willadsen et al., 1995). It is also 
notable that the increased mortality seen in this experiment resulted after a single 
bloodmeal, whereas in nature the mites would feed repeatedly, potentially generating 
an enhanced cumulative effect of the antibodies generated against the PBS-soluble 
protein fraction on the mortality of the mites.  
 
Numerous proteins with a broad range of molecular masses were recognised by IgY 
from vaccinated hens, and the profiles of proteins recognised differed between the 
mite protein extracts used for immunisation (figure 3.2). When comparing the 
reactivity of the vaccinated groups to the reactivity of the adjuvant-only groups, there 
was a marked difference in the number and intensity of the bands. Some of the bands 
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detected in both the vaccinated and control groups represented the two IgY subunits. 
Bands of approximately 62 kDa and 25 kDa in lanes 1 and 6 and, to a lesser extent, 2 
and 7, most likely represent the IgY subunits present in the mites‟ bloodmeal that 
were detected with the anti-IgY secondary antibody.  
 
The differences between the profile of the PAGE gel (figure 3.1) and the banding 
patterns of the Western blot (figure 3.2) could be explained by the co-purification of 
chicken proteins present in the mite‟s gut that were injected into the chicken. 
Because of MHC restriction, the chicken would not mount an antibody against “self” 
proteins. The immunogenic proteins that create bands on the Western Blot might not 
be very abundant. 
 
Chick skin was used as a feeding membrane during the development of the assay and 
so was used throughout the experiments (McDevitt et al., 2006). To find a suitable 
storage method for the chick skin, an assay was carried out using skin stored in 
various ways. The mites fed best through the skins that had been stored at 4 C in 
ethanol, which was an easy method for storage.  
 
The feeding assays carried out using antibodies raised against all four mite protein 
fractions demonstrated that the antibodies raised against the PBS-soluble protein 
fraction did increase the mortality of the mites significantly when compared to the 
controls two days after feeding. The proteins present in the PBS-soluble protein 
fraction have not yet been identified. Immunoreactive bands have been found when 
antibodies against tropomyosin and paramyosin were used to probe the PBS-soluble 
protein fraction. The other mite protein fractions did not seem to generate antibodies 
that increased the mortality of the mites. These protein fractions could contain 
potential vaccine candidates, but due to a very low abundance of the protein in the 
immunisation, a low antibody response was generated.  
 
The PBS-soluble protein fraction was further fractionated, based on the charge of the 
proteins, by a Mono-Q column. The antibodies generated against these proteins were 
compared to the antibodies generated against the whole PBS-soluble protein fraction 
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(figure 3.6). The banding pattern from the Western blot showed differences between 
the immunoreactive proteins in the three fractionated protein groups.  
 
An in vitro feeding assay was performed using the antibodies generated against the 
three fractionated PBS-soluble protein fractions. The mortality of all the test groups 
was higher than that of the control group (figure 3.9). This assay was not repeated, so 
no statistical analysis could be carried out. The mortality of the control groups was 
lower in the fractionated PBS-soluble protein assay at 6.7 % for every time point 
(figure 3.9) than in the PBS-soluble protein fraction assay, where the mortality in the 
control group went from 7.3 % to 10.9 % from day one to four (figure 3.8). Group 1 
had the highest mortality of the mites fed antibodies raised against the protein of the 
fractionated PBS-soluble proteins (figure 3.9, 26.6 % by day four). This was lower 
than the mortality induced by the whole PBS-soluble protein fraction (figure 3.8,  
38 % by day four). When compared to the mortality in the control group, the 
mortality of all the groups in the fractionated PBS-soluble protein assay was lower 
than the mortality in the test group fed antibodies against the complete PBS-soluble 
protein fraction. However, there was only data from a single assay for the 
fractionated PBS-soluble protein fractions, where the number of mites feeding in the 
assay was low, with only 15 mites feeding in the control group and 12 in group 3. 
 
The number of mites feeding was variable from chamber to chamber in all of the 
experiments. In some of the chambers, over 50 % of the mites fed, whereas in others 
none were observed to feed. This may have depended upon the part of the chick‟s 
body from which the skin was derived, and factors such as skin thickness or attached 
mesoderm may have influenced the mite‟s ability to penetrate and feed. The method 
of storing the skins may also have contributed to the low feeding rates. Ethanol was 
chosen as a preservative based on the results of a single assay. Assays using a similar 
technique stored the chick skins at -20 C to produce a high feeding rate. However, 
there appeared to be some inconsistencies in the reporting of the results (Arkle et al., 
2009). A kairomone has been identified in hen skin that is an attractant to mites 
(Zeman, 1988). This kairomone may have differed in concentration on the skin used 
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as a feeding membrane of the different chambers, affecting the overall feeding of 
mites in each replicate.  
 
Some of the mites in the assay took a bloodmeal and then died. The chicken blood 
present in the legs could have seeped through damaged sections of the mites‟ gut. 
Figure 3.10 is a photograph of a dead mite that had internal damage leading to 




Figure 3.10. A photograph of a dead mite after taking a bloodmeal containing antibodies raised 
against the PBS-soluble protein fraction. This mite had suffered internal damage causing blood 
from the gut to seep into the mite‟s legs. 
 
The efficacy of PBS-soluble proteins as vaccine candidates against mites differs 
somewhat from results for the tick R. microplus where membrane-associated proteins 
gave the most promising results in reducing populations as discussed above 
(Willadsen et al., 1995). The data presented here are, however, in agreement with 
work performed previously, using a similar approach to identify protective antigens 
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from P. ovis. PBS-soluble components were more protective than any other extracts, 
eliciting a 15-fold reduction in mite burden and four-fold reduction in scab lesion 
when sub-fractionated PBS-soluble protein extracts were used in in vivo vaccine 
trials (Smith et al., 2002).  
 
In summary the experiments described in this chapter indicate that the immunised 
hens generate antibodies against proteins in the PBS-soluble protein fraction that 








Chapter 4:  
 
Identification of vaccine candidates by the 






Studies were performed to identify native vaccine candidates, as described in chapter 
3. Crude protein fractions were injected into laying hens and, by use of an in vitro 
feeding assay, it was established that the mites fed antibodies raised against the PBS-
soluble protein fraction from D. gallinae, had a higher mortality than those fed 
antibodies from the control group (Wright et al., 2009). Although antibodies raised 
against the PBS-soluble protein fraction were clearly effective at increasing the mite 
mortality in vitro, as a practical vaccine it has disadvantages because the production 
of the antigen is time consuming and requires a large quantity of mites as starting 
material. A commercial vaccine against D. gallinae has to be produced using a cost-
effective and rapid method. Recombinant proteins have been used to successfully 
immunise host animals against parasitic species; for example TickGARD™ was 
developed using the recombinant form of Bm86 to protect cattle from the tropical 
tick Rhipicephalus microplus (Rand et al., 1989). To obtain a single, or cocktail of, 
recombinant proteins, a detailed analysis of D. gallinae proteins is required to 
identify putative vaccine candidates through inferred critical function or orthology to 
known antigens in other species. 
 
At the start of this project there were only five sequences for D. gallinae on any of 
the publically available online genomic or proteomic databases. Of the sequences 
present, tropomyosin (Nisbet et al., 2006a) was the only non-ribosomal sequence. 
During this project new sequencing technology, Roche 454 and Illumina Solexa, 
became available that allowed large numbers of sequences to be generated relatively 
cheaply, allowing the discovery of much larger volumes of gene sequences. 
 
4.1.1 Expressed sequence tag (EST) database generated from fed  
D. gallinae  
 
Expressed sequence tag (EST) databases can be quickly generated and provide 
portions of the sequence of genes encoding proteins that are expressed in an 
93 
 
organism. The proteins translated from these mRNAs may be identifiable as vaccine 
candidates and drug targets, as described for the parasitic filarial nematode 
Onchocerca volvulus, where EST databases were generated using larvae at those 
stages targeted by the host immune response to identify potential targets for vaccine 
development. Contiguous sequences (contigs) that were homologous to proteases 
such as cathepsin L, B and a metalloproteinase were thus identified in the EST 
databases as vaccine candidates (Lizotte-Waniewski et al., 2000).  
 
An EST database can be specifically constructed to study the expressed proteins in a 
particular tissue type or life cycle stage depending on the starting material from 
which the complementary DNA (cDNA) is made. To build a database, Sanger 
sequencing single pass technology (Sanger et al., 1977) is used to sequence 
individual clones of a cDNA library. The individual sequences are built into larger 
contigs based on overlapping DNA sequence. Homologous genes and their inferred 
protein products are identified using a basic linear alignment search tool (BLAST) 
(Altschul et al., 1994) analysis with the partial sequence of the EST. This analytical 
technique has been used to find homologues of proteins that are potential vaccine 
candidates in the larval stage of Brugia malayi (Blaxter et al., 1996) and Psoroptes 
ovis (Kenyon et al., 2003). The analysis of EST datasets can now be carried out 
quickly using computer software inputting raw EST sequences and returning 
assembled annotated ESTs. ESTExplorer is an example of an automated platform 
that can accept two forms of input raw EST sequences or pre-assembled contigs. 
Software is used to assign annotation to the EST such as blastx and BLAST2GO, 
which assigns protein function based on Gene Orthology (GO), from the National 
Centre for Biotechnology Information (NCBI), KOBAS, which maps the contigs to 
biochemical pathways from the Kyoto Encyclopaedia of Genes and Genomes 
database (KEGG) and InterProScan (Quevillon et al., 2005), which recognises 
protein signatures (Ranganathan et al., 2009).  
 
The contigs in an EST database are a representative sample of all the genes 
expressed. For identification of potential vaccine candidates it may be necessary to 
refine the dataset to identify genes involved in essential physiological processes, 
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such as feeding. Two techniques were used in the experiments described in this 
chapter to identify differentially expressed genes that could be vaccine candidates. 
The first used suppression subtractive hybridization (SSH) to remove all the common 
genes between two samples of cDNA, as described in 4.2.2. The second technique 
used Illumina Solexa sequencing to generate millions of sequences of approximately 
25 base pairs, which were compared to a Roche 454 database generated, as described 
in 4.1.3. The fold change between two samples for each RNA transcript can be 
calculated, as described in 4.1.4. In both cases, these technologies were used to 
identify genes up-regulated by feeding, as these genes are likely to encode proteins 
critical to mite development, reproduction and survival and which are likely to have 
been expressed in gut tissue, which is accessible to the host immune response. As 
previously stated, the R. microplus protein Bm86 is a gut-bound glycoprotein that 
has previously been successfully used as the antigen in a commercial vaccine. 
Although it is not highly expressed, the protein can generate a protective immune 
response that significantly damages the tick, causing a reduction both in tick body 
weight and in cumulative egg weight of 31 % and 77 % respectively (Rand et al., 
1989). As previously stated the vaccine causes an overall vaccine effect of 90 % 
when the parameters weight of engorged ticks, number of engorged ticks and weight 
of eggs were taken together (Willadsen et al., 1995). 
 
4.1.2 Suppression subtractive hybridisation 
 
To study the differences in gene expression between fed and starved mites an SSH 
cDNA library was constructed. The library was made by subtracting cDNA made 
from RNA extracted from starved mites, from cDNA made from RNA extracted 
from fed mites. This removed the common genes from the two libraries and left the 
unique genes expressed in fed mites (Diatchenko et al., 1996). These unique genes 
would therefore have been up-regulated and would be potential vaccine targets. 
 
SSH has been used to target groups of genes that were up-regulated in fed Psoroptes 
ovis (McNair et al., 2010) and Ixodes scapularis (Xu et al., 2005). P. ovis total RNA 
was extracted and an SSH library was constructed from fed and starved populations 
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of mites. The genes up-regulated in the fed mites were homologous to known 
allergens, enzymes and secretory proteins from the salivary gland of the tick (McNair 
et al., 2010). An SSH library was made from cDNA libraries constructed from 
mRNA extracted from the salivary glands of fed and starved I. scapularis females. 
Five hundred colonies from this SSH library were sequenced, and 20 individual 
clones were identified. Primers specific to the 20 clones were used to amplify the 
genes from the two starting fed and starved cDNA libraries. Differential expression 
of ten genes was determined; two of which were entirely absent from the starved 
cDNA library. Of the 10 proteins, seven were of unknown function but had 
previously been described in Anopheles gambiae, the salivary gland of I. scapularis 
and from the mammary gland of the mouse Mus musculus. The three proteins of 
known function were thioredoxin-1, a secreted growth factor characterised in 
Mesobuthus cyptius (scorpion), a heat shock protein characterised in  
I. scapularis and a proclotting enzyme characterised in Tachypleus tridentatus 
(Japanese horseshoe crab). These proteins can be fully characterised and their 
successful expression could make them potential vaccine candidates (Xu et al., 
2005).  
 
4.1.3 Roche 454 sequencing of D. gallinae transcriptome 
 
Roche 454 sequencing uses an emulsion-based method to isolate single DNA 
molecules in vitro, and then acquires the genetic sequence by use of pyrophosphate-
based sequencing. Roche 454 sequencing technology can produce more than  
25 megabases of sequence for every four hour run, with an accuracy of 99 %, 
whereas classical Sanger sequencing technology provides approximately  
67 kilobases of sequence in a one hour run. Roche 454 technology does not require 
the use of bacteria to grow individual clones as it can use purified RNA as a starting 
material (Margulies et al., 2005).  
 
The technology has progressed in the past five years and now Roche 454 sequencing 
can produce sequences with an average of length of 250 base pairs for approximately 
96 
 
400,000 reactions per run, giving about 100 megabases (The GenePool, Edinburgh 
University). These sequences are built into contigs as described for EST databases.  
 
4.1.4 Illumina Solexa 
 
Illumina Solexa sequencing (Bennett et al., 2005) can produce 3,000 megabases of 
sequence per run, which relates to 60 million individual sequences of 50 bases. Both 
DNA and RNA can be used as a starting material for the sequencing procedure.  
 
Illumina Solexa sequencing was used to compare the expression levels of genes in 
two populations of mites, one of which had recently fed and a second that had been 
starved. Pre-processing of the RNA left an adapter sequence followed by 17 gene 
specific base pairs that can be identified by Sanger sequencing and then therefore the 
number of each gene present can be counted (Morrissy et al., 2009). The identity of 
these sequences can then be allocated by comparing them to the Roche 454 database. 
 
4.1.4 Aims of chapter 
 
The aim of this chapter was to identify possible vaccine candidates by inferred 
critical function or homology to known vaccine candidates from other species, using 
four sequencing techniques; two EST databases were generated from cDNA libraries, 
the first from total RNA extracted from D. gallinae and the second from a 
suppression subtractive hybridization library generated from fed and starved mites. A 
third EST database was generated by Roche 454 sequencing using total mite mRNA 
and Illumina Solexa sequencing was then used to compare the levels of gene 




4.2.1 D. gallinae used for RNA extraction 
 
The D. gallinae collected from a commercial egg production unit were of mixed life 
stages and gender. The majority (> 60 %) of the mites were recently engorged. For 
RNA preparation, the mites were snap frozen in liquid nitrogen within 4 hr of 
collection and stored at -80 C until required.  
 
Starved D. gallinae used for SSH and Illumina Solexa sequencing were conditioned 
by initial incubation at room temperature (RT) (~ 21 C +/- 2 C) for 7 days, followed 
by storage at 4 C +/- 1 C  for 21 days (McDevitt et al., 2006). At the end of the 
conditioning period the mites were snap frozen in liquid nitrogen and stored at -80 C 
until required. 
 
4.2.2 RNA extraction 
 
A mortar and pestle were cooled to -80 C. The mortar was filled with liquid nitrogen 
and a known weight of D. gallinae, prepared as described in 4.2.1, was added. The 
pestle was used to grind the mites until the liquid nitrogen had evaporated. TRIzol 
(Invitrogen) was added at 2 ml per 100 mg of mites. The TRIzol reagent was mixed 
with the powdered mites and frozen. The pestle was used to break apart the frozen 
TRIzol. The TRIzol/D. gallinae sample was ground and then mixed until it had 
thawed. Aliquots (1 ml) of the sample were put into RNase/DNase free 1.5 ml tubes 
(Axygen). They were incubated for 5 min at RT. Chloroform (Sigma)(200 µl) was 
added to each aliquot then inverted to mix, followed by 3 min incubation at RT. The 
samples were then centrifuged at 12,000 x g for 15 min at 4 C. A pipette was used to 
carefully remove the supernatant, the aqueous fraction, into a new 1.5 ml tube. 
Isopropanol (Fisher)(0.5 ml) was added to the 1.5 ml tube to precipitate the RNA, 
which was then inverted to mix and incubated at RT for 10 min. The 1.5 ml tube was 
centrifuged for 10 min at 12,000 x g at 4 C. A needle and syringe were used to 
remove and discard the supernatant to decrease the chance of disturbing the pellet of 
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RNA. Then 1 ml of 75 % ethanol was added and incubated for 5 min at RT. The  
1.5 ml tube was centrifuged for 5 min at 7,500 x g at 4 C. All the supernatant was 
removed and the pellet was re-suspended in 50 µl of RNase free water (Promega).  
 
An agarose gel was prepared, as described in 2.2.9, on which 2.5 µl of the RNA was 
examined for integrity by electrophoresis. RNasin (Promega) [2.5 µl (100 units)], an 
RNase inhibitor, was added to the RNA. The concentration of the RNA was 
measured using a nanodrop spectrometer (Nanodrop® Technologies).  
 
4.2.3 DNase digestion of RNA sample 
 
To 100 µg of RNA (88 µl) 2 µl of DNase (Ambion) and 10 µl of 10 times reaction 
buffer was added. The RNA was incubated at 37 C in a water bath for 30 min.  
 
4.2.4 RNA purification using RNeasy® MinElute Cleanup kit (QIAGEN®) 
 
The RNA was purified after DNase digestion using the RNeasy ® MinElute Cleanup 
kit (QIAGEN®) as per manufacturer‟s instructions. To the 1.5 ml tube containing the 
RNA following DNase digestion, 350 µl of Buffer RLT was added and the tube was 
well mixed. Pure ethanol (200 µl) was added to the 1.5 ml tube and mixed using a 
pipette. The sample was transferred to a RNeasy MinElute spin column, which had 
been placed in a 2 ml collection tube. The column was centrifuged at 8,000 x g for  
15 sec and the flow-through was discarded. The spin column was placed in a fresh 
collection tube and 500 µl of Buffer RPE was added. The column was centrifuged at 
8,000 x g for 15 sec and the flow through was discarded. 80 % ethanol (500 µl) was 
added to the spin column and it was centrifuged at 8,000 x g for 2 min. The flow-
through and collection tube were discarded. The column was placed in a fresh 
collection tube and centrifuged at 14,200 x g for 5 min. The flow-through and 
collection tube were discarded. The spin column was placed in a fresh 1.5 ml tube 
and 14 µl of RNase free water was added to the spin column. The column was 




4.2.5 cDNA library construction from total RNA 
 
The cDNA library was then synthesised from the RNA using the SMART cDNA 
library construction kit (Clontech). To a 0.5 ml tube, 0.4 µl of RNA (1µg of RNA), 
2.6 µl of RNase free water, 1 µl of SMART VI Oligonucleotide and 1 µl of CDS 
III/3‟ PCR primer were added. This was centrifuged briefly and incubated at 72 C 
for 2 min, then placed straight onto ice for a further 2 min. The tube was centrifuged 
briefly to collect the content at the bottom. Then to the same tube, 2 µl 5 x First-
strand Buffer, 1 µl DTT (20 mM), 1 µl dNTP mix (10 mM) and 1 µl PowerScript 
Reverse Transcriptase were added. The sample was incubated at 42 C for 1 hr in an 
air incubator and then put on ice to stop the 1
st




 cDNA strand was synthesised by PCR. The GeneAmp 2400 PCR machine 
was preheated to 95 C. To a 0.5 ml PCR tube, 2 µl First strand cDNA, 80 µl dH2O, 
10 µl 10x Advantage 2 PCR buffer, 2 µl 50x dNTP mix at 10 mM per dNTP, 2 µl 5‟ 
PCR Primer, 2 µl CDS III/3‟ PCR Primer and 2 µl 50x Advantage 2 Polymerase mix 
were added. The program 1 cycle at 95 C for 20 sec, then 20 cycles of 95 C for 5 sec 
and 68 C for 6 min was run on the preheated PCR machine. A 5 µl aliquot was 
examined by electrophoresis on a 1.1 % agarose gel, alongside a 1 kb DNA ladder. 
cDNA appeared as a smear between 0.1 and 4 kb. 
 
The QIAquick PCR purification kit (QIAGEN®) was used to purify the cDNA 
sample (protocol as described in 2.2.13). 
 
The cDNA was size-fractionated using CHROMA SPIN-400 (Clontech) size 
exclusion columns. At RT, a spin column matrix was re-suspended using a 1 ml 
pipette. The bottom cap was removed and the buffer was allowed to drain. Carefully, 
700 µl of column buffer was added to the top of the column. cDNA (50 µl) was 
added to the top of column matrix. To the tube, 100 µl of column buffer was added 
to rinse any residual cDNA, which was then added to the column. The buffer and 
cDNA was allowed to absorb into the matrix. To the column, 600 µl of column 




A 1.1 % agarose gel was prepared as described in 2.2.9 (using 0.66 g of agarose) and  
3 µl of each drop with 0.5 µl of loading buffer was examined by electrophoresis. The 
four fractions that had a smear of cDNA between 0.5 and 2 kb were collected to give 
a total volume of 125 µl.  
 
The cDNA was precipitated using reagents supplied in the SMART cDNA synthesis 
kit (Clontech). To the pooled cDNA 0.1 volumes of sodium acetate (3 M; pH 4.8), 
1.3 µl of glycogen (20 mg/ml) and 2.5 volumes of 95 % ethanol (-20 C) were added. 
The tube was placed on an orbital rocker to gently mix, and then incubated at -20 C 
for 1 hr.  
 
The tube was centrifuged at 14,200 x g for 20 min to pellet the cDNA. The 
supernatant was carefully removed and discarded. The tube was centrifuged again 
briefly at 14,200 x g and the last drop of fluid removed. The pellet was air dried for 
10 min then 7 µl of dH2O was added. The concentration of the cDNA was measured 
using a nanodrop spectrometer. 
 
4.2.6 Suppression subtractive hybridization 
 
A cDNA expression library of feeding-induced genes was prepared by Dr. A. Nisbet 
(Moredun Research Institute) using the PCR Select synthesis kit (Clontech) 
(Diatchenko et al., 1996). cDNA was synthesised from mRNA extracted from fed or 
starved mites, as described in 4.2.1.  
 
SSH was performed according to the manufacturer‟s protocol (PCR-Select  cDNA 
subtraction kit, Clontech) with minor modification (see Nisbet et al., 2008). This 
procedure involved the synthesis of cDNA from fed or starved mite mRNA by 
reverse transcription, digestion of the cDNA with endonuclease RsaI and ligation of 
adapters to the digested fragments to produce „tester‟ cDNA for fed mites. The “fed 
tester cDNA” was then hybridised with an excess of starved cDNA („driver‟) to 
remove common cDNA species from the adapter-ligated, fed cDNA. Hybridised 
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fractions were then subjected to PCR to amplify differentially expressed cDNAs. 
PCR-amplified, fed-specific cDNA, produced by SSH, was ligated into the pGEM -
T Easy vector (Promega) and transformed into competent Escherichia coli (strain 
JM109, Promega). Individual positive clones were picked (based on blue/white 
selection), and the plasmid was purified and sequenced. 
 
Semi-quantitative real-time PCR (RT-PCR) was used to verify the differential 
expression in genes expressed in the SSH library. Single stranded cDNA (ss-cDNA) 
was synthesized from total RNA isolated from fed or starved mites using oligo dT 
primer and the Superscript II kit (Invitrogen) according to the manufacturer‟s 
instructions. These ss-cDNAs were used as templates in semi-quantitative PCR 
reactions using internal primers specific for each of six randomly selected ESTs 
identified during initial sequencing of the “fed-specific” library. The following 
cycling conditions were used: 94 C for 5 min followed by up to 28 cycles of 94 C 
for 15 sec, 53 C for 30 sec, 72 C for 30 sec with a final 10 min extension at 72 C. 
Negative controls were performed where ss-cDNA was replaced by 1 µg of total 
RNA. No amplification of products from contaminating genomic DNA was seen. 
Amplification products were separated on a 1.5 % agarose gel, prepared as described 
in 2.2.9 (using 0.9 g of agarose). 
 
4.2.7 Sequencing of Expressed Sequence Tags  
 
cDNA from the SSH (4.3.4) or unsubtracted library (4.3.2) was used to transform  
E. coli JM109 competent cells as described in 2.2.10. Colonies that were non-
contiguous were picked from the plates.  
 
LBG broth (150 µl) was added to each well of five 96-well plates. Pipette tips were 
used to pick colonies from the plates and add the cells to the wells. The tips were left 
in the wells for at least 10 min before being discarded. The plates were incubated 




To another 96 well plate, the Working plate, 50 µl of cell suspension was transferred 
from each well of the Master plate. A PCR was set up for one of the plates to make 
sure the plasmid had an insert, i.e. to establish the transformation rate. A Master mix 
was prepared using 200 µl of M13 Forward primer (10 pmol/µl), 200 µl of M13 
Reverse primer (10 pmol/µl), 200 µl of 10 x Buffer(1.5 mM MgCl2), 1300 µl of H2O, 
20 µl of Taq polymerase (5 U/µl) and 40 µl of dNTPs (2 mM) . A multi-channel 
pipette was used to dispense 18 µl into each well of a 96-well PCR plate. Cell 
suspension (2 µl) was pipetted from the Working plate to the PCR plate as a 
template. The plates were foil heat sealed to prevent evaporation. A 1 % agarose gel 
was poured with six rows of 18 wells to make sure the PCRs were successful before 
sequencing. Ethidium bromide (1.5 µl) was used as a dye.  
 
The PCR products were purified using the restriction Exonuclease 1 and Shrimp 
Alkaline Phosphotase (SAP), as described in 2.2.14. The plates were then set up for 
sequencing. A sequencing Master mix was prepared using  200 µl of 5x Sequencing 
Buffer, 434 µl of ddH2O, 150 µl of BigDye 3.1 mix and 16 µl of Primer (1.6 pmol 
per reaction) per plate. The plates were put on a FAST PCR machine using the 
folowing program; one cycle for 96 C for 1 min, 25 cycles of 96 C for 10 sec, 50 C 
for 5 sec and 60 C for 75 sec. The plates were stored at 4 C until required. The 
plates were sequenced on the 3730 DNA Analyzer. 
 
The EST sequences were organised into clusters, and homology searches were 
performed using the programs Trace2BDEST and PartiGene (Parkinson et al., 2004) 
to search databases uniprot, arthclus and rRNAe. The sequences were put into a 
database, which was mounted on the web 
(http://xyala.cap.ed.ac.uk/NeglectedGenomes/Dermanyssus/). 
 
4.2.8 Roche 454 sequncing 
 
RNA was extracted, DNase-treated and purified from freshly collected D. gallinae, 
as described in 4.2.2-4.2.4. An aliquot of this RNA (10 µg) was used for Roche 454 
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sequencing by The GenePool Sequencing Service following the manufacturer‟s 
instructions (Margulies et al., 2005). 
 
4.2.9 Illumina Solexa sequencing  
 
RNA was extracted from three populations of freshly collected D. gallinae, 
approximately 60 % of which were engorged, and from starved mites as described in 
4.2.2. The RNA was DNase digested, as described in 4.2.3, and then purified, as 
described in 4.2.4. RNA (30 µg) from three samples of fed mites and three samples 
of starved mites, which were biological replicates, was sent to the GenePool 
Sequencing Service for Solexa sequencing, where the manufacturer‟s protocol was 
followed (Morrissy et al., 2009).  
 
The data received from the Illumina Solexa sequencing was BLAST searched against 
the database generated from the Roche 454 sequencing described in 4.3.3 to identify 
differentially expressed transcripts from fed and starved mites. 
 
The GeneSpring GX 11.0 software was used to analyse the data. Only the sequences 
that had homology to contigs from the Roche 454 database and were identified in all 
six samples were used in the analysis. A filter was applied that removed all the 
contigs that had less than a threefold change between the fed and starved groups, 
either up- or down-regulated. An unpaired Benjamini and Hochberg t-test was 




4.3.1 Expressed sequence tag (EST) database generated from a  
D. gallinae cDNA library  
 
An EST database was generated, as described in 4.2.7, from a library constructed 
from cDNA, as described in 4.2.5. 
 
The database was generated from 398 sequences and these produced 252 ESTs 
formed from the individual sequences. Fifty of these were contigs generated from 
multiple sequences and the other 202 ESTs were individual sequences. BLAST 
analysis was carried out, first translating the nucleotide sequence (blastx) then 
comparing the amino acid sequence to the NCBI non-redundant (nr) protein 
database. Secondly, the nucleotide sequences (blastn) were compared to a database 
of all eukaryote ribosomal RNA (rRNA) sequences (The GenePool, Edinburgh 
University). Homologous sequences to 42 of the 252 contigs were identified. The 
other 210 contigs had no significant hit in either of the databases. Table 4.1 contains 








Table 4.1. List of the contigs with significant hits against either the NCBI nr database or the eukaryote rRNA database kept at The GenePool (Edinburgh 
University). The “Nos. of EST” was the number of individual sequences used to form each contig. The column labelled “Length” was the length of the contig in bases. 
The column marked “Top Hit” has a description of the top hit from the BLAST analysis, except where noted in the description. The Database column showed which 
database the homologous protein was found in.  
Contig Nos. of EST  Length Top Hit Database Score e value 
DCG00056 17 1080 5.8S ribosomal RNA gene AF061796 [Branchiostoma floridae] rRNAe 551 1E-157 
DCG00005 33 2279 Non-structural polyprotein, Kashmir bee virus NCBI nr 320 1E-139 
DCG00031 1 668 Polyubiquitin [Tribolium castaneum] (Not top Hit) NCBI nr 262 2E-70 
DCG00226 1 732 Cytochrome oxidase subunit I CAP58872.1 [Dermanyssus gallinae]  NCBI nr 254 6E-66 
DCG00181 2 296 18 rRNA gene X77784 [X.vesparum] rRNAe 246 2E-65 
DCG00026 1 126 18S ribosomal RNA gene L76343 [Cosmolaelaps trifidus] rRNAe 234 2E-62 
DCG00222 1 798 Alpha-parvin, putative [Ixodes scapularis] NCBI nr 197 1E-48 
DCG00166 1 746 Cuticular protein putative [Ixodes scapularis] NCBI nr 191 9E-47 
DCG00209 1 771 Hypothetical protein BRAFLDRAFT_255626 [Branchiostoma floridae] NCBI nr 178 5E-43 
DCG00102 1 668 Similar to GA19430-PA [Nasonia vitripennis] NCBI nr 140 1E-31 
DCG00079 1 690 39S ribosomal protein L51 [Rhipicephalus sanguineus] NCBI nr 140 2E-31 
DCG00094 1 720 Arginyl-tRNA synthetase [Xenopus (Silurana) tropicalis] NCBI nr 139 4E-31 
DCG00159 1 751 Similar to RIKEN cDNA 1810011O16 isoform 6 [Canis familiaris] NCBI nr 135 6E-30 
DCG00269 1 637 Translation elongation factor 2 [Lycosa singoriensis] NCBI nr 127 8E-28 
DCG00130 2 801 Ly1 antibody reactive homolog [Saccoglossus kowalevskii] NCBI nr 124 9E-27 
DCG00082 2 663 Lysine-specific demethylase NO66 [Bos taurus] NCBI nr 122 3E-26 
DCG00034 2 557 Proteasome maturation protein (Proteassemblin) [Homo sapiens]    NCBI nr 120 9E-26 
DCG00040 1 571 Similar to TRAP/Mediator complex component TRAP25 isoform 1 [Apis mellifera] NCBI nr 105 3E-21 
DCG00027 6 492 16S ribosomal RNA gene AF177143  [Pseudhemilea longistigma] rRNAe 100 4E-21 








Contig Nos. of EST  Length Top Hit Database Score e value 
DCG00193 1 662 Secreted protein, putative XP_002433530.1 [Ixodes scapularis]  NCBI nr 103 1E-20 
DCG00098 1 266 Ribosomal protein S15A [Lysiphlebus testaceipes]      NCBI nr 99 2E-19 
DCG00038 1 531 Replication-associated protein [Gull circovirus]      NCBI nr 94 8E-18 
DCG00259 1 485 rad25/xp-B DNA repair helicase, putative XP_002399857.1 [Ixodes scapularis] (Second Hit) NCBI nr 91 4E-17 
DCG00215 3 606 40S ribosomal protein S13 [Ixodes scapularis]      NCBI nr 90 1E-16 
DCG00063 2 578 10 kDa putative secreted protein  [Argas monolakensis] NCBI nr 109 3E-16 
DCG00019 3 582 Cytoplasmic cystatin [Ixodes scapularis] NCBI nr 88 6E-16 
DCG00157 1 431 26S protease regulatory subunit S10B [Anoplopoma fimbria] (Second Hit) NCBI nr 76 9E-15 
DCG00163 1 736 Venom serine protease precursor [Polistes dominulus]      NCBI nr 82 6E-14 
DCG00066 2 177 Endomyces fibuliger 8014 17S ribosomal RNA and 5.8S ribosomal RNA genes, complete sequence rRNAe 70 1E-12 
DCG00171 1 466 Hypothetical protein IscW_ISCW007013 XP_002408298.1 [Ixodes scapularis]  NCBI nr 69 2E-10 
DCG00141 2 360 Glutathione S-transferase putative [Ixodes scapularis]      NCBI nr 68 4E-10 
DCG00060 1 566 KNSL2 protein [Oryzias latipes]      NCBI nr 66 2E-09 
DCG00043 1 732 Nonstructural polyprotein [Solenopsis invicta] virus 1     NCBI nr 65 5E-09 
DCG00018 41 288 25S ribosomal RNA gene M26190 [M. racemosus] rRNAe 52 5E-07 
DCG00198 1 544 Defender against apoptotic cell death 1 [Araneus ventricosus] NCBI nr 57 7E-07 
DCG00172 1 644 Conserved hypothetical protein XP_002434012 [Ixodes scapularis]  NCBI nr 52 3E-05 
DCG00107 1 256 Beta-ureidopropionase, putative [Ricinus communis] (Not top hit) NCBI nr 49 1E-04 
DCG00096 1 192 DNA-directed RNA polymerase [Cytophaga hutchinsonii] NCBI nr 46 1E-03 
DCG00148 1 629 Similar to GTP binding protein 3 [Ciona intestinalis] NCBI nr 45 5E-03 
DCG00131 1 353 NADH:ubiquinone oxidoreductase, NDUFB6/B17 subunit, putative [Ixodes scapularis] NCBI nr 43 1E-02 






In the database there were ten contigs with significant homology to rRNA molecules, 
from both the NCBI nr and the eukaryote rRNA databases. The contig which was 
made up of the highest number of individual sequences (41) was homologous to a 
ribosomal RNA (rRNA) molecule. Of the 42 contigs that had significant homology 
to other proteins, 11 had homology to proteins expressed in ticks of the Ixodes genus. 
Nine of the contigs were homologous to enzymes, one of which has been identified 
as cytochrome oxidase subunit 1 from D. gallinae (Roy et al., 2009) and another was 
homologous to the deer tick Ixodes scapularis glutathione S-transferase (GST). The 
Kashmir bee virus was represented by a large number of individual sequences (33) 
that clustered together into a single contig 2279 bases long. Another two of the 
contigs were homologous to other viral proteins. 
 
4.3.2 EST database generated from an SSH cDNA library 
 
An EST database was generated using an SSH library constructed from cDNA made 
by suppression subtractive hybridization, as described in 4.2.6.  
 
Semi-quantitative RT-PCR, as described in 4.2.6, was used to verify the differential 
expression in genes expressed in the SSH library. Figure 4.1 is a photograph of a gel 
on which the PCR products were examined. Three of the gene expression levels were 
higher in the fed sample than the starved sample. The control samples were a similar 





Figure 4.1. Semi-quantitative RT-PCR to confirm differential expression of transcripts 
represented in fed D. gallinae. * Control shows ribosomal band from equal quantities of RNA from 
fed and starved mites used in the cDNA synthesis step of the RT-PCR. Reproduced with consent of 
Dr. A. Nisbet. 
 
Individual clones from the library were grown in bacterial colonies on agar plates. 
Colonies (960) were picked and sequenced, as described 4.2.7. Of the 960 
sequencing reactions, 770 had good traces and were used to form 310 contigs. After 
BLAST analysis comparing the contigs using blastx, to the NCBI nr database and 
then KEGG database 133 of the contigs had significant homology to proteins in the 
database (e ≤ 0.05).  
 
The contigs which had significant homology to a protein in either database were 
grouped together based on their function. Figure 4.2 is a pie chart that shows the 
proportion of individual sequences, which clustered to form the contigs in each 
group, of the total number of individual sequences in the database. A table of all the 
contig descriptions along with the length of the contig, the number of individual 












homologous protein was characterised and the database containing the homologous 
protein was tabulated and shown in Appendix 1. InterProScan (Hunter et al., 2009; 
Quevillon et al., 2005) was used to identify regions of the contigs that were 
conserved protein domains.  
 
 
Figure 4.2. Pie chart showing proportion of the number of sequences used to build contigs with 
known homologue to the total number of good sequences used to make the SSH EST database.  
The number of sequences used to build each contig within a classification was calculated  as a 
proportion of the total number of readable sequences.  
 
The largest proportion of individual sequences differentially expressed in the fed 
group (9.2 %) formed contigs that were homologous to vitellogenin. The second 
highest proportion of individual sequences that made up contigs homologous to a 
single protein was 2.9 %, the protein being GP80, a derivative of vitellogenin. 
Proteinases, peptidases and other metabolic enzymes were highly represented in the 


















subtraction of fed versus starved mites removed the predominance of ribosomal RNA 
from the derived sequences observed in the initial EST database described in 4.3.1. 
 
4.3.3 Roche 454 database 
 
From the Roche 454 sequencing reaction, 4,014,119 bases of sequence were 
produced, which formed 13,363 contigs, the longest of which was 8,641 bases. The 
contigs were compared to NCBI nr protein database, using the blastx function. From 
this search 3,418 (26 %) of the contigs had a significant hit to a protein of known 
function. 6,114 (46 %) of the contigs had no homology to any protein in the 
database. The rest of the sequences had a positive hit to a protein but an e-value 
greater than 0.05, which was considered non-significant. 
 
The NCBI clusters of orthologous groups (COGs) of proteins function was used to 
identify the functional classification of the 13,363 contigs built from the Roche 454 
sequencing. The contigs that did not match any protein in the database or those with 
no COG reference (9201 contigs; 69 %) were removed from the annotated dataset. 
The contigs that had homologues (4162 contigs, 31 %) were allocated to one or more 
of four main classifications, as described on the COG website; “Information Storage 
and Processing (I)”, “Cellular Processes and Signalling (C)”, “Metabolism (M)” and 
“Poorly Characterised”. The proteins that were classified as “Poorly Characterised” 
only were removed, since the proteins were of unknown function or the function was 
generalised. Of the 4162 contigs with homologues in the databases 852 contigs were 
“poorly classified”. Figure 4.3 is a pie chart showing the proportion of contigs in 
each of the remaining classifications (I, C or M). Tables showing the contig number, 
a brief description of the top hit from the NCBI nr database, e value, and the 




 Figure 4.3. Pie chart showing the proportion of contigs from the Roche 454 sequencing in each 
of the major classifications. The single letter codes in the legend were: C, Cellular Processes and 
Signalling; I, Information Storage and Processing and M, Metabolism. The numbers on the pie chart 
were the number of contigs in each classification (3310 contigs in total). 
 
The contigs in the “Cellular Processes and Signalling” group, which accounted for  
45 % of all the total significant hits, were split into 10 sub-categories. The sub-
category with the largest percentage of contigs (32 %) was Post-translational 
modification, protein turnover, chaperones (o), which comprised 481 contigs. This 
group included proteins such as cathepsins L, Z and D, (Dalton et al., 2003; 
Lustigman et al., 2004; Verity et al., 2001)  and glutathione S-transferases (Sexton et 
al., 1990), which have been shown to be possible vaccine candidates in other blood-
feeding parasitic species.  
 
The contigs that were classified in the “Metabolism” categories comprised 26 %  
(869 contigs) of the total contigs classified by COG. These contigs were sub-
classified into eight catagories. There were 183 contigs (21 %) that had homology to 



















Of the 828 contigs that form the “Information storage and processing” classification,  
25 % of the total number of contigs that had COG classifications, 36 % were sub-
classified as Translational, ribosomal structure and biogenesis (j). Many of the 
contigs in this sub-classification were ribosomal proteins. Another 20 % of the 
contigs had homology to proteins involved in protein transcription (k). 
 
The remaining 4 % of contigs (125) were allocated into at least two of the above 
categories.  
 
4.3.4 Illumina Solexa database 
 
The data from the Illumina Solexa sequencing was filtered so that only contigs that 
were identified in all six samples and that had homology to contigs from the Roche 
454 database were used in the analysis (2086 contigs). A second filter was applied 
that removed all the contigs that were not differentially expressed by at least three-
fold between the fed and starved groups, either up- or down-regulated (448 contigs). 
There were 66 contigs and 227 contigs that were significantly differentially 
expressed between the fed and starved RNA samples when the test was performed 
with and without multiple test correction, respectively (p ≤ 0.05). 
 
Table 4.2 contains the description of the 66 contigs, which were up-regulated in fed 
mites, along with the contig number from the Roche 454 database, the fold change, 
corrected p value, p value, a description of the contig and the number of sequences 
counted in each sample. The top two contigs with the highest fold change were  
up-regulated and homologous to vitellogenin. Other transcripts that were up-
regulated encoded a cathepsin L homologue and various salivary proteins. Four 
transcripts were down-regulated, one of which encoded a protein which was 
homologous to the myosin heavy chain. The contigs that were not significantly 
differentially expressed when the multiple test correction was used during the t–test 
were listed in Appendix 3 in the same format as table 4.2. This list included the  





Figure 4.4 is a graph that shows the distribution of the fold change of the 66 contigs. 
The majority of the contigs were up-regulated in fed mites. Of those contigs, more 











Table 4.2. Table showing all the contigs that had count data in each sample and had a significant fold change of more than three with multiple test correction. 
The column marked Probe contains Roche 454 reference of the sequence. The fold change was calculated such that a positive value represents an up-regulated protein 
and a negative was down-regulated. The corrected p value was generated using t-test with MTC and the p value was generated without MTC. The gene description was 
taken from the Roche 454 database. Columns F1, F2, F3, S1, S2 and S3 contained the number of sequences from each RNA sample (F  = Fed sample, S = Starved 
sample). 
 
Probe Fold change  
Fed vs Starved 
Corrected  
p  value 
p  value Gene description F1 F2 F3 S1 S2 S3 
contig12543 110.853 0.016 0.00026 gi|17570195|ref|NP_508868.1| VITellogenin 
structural genes (yolk...    60 
28738 99606 52525 561 361 545 
contig12032 69.317 0.042 0.00511 gi|82878755|gb|AAW78557.2| vitellogenin 
[Dermacentor variabilis]      209 
7916 2465 2294 150 16 56 
contig12020 58.038 0.044 0.00587 No hits found 11528 3657 8541 473 66 59 
contig12579 55.864 0.009 6.5E-05 gi|169215918|ref|XP_001718712.1| PREDICTED: 
hypothetical protein...    42 
11859 7087 10710 191 124 218 
contig00712 39.675 0.011 0.00012 gi|167035216|ref|YP_001670447.1| hypothetical 
protein PputGB1_42...    35 
9327 11563 15466 225 271 438 
contig00149 38.910 0.008 1.7E-05 No hits found 6404 7744 8025 224 145 208 
contig12724 36.924 0.030 0.00204 gi|74267388|dbj|BAE44191.1| cuticular protein 
[Tachypleus triden...    50 
1071 1231 2291 25 25 96 
contig01395 35.517 0.022 0.00082 gi|119715610|ref|YP_922575.1| hypothetical protein 
Noca_1374 [No...    35 
1471 1353 1569 24 88 33 
contig12013 26.812 0.034 0.00267 gi|82878755|gb|AAW78557.2| vitellogenin 
[Dermacentor variabilis]      831 
127950 71499 50643 5890 1400 2915 
contig12861 21.875 0.025 0.00126 gi|158316180|ref|YP_001508688.1| hypothetical 
protein Franean1_4...    35 
648 1276 1940 43 44 81 
contig12148 21.540 0.011 0.00015 gi|170696288|ref|ZP_02887419.1| transcriptional 
regulator, winge...    34 
2905 1962 3000 85 136 148 
contig04772 17.297 0.042 0.00521 No hits found 1530 1486 4942 85 103 248 
contig00317 13.486 0.041 0.00433 No hits found 369 532 1417 45 36 70 
contig00690 12.945 0.022 0.00092 gi|56684769|gb|AAW22505.1| ferritin heavy chain-
1b [Carcinoscorp...   160 
462 270 378 19 44 26 
contig13306 11.777 0.022 0.00098 gi|195114014|ref|XP_002001562.1| GI16461 
[Drosophila mojavensis]...   275 
2917 2853 4239 341 168 377 
contig12606 10.089 0.042 0.00500 gi|109506318|ref|XP_226158.4| PREDICTED: 
similar to Mucin-2 prec...    57 








Probe Fold change  
Fed vs Starved 
Corrected  
p  value 
p  value Gene description F1 F2 F3 S1 S2 S3 
contig12810 9.969 0.030 0.00184 gi|114675653|ref|XP_001170388.1| PREDICTED: 
deoxyribonuclease II...   119 
1910 833 1827 172 104 164 
contig00670 9.900 0.025 0.00127 gi|72008176|ref|XP_780713.1| PREDICTED: similar 
to cathepsin L [...   377 
3956 4789 8377 741 541 408 
contig13131 9.699 0.041 0.00447 gi|91081217|ref|XP_975622.1| PREDICTED: similar 
to ecdysteroid r...   116 
823 1202 2413 89 200 147 
contig11417 8.536 0.016 0.00041 gi|91080885|ref|XP_972748.1| PREDICTED: similar 
to GA14321-PA [T...    37 
97 73 137 12 10 13 
contig11787 8.513 0.016 0.00035 gi|15219757|ref|NP_176856.1| unknown protein 
[Arabidopsis thalia...    42 
74679 140492 100406 12198 12937 10821 
contig11836 7.939 0.030 0.00187 gi|40548304|ref|NP_954972.1| carboxypeptidase, 
vitellogenic-like...   303 
4773 1846 2783 321 376 406 
contig12768 7.628 0.020 0.00065 gi|196236958|ref|ZP_03135749.1| conserved 
hypothetical protein [...    49 
4136 3918 7235 698 550 688 
contig12017 7.522 0.043 0.00561 No hits found 2824 1319 2093 350 145 361 
contig13173 7.215 0.009 6.3E-05 gi|1389604|gb|AAC59905.1| acetylcholinesterase                        
186 
13321 12603 16570 2172 2027 1682 
contig11590 6.225 0.020 0.00057 gi|149287022|gb|ABR23410.1| p8 nuclear protein 
[Ornithodoros par...    80 
7885 6337 6074 776 1263 1284 
contig13129 5.688 0.047 0.00650 gi|118429511|gb|ABK91803.1| aspartic protease 
precursor [Clonorc...   177 
1625 666 1574 226 266 154 
contig11293 5.372 0.047 0.00662 gi|148717315|dbj|BAF63671.1| protein disulfide 
isomerase-2 [Haem...   385 
1079 991 1433 118 261 321 
contig12246 5.285 0.025 0.00141 gi|194226870|ref|XP_001917242.1| PREDICTED: 
similar to adenylosu...   263 
800 656 796 102 136 204 
contig13068 4.948 0.035 0.00303 gi|27733415|gb|AAO21505.1|AF413064_1 serpin 
3a [Manduca sexta] >...    35 
86 141 113 26 29 15 
contig01538 4.922 0.047 0.00647 gi|47522760|ref|NP_999131.1| long-chain 3-
ketoacyl-CoA thiolase ...   129 
236 261 262 36 94 40 
contig01772 4.839 0.042 0.00507 gi|169217278|ref|XP_001732938.1| PREDICTED: 
hypothetical protein...    34 
1855 924 873 316 209 200 
contig12894 4.807 0.041 0.00395 gi|114153234|gb|ABI52783.1| mucin peritrophin 
salivary protein [...    70 
10902 25028 18318 3651 2948 4181 
contig02157 4.781 0.020 0.00072 gi|67083785|gb|AAY66827.1| secreted salivary 
protein [Ixodes sca...    48 
2033 2647 2771 406 517 650 
contig11681 4.723 0.025 0.00141 No hits found 270 184 294 55 63 40 
contig07116 4.637 0.041 0.00447 No hits found 318 384 429 54 128 76 
contig02324 4.524 0.041 0.00413 gi|41617918|tpg|DAA02898.1| TPA: TPA_inf: 
HDC09484 [Drosophila m...    33 
236 544 385 70 93 82 








Probe Fold change  
Fed vs Starved 
Corrected  
p  value 
p  value Gene description F1 F2 F3 S1 S2 S3 
protein VspiD_15445...    33 
contig03269 4.501 0.030 0.00197 No hits found 2036 3587 2760 784 530 532 
contig00212 4.364 0.043 0.00561 gi|193594270|ref|XP_001942800.1| PREDICTED: 
similar to S-adenosy...   154 
357 180 268 85 46 53 
contig00498 4.352 0.034 0.00261 gi|88602953|ref|YP_503131.1| HNH endonuclease 
[Methanospirillum ...    36 
4921 2929 3131 793 1072 644 
contig07176 3.996 0.041 0.00381 gi|28422163|gb|AAH46839.1| Plk-prov protein 
[Xenopus laevis]          147 
885 1163 1322 209 405 252 
contig10262 3.991 0.034 0.00272 gi|74318688|ref|YP_316428.1| metal dependent 
phosphohydrolase, H...    36 
176 117 129 25 44 38 
contig13261 3.972 0.016 0.00034 gi|157776976|ref|XP_001666554.1| hypothetical 
protein CBG15153 [...    65 
630 597 700 181 180 129 
contig07208 3.846 0.041 0.00411 gi|118462588|ref|YP_882079.1| CDP-alcohol 
phosphatidyltransferas...    37 
499 331 460 84 100 159 
contig11796 3.842 0.041 0.00432 gi|82705844|ref|XP_727137.1| hypothetical protein 
PY06477 [Plasm...    39 
1376 1865 1151 278 359 522 
contig04085 3.688 0.016 0.00042 gi|170094979|ref|XP_001878710.1| predicted 
protein [Laccaria bic...    33 
421 449 326 97 123 103 
contig03700 3.684 0.041 0.00426 gi|191171858|ref|ZP_03033404.1| Cps2D 
[Escherichia coli F11] >gn...    33 
767 464 416 141 178 118 
contig11620 3.591 0.047 0.00665 gi|149287114|gb|ABR23456.1| cytochrome c 
oxidase polyprotein IV ...    50 
237 202 392 65 99 63 
contig12001 3.529 0.049 0.00722 gi|50758110|ref|XP_415765.1| PREDICTED: similar 
to Malate dehydr...   326 
769 1149 1243 436 246 233 
contig09563 3.514 0.041 0.00459 gi|169213190|ref|XP_001714612.1| PREDICTED: 
hypothetical protein...    34 
74 48 61 24 13 16 
contig04310 3.443 0.025 0.00134 gi|158287073|ref|XP_309120.3| AGAP000935-PA 
[Anopheles gambiae s...   305 
409 371 600 127 122 144 
contig12071 3.434 0.034 0.00253 gi|109118856|ref|XP_001109939.1| PREDICTED: 
acid alpha-glucosida...    61 
1354 1749 1891 370 628 476 
contig00470 3.313 0.009 7.9E-05 gi|156353921|ref|XP_001623156.1| predicted 
protein [Nematostella...    66 
5270 5577 4710 1466 1497 1735 
contig11441 3.293 0.042 0.00473 gi|148657070|ref|YP_001277275.1| putative 
endoribonuclease L-PSP...   143 
1935 3275 3082 647 1005 841 
contig00543 3.287 0.049 0.00725 gi|170596615|ref|XP_001902831.1| FKBP-type 
peptidyl-prolyl cis-t...   103 
1640 1074 1284 276 418 552 
contig00223 3.269 0.022 0.00091 No hits found 3822 3836 5632 1437 1264 1301 
contig01770 3.234 0.029 0.00166 gi|189240738|ref|XP_968166.2| PREDICTED: 
similar to AGAP007574-P...   107 
586 461 712 209 152 179 








Probe Fold change  
Fed vs Starved 
Corrected  
p  value 
p  value Gene description F1 F2 F3 S1 S2 S3 
contig13047 3.100 0.042 0.00494 No hits found 3254 1913 1743 778 721 649 
contig03384 3.089 0.016 0.00041 No hits found 178 212 200 69 53 70 
contig12306 3.043 0.034 0.00259 gi|39653771|ref|NP_945222.1| NADH 
dehydrogenase subunit 5 [Haema...   125 
30010 22941 36701 7970 10556 10662 
contig00603 -4.429 0.035 0.00303 gi|77553801|gb|ABA96597.1| MYB10, putative, 
expressed [Oryza sat...    36 
849 921 954 2547 4826 5273 
contig07154 -4.765 0.035 0.00301 No hits found 36 49 42 193 138 301 
contig04870 -5.137 0.032 0.00218 gi|183979376|dbj|BAG30740.1| muscle myosin 
heavy chain [Papilio ...   244 
19 37 31 181 120 136 
contig00606 -32.170 0.020 0.00071 gi|189242145|ref|XP_001813277.1| PREDICTED: 
similar to polyprote...    70 






Figure 4.4. Frequency graph showing the number of contigs that had a fold change of over three 
between the number of sequences obtained from all three of the fed mite RNA samples and the 
number of sequences obtained from all three of the starved mite RNA samples. The values along 
the X-axis show fold changes between the fed and starved mites. The first column (Down) comprised 
of four contigs that were significantly down-regulated, with a fold change of more than three when the 

























4.4 Discussion  
 
The aim of the experiments described in this chapter was first to generate EST 
databases to provide EST sequences to identify homologues of possible vaccine 
candidates in D. gallinae; and second to use SSH and Illumina Solexa digital 
transcriptomics to identify transcripts that were differentially expressed between fed 
and starved populations of mites that could be potential vaccine candidates.  
 
To generate the initial database, total RNA was extracted from a population of fed  
D. gallinae mites and converted into cDNA. The cDNA was then transformed into a 
bacterial system to grow colonies that were then sequenced using Sanger sequencing 
(Sanger et al., 1977) of individual clones. BLAST analysis was then performed to 
identify proteins homologous to previously characterised vaccine candidates in other 
parasitic species. This classical approach has been used to generate EST databases 
for other species of ectoparasite, for example Psoroptes ovis (Kenyon et al., 2003). 
Mining the EST database to identify possible vaccine candidates can be achieved by 
probing two dimensional Western blots, prepared using a crude mix of parasite 
protein, with sera from immunised animals. MALDI-ToF analysis of protein spots, 
detected by Western blot, would identify peptide fragments that can be identified in 
the EST database (Tawe et al., 2001).  
 
The first database generated during the experiments described in this chapter 
contained only 46 contigs that had a significant homology to previously described 
sequences, 10 (22 %) of which were homologous to ribosomal sequences. These 
ribosomal RNA molecules were possibly present as an artefact of the synthesis step 
in the cDNA library construction, and demonstrates the problem of redundancy in 
this form of EST dataset mining.  
 
In this initial EST database, nine of the contigs had significant homology to enzymes. 
Enzymes have been studied as potential vaccine candidates in many parasitic species, 
and interference with their function may be a factor in protection. Immunisation with 




against a challenge of Leishmania mexicana. Mice that had been immunised with the 
recombinant protein and then challenged with 10
3
 parasites found to have a total 
absence of infection 10 weeks after the challenge (Connell et al., 1993). The native 
H-gal-GP, a protein complex of Haemonchus contortus that contains a pepsin-like 
aspartyl protease and several metallopeptidases, generates an immunological 
response that protects against a challenge of H. contortus, reducing the worm burden 
by up to 83 % and egg production by up to 97 % (Smith et al., 2003).  
 
One of the contigs was homologous to a glutathione S-transferase (GST) of Ixodes 
scapularis. GST is involved in the cellular detoxification process, and has been 
characterised and shown to reduce parasite burden by 78 % in GST-vaccinated sheep 
challenged with the liver fluke Fasciola hepatica (Rossjohn et al., 1997; Sexton et 
al., 1990). Another contig had significant homology to a serine protease precursor of 
the European paper wasp. The subsequent hits for this contig on the database were 
mostly serine proteases. On inspection of the BLAST alignments, a specific domain 
was recognised, and using InterProScan it was identified as the serine protease 
chymotrypsin. The proteinases hypodermin A, B and C, which are serine proteases, 
were purified from the instar stages of Hypoderma lineatum, a Dipteran which has a 
parasitic larval stage that lives in cattle, and were used to immunise naïve calves. The 
cattle develop a natural immunity to the parasitic stages after repeat infestation. 
Immunisation with these proteases generated an immune response in naïve animals 
comparable to the natural immunity during infestation. An antigen-specific 
lymphocyte response and antigen-specific antibody titres were observed in 
immunised animals. It was suggested that both the cellular and humoral pathways 
were involved in the immune response generated by the immunisation with these 
proteinases (Baron & Colwell, 1991). Serine proteases have also been used more 
recently to significantly lower parasite numbers when mice immunised with a serine 
protease were then challenged with 5x10
5 
L. donovani parasites, and showed 
complete protection. When the challenge was increased to 5x10
8
 parasites, an initial 






Three of the contigs present were homologous to viral proteins. The longest contig in 
the database was homologous to the Kashmir Bee virus, which is a virus of the 
Family Dicistroviridae. It has a worldwide distribution and infects bee and wasp 
species (de Miranda et al., 2010). The virus present in the mites could be a relative of 
this virus, or the mites could be a reservoir, or both. The rest of the top 25 hits in the 
unipr database for this contig were all viruses, many of which were closely related to 
the Kashmir Bee virus.  
 
The second EST database to be generated used Sanger sequencing technology to 
obtain the sequences of 960 cDNA clones from an SSH library constructed 
specifically to enrich for genes expressed after feeding. The common cDNA 
molecules between a library of fed and starved mites were removed, leaving only 
differentially expressed genes in fed mites. The contigs were organised into separate 
groups by hand since there were only 310 contigs in the database. After 
bioinformatic analysis, 133 contigs had significant homology to proteins in either the 
KEGG or the NCBI nr database, or had a protein domain predicted by InterProScan 
(Appendix 1).  
 
The two contigs assembled from the highest number of individual sequences had 
homology to vitellogenin and GP80, a precursor of vitellogenin (Tellam et al., 2002). 
Of the next four contigs in the list, three were vitellogenin or contained vitellogenin 
domains, determined by InterProScan (Hunter et al., 2009). Vitellogenesis is the 
process of yolk formation, where nutrients are deposited in the oocyte. For ticks, a 
bloodmeal is required to initiate the process. The meal stimulates the production of 
vitellogenesis inducing factor, which in turn stimulates the tick to secrete a fat body 
stimulating factor that stimulates the fat body to produce vitellogenin (Ogihara et al., 
2007). As previously described in 4.2.1, the mites collected were of mixed life stage 
and gender, and the majority were engorged. The female mites in the population 
would have been reproductively active and therefore ovigerous. Both purified native 
and recombinant GP80, from the tick R. microplus, have been used in a vaccine trial 




by 25 %. However, the recombinant form of the protein had no effect on the ticks 
(Tellam et al., 2002). 
 
As described previously, many different types of proteinases have been used to 
immunise hosts against a variety of parasites. Some of the contigs, comprising 7.2 % 
of the individual sequences, were homologous to proteolytic enzymes such cathepsin 
D, an aspartyl protease. Protection against the obligate haematophagous nematode  
H. contortus was generated after immunisation of sheep with a native aspartyl 
protease, which was purified from the H-gal-GP complex using gel filtration, with a 
reduction of 48 % in egg output and 36 % in worm burden. The protease was found 
to be located in the brush border of the worm‟s intestinal tract (Smith et al., 2003). 
Immunisation with a cocktail of proteases from H. lineatum, including a serine 
protease reduced the average number of the parasitic larval stage of the fly from 32 
larvae in the control group of cattle to five larvae in the immunised group (Baron & 
Colwell, 1991). Recombinant cysteine proteases have also been used to immunise 
dogs against hookworm. The proteases used were located in the brush border of the 
hookworm intestine, as for H. contortus. The immunised group had a significantly 
lower egg count (p ≤ 0.05) than the controls, although there was no significant 
difference in the number of worms recovered from the large and small intestine of 
vaccinated and control dogs (Loukas et al., 2004). The proteases that were located in 
the brush border either had their enzymatic activity inhibited (Newton & Munn, 
1999; Smith et al., 1997) or were blocked by a physical antigen-antibody complex 
(Knox et al., 2003). The protein Bm91 was characterised in R. microplus and a 
recombinant form of the protein was used to immunise cattle, which were then 
challenged with ticks. The recombinant protein generated an immune response that 
reduced the number of feeding ticks by up to 52 % when compared to the control, 
non-immunised cattle (Riding et al., 1994). Further studies of Bm91 showed that it 
has a similar amino acid sequence to carboxydipeptidases (angiotensin converting 
enzymes [ACE]) of mammals and is active in the convertional assay for ACE, which 
uses hippuryl-Gly-Gly as a substrate. It can also be inhibited by the drug Captopril 
and by 5 mM EDTA (Jarmey et al., 1995).  Proteinase inhibitors have also been used 




containing a range of inhibitors (McDevitt et al., 2006). Proteinases cleave proteins 
into smaller peptides or single amino acids for use by the organism, and blocking the 
protein‟s function causes disruption to the organism that can increase mortality. 
Proteolytic enzymes such as these are therefore suitable candidates for vaccines in  
D. gallinae, especially considering their role in bloodmeal digestion (Nisbet & 
Billingsley, 2000).  
 
The SSH library also contained four contigs, identified from seven sequences that 
were homologous to ribosomal proteins. More protein synthesis would be required 
during moulting, reproduction and egg-laying, which the mites require a bloodmeal 
to perform.  
 
Roche 454 sequencing technology allowed the formation of a large D. gallinae EST 
database in a very short space of time. This is especially useful when working with 
an organism that has not yet had its genome completely sequenced. The EST 
database formed from the Roche 454 sequencing described in this chapter contained 
13,363 contigs. The genome of Caenorhabditis elegans, a free-living nematode, has 
been completely sequenced (~10
8
 basepairs [bp]) and annotated, and has 
approximately 19,000 predicted genes (Hashmi et al., 2001). The tick Ixodes 
scapularis has a genome size of approximately 2.15
9
 bp (Ullmann et al., 2005) and 
has 24,785 genes described in the NBCI database (as of 27 June 2009). With the 
similarity observed in protein homology between tick species and D. gallinae, the 
number of genes expressed in the mite could be close to the total number of genes 
expressed in I. scapularis. With a redundancy in the database of 30 %, the  
13,363 contigs in this EST database could represent approximately a third of the 
genes of D. gallinae.  
 
The EST database generated by Roche 454 sequencing was too large to be analysed 
manually like the initial EST databases. The contigs were analysed using a semi-
automated process using BLAST to compare the contigs to the NCBI nr protein 
database and to assign identities to each contig; 26 % of the contigs had homology to 




that allocated the contigs into groups based on inferred function (Figure 4.3). The 
group containing the highest number of contigs was Cellular Processes and 
Signalling (45 %). Of the top 100 contigs that had significant homology to a known 
or predicted protein, 63 % were classified as Post-translational modification, protein 
turnover or chaperone proteins. The top three most significant hits in this group were 
contigs homologous to heat shock proteins. Heat shock proteins are up-regulated 
when an organism is under stress. They are also involved in monitoring the proteins 
within a cell, including chaperoning proteins to the proteasome to be recycled and 
folding proteins into their three dimensional structure (Tutar & Tutar, 2010). High 
turnover of proteins would be expected after feeding since there is a different 
expression profile of genes. Some of these differentially expressed genes have been 
identified in this study by sequencing an SSH library (4.3.2) and by using Illumina 
Solexa sequencing (4.3.4) to count the number of each transcript in RNA samples 
extracted from fed and starved mite populations.  
 
Other contigs in this group were cathepsin proteases. Cathepsin L, which has been 
used successfully in vaccination trials against parasites, was present in the database. 
It is a cysteine protease and has implied function in the moulting process of the 
filarial parasite Onchocerca volvulus (Lustigman et al., 2004) and feeding and 
immune evasion in Fasciola hepatica (Dalton et al., 2003). Multiple forms of the 
protein have been found that exhibit different tissue expression patterns and are 
expressed at different life stages (Irving et al., 2003). Native cathepsin L molecules 
have been purified from F. hepatica, the liver fluke, and were used in a vaccine trial 
that reduced parasite burden in the host by between 38.2 % and 69.5 % (Dalton et al., 
1996). Vaccine trials have also been carried out using different recombinant versions 
of F. hepatica cathepsin L. Immunisation of rats with recombinant cathepsin L and 
B, another cysteine protease, either singly or in combination, significantly reduced 
the parasite burden by at least 50 % (Jayaraj et al., 2009). RNA interference has also 
been used to interrupt the function of cathepsin L in the filarial parasite O. volvulus. 
This interruption to the function of cathepsin L resulted in the failure by the parasite 
to shed its cuticle and complete the moulting process; 86 % of the parasites failed to 




2004). As described in 1.2.2, D. gallinae moults three times during its life cycle, two 
of which require a bloodmeal to occur. The use of cathepsin L as a vaccine may 
result in the inability of the mite to moult if the molecule identified is involved in this 
developmental process. The presence of cathepsin L activity in D. gallinae has 
previously been established, where reduction in specific enzymatic activity was 
observed when using specific inhibitors (Nisbet & Billingsley, 2000). The cysteine 
protease Der p 1 was found in the excreta of the house dust mite Dermatophagoides 
pteronyssinus, suggesting the protein has a digestive function (Chua et al., 1988) as 
an alternative to, or in addition to, a role in moulting. The protein is produced in 
greatest quantity in cells of the gut epithelia and stored in secretary vesicles. This 
localisation of the protein to the gut suggests that cathepsin L could potentially be a 
vaccine candidate (Dalton et al., 2003).  
 
In the Roche 454 database there were also contigs that had significant homology to 
structural proteins such as tropomyosin, paramyosin, actin, tubulin and troponin T. 
Tropomyosin, actin and troponin T are all parts of the troponin complex, which is 
involved in muscle contraction (Ebashi et al., 1968). Recombinant troponin 
molecules have been used in immunisation trials against ticks, with mixed results. A 
troponin I-like protein of Haemaphysalis longicornis was characterised and a 
recombinant version was produced (You et al., 2001) and used in two immunisation 
trials. The first trial generated a protective immune response when rabbits were 
immunised with the recombinant protein. The ticks in the immunised group laid eggs 
that had a significantly lower weight than eggs laid by ticks in the control group. 
Also, adult and larval ticks took a significantly longer time to feed on animals 
immunised with the recombinant protein, but there was no significant difference for 
nymphs (You, 2004). During the second immunisation trial, mice were injected with 
the recombinant protein. Again a protective immune response was generated. The 
immune response caused a lowering of tick attachment rates from 98 % for the 
controls to 31.1 % for the test group (You, 2005). Troponin T has been cloned from 
the tick H. qinghaiensis and a recombinant protein was produced that was used with 
little effect in an immunisation trial. Sheep were immunised with the recombinant 




cause an increase in tick mortality, and the mass of engorged adults and nymphs 
from the immunised group were not significantly different than the controls. The 
percentage of viable eggs laid was also higher in immunised groups (Gao et al., 
2008). As described in chapter 5, paramyosin and tropomyosin have been 
successfully used to generate a protective immune response in hens against  
D. gallinae in immunisation trials. 
 
The group containing contigs homologous to proteins involved in “metabolism” was 
the second biggest category (26 %). Vitellogenin is a protein found in the yolk of 
eggs of many species, which provides nutrition to the developing organism (Tellam 
et al., 2002). It was represented three times in the top 10 most significant hits in this 
group. Of this category, 183 contigs (21 %) were homologous to proteins involved in 
energy production and conversion. The mite is a very active organism and, as 
previously described, travels relatively large distances to find a bloodmeal, which 
requires a great deal of energy. Contigs that were homologous to kinases were also 
present in the metabolism group. Kinases add phosphate groups to proteins from 
donor molecules such as adenosine triphosphate (ATP) to substrate proteins that are 
part of metabolic pathways. Glycolysis is the process by which hexokinase 
phosphorylates glucose, using ATP as a phosphate donor molecule as it enters the 
cell, to glucose-6-phosphate (Caret et al., 1993).  
 
Illumina Solexa sequencing was used in this study to count the numbers of each 
transcript in samples of RNA extracted from fed and starved mites, a process known 
as digital transcriptomics (Morrissy et al., 2009). The sequences were compared to 
the Roche 454 database to assign homology and a name to the count data. Only 
sequences with a count in all of the replicate samples were analysed to see if the gene 
expression was up- or down-regulated.  
 
The majority of the 66 differentially expressed contigs (fold change > 3x) in this 
dataset were up-regulated in fed mites. However, there were four transcripts that 




in fed mites was homologous to a characterised protein, which was muscle myosin 
heavy chain.  
 
The contig with the highest significant fold change was homologous to a vitellogenin 
gene (fold change of 110.853; p < 0.001); the second was also homologous to 
vitellogenin. Both these genes were up-regulated in fed mites. This result 
complemented that from the SSH library analyses, where vitellogenin was the most 
abundant gene. This is likely to have been due to a high percentage of adult female 
mites that were ovigerous following feeding.  
 
Another contig that was present in the Roche 454 EST database and the SSH library, 
and was found to be up-regulated was homologous to cathepsin L. The up-regulation 
of a proteinase such as capthepsin L was expected as a large quantity of protein from 
the hen blood would be present in the mite cells, and the proteinase would be 
required to digest it (Delcroix et al., 2006). As previously stated, cathepsin L has a 
role in moulting (Lustigman et al., 2004), and coupled with its digestion function 
cathepsin L could be a potential vaccine candidate.  
 
Experiments described in this chapter generated three EST databases that identified 
proteins that have been previously used in immunisation studies against various 
parasitic organisms, and that have been therefore selected by a rational process as 
potential vaccine candidates. The use of Roche 454 sequencing allowed the 
generation of a very large database. This database can now be further mined for 
previously described vaccine candidates from other parasitic species, as well as new 
candidates. A partial sequence of paramyosin was found in the Roche 454 database. 
Paramyosin has been used in vaccine trials against Schistosoma japonicum, where a 
recombinant form of the protein generated an immune response that reduced the 
adult worm burden of mice by up to 86 % (Ramirez et al., 1996). The full sequence 
for paramyosin was characterised and a recombinant version was used in an 
immunisation trial in chapters 5 and 6, respectively. The SSH library analysis found 
that vitellogenin was the most abundantly expressed transcript, and the transcripts 




that it was the most highly up-regulated transcript in fed mites. Using digital 
transcriptomics to count the exact numbers of each sequence in the samples gave a 
quantitative analysis which is not possible using an SSH library. The generation of 
the count data allowed statistical analysis to be performed, showing that there were 
significant differences in the levels of expression of genes between fed and starved 
mites.  
 
As stated at the start of this chapter, there were five sequences identified in publically 
available D. gallinae databases in January 2008. There are now currently three EST 
databases with over 13,000 contigs derived from D. gallinae, of which over 25 % 
have significant homologies to proteins from other species. Using the new 
sequencing technologies such as Roche 454 and Illumina Solexa, the genetic 
sequence of D. gallinae could be determined and then annotated. 
 
In summary, the experiments described in this chapter used four genetic sequencing 
approaches to identify possible vaccine candidates. Two EST databases were 
generated using material derived from total RNA; they were formed using classical 
EST techniques and Roche 454 sequencing technology to produce over 13,000 
contigs. A second EST database was generated using an SSH library, to identify 
genes that were differentially expressed between fed and starved mite populations. 
The fourth dataset was generated using Illumina Solexa sequencing to quantitatively 
analyse the differentially expressed genes between fed and starved mites. The genes 
identified in the SSH library were confirmed as being differentially expressed in the 
dataset generated using Illumina Solexa sequencing. All four datasets identified 









Chapter 5:  
 
Identification and characterisation of paramyosin and 






Recombinant proteins have been used successfully to immunise susceptible host 
organisms against many pathogens. Three protein antigens from the cell wall of 
Coccidioides posadasii, a soil-borne fungus that causes the human respiratory 
disease Coccidioidomycosis, were expressed and used to immunise mice. Of the 
vaccinated mice, which had been challenged with fungal spores, 90 % survived past 
90 days whereas all the control mice died by day 20 (Tarcha et al., 2006). In the field 
of ectoparasitology, the vaccine TickGARD™ was developed with the recombinant 
protein Bm86 as the antigen (Rand et al., 1989). However, Bm86 has only been fully 
characterised in Rhipicephalus microplus, R. annulus, R. decoloratus and 
Haemaphysalis longicornis (Canales et al., 2008; Liao et al., 2007).  
 
Two potential vaccine candidates for D. gallinae are paramyosin and tropomyosin. 
These proteins are powerful allergens (Nisbet & Huntley, 2006) that have been 
studied extensively worldwide as possible vaccine candidates against many parasite 
species, such as schistosomiassis (Chen et al., 2000; Ramirez et al., 1996), for 
paramyosin, and Acanthocheilonema viteae (Hartmann et al., 1997; Hartmann et al., 





Tropomyosin is a 41 kDa structural protein that is present in all types of eukaryotic 
cells. It is made up of two α-helical structures arranged as a coiled-coil and provides 
structural stability when joined end to end as part of the F-actin filament along with 
troponin, another actin filament binding protein. Tropomyosin has been found in 
many isoforms that have specific characteristics for the tissue in which they are 
found (Perry, 2001; Sereda et al., 2008). It is a flexible molecule that has regulatory 
properties in the sliding movement of actin filaments on myosin molecules. In the 




When calcium ions bind to troponin the tropomyosin molecules moves allowing 
myosin to bind the actin filament.  
 
The full sequence for tropomyosin has been identified in invertebrate species such as 
Dermatophagoides pteronyssinus (Asturias et al., 1998), D. farinae (Aki et al., 
1995), Psoroptes ovis (Huntley et al., 2004) and Dermanyssus gallinae (Nisbet et al., 
2006a). It is highly conserved, with the predicted D. gallinae protein having 89 % 
and 88 % identity to tropomyosin in two tick species, (R. microplus and  
H. longicornis) and 85 % identity to tropomyosin in the house dust mite (HDM) 
(Nisbet et al., 2006a). 
 
Tropomyosin has been used successfully in immunisation trials to elicit a protective 
immune response. Tropomyosin from A. viteae, a filarial nematode, has been used to 
immunise jirds against a challenge infection. For the initial immunisation, the native 
form of the protein was used with Tween 80 and Pluronic, Squalan adjuvant, and 
reduced the worm burden by up to 64.4 % (Hartmann et al., 1997). Jirds were also 
immunised with a recombinant version of the protein, which elicited up to a 35 % 
reduction in adult worm burden (Hartmann et al., 2006). 
 
However, immunisation of mice with DNA encoding the tropomyosin gene failed to 
provide protection against Onchocerca volvulus, even though a strong immune 




Paramyosin forms the core of the thick filament of invertebrate muscles, only, unlike 
tropomyosin, it is not found in vertebrates (Elfvin et al., 1976). It is a larger protein 
than tropomyosin, with a molecular mass of approximately 100 kDa.  
 
Paramyosin has been identified in many invertebrate species, including R. microplus 
(Ferreira et al., 2002), and has been identified as a possible vaccine candidate. The 




which were then challenged with the parasite. The reduction of adult worm burden in 
immunised mice compared to control mice was between 62.3 % and 86.0 % 
(Ramirez et al., 1996). Recombinant fragments of S. japonicum paramyosin were 
expressed and used to immunise mice, which were challenged after the final 
immunisation. All recombinant fragments reduced worm burden by between 23.1 % 
and 39.9 %, and reduced the number of eggs present in the host liver by between 
25.7 % and 77 .9 % (Zhang et al., 2006).  
 
5.1.3 Aims of chapter 
 
The aim of the work described in this chapter was to use the rational approach to 
vaccine development. This consisted of selecting proteins known to be vaccine 
candidates for other species of parasite (namely tropomyosin and paramyosin) and 
identifying, characterising and expressing the proteins to be used in an immunisation 
trial to generate antibodies. The protective nature of the antibodies generated was 







5.2 Material and Methods 
5.2.1 Polymerase chain reaction (PCR) 
 
PCR was used to amplify the genes of interest. The protocol for a standard PCR has 
been described in 2.2.8. 
 
The Advantage 2 polymerase mix (Clontech) was used to amplify DNA that was 
later used as a template to express a recombinant protein or DNA that was sent for 
sequencing. The Advantage 2 polymerase mix (Clontech) was used since it contains 
a proof-reading polymerase. For PCR using RACE ready cDNA, constructed as 
described in 5.2.5, the Advantage 2 kit was also used and a typical reaction is shown 
in Table 5.1. 
 
Table 5.1. Typical reaction using RACE ready cDNA and Advantage 2 polymerase mix. 
 Ingredient      Volume (µl) 
 Template (either 3‟ or 5‟ RACE ready cDNA) 2.5  
 Universal primer mix (UPM)    5  
 Gene specific primer (10 pmol)   1  
 10x Advantage 2 PCR Buffer    5  
 dNTP mix (10mM)     1  
 50x Advantage 2 Polymerase mix   1  
 PCR grade water     34.5  
 
The primers used in the cloning of tropomyosin and paramyosin are shown in tables 
5.2 and 5.3, respectively. The primers to amplify tropomyosin from a pGEM®-Teasy 
template, supplied by Dr A. Nisbet (Nisbet et al., 2006a), added Not1 and BamH1 
restriction sites. The reaction to amplify tropomyosin had an extension time of 1 min 
and the reaction to amplify paramyosin had an extension time of 3 min. All other 
















































































































































































































































































































































































































































































































































































































































































































































5.2.2 Restriction digestion of PCR products and pET-22b(+) plasmid 
DNA for ligation 
 
Approximately 350 ng of PCR product (20 µl) and 700 ng of pET-22b(+) plasmid 
(Novagen) were digested with 10 u of Not1 enzyme (1 µl) (Promega) and 1 µl of 10x 
buffer D. The volume was made up to 10 µl with molecular biology grade water 
(Sigma). The reaction was incubated for 1 hr in a 37 C waterbath. The QIAquick 
PCR purification kit (QIAGEN®) was used to purify the DNA from the excess 
enzyme and buffer, as described in 2.2.13. 
 
Approximately 200 ng of PCR product (15 µl) and approximately 400 ng of  
pET-22b(+) plasmid (15 µl), which had been digested with Not1, were then digested 
with BamH1 (1 µl; 10 u), diluted with 16 µl of 2x buffer E. The reaction was 
incubated for 1 hr in a 37 C waterbath. The QIAquick PCR purification kit 
(QIAGEN®) was used to purify the DNA from the excess enzyme and buffer, as 
described in 2.2.13. 
  
5.2.3 Dephosphorylation of plasmid by shrimp alkaline phosphotase  
 
The pET-22b(+) plasmid (30 µl) that had been digested sequentially with Not1 and 
BamH1 was dephosphorylated using 2 u (2 µl) of shrimp alkaline phosphotase (SAP) 
(Promega) and 3.5 µl of 10x buffer. The digestion was incubated at 37 C for 1 hr. 
The dephosphorylated pET-22b(+) plasmid was stored at -80 C until required. 
 
5.2.4 RACE ready cDNA  
 
The RACE ready cDNA was constructed by, and used with permission of,  
Dr A. Nisbet. The cDNA was constructed using the SMART RACE ready cDNA 





5.2.5 Cloning and characterisation of the paramyosin gene 
 
A partial sequence for paramyosin was found in the Roche 454 EST database, as 
described in chapter 4. This was used as a template to design primers to clone the rest 
of the sequence. The start of the known sequence was used to design the reverse 
primer Para454_Rev_Begin, and the end of the known sequence was used to design 
the forward primer Para454_For_End. The 5‟ RACE ready cDNA was used with the 
Para454_Rev_Begin primer to amplify the 5‟ end of the gene, and the 3‟ RACE 
ready cDNA was used with the Para454_For_End primer to amplify the 3‟ end of the 
gene. The UPM was used to extend the sequence in both directions. Figure 5.1 shows 






Figure 5.1. Diagram of initial primer sites for first PCR to extend the sequence of paramyosin. 
The dashed line represents the known part of the sequence from Roche 454 sequencing. The red 
primers are the UPM binding sites, the blue primer is Para454_For_End and the black primer is 
Para454_Rev_Begin. The unknown sequence would be filled in by PCR and Sanger sequencing. 
 
A second PCR reaction was set up, as described in 2.2.8, to amplify the 5‟ end of the 
paramyosin gene using the gene-specific primer Para454_Rev_Begin and the UPM, 
as shown in figure 5.1. The 5‟ RACE ready cDNA was used as a template and the 
number of cycles was increased from 25 to 30. Negative control reactions were also 
set up by replacing the UPM or the gene-specific primer with PCR grade water 
(Sigma) as negative controls.  
 
Four bands were cut out of the agarose gel and the DNA was extracted using the 
QIAquick gel extraction kit (QIAGEN®). All four DNA samples, 5‟, 3‟ A, 3‟ B and 
3‟ C, had very low concentrations of approximately 2.1 ng/µl. A PCR reaction was 
set up as described in 2.2.8 with the number of cycles increased from 25 to 30. The 





DNA sample 5‟ was used as template. The primers used in reactions 2, 3 and 4 were 
Para454_For_End and the UPM, and the extracted DNA samples 3‟ A, 3‟ B and 3‟ 
C, respectively were used as templates.  
 
A ligation was set up using the pGEM
®
-T vector and T4 ligase, as described in 
2.2.19. The construct plasmids were used to transform JM109 competent cells 
(Promega), as described in 2.2.10. After transformation, five white colonies were 
picked for samples 5‟, 3‟ B and 3‟ C and three white colonies were picked for sample 
3‟ A. These colonies were used to inoculate LBroth (10 ml) with 10 µl ampicillin  
(25 µg/µl stock). The cultures were incubated at 37 C overnight with shaking. The 
plasmids were purified using the Wizard Plus SV miniprep DNA purification kit 
(Promega), as described in 2.2.11. 
 
A gap of unknown sequences was left between the two contigs representing the 5‟ 
and 3‟ ends of the paramyosin gene. To sequence across this gap in the sequence, 
two primers were designed: Para_For_Gap and Para_Rev_Gap, as described in 5.2.1. 
These primers were used in two PCR reactions as described in 2.2.8, one with the 5‟ 
RACE ready cDNA using the gene-specific primers Para_For_Gap and 
Para_Rev_Gap and the other with the 3‟ RACE ready cDNA using the gene-specific 
primers Para_454_for and Para_454End_Rev.  
 
Primers were designed at the start and the end of the gene, excluding the termination 
codon, to allow the addition of a His-tag to be added by the pET-22b(+) plasmid, to 
amplify the whole gene: Para_start_For and Para_454End_Rev, as described in 5.2.1. 
Two PCR reactions were set up using Advantage 2 polymerase mix (Clontech), with 
primers Para_start_for and Para_454End_rev to amplify the full length paramyosin 
open reading frame (ORF) from both the 5‟ and 3‟ RACE ready cDNA. This full 
length amplicon was ligated into the pGEM
®
T vector, as described in 2.2.19, and 
transformed into JM109 competent cells, as described in 2.2.10. Three colonies were 
picked and a PCR reaction was set up using primers Para_start_for and 




reaction was purified using the QIAquick PCR purification kit (QIAGEN®), as 
described in 2.2.13. 
 
5.2.6 Expression of paramyosin and tropomyosin protein 
 
Tropomyosin had previously been cloned into pGEM
®
-T (Nisbet et al., 2006a) and 
this was used as the template for expressing the protein in pET-22b(+). A PCR was 
performed that used the primers DGTroFor2pet2 and DGTroRev2pet2 through  
30 cycles, and that used the pGEM
®
-T plasmid containing the tropomyosin amplicon 
as a template. 
 
The digested amplicons for tropomyosin and paramyosin were ligated into  
pET-22b(+) and pET-SUMO plasmids respectively. The pET-22b(+) plasmid had 
been digested with both Not1 and BamH1 and then dephosphorylated. The ligation 
reactions were described in 2.2.19. 
 
These constructed plasmids were first transformed into JM109 competent cells 
(Promega) to grow enough plasmid for the inefficient transformation into BL21-
CodonPlus® (DE3)-RIL competent cells (Stratagene), which were used to express 
the proteins. Transformations were carried out as described in 2.2.10. One colony 
from the first transformation into JM109 was grown in 10 ml of LBroth and 10 µl of 
ampicillin (25 µg/µl stock) overnight at 37 C with shaking. The plasmid was 
extracted using the Wizard SV plasmid purification kit (Promega). A PCR reaction 
was set up, as described in 2.2.8, to confirm transformation of the cells (data not 
shown). Another transformation was carried out using BL21-CodonPlus® (DE3)-
RIL competent cells.  
 
A single colony was grown in 10 ml of LBroth with 10 µl of both ampicillin  
(25 µg/µl stock) and chloramphenicol (50 µg/µl stocks) added overnight at 37 C 
with shaking. Glycerol stocks of BL21-CodonPlus® (DE3)-RIL cells transformed 
with plasmid containing either of the two genes were stored at -80 C, as described in 




LBroth in 1 L baffled conical flasks. D-glucose (10 ml, 100 mg/ml stock) was added 
to stop expression of the protein before induction, and 200 µl of both ampicillin  
(25 µg/µl stock) and chloramphenicol (50 µg/µl stock) were added. The cultures 
were incubated for 3 hr at 37 C with shaking. The optical density (OD) was 
measured using the Cecil spectrophotometer at a wavelength of 600 nm. Once the 
OD reached 0.4, a 1 ml aliquot was taken as a pre-induction sample; the sample was 
centrifuged at 14,200 x g on a bench top centrifuge the supernatant was removed and 
the cell pellet was stored at -20 C. Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
(400 µl of a 0.5 M stock) was added to each culture to induce protein expression. The 
cultures were incubated for a further 3 hr at 37 C with shaking. Another 1 ml aliquot 
was taken as a post-induction sample after the incubation, and treated the same as the 
pre-induction aliquot. The cultures were then split into 50 ml Falcon tubes and 
centrifuged at 3000 x g for 15 min at 4 C to pellet the cells. The supernatant was 
discarded and the pellet was stored at -80 C until required. 
 
The proteins were extracted from the cell culture that expressed paramyosin pre- and 
post- induction samples. The cell pellets were thawed and re-suspended in 1 ml of 
binding buffer without urea, as described in 2.1.6. The cells were sequentially frozen 
at -80 C then thawed in a waterbath at 42 C three times. The cell suspension had  
100 µl Triton X100 (20 %) in binding buffer without urea added and was mixed by 
inversion. The aliquots were centrifuged at 14,200 x g at RT. The supernatant 
contained the soluble proteins from the culture and the pellet contained all of the 
insoluble proteins. The supernatant (soluble fraction) was stored at -80 C until 
required. The insoluble protein pellet was re-suspended in 100 µl of binding buffer 
without urea. Once partly into solution, 900 µl of binding buffer with urea was added 
and as much of the pellet as possible was solubilised. The tubes were centrifuged at 
14,200 g for 10 min. The pellet was discarded and the supernatant, which contained 
the urea soluble proteins, was stored at -80 C until required. A PAGE gel was run to 
visualise the proteins to determine how the protein was expressed, soluble or 





Following these initial analyses, larger scale extractions were performed as follows: 
A cell pellet from a 50 ml culture was re-suspended in 5 ml of binding buffer with no 
urea. Cells were sonicated on ice for two 20 sec bursts. The sample was incubated at 
-80°C for 10 min then thawed. Triton X100 (20 %) in binding buffer without urea 
(500 µl) was added and the sample was incubated on ice on a rocker for 30 min. The 
bacterial culture was transferred into 1.5 ml tubes and centrifuged at 14,200 x g for 
10 min. The soluble proteins were in the supernatant, which was stored at -80 C until 
required, and the insoluble proteins were in the pellet. The pellets were re-suspended 
in 100 μl binding buffer without urea and then 900 µl of binding buffer with urea 
was added. The pellet was solubilised and centrifuged at 14,200 x g for 10 min. The 
supernatant, containing the urea-soluble protein, was decanted into a 1.5 ml tube and 
stored at -80 C. The remaining pellet was discarded. 
 
A PAGE gel was prepared showing the protein profile of the soluble and urea-
soluble fractions of the cell culture expressing the recombinant proteins.  
 
5.2.7 Purification of His-tagged urea-soluble protein using His-trap 
columns (GE-Healthcare) 
 
A 5 ml His-trap column (GE-Healthcare) was used to purify the His-tagged protein 
from the bacterial proteins. Five 1 ml urea-soluble protein fraction aliquots were 
purified at a time using the following protocol. 
 
The pump tubing was washed with dH2O and the flow rate was set to 5 ml/min. The 
column was attached to the pump using an adaptor. The column was washed with  
15 ml dH2O. Binding buffer with urea (15 ml) was used to equilibrate the column. 
The urea-soluble protein fraction (5 ml) was applied to the column using a syringe. 
An aliquot of 100 µl was retained as a pre-purified control (Sample A). The column 
was sealed top and bottom and placed on a rocker for 30 min at RT. The column was 
placed vertically on a stand to settle for 10 min. The column was washed with 25 ml 
of binding buffer without urea. The first 5 ml of elute was retained as Sample B, 




described in 2.1.6, was applied and the 5 ml elute was collected (Sample C). Elution 
buffer 2 (5 ml) described in 2.1.6, was applied and the 5 ml elute from the column 
was collected (Sample D). Elution buffer 3 (5 ml), described in 2.1.6, was applied 
and the 5 ml elute from the column was collected (Sample E). Elution buffer 4  
(15 ml), described in 2.1.6, was applied and the 15 ml from the column was collected 
in three 5 ml aliquots (Samples F, G and H). The column was washed with dH2O, 
recapped and stored at 4 C. The samples were stored at -80 C until required. 
 
The fractions were analysed by PAGE. 
 
5.2.8 Dialysis of urea and imidazole from protein  
 
Dialysis was used to remove the urea and imidazole buffer that was used to purify 
the recombinant protein. Purified protein (5ml) in 8 M urea and 500 mM imidazole 
was added to a section of dialysis tubing. A buffer with 2 M urea was prepared and 
the dialysis tubing was submerged and incubated overnight at 4 C. The protein in the 
2 M urea buffer was removed and stored at -80 C until required. 
 
5.2.9 Raising of antibodies against recombinant paramyosin and 
tropomyosin in Blackrock hens 
 
An immunisation study was carried out to raise antibodies against the recombinant 
paramyosin and tropomyosin. Four Blackrock hens were sourced at 16 weeks of age 
and housed in two floor pens under standard environmental and feeding conditions 
for four weeks prior to the study commencing. The hens began producing eggs at  
19-20 weeks of age. At 20 weeks of age, the hens were immunised with either 
recombinant paramyosin or tropomyosin. Each dose comprised 75 µg of recombinant 
protein (1 µg/µl), 200 µg of QuilA adjuvant (200 µg/µl), and PBS in a final volume 
of 300 µl. The injections were administered into alternate breast muscles of the hens. 
Following the primary injection, two booster injections were administered at two 





The experiment was carried out in accordance with the Animals (Scientific 
Procedures) Act 1986. The experiment was ratified by the ethics committee at 
Moredun Research Institute.  
 
5.2.10 Immunolocalisation of tropomyosin and paramyosin in sections 
of D. gallinae  
 
The antibodies raised in 5.2.9 could not be used to probe sections of D. gallinae 
since the mites in the sections had fed shortly before use so would have IgY in the 
gut. This would be detected by the anti-chicken IgY/HRP-labelled secondary 
antibody required to detect the antibodies raised. Sections of D. gallinae prepared for 
immunolocalisation, as described in 2.2.7, were probed with sera generated against 
Blomia tropicalis paramyosin (Blo t 11) and Dermatophagoides pteronyssinus 
tropomyosin (Der p 10). Table 5.4 shows the names and sources of the primary 
antibodies used. 
 
Table 5.4.  Antibodies used in the immunolocalisation, with references. 
Antibody       Reference 
Mouse monoclonal IgG anti-Blo t 11    (Ramos et al., 2003) 
Mouse polyclonal IgG anti-Der p 10    (Huntley et al., 2004) 
 
The anti-paramyosin antibody used in the immunolocalisation was raised against  
Blo t 11 and recognises paramyosin of other species of mites since, the protein is 
highly conserved.  
 
For immunolocalisations, the mouse monoclonal IgG anti-Blo t 11 was diluted 1:200 
and the mouse polyclonal IgG anti-Der p 10 was diluted 1:1000.  
 
The secondary antibody used was rabbit anti-mouse IgG/HRP conjugate (Sigma) at 






5.3.1 Cloning tropomyosin into expression plasmid pET-22b(+)  
 
Figure 5.2 is a photograph of a gel showing the tropomyosin amplicons amplified by 
PCR using the D. gallinae tropomyosin in the pGEM
®
-T Easy vector (used with 
permission of Dr. A. Nisbet) as a template. The tropomyosin amplicon purified using 
the QIAquick PCR purification kit (QIAGEN®) described in 2.2.15, that was 
digested using the restriction enzymes Not1 and then BamH1, as described in 5.2.2, 
had a concentration that was determined to be 69.1 ng/µl by nanodrop.  
 
 
Figure 5.2. The tropomyosin amplicon after amplification by PCR from pGEM®-T Easy 
construct. Lane M: 1 kb DNA markers (Invitrogen). Lane 1: 5 µl of PCR product was run. 
Tropomyosin amplicon is the intense band smaller than 1 kb. The size was consistent for the 
tropomyosin gene. * kb. 
 
5.3.2 Characterisation and cloning of paramyosin  
 
Figure 5.3 is a photograph of a 1 % agarose gel that shows the PCR product sizes 
from the initial PCR reaction to clone paramyosin from 5‟ RACE ready cDNA, as 
described in 5.2.4. Three DNA molecules were amplified from the 3‟ RACE ready 
cDNA (lane 2) and were extracted using the QIAquick gel extraction kit 










Figure 5.3. 5’ and 3’ RACE ready cDNA amplified by PCR using primers from both ends of the 
paramyosin gene sequence from the Roche 454 database to find the unknown intervening 
sequence. Lane M: 1 kb DNA markers (Invitrogen). Lane 1: 5 µl of product using 5‟ RACE ready 
cDNA as a template, no bands were present. Lane 2: 5 µl of product using 3‟ RACE ready cDNA as a 
template, bands marked A, B and C were cut out and purified. * kb. 
 
Figure 5.4 is a photograph of a 1 % agarose gel showing the size of DNA molecules 
amplified during the second PCR reaction using the primers Para454_Rev_Begin and 
the UPM, and the 5‟ RACE ready cDNA as a template, as described in 5.2.5. In 
figure 5.4, the DNA amplified in the reaction with both primers can be seen in lane 1. 
Lane 2 contained only UPM and lane 3 contained only the gene-specific primer, 
Para454_Rev_Begin. As can be seen, there is a band present in the reaction with both 
primers (indicated with a white arrow in figure 5.4, which is absent from the single 
primer controls in, lanes 2 and 3. This band, named 5‟, was excised from the gel and 

















Figure 5.4. 5’ RACE ready cDNA amplified by PCR using a gene-specific primer and the UPM 
to find the unknown sequence at the 5’ end of the paramyosin gene.  Lane M: 1 kb DNA markers 
(Invitrogen). Lane 1: Both UPM and gene-specific primer and 5‟ RACE ready cDNA as a template. 
Lane 2: As lane 1 but without the gene-specific primer. Lane 3: As lane 1 but without the UPM. The 
white arrow shows a band present in lane 1 that is absent in lanes 2 and 3. * kb. 
 
Figure 5.5 is a photograph of a 1 % agarose gel showing the sizes of the DNA 
amplified by the PCR reaction to increase the quantity of DNA present in each 
sample, as described in 5.2.5. The bands marked with a white arrow in figure 5.5 
were cut out and the DNA extracted using the QIAquick gel extraction kit 
(QIAGEN®), as described in 2.2.15. The concentration of the DNA extracted, which 
was measured by nanodrop, was higher than the first PCR, at approximately  













Figure 5.5. DNA, amplified by PCR to increase the quantity, was increased for ligation into the 
pGEM®T vector. Lane M: 1 kb DNA markers (Invitrogen). Lane 1: Sample 5‟. Lane 2: Sample 3‟ A. 
Lane 3: Sample 3‟ B. Lane 4: Sample 3‟ C. The bands marked with a white arrow were cut out. * kb. 
 
Figure 5.6 is a photograph of a 1 % agarose gel showing the size of DNA molecules 
amplified from the cloning sites of the constructed plasmids, as described in 5.2.5. 
As can be seen, the sizes of the DNA amplified were similar to that of the original 















Figure 5.6. Insert DNA, amplified by PCR, from each of the colonies that had DNA from 
unknown sections of the paramyosin gene. Lane M: 1 kb DNA markers (Invitrogen). Lanes 1-18: 
Amplified DNA inserts. Lanes 1-5: DNA sample 5‟ colonies 1-5 respectively. Lanes 6-8: DNA 
sample 3‟A colonies 1-3 respectively. Lanes 9-13: DNA sample 3‟B colonies 1-5 respectively. Lanes 
14-18: DNA sample 3‟C colonies 1-5 respectively. As can be seen, there was no inserts in samples 3‟ 
A1 or 3‟ A2. The insert size was similar to that of the equivalent bands in figure 5.5. * kb. 
 
Aliquots of plasmid extracted using the Wizard Plus SV Miniprep DNA purification 
system (Promega), as described 2.2.11, from the colonies that had a plasmid 
containing the gene were sent for sequencing at Eurofins MWG Operon, as described 
in 2.2.16.  
 
The Lasergene software Seqbuilder (DNASTAR) was used to find vector sequence, 
gene-specific primer sequence or UPM sequence and to trim them off the nucleotide 
sequence obtained from MWG Biotech. A search of the NCBI non-redundant protein 
database was then performed on the remaining sequence using the blastx function. 
Samples 5‟ 1, 3, 4 and 5 represented paramyosin genes, as did the sequences from 3‟ 
B. The insert from samples 3‟ A, 3‟ C and 5‟ 2 were not paramyosin; 5‟ 2 was 
vitellogenin. The Lasergene SeqMan program (DNASTAR) was used to assemble 
the sequences from sample 3‟ B, along with sequences from plasmids 5‟ 1, 5‟ 3, 5‟ 4, 
5‟ 5 and the sequence obtained from the Roche 454 sequencing, into two contigs; 
1 2 3 4 5 6 7 8 9 












contig 1 was 459 bases, which included the initiation codon, and contig 2 was  
2100 bases that included the termination codon and the poly A tail.  
 
Figure 5.7 is photograph of a 1 % agarose gel showing the size of the DNA 
molecules amplified by PCR using the gene-specific primers to amplify across the 
gap of missing sequence. The DNA molecule amplified in the reaction shown in lane 
1 was the unidentified sequence between the two contigs. It was amplified using the 
gene-specific primers Para_For_Gap and Para_Rev_Gap from the 5‟ RACE ready 
cDNA. A DNA molecule with a size of approximately 1 kb was cut from the gel and 
extracted using the QIAquick gel extraction kit (QIAGEN®), as described in 2.2.15. 
The concentration was measured by nanodrop (4.7 ng/µl) and the DNA sample was 
sequenced by Eurofins MWG Operon. The DNA molecule amplified in the reaction 
shown in lane 2 was amplified from the 3‟ RACE ready cDNA using the gene-
specific primers Para_454_for and Para_454End_Rev. A single band less than 1 kb 
was excised and extracted using the QIAquick gel extraction kit (QIAGEN®), as 
described in 2.2.15. The concentration was measured by nanodrop (7.1 ng/µl) and the 
DNA sample was sequenced by Eurofins MWG Operon.  
 
 
Figure 5.7. DNA amplified by PCR to sequence the unknown region between the two known 
contigs and the sequence generated by Roche 454 sequencing. Lane M: 1 kb DNA markers 
(Invitrogen).  Lane 1: DNA amplified to sequence the gap between two contigs.  Lane 2: DNA 
amplified to sequence the Roche 454-generated sequence. * kb. 
 
All the sequences obtained by PCR described in 5.2.5 were trimmed and assembled 
using the Lasergene suite software into one contig that contained the sequence for 
paramyosin. The entire sequence was 3,329 bases long with an ORF of 2,622 bases. 
Figure 5.8 shows the full nucleotide sequence for the paramyosin gene, along with 
the positions of all the primers used in the characterisation and cloning of the protein.  
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Figure 5.8. The full nucleotide sequence for D. gallinae paramyosin. This figure shows the full 
nucleotide sequence for the paramyosin gene, from the initiation codon to the poly-A tail. Primer 
binding sites are highlighted in colour. The termination codon is in bold. Para_start_For is highlighted 
in purple. Para_For_Gap is highlighted in yellow. Para_Rev_Gap is highlighted in red. Para_454_for 
is highlighted in green. Para_454End_rev is highlighted in blue. Para454_For_End is highlighted in 
dark blue. Para454_Rev_Begin is highlighted in light green. 
 
The complete paramyosin ORF was amplified by PCR, as described in 5.2.5. The 
amplified DNA had a size of ~3000 kb on a 1 % agarose gel (data not shown). The 
PCR amplicon from the reaction using the 5‟ RACE ready cDNA and a 3‟ RACE 
ready cDNA were excised and extracted using the QIAquick gel extraction kit 
(QIAGEN®), as described in 2.2.15. The DNA from each band was combined and 
the concentration measured by nanodrop (5.1 ng/µl). 
 
The amplicons from the PCR reactions to test the transformation of JM109 
competent cells with the paramyosin ORF inserts were the correct size in colonies 1 
and 2, shown on a 1 % agarose gel (data not shown). 
 
The plasmid from colony 2 was purified using the Wizard Plus SV miniprep 
(Promega), as described in 2.2.11. The concentration was measured by nanodrop to 
be 410 ng/µl. This plasmid was used in a transformation of BL21-CodonPlus® 
(DE3)-RIL competent cells (Stratagene), as described in 2.2.10. 
 
5.3.3 Expression and quantification of tropomyosin and paramyosin 
 
Tropomyosin and paramyosin were expressed as described in 5.2.6.  
 
Figure 5.9 is a scan of a PAGE gel prepared using an aliquot of total protein 
extracted by sonication from a BL21-CodonPlus® (DE3)-RIL cell pellet of a 50 ml 
culture, which had been induced to express tropomyosin. The bands around the  
38 kDa molecular mass marker were cut out and given to the Proteomics Department 
at Moredun Research Institute for Matrix Assisted Laser Desorption/Ionization 




tropomyosin was present in both samples. MALDI-ToF found peptides that covered 
55.4 % of the amino acid sequence for tropomyosin in band A but only covered  
27.8 % of the sequence in band B.  
 
 
Figure 5.9. A PAGE gel showing the protein profile of the soluble proteins of BL21 cells after 
induction of the plasmid containing the tropomyosin gene. Lane M: SeeBlue plus 2 molecular 
mass markers (Invitrogen). Lane 1: The soluble protein profile from the BL21 cells after protein 
extraction. The gel was stained with SimplyBlue
™
 SafeStain. The two bands at a molecular mass of 
approximately 38 kDa. Band A and Band B were cut out and sent for MALDI-ToF analysis. * kDa. 
 
Figure 5.10 is a scan of the PAGE gel showing the tropomyosin protein extracted in 
the soluble and insoluble phases. Tropomyosin was expressed at higher quantities in 


















Figure 5.10. A PAGE gel showing the expression of tropomyosin in the soluble and insoluble 
phases. Lane M: SeeBlue plus 2 molecular mass markers (Invitrogen). Lane 1: The soluble protein 
profile from the BL21 cells after protein extraction. Lane 2: The insoluble protein profile from the 
BL21 cells after protein extraction. Tropomyosin can be seen as a band with a molecular mass slightly 
higher than 38 kDa. * kDa 
  
Figure 5.11 is a scan of a PAGE gel showing the fractions from one of the 
purifications of tropomyosin. PAGE gels for the other purifications were similar 
(data not shown). Tropomyosin was eluted in protein fractions D and E in all the 
purifications. 
  











Figure 5.11. A PAGE gel showing protein fractions eluted during a purification of His-tagged 
tropomyosin expressed by BL21 competent cells. Lane M: SeeBlue plus 2 molecular mass markers 
(Invitrogen). Lane 1: Fraction A sample before binding to the column. Lane 2: Fraction B unbound 
proteins after first elution. Lanes 3-8: Fractions C-H with increasing concentration of imidazole. 
Tropomyosin released from the column over fractions D and E. * kDa. 
 
Figure 5.12 is a scan of the PAGE gel that shows the pre- and post-induction samples 
taken from the BL21-CodonPlus® (DE3)-RIL competent cell culture expressing 
paramyosin. The bands at about 98 kDa in both the soluble and insoluble protein 
phases were cut out for MALDI-ToF analysis. Searches of the public databases 
Uniprot and NCBI nr databases were performed, as described in 2.2.17. After peptide 
mass fingerprint analysis, the R. microplus form of paramyosin was found to be the 
top hit in the insoluble protein fraction. Paramyosin was purified as described in 


















Figure 5.12. A PAGE gel showing the insoluble and soluble protein extracts of the pre- and post-
induction samples of the paramyosin culture. Lane M: SeeBlue Plus 2 protein markers. Lane 1: 
Post-induction soluble proteins. Lane 2: Pre-induction soluble proteins. Lane 3: Post-induction 
insoluble proteins. Lane 4: Pre-induction insoluble proteins. Bands at 98 kDa in both lanes 1 and 3 
were paramyosin; the bands were cut out for MALDI-ToF analysis to confirm. Paramyosin was 
expressed in greater quantities in the insoluble proteins post-induction.  
 
Figure 5.13 is a scan of a PAGE gel showing the eight eluted fractions from one of 
the paramyosin protein purifications; the protein was eluted in the same fraction 
during the other purifications (data not shown). As can be seen, the protein was 
eluted from the column in fractions D and E with a very small quantity eluted in 
fraction F. 
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Figure 5.13. A PAGE gel showing protein fractions eluted during a purification of His-tagged 
paramyosin expressed by BL21 competent cells. Lane M: SeeBlue plus 2 molecular mass markers 
(Invitrogen). Lane 1: Fraction A sample before binding to the column. Lane 2: Fraction B unbound 
proteins after first elution. Lane 3-8: Fractions C-H with increasing concentration of imidazole. 
Paramyosin released from the column over fractions D and E. * kDa. 
 
Fractions D and E that contained paramyosin were combined, and fractions D and E 
that contained tropomyosin were combined. The concentration of protein was 
measured in the two samples using the BCA assay (Pierce), as described in 2.2.1, to 
be 7 µg/µl for tropomyosin and 5 µg/µl for paramyosin. Both were diluted to a final 
concentration of 1 µg/µl.  
 
5.3.4 Seroconversion of paramyosin and tropomyosin in Blackrock 
hens 
 
Antibodies were raised against the two proteins using the protocol described in 5.2.9. 
Western blots, as described in 2.2.5, were prepared and probed with antibody raised 
against the recombinant forms of these proteins. Immunolocalisations, as described 
in 2.2.7, were prepared and probed with antibody raised in mice against Der p 10 and 
Blo t 11. 
 
Figure 5.14 shows scans of Western blots of native D. gallinae proteins and 
recombinant forms of tropomyosin and paramyosin probed with antibodies raised 
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against recombinant D. gallinae tropomyosin and paramyosin. These proteins are not 
detected by antibodies from non-immunised hens. Bands can be seen at the correct 
molecular mass for tropomyosin in all lanes probed with the test sera. The 
recombinant form for paramyosin appeared to have break-down products. An intense 
band is detected at about 98 kDa, the correct molecular mass for paramyosin, along 
with numerous bands at smaller molecular masses down to approximately 40 kDa 










Figure 5.14. Scans of Western blots showing immunoreactive bands at the correct molecular 
masses for native and recombinant tropomyosin and paramyosin. Panel A: tropomyosin. Panel B: 
paramyosin. For both Western blots: Lanes 1 and 6: PBS-soluble proteins. Lanes 2 and 7: Membrane-
associated proteins. Lanes 3 and 8: Integral membrane proteins. Lanes 4 and 9: Insoluble proteins. 
Lanes 5 and 10: Recombinant protein. Lanes 1-5 were probed with test sera and lanes 6-10 were 
probed with control sera. Lane M: SeeBlue plus 2 molecular mass markers (Invitrogen). * kDa. 
 
Figure 5.15 shows three photographs of sections of D. gallinae probed with 
antibodies against Blo t 11 and Der p 10, as described in 5.2.10. A control section 
was probed only with the secondary antibody, a rabbit polyclonal anti-mouse 
IgG/HRP conjugate (DakoCytomation). There was a higher intensity of staining 
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present in the locomotory muscle bundles in the two test sections when compared to 
the control section. 
 
 
Figure 5.15. Immunolocalisations of sections of D. gallinae probed with sera raised against 
paramyosin and tropomyosin. Panel A: paramyosin. Panel B: tropomyosin. Panel C: No primary 
antibody control slide. LM = locomotory muscle bundles. Brown staining from DAB represents the 
presence of protein.  
 
5.3.5 Assessment of paramyosin and tropomyosin as vaccine 
candidates by in vitro feeding assays  
 
Three in vitro feeding assays were carried out on different dates to assess the 
protective capabilities of the antibodies raised against the two recombinant proteins 
along with a control group. The assay was set up as described in 2.2.6. Antibody was 
extracted from the yolk of eggs laid six weeks after initial immunisation for the test 
groups, as described in 2.2.4. Eggs from unvaccinated hens were collected and the 
IgY was extracted to act as controls. Fresh blood (2 ml) from Lohmann Brown hens, 
which had no prior exposure to mite antigens, was collected and mixed with 6 mg of 
antibody in solution (1 ml). 
 
Figure 5.16 is a graph of the cumulative percentage mortality of the mites fed 
antibodies raised against tropomyosin and paramyosin against time in days. The 
mortality of the mites from the test groups was higher than that of the control groups. 
On day four the average percentage mortality was 33 %, 28 % and 9% in the 










paramyosin, tropomyosin and control groups, respectively. The data was fitted to a 
simple logistic regression model, which individually compared the mortality from 
both test groups with that of the controls over the course of the experiment. This 
model gave a p value of ≤0.001 when the anti-tropomyosin antibody group was 
tested against the controls and a p value of 0.004 when the anti-paramyosin group 
was tested against the controls. 
 
Figure 5.16. Cumulative percentage mortality of D. gallinae fed heparinised chicken blood 
enriched with antibodies raised against tropomyosin, paramyosin and negative control. 
Mortality was monitored daily over a four day period following feeding. Each point represents 
cumulative mean percentage mortality and is derived from data recorded in three independent 
experiments. A simple logistic regression model was fitted using three replicates per group. The  
p values for tropomyosin ≤0.001 and for paramyosin ≤0.004. The error bars represent the SEM. 
 
5.3.6 Phylogenetic analysis of paramyosin and tropomyosin 
 
Phylogenetic trees were constructed showing the relative distance and genetic 
identity of the proteins compared to orthologues of the same protein in other species 












































neighbour-joining trees 1000 times based on the amino acid sequence of the protein, 
which were then viewed in TreeView (Page, 1996).  
 
Figure 5.17 is a phylogenetic tree showing the relationship between the sequences of 
20 tropomyosin molecules from different species. The tropomyosin sequence from  
D. gallinae was placed closely with those of two tick species, R. microplus and  
H. longicornis, with an amino acid sequence identity of 89 % and 88 %, respectively. 
The sequences for tropomyosin from four mite species were more distantly related.  
D. farinae and Psoroptes ovis both had an 85 % amino acid identity with D. gallinae.  
 
Figure 5.18 is a phylogenetic tree showing the relationship between the sequences of 
17 paramyosin molecules from different invertebrate species. The D. gallinae 
paramyosin sequence was again closely related to the tick species R. microplus and 
Ixodes scapularis, with which it had amino acid sequence identities of 83 % and  
81 %, respectively. The identity of this sequence to the other mite species was 76 % 








































































Figure 5.17. Phylogenetic relationship between selected sequences for the tropomyosin protein 
from different species. The neighbour-joining tree was bootstrapped 1000 times using Clustal X and 
the resulting tree viewed with TreeView. Each node is annotated with a figure indicating the degree of 
bootstrap support for each branch. Abbreviations and Accession numbers are as follows: Dermanyssus 
gallinae (AM167555), chicken (Gallus gallus AAA48580), Psoroptes ovis (CAJ38272), Der p 10 
(Dermatophagoides pteronyssinus AAB69424), Der f 10 (Dermatophagoides farinae Q23939), Lep d 
10 (Lepidoglyphus destructor CAB71342), Tyrophagus (Tyrophagus putrescentiae AAT40866), 
Haemaphysalis (Haemaphysalis longicornis AAN05633), Boophilus (Rhipicephilus (Boophilus) 
microplus AAD17324), Homarus (American lobster Homarus americanus O44119), Pen a 1 (brown 
shrimp Farfantepenaeus aztecus AAZ76743), Toxoptera (brown citrus aphid Toxoptera citricida 
AAU84930), Periplaneta (American cockroach Periplaneta americana AAD19606), Anisakis 
(Anisakissimplex CAB93501), Trichostrongylus (Trichostrongylus colubriformis A44980), Haliotis 
(California red abalone Haliotis rufescens CAA53028), Schistosoma (Schistosoma haematobium 
Q26503), human3 (Homo sapiens tropomyosin 3 CAH71269), Danio (zebrafish Dino rerio 












































Figure 5.18. Phylogenetic relationship between selected sequences for the paramyosin protein 
from different species. The neighbour-joining tree was bootstrapped 1000 times using Clustal X and 
the resulting tree viewed with TreeView. Each node is annotated with a figure indicating the degree of 
bootstrap support for each branch. Abbreviations and Accession numbers are as follows: dgall 
(Dermanyssus gallinae), Povis (Psoroptes ovis (CAJ38271)), HDM (Dermatophagoides 
pteronyssinus AAO73464), Rmicroplus (Rhipicephalus (Boophilus) microplus AAO20875), 
Schistosoma (Schistosoma japonicum AAD29285), Ancylostoma (dog hookworm Ancylostoma 
caninum ABC86903), Brugia (Brugia malayi Q01202), Sarcoptes (Sarcoptes scabiei AAK01181), 
Blomia (Blomia tropicalis AAM83103), Drosophila (Drosophila melanogaster CAA41557), 
Dictyocaulus (bovine lungworm Dictyocaulus viviparus AAT36324), Onchocerca (Onchocerca 
volvulus A48575), Apis (honey bee Apis mellifera XP_393281), Taenia (pork tapeworm Taenia 
solium AAK58494), Cpanda (Chorioptes panda ACB30406),  Celegans (Caenorhabditis elegans 






The experiments described in this chapter highlight the potential of two proteins, 
tropomyosin and paramyosin, to be used as a vaccine, either singly or as part of a 
cocktail of recombinant proteins along with other proteins such as histamine release 
factor, which has been shown to generate antibodies that significantly (p = 0.004) 
increase the mortality of mites (Bartley et al., 2009). To that end, the coding 
sequence of paramyosin has been identified (figure 5.8). Tropomyosin had already 
been characterised (Nisbet et al., 2006a), and both proteins were expressed as 
recombinant proteins (figures 5.11 and 5.13, respectively). The proteins were 
expressed in the insoluble fraction in the bacterial expression system. This could 
have been due to the large volume that the cultures were grown in. In future, cultures 
could be grown in a smaller volume to solubilise the proteins successfully. However, 
the proteins were diluted in PBS when the immunisations were formulated, so the 
concentration of urea injected into the hens was relatively small and did not seem to 
have a deleterious effect on the hens.  
 
Antibodies generated against Der p 10 (tropomyosin) and Blo t 11 (paramyosin) 
were used to probe sections of D. gallinae, showing that homologous proteins 
recognised by the antibodies were present in locomotory muscle bundles, where the 
proteins would be expected to be expressed (figure 5.15). Antibody extracts from egg 
yolks collected from Blackrock hens immunised with the recombinant form of the 
two proteins were used in a Western blot and showed that a strong antibody response 
was generated (figure 5.14). This would be passed on to the chick as a large part of 
the early defence system (Rose, 1979). These antibodies were tested in the in vitro 
feeding assay described in chapter 3. There was a statistically significant increase in 
the mortality of the mites fed blood mixed with antibodies raised against the 
recombinant proteins, when compared to the control group (tropomyosin p < 0.001; 
paramyosin p = 0.004). This suggests that the antibodies generated bond to the 
proteins and interfere with their function to a significant degree. In the case of 
tropomyosin, these antibodies could inhibit the flexibility of the protein, which it 




form a stiff version of tropomyosin, which was found to inhibit the proper function in 
tropomyosin and allow actin filaments to slide on myosin molecules, even when 
calcium ions were bound to troponin (Mizuno et al., 2007). Paramyosin forms the 
core of the cytoskeleton filament so flexibility, to the same degree as tropomyosin, is 
not required. The antibodies that bind to paramyosin may disrupt the formation of the 
filament, which in turn would lead to a breakdown of the cellular cytoskeleton. The 
malformation of the cellular cytoskeleton could lead to cell death and the breakdown 
of the mite‟s gut, which could explain the characteristic “red leg” phenotype that can 
be seen in some of the dead mites observed (figure 3.10).  
 
The cumulative percentage mortality of the mites that had been fed antibodies 
generated against the recombinant protein after five days for tropomyosin and 
paramyosin was 28.0 % and 32.8 % respectively. These figures are comparable to the 
34.4 % reduction in A. viteae adult worm burden when tropomyosin was used to 
immunise jirds (Hartmann et al., 1997) and the reduction of S. japonicum burden of 
between 23.1 % and 39.9 % when paramyosin was used to immunise mice (Zhang et 
al., 2006). These are both endo-parasitic organisms and are continually under 
pressure from the host immune system. As discussed in chapter 3, this assay offers 
D. gallinae mites blood for only one night, which relates to one bloodmeal. During 
the course of the D. gallinae life cycle, a mite will feed multiple times, which 
exposes it to the host immune system. The percentage mortality observed could 
increase as mites feed multiple times. 
 
There are many vaccines on the market that use recombinant proteins as the active 
component such as RECOMBIVAX HB
®
, which is a vaccine against Hepatitis B. 
The active antigen in the vaccine is a recombinant version of the surface antigen 
HBsAg. To date however, there have been only two recombinant protein vaccines on 
the market to control ectoparasites. These are TickGARD™ and Gavac™, which are 
used to control the tropical cattle tick R. microplus. TickGARD™ has now been 
withdrawn from the market in favour of using chemical control to the tick  
R. microplus. The active part of these vaccines is the gut-associated membrane-




as H. longicornis (Liao et al., 2007) and Boophilus annulatus (Canales et al., 2008). 
Bm86 has not yet been characterised in D. gallinae. Probing a Western blot with the 
urea-soluble proteins extracted from D. gallinae with an antibody raised in rabbits 
against Bm86 shows an immunoreactive protein with a molecular mass of about  
98 kDa (data not shown). The immunoreactive band was very specific with only a 
single band appearing on the lane of the Western blot. However, when the proteins 
around the region of the immunoreactive bands were excised and analysed by 
MALDI-ToF spectrophotometry, none showed any homology to Bm86. The quantity 
of D. gallinae protein loaded on to the gel may have been too low to have the Bm86 
homology in D. gallinae present in sufficient quantity for the MADLI-TOF analysis 
to detect. MALDI-ToF analysis would only detect the proteins present in greater 
quantities. To obtain 3.3 mg of antigenic material, which would have included 
Bm86, 1.368 kg of ticks were processed (Willadsen et al., 1988). Therefore this 
protein only makes up a tiny fraction of the proteins present in the tick and possibly 
in D. gallinae. Although Bm86 has not yet been characterised in D. gallinae, there is 
evidence to suggest that there is a homologue present, and it could be identified by 
using the same protocol (Willadsen et al., 1988). However, the amino acid identity of 
a possible D. gallinae homologue of Bm86 could be as low as 37 %, which was the 
case for Ba86 (Canales et al., 2008). The low percentage identity could explain why 
degenerate primers designed from the sequences already present did not amplify the 
gene from D. gallinae cDNA (data not shown). 
 
Although Bm86 has not been identified in D. gallinae, recombinant Bm86 and 
subolesin, a regulatory protein in control of multiple cellular pathways (Galindo et 
al., 2009), have been used to immunise hens. An in vitro feeding assay was then used 
to monitor and assess any protective qualities of the antibodies raised. The antibodies 
raised against these recombinant proteins significantly increased the mortality of the 
mites when compared to mites fed antibodies from a control group, but not to a 
degree where they could be used on their own as a vaccine (Harrington et al., 2009a).  
 
The reduction in survival elicited by the antibodies generated against all the proteins 




immunise cattle against R. microplus. Homologues of Bm86 and subolesin might not 
be present in D. gallinae. Since the mortality of the mites fed anti-tropomyosin and 
paramyosin antibodies was only a maximum of 28.0 % and 32.8 % respectively, 
these and other antigens may have to be combined to produce a cocktail vaccine that 
would offer a higher level of mortality in the mites.  
 
Phylogenetic analysis of tropomyosin (figure 5.17) and paramyosin (figure 5.18) 
identified the species with the closest sequence identity to ticks rather than other 
mites. Amino acid homology with D. gallinae tropomyosin was highest in  
H. longicornis and I. scapularis for tropomyosin and paramyosin respectively. A 
protein homologous to the tick histamine release factor (HRF), which is expressed in 
many tissues of the tick, including the salivary glands, mid-gut, ovary and 
haemocytes, was identified in D. gallinae and expressed as a recombinant protein. A 
phylogenetic analysis of HRF showed that the D. gallinae protein was closely related 
to that in orthologous proteins from  tick species of the order Ixodida (Bartley et al., 
2009). The similarities in the genetic makeup of D. gallinae and ticks could be very 
important. If there is a close relationship between D. gallinae and tick it could mean 
that the vaccine candidates targeting tick species could be successful in D. gallinae. 
For example, Bm86 the antigen in TickGARD™, which has been reference 
throughout this thesis, was used to immunise hens. There was no significant 
difference between the mortality of mites in the test and control groups when  
D. gallinae were fed antibodies against Bm86 (Harrington et al., 2009a). However 
Bm86 has not been identified in many tick species and where it has been identified 
the sequence homology was very low. A Bm86 like protein in D. gallinae may 
perform the same role as in R. microplus but have a very different genetic sequence. 
This may be the case for other proteins identified in ticks as vaccine candidates. 
 
The experiments described in this chapter have shown that tropomyosin and 
paramyosin are present in D. gallinae and an immune response, specifically an 
antibody response, is generated against them. When these antibodies were tested in 
an in vitro feeding system, they had a significantly deleterious effect on the longevity 










Testing the protection afforded to hens after 
immunisation with a cocktail of recombinant proteins 
and a complex mix of PBS-soluble proteins from  







The experiments described in chapters 3 and 5 demonstrated that both the PBS-
soluble fraction of proteins extracted from Dermanyssus gallinae (Wright et al., 
2009) and two recombinant proteins, tropomyosin and paramyosin, generated 
antibodies that had a killing effect on D. gallinae when fed to mites in an in vitro 
feeding assay. The experiments described in this chapter used those proteins along 
with three additional recombinant D. gallinae proteins, cathepsin D, cathepsin L and 
histamine release factor (HRF) (Bartley et al., 2009), in an in vivo immunisation trial.  
 
When working with an ectoparasitic species which spends all its time on a 
mammalian host, a vaccine trial is relatively simple to design. The trials which tested 
the vaccine TickGARD™ against the tick Rhipicephalus microplus, in cattle, were 
straightforward in design. The tick attaches to its host and can be easily monitored 
throughout the experiment. After the parasite has fed, it will be engorged with blood 
and will be easy to locate in the animal enclosure (Hope et al., 2010). The 
ectoparasite can also be restricted to specific area of the host animal. For example, 
rabbits were infested with the brown ear tick R. appendiculatus, the ticks could be 
restricted to the ears by the use of ear bags (Yamada et al., 2009). When working 
with D. gallinae, the main problem is containment. The mites can move freely 
between the cages in a battery system (personal unpublished observation) and are 
therefore difficult to retain for observation. Although the hen is a relatively small 
animal, experiments have been performed where specifically built containers with 
mites inside were attached to the back of hens (Arkle et al., 2009). The feeding rate 
of the mites fed using this in vivo method was compared to the feeding rate of mites 
using an in vitro feeding assay. The feeding rates of those fed using the in vitro 
feeding assay were higher than those fed using the in vivo system. However as, 
discussed in chapter 3, the reporting of some results in that study was inconsistent.  
 
During the immunisation trial described in this chapter, the hens were injected with 
proteins known to generate a protective antibody response (PBS-soluble fraction), 




cathepsin D, cathepsin L and HRF, and then challenged with D. gallinae. To contain 
the mites, the legs of the cages were placed in buckets of water and diatomaceous 
earth, which can be used as a non-chemical control agent (Maurer et al., 2009), was 
piled around the blocks of cages to contain the mites within their designated 
treatment groups.  
 
6.1.2 PBS-soluble fraction extracted from D. gallinae  
 
The PBS-soluble fraction was included in this experiment as the proteins generated 
an anti-mite antibody response, which was demonstrated by use of the in vitro 
feeding assay experiments described in chapter 3. The PBS-soluble protein fraction 
was made up of a complex mix of proteins and other macromolecules. The 
antibodies raised against the PBS-soluble fraction, as described in chapter 3, 
recognised proteins with molecular masses from 17 kDa to 188 kDa. The PBS-
soluble protein fraction has been shown to contain proteins such as tropomyosin and 
paramyosin, as described in chapter 5, which were also represented in the 
recombinant protein cocktail.  
 
6.1.3 Recombinant protein cocktail 
 
A recombinant protein cocktail was used to immunise one of the groups of hens in 
the trial. The recombinant proteins included tropomyosin, paramyosin, cathepsin D, 
cathepsin L and HRF. These proteins were expressed using either the pET SUMO 
expression system (Invitrogen) or the pET-22b(+) plasmids expressed in  
BL21-CodonPlus® (DE3)-RIL competent cells (Stratagene). 
 
Tropomyosin and paramyosin, which have molecular masses of 38 kDa and 98 kDa 
respectively, have been shown to generate antibodies that significantly increased the 
mortality of a population of mites that were fed blood containing the antibody in the 
in vitro feeding assay, as described in chapter 5. The mortality of the mites was 
increased from 9 % in the control group to 28 % in the tropomyosin group and 33 % 





Cathepsin D and L proteinases, which have molecular masses of approximately  
45 kDa and 40 kDa respectively, were produced in recombinant form and used to 
generate antibodies by Dr. K. Bartley (Moredun Research Institute). The antibodies 
were fed to mites in the in vitro feeding assay and an increase in mortality was seen 
when compared to the controls. The mortality increased from 9 % in the controls to 
32 % in the cathepsin D group and 18 % in the cathepsin L group (Bartley et al., 
unpublished). Proteinase inhibitors, which inhibit a broad range of enzymes such as 
serine, cysteine, aspartic and metalloproteinases, were added to hen blood fed to  
D. gallinae in the in vitro feeding assay. The results showed an increase in mortality 
of mites fed the proteinase inhibitors when compared to the control group (McDevitt 
et al., 2006).  
 
HRF, which has a molecular mass of 23 kDa, has been identified in D. gallinae and 
the sequence has been obtained. Phylogenetic analysis of the sequence showed that it 
clustered with the homologous proteins in ticks, however this was the first 
description of the protein in a mite species. Antibodies were raised against HRF in 
hens and fed to mites in the in vitro feeding assay. There was a significant difference 
in the mortality (p = 0.004) between the control (2.8 %) and test groups (9.2 %) 





The purpose of the experiments described in this chapter was to test the protective 
capability of native mite PBS-soluble proteins and a recombinant protein cocktail 
(containing tropomyosin, paramyosin, cathepsin D, cathepsin L and HRF) in vivo. 
The protective nature of the antibodies generated in the hens was measured by 
monitoring the population of a D. gallinae challenge. Western blots were prepared 
with the proteins, probed with the antibody raised in the hens, and developed using 
DAB. A densitometric measurement of the intensity of the DAB staining was used as 





Behavioural observations, egg production and hen plumage and skin condition were 






6.2.1 In vivo trial schedule  
 
Seven weeks old Lohmann Brown hens (180 birds) were housed in two pens in a 
single room and wing tagged on arrival at SAC Auchincruive. The hens were 
allowed to acclimatise for four weeks. 
 
At 10 weeks of age all the hens were then weighed, and allocated into three groups 
balanced for weight. Each group was then allocated to one of the three treatments, 
which were control group (adjuvant only), recombinant protein cocktail group 
(tropomyosin, paramyosin, cathepsin L, cathepsin D and HRF) or the PBS-soluble 
fraction group. The hens were injected with the proteins, prepared as described in 
6.2.2, at 11 weeks of age. Booster injections were administered in weeks 14 and 17, 
as shown in figure 6.1. All the injections were administered into the hens‟ breast 
muscle, alternating sides for each injection. On week 16, the hens were places in 
cages. Each cage housed two hens, with 10 cages per block. The treatment groups 
were spaced evenly throughout the room and diatomaceous earth was formed into 
barriers around each block of cages and the legs of the cages were also placed in 
water buckets to stop the transfer of mites from one treatment group to the next, as 
shown in figure 6.2.  
 
Blood samples were taken from the hens‟ brachial veins at 10, 17, 19, 23, 27 and 32 
weeks of age for antibody titre monitoring and haematology measurements described 
below. The blood samples for antibody titre monitoring were centrifuged at 3000 x g 











Figure 6.2. A diagram of the battery cage layout during the mite challenge portion of the in vivo 
experiment. Each group contained 10 cages, with two hens per cage. 
 
The hens were challenged with 1000 mites per cage in week 19, prepared as 
described in 6.2.3, and in week 22, were challenged with more than 10,000 mites and 
eggs, per cage. The size of mite population was monitored in weeks 19, 21, 23, 25, 
27, 29 and 31 using ADAS MiteMonitor traps, which were placed in the base of the 
cages. The mites collected were stored at -20 C until they were counted under a light 
microscope. Mite numbers were analysed using a generalised linear mixed model 
(GLMM), fitted using residual maximum likelihood (REML) to the mite counts to 
determine differences between the treatment groups. 
 
The experiment was carried out in accordance with the Animals (Scientific 
Procedures) Act 1986. The experiment was ratified by the ethics committee at the 





6.2.2 Immunisations dose preparation 
 
The PBS-soluble proteins injected into the hens were prepared as described in the 
first part of 3.2.2. Each dose comprised of 75 µg of PBS-soluble mite extract  
(75 µl), 200 µg of QuilA (1 µl) and was made up to 500 µl with PBS (224 µl). 
 
The recombinant proteins used in the trial were tropomyosin and paramyosin, which 
were expressed and purified as described in chapter 5; cathepsin D, cathepsin L, and 
HRF (Bartley et al., 2009). Each dose comprised of 25 µg of tropomyosin, 
paramyosin, HRF and cathepsin D (25 µl of each protein) and 10 µg of cathepsin L 
(10 µl), 200 µg of QuilA (1 µl) and was made up to 500 µl with PBS (389 µl). 
 
The dose for the adjuvant only control group was made up with 499 µl of PBS and  
200 µg QuilA (1 µl). 
 
PAGE gels were prepared with the PBS-soluble protein (13 µg) or the recombinant 
protein cocktail made up of tropomyosin (2 µg), paramyosin (2 µg), cathepsin D  
(2 µg), HRF (2 µg) and cathepsin L (0.75 µg) as described in 2.2.3. 
 
The immunisation doses were stored at -80 C until required. The doses were thawed 
and warmed to RT shortly before use. 
 
QuilA, which is a saponin extracted from plants (Rajput et al., 2007), was used as the 
adjuvant since it has been used at Moredun Research Institute in the past, when 
administered at the correct dose has no side effects, it can enhance antibody 
production and can be used in low doses (Oda et al., 2000).  
 
6.2.3 Challenge with D. gallinae  
 
For the first challenge, D. gallinae collected fresh from a commercial poultry farm 
were split into 90 aliquots of roughly 1000 mites (0.13 g), based on weight, in 




overnight. An opened tube and its cap were placed separately in the corner of each 
cage of hens to allow the mites to infest the cage blocks.  
 
Due to the failure of the first mite challenge, the cages were re-challenged with a 
greater number of mites. The mites of the second challenge were added to the 
experimental cages with the battery cage debris they were collected in. 
Approximately 2 g of debris and mites of all life stages including eggs were placed in 
a universal tube (50 ml) with vented caps (Corning). The mites were added to the 
cages in the same manner as described in the first challenge. The number of mites 
added to each cage was estimated to be greater than 10,000. 
 
6.2.4 Western blots and densitometry estimation of antibodies raised 
 
Western blots were prepared as described in 2.2.5. Serum (10 µl), collected as 
described in 6.2.1 from each hen within a cage block (20 hens), was pooled for the 
primary antibody. A Western blot was prepared for each pooled sample from the 
immunised groups using either the PBS-soluble protein (10 µg of protein) fraction or 
the recombinant protein cocktail (tropomyosin (3 µg), paramyosin (3 µg), cathepsin 
D (3 µg), cathepsin L (1 µg) and HRF (3 µg)). Each Western blot was probed with 
both the test and control sera, which were diluted 1:100.  
 
One lane on each of the Western blots was prepared with recombinant tropomyosin, 
which was probed with sera raised during the experiments, as described in chapter 5, 
as a positive control. 
 
The antibody response was estimated by densitometry. The Western blots were 
scanned onto a computer and stored as JPEG files, with the dimensions 980 x 1118 
pixels. The AlphaEaseFC program (Alpha Innotech) was used to measure the density 






The JPEG file containing the image of the Western blot was opened in this 
programme. The Analysis tool was used for one lane at a time, with a width setting 
of 17 and the Invert button set to „on‟. Once the software had measured the average 
density down the lane, all the peaks automatically detected were removed, a 
horizontal base line was added and the whole length of the lane was selected to 
measure the area under the graph. The density was measured for each lane, including 
the tropomyosin positive control. To normalise the data, the densities of each lane 
were divided by the density of the tropomyosin positive control lane.  
 
A two-sampled unequal variance t-test with two-tailed distribution was performed on 
the density measurements obtained from the Western blots at each time point, 
comparing the normalised PBS-soluble protein group data to the normalised control 
group data. The data from the recombinant protein cocktail group was analysed in 
the same manner. 
 
ELISA could have been used to calculate the antibody titre however it would not 
have given an informative analysis of the molecular mass range of protein detected 
by the antibodies raised and due to project time constraints the testing of an ELISA 








6.3.1 PAGE gel of proteins used in immunisations 
 
PAGE gels were prepared using aliquots of the PBS-soluble protein fraction and 
aliquots of the recombinant protein that was used in the recombinant protein cocktail. 
Figure 6.3 is a scan of the two PAGE gels on which the PBS-soluble proteins and the 
recombinant proteins were run. As can be seen, the PBS-soluble protein fraction was 
a complex mix of proteins with a wide range of molecular weights. The recombinant 
proteins used in the protein cocktail had been expressed and purified using a His-trap 
column as described in 5.2.4 and 5.2.5 respectively. 
 
 
Figure 6.3. A scan of two PAGE gels on which PBS-soluble proteins and the recombinant 
proteins were run. Lane M: SeeBlue plus 2 protein markers. Lane 1: PBS-soluble protein fraction. 
Lane 2: tropomyosin. Lane 3: cathepsin L. Lane 4: paramyosin. Lane 5: cathepsin D. Lane 6: HRF. 
 
Due to possible autoproteolysis activity by cathepsin L, the band was very faint on 
the gel. This could have lowered the concentration of intact protein in the 
immunisations described in 6.2.2. However immunisation with cathepsin L in 
previous studies (performed by Dr. K. Bartley) showed that even a low concentration 
of the protein was enough to generate an antibody response that when fed to mites in 













6.3.2 Seroconversion and densitometry estimation of antibodies raised 
against injected proteins 
6.3.2.1 PBS protein fraction group 
 
Three Western blots were prepared with the PBS-soluble protein fraction from  
D. gallinae and were probed with the antibodies raised against the protein in the 
light, medium and heavy weight hen groups as described in 6.2.4. Figure 6.4 is a 
scan of the three Western blots. Panel A was probed with sera collected from block 
H (the heavy hens), panel B was probed with sera taken from block M (the medium 
weight hens) and panel C was probed with sera taken from block L (the light hens). 
As can be seen from all three Western blots, an antibody response was generated 
after the initial week 10 pre-bleed when compared to the controls. However, only the 
hens injected with PBS-soluble proteins in block L appeared to generate a stronger 






























Figure 6.4. Western blots probing PBS-soluble protein with antibodies raised against PBS-
soluble proteins and control antibodies for six time-points throughout the experiment. Lane M: 
SeeBlue plus 2 molecular weight markers (Invitrogen). Lane T: tropomyosin protein probed with anti-
tropomyosin, as described in 6.2.5. The protein probed on lanes 1 through 12 for all three blots was 
~13 µg of D. gallinae PBS-soluble protein. Panel A was probed with antibody from block H. Panel B 
was probed with antibody from block M.  Panel C was probed with antibody from block L. Lanes 1 
and 7: probed with antibody from week 10. Lanes 2 and 8: probed with antibody from week 16. Lanes 
3 and 9: probed with antibody from week 18. Lanes 4 and 10: probed with antibody from week 22. 
Lanes 5 and 11: probed with antibody from week 26. Lanes 6 and 12: probed with antibody from 
week 30. * kDa 
 
The average of the three normalised densitometry readings from each time-point of 
the Western blots (figure 6.4) was calculated. Figure 6.5 is a graph of the normalised 
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6.2.4, which revealed that there was not a statistically significant difference between 




Figure 6.5. Graph showing the normalised intensities from the Western blots prepared with the 
PBS-soluble protein fraction. The densitometry values started between 0.75 and 1.5. Throughout the 
experiment there was no significant difference between antibody levels between all of the groups. The 
hens from the test group in the light hen block did generate antibodies that appeared to follow the 
same pattern as the antibody response against the recombinant proteins. Arrows indicate dates of 
immunisation. The error bars represent the standard error of the mean, n = 3.  
 
6.3.2.2 Recombinant proteins group 
 
Three Western blots were prepared with each of the five recombinant proteins used 
in the recombinant protein cocktail: paramyosin, tropomyosin, cathepsin D, 
cathepsin L and HRF. The blots were probed with the antibodies raised against the 
proteins in the light, medium and heavy weight hen groups during the immunisation 
experiment. Figure 6.6 is a scan of three Western blots. Panel A was probed with 
sera collected from block H, panel B was probed with sera taken from block M and 



























Western blots, a strong antibody response was generated after the initial week 10 
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Figure 6.6. Western blots probing recombinant protein with antibodies raised against them and 
control antibodies for six time points throughout the experiment. Lane M: SeeBlue plus 2 
molecular weight markers (Invitrogen). Lane T: tropomyosin protein probed with anti-tropomyosin as 
described in 6.2.5. The proteins loaded onto lanes 1 through 12 for all three blots were 2 µg of 
tropomyosin, paramyosin, cathepsin L. Panel A was probed with antibody from block H. Panel B was 
probed with antibody from block M.  Panel C was probed with antibody from block L. Lanes 1 and 7: 
probed with antibody from week 10. Lanes 2 and 8: probed with antibody from week 16. Lanes 3 and 
9: probed with antibody from week 18. Lanes 4 and 10: probed with antibody from week 22. Lanes 5 
and 11: probed with antibody from week 26. Lanes 6 and 12: probed with antibody from week 30. * 
kDa 
 
For the PBS-soluble protein fraction group, the density of DAB deposited on the 
Western blot prepared with the recombinant protein cocktail was normalised and the 
average of the three groups was plotted on a graph. Figure 6.7 is a graph of the 
normalised densitometry from the Western blot (figure 6.6) against time. The 
antibody densitometry rises from week 10 to week 18 where a difference can be 
clearly seen between the immunised and control groups. A t-test performed as 
described in 6.2.4, showed that there was a significant difference between the test 
recombinant and control groups for three of the time points. The p value on weeks 16 









Figure 6.7. Graph showing the normalised intensities from the Western blots prepared with the 
recombinant protein cocktail. The densitometry value started at approximately 1. The antibodies in 
the test groups all increased to a maximum of almost 2.5. After the maximum at week 18, the antibody 
level for all three test groups stayed at an increased level compared to the controls. Throughout the 
experiment the antibody levels for the control groups did not vary significantly. Arrows indicate dates 
of immunisation. The error bars represent the standard error of the mean, n = 3. * indicates a p value 
of <0.05. ** indicates a p value of <0.01. 
 
6.3.3 Monitoring mite numbers 
 
ADAS MiteMonitor traps (ADAS limited, Oxon, UK) were used to monitor the 
population of the mites in the battery cages, which was used as an estimate of the 
total population of mites in the cage. The traps consists of two parts a holder that was 
attached to the cage and an insert that resembles corrugated cardboard that offer the 
mites a small dark places to hide. The insert, which contains the mites, can be 
removed and stored for mite collection. 
 
Figure 6.8 is a graph that shows the average number of mites collected from the 































on weeks 19, 21, 23, 25, 27, 29 and 31. D. gallinae were first observed in the traps in 
week 21, where the total number collected was 26 mites from the PBS-soluble 
protein fraction groups, 20 mites from the recombinant protein cocktail group and 
nine mites from the control group. The number of mites collected from all groups 
increased sharply after week 27, following after the second challenge was 
administered. As can been there are more mites collected from the PBS-soluble 
protein fraction group and the recombinant cocktail group than the control group. 
There were no statistical differences between the groups. 
 
Figure 6.8. A graph showing the number of mites collected from all three groups during the 
course of the experiment.  Each point on the graph represents the average count of 30 cages. The 
error bars represent the standard error of the mean, n = 3. The first challenge was added on week 19. 




































The experiments described in this chapter were carried out to assess the capability of 
the PBS-soluble protein fraction and a cocktail of recombinant proteins to generate a 
protective immune response in laying hens against a challenge of D. gallinae.  
 
Western blots were used to determine a semi-quantitative measure of antibody titre 
instead of enzyme linked immunosorbant assay (ELISA). The PBS-soluble protein 
fraction was a complex mix of proteins, which had molecular masses from less than  
18 kDa to greater than 188 kDa. The visualisation of the immunoreactive proteins on 
Western blots gave a more informative analysis of the antibodies generated in the 
study. The Western blots for each cage block could be compared since a sample of 
recombinant tropomyosin probed with sera raised during the experiments in chapter 
5 was used to normalise the data (figures 6.5 and 6.7). The Western blots showed 
that antibodies were generated against these proteins by the hens in each block of 
cages (figures 6.4 and 6.6). Even though antibodies were generated against both the 
PBS-soluble protein fraction and the recombinant protein cocktail, they were not 
effective in generating a protective immune response in the hens against D. gallinae 
over the period of study. 
 
Antibodies raised against the PBS-soluble protein fraction detected protein across a 
range of molecular masses from 18 kDa to 188 kDa (figure 6.4). When the PBS-
soluble protein fraction was probed with sera from the control group, proteins were 
detected at low molecular masses up to 38 kDa (figure 6.4). The normalised 
intensities showed that the intensity of the bands generated in the controls was not 
significantly lower than that of the bands generated when the test antibodies were 
used to probe the PBS-soluble protein fraction. The bands present on the control blot 
could represent antibodies generated against exposed antigens that were excreted or 
secreted from D. gallinae during the challenge, eliciting an antibody response. The 
data from the control group during this trial suggest that antibodies were generated 
against PBS-soluble mite proteins but did not lead to an increase in mite mortality in 





The antibody responses generated to the PBS-soluble fraction were not equal 
between the replicates, as shown on the Western blots (figure 6.6) - the hens in the 
light group generated a higher antibody response. However, statistical analysis did 
not show a significant difference between the test and control groups when all three 
replicates were analysed. Bands can be seen on the Western blot probing the PBS-
soluble protein fraction with the antibodies generated by the hens from the light 
group (figure 6.6, panel C), which was clearly greater than the antibody response 
generated by the medium and heavy hen groups. This could be due to a degradation 
of protein in the immunisation dose before injection of the heavy and medium 
groups. A more accurate measurement of antibody titre would be by ELISA. 
However, time restraints did not allow for an ELISA to be developed. 
 
Bands were present on the Western blots in the control lanes, suggesting that there 
were antibodies in the control hens that recognised mite proteins with low molecular 
weights. A possible source of these immunoreactive proteins could be salivary 
proteins that were transferred to the hens whilst the mites were feeding. Unlike ticks, 
which can spend days feeding and have mechanisms to interrupt the host immune 
response (Ribeiro, 1987), D. gallinae feeds for a comparatively short period of time, 
approximately 1.5 hours per night. This timeframe would still allow significant 
transfer of antigens, although it is unlikely an effective protective immune response 
to these antigens would be mounted. Experiments would have to be performed that 
feed antibodies extracted from hens infested with D. gallinae to mites in the in vitro 
feeding assay, and then compare the mortality to that of mites fed blood from hens 
not infested with D. gallinae. Any significant differences between the mortality of 
the mites could be attributed to antibodies raised as a natural immunity to  
D. gallinae. 
 
Although there is limited evidence to suggest that there is natural immunity in hens 
against D. gallinae, a study carried out in England showed no significant relationship 
between mite population size and antibody titres (Arkle et al., 2006). The Northern 




entire life cycle on the host, and a study has shown that the hens develop an antibody 
response to NFM. However, in that study the antibody response alone was not 
enough to affect the mites (Minnifield et al., 1993). Another study with NFM found 
that a local inflammatory response in the skin blocked access of the NFM mouthparts 
to the hens‟ blood vessels, firstly by an increase in epidermal thickness, which 
blocked the feeding of the nymph stage, and secondly by the formation of scabs by 
an exudate, which blocked the feeding of all mites (Owen et al., 2009). The NFM is 
always on the host, whereas D. gallinae is predominantly off the host where it 
reproduces, lays eggs and moults. The difference in life styles could be the major 
factor in why the hens develop some level of immunity to NFM but not to  
D. gallinae. 
 
On the Western blots prepared with the recombinant proteins and probed with the 
test sera, intense bands can be seen at the molecular mass calculated for each of the 
proteins. Antibodies also bound to proteins with a molecular mass in between that of 
the recombinant proteins. These bands could represent breakdown products of the 
recombinant proteins that contain epitopes the antibodies recognise (figure 6.6). 
Bands were also present in the control blots to a varying degree, with some more 
intense bands indicating a stronger antibody response (figure 6.6). There was a 
significant difference between the intensities of the DAB deposited on the Western 
blots, and therefore between antibody titres, on weeks 16, 18 and 26. This difference 
in antibody titre could be due to the fact that the control hens were not exposed to 
these proteins during the challenge, since the proteins were probably not excreted or 
secreted while the mites were feeding. The lack of antibodies present in the control 
hens would suggest that the immune response could not be maintained naturally 
since the immune response would not be exposed to the proteins in this 
immunisation. This would mean the vaccination dose would have to prime the hen‟s 
immune system memory to ensure it produces antibody throughout its year-long 
laying life. 
 
Even though a strong antibody response was generated against the recombinant 




response against the hens in vivo. The hens were subjected to a challenge of  
D. gallinae mites at two points during the experiment. From the first mite challenge 
(week 19) approximately 1000 mites, were carefully purified from the cage debris 
they were collected in, sorted into challenge number by weight, and released into 
each cage. Very few mites were captured the first three times the traps were set out 
(weeks 19, 21 and 23 (figure 6.8)). This suggests that a challenge of 500 mites per 
bird was not enough to start a colony of D. gallinae, since very few mites found were 
even in the control cages. During a study where the population of D. gallinae was 
monitored in a free range laying unit, approximately 6 mites were collected per hen 
in the unit (Arkle et al., 2004), so a low count may have been expected. However, a 
second challenge (week 22) was added to the cages where the number of mites was 
much greater (at least 20 times greater than the first). The mites were added to the 
cages along with the cage debris they were collected in from the poultry shed, 
consisting of possibly faecal material, dead mites and hen skin. The debris contained 
a great many eggs so there was no way of knowing exactly how many mites were 
added to the experiment. The sudden increase in mite population between weeks 23 
and 31 (figure 6.8) appears to have been directly due to the second addition of mites 
that may have overloaded the system. This conclusion was drawn because the 
average mite numbers started to increase three weeks after the second addition of 
mites, when an exponential increase in population size occurred. A study conducted 
in Denmark artificially infested ISA brown laying hens and monitored the mite 
population for 96 days and the behaviour of the infested hens in floor pens. A second 
challenge of mites was required since the initial challenge did not establish a viable 
colony. A conclusion drawn during that experiment was that a population of between 
150,000 and 200,000 mites per hen would be required before clinical signs and 
health problems were observed in the hens (Kilpinen et al., 2005). In the current 
work, mite numbers grew exponentially five weeks after the second addition of 
mites, when there would have been antibodies present which recognised the proteins 
used for immunisation (figures 6.5 and 6.6). There was no reduction in the average 
number of mites in the immunised groups when compared to the control group, 
which would suggest that the immunisations did not have a protective element in the 




each of the cages that migrated into the traps was unknown. The detection method 
used, ADAS MiteMonitor traps, might not have been sensitive enough to measure 
the reduction in mite population. There was also a large variation in the number of 
mites collected within a single treatment group. The number of traps could probably 
have been reduced and left in the cages from one collection date to the next to allow 
the mites to find and then utilise the traps. For monitoring of mite population, a study 
conducted in Sweden left traps in place for the duration of the experiment, changing 
them once a week (Chirico & Tauson, 2002).  
 
The challenge mites had not been conditioned prior to addition into the study. This 
meant that a proportion of the mites had recently taken a bloodmeal from 
unvaccinated hens with which they could moult, reproduce or lay eggs before they 
had to feed again. This fed mite population would have then increased immediately 
after the massive second challenge without being exposed to the hen‟s primed 
immune system. If the mites had been starved they would have had to feed as soon as 
they were able in order to moult, reproduce and lay eggs. This would have brought 
them directly into contact with the hen‟s immune system, and a more accurate test of 
the immune response generated against the injected proteins may have been made. 
 
At the end of the experiment, the number of mites trapped was counted. As discussed 
in chapter 3, when mites have recently fed they appear bright red in colour, which 
darkens to almost black after a few days. If the levels of mites feeding and how 
recently they had fed had been scored, a more accurate picture of what was 
happening in the cages could have been gathered. A week after the second challenge 
was added, the number of mites increased, however the number of mites at each life 
cycle stage was not recorded, so these could have been all larval or nymph stages 
that had not fed.  
 
During the experiment, other measurements were taken by colleagues at SAC 
Auchincruive, such as haematology, feed intake, egg production, external and 
internal egg quality, feather score, behaviour and mortality. There was no statistically 




were not affected by the injected proteins was a positive outcome since the poultry 
would still have to perform at peak efficiency during their laying life or any potential 
vaccine would not be commercially viable. 
 
There were seven haematological tests carried out on the blood from the hens: red 
blood cell count, haemoglobin, haematocrit, mean cell volume, mean corpuscular 
haemoglobin concentration (MCHC), mean cell haemoglobin (MCH) and white 
blood cell counts. Linear mixed models (LMM) were fitted using residual maximum 
likelihood (REML) to all seven measurements. There was no statistically significant 
difference in five of the tests. However, there was a statistically significant difference 
in the means of the MCHC and MCH measurements when compared to the controls 
at week 32, where the means were lower in both test groups than in the control. The 
MCHC is a measurement of the concentration of haemoglobin for a given volume of 
red blood cells and the MCH is a measurement of the mean amount of haemoglobin 
in a red blood cell. The drop in haemoglobin concentration did not appear to affect 
the performance of the birds in any way as there was no statistical difference 
between the three groups for egg production and feather score. 
 
A generalised linear mixed model (GLMM) was fitted using REML to the counts of 
the different activities a bird could perform during each monitoring period. There 
was marginally more feather pecking by the control hens than hens injected with 
either the PBS-soluble protein fraction or the recombinant protein cocktail  
(p = 0.038). The injected proteins could have resulted in a reduction of the number of 
mites on the hens in the test groups since they did not appear to peck their feathers as 
much. The control hens might have been more heavily parasitized than the 
immunised hens, though there was no evidence for this from the mite trap data. 
 
This experiment did not show clear evidence that the PBS-soluble protein fraction or 
the recombinant protein cocktail generated a protective antibody response. However, 
as discussed, the experimental system may have been overloaded with mites after the 
second mite challenge and the duration of study was truncated because of this. If this 




system would have to be increased and properly conditioned, which would ensure 
that the mites added to the system would have to feed from the hens to survive and 
propagate. The simplest method to achieve this would be to use a set of cages that 
were already infested with D. gallinae or for the cages to be specifically infested 
shortly before the hens were introduced. Also, a more sensitive method for detecting 
changes in the mite population would be beneficial for future studies since the 
















Dermanyssus gallinae is an haematophagous ectoparasite that parasitizes poultry. A 
population of mites can increase exponentially over only a few weeks in optimum 
conditions. When hens are heavily infested by D. gallinae they suffer from anaemia 
and severe irritation, which can lead to restlessness, feather pecking and death (of 
hens). Currently, the most successful control of D. gallinae is based on spraying 
chemical acaracides and cleaning empty cages before restocking (Chauve, 1998). 
The use of chemical control is unsustainable due to the emergence of acaricide 
resistance in mites (Marangi et al., 2009a; Zeman & Zelezny, 1985) and 
contamination of the environment and food products with harmful chemicals 
(Hamscher et al., 2003). At present the only acaricide spray licensed for use in the 
UK, when cages are stocked, is ByeMite® (Animal Health, Bayer Health Care) 
(Meyer-Kuhling et al., 2007). Alternative control methods that have no adverse 
effects on poultry or the environment need to be identified. This study was 
performed to identify protein antigens that could be used as a vaccine against  
D. gallinae.  
 
Both pragmatic and rational approaches were employed during this study to identify 
proteins from D. gallinae that could be used in a vaccine. The pragmatic approach 
was used to identify potential vaccine candidates. Hens were immunised with 
fractions of D. gallinae and mites were fed the resultant antibodies in the in vitro 
feeding assay. The increase in mortality of the mites was then measured (Wright et 
al., 2009). The results indicated that the PBS-soluble protein fraction generated 
antibodies that increased the mites‟ mortality to the greatest extent (chapter 3). This 
approach has been successful in identifying the protein Bm86, which is found in the 
membrane of gut digest cells of the cattle tick Rhipicephalus microplus (Willadsen et 
al., 1988; Willadsen et al., 1989). Bm86 is the antigenic element of TickGARD™ 
and Gavac™ (Revetmex, Mexico City) (Willadsen et al., 1995), which have been the 
only commercially available vaccines on the market against ectoparasites. When 
ticks feed on vaccinated animals, antibodies specific to Bm86 bind to the protein in 
the gut of the tick and the digest cells are destroyed. The mechanism of this 
destruction has been investigated, and evidence would suggest that anti-Bm86 




products, such as complement, to lyse the cells using the membrane attack complex. 
Lysis of the digest cells allows bovine blood to leak into the tick haemolymph. The 
observed effects on the tick are low weight gain during engorgement, a reduction in 
the number of eggs laid and death of the tick (Kemp et al., 1989). In the mammalian 
immune system, the Fc region of IgG bound to antigen activates immunological 
processes such as the complement cascade, as described in chapter 1. Since avian 
IgY has a different heavy chain, and therefore a different Fc region, it cannot activate 
the complement cascade in hens (Cova, 2005). Although IgY does not activate the 
hen‟s complement cascade in the same manner as mammalian IgG, a homologue of 
the mammalian C1q protein, which is part of the antibody binding C1 complex, has 
been found in hen blood (Yonemasu & Sasaki, 1986). Therefore the complement 
system may damage the gut of D. gallinae in a similar way to the damage seen in  
R. microplus. TickGARD™ was very effective at reducing the tick population on 
cattle. During a trial in Australia, there was a 56 % reduction in tick numbers after a 
single generation and a reduction of 72 % in reproductive capacity (Jonsson et al., 
2000). Although the vaccine could not generate a long lasting immunity, in a trial 
where 35 cattle were injected with Gavac™ and then challenged with R. microplus, 
after 6 weeks the number of ticks had built up to an average of 20 per animal 
(Garcia-Garcia et al., 2000). Another vaccination trial was carried out where cattle 
were injected with either TickGARD™ or Gavac™ at weeks zero and four. 
Measurements of the antibody response showed a maximum titre was reached by 
week six, after which the titre dropped steadily during the 11 week trial (Andreotti, 
2006). To maintain the circulating antibody titre, doses of the vaccine had to be 
given throughout the year. A commercially viable vaccine for D. gallinae (based on 
hidden antigens) would have to elicit an antibody response that had an enhanced titre 
throughout the hen‟s year-long laying life. Although proteins similar to Bm86 have 
not been identified in D. gallinae, the proteins that line the parasite‟s gut could be a 
possible source of vaccine candidates. Proteins located in the gut are “hidden” from 
the host, so any immune response would have to be initiated and maintained by 
repeated exposure to the antigen(s) by immunisations, rather than during infestation. 
Despite the fact that the TickGARD™ vaccine was very effective, it was withdrawn 




market, several other single antigens have been discovered that offer protection 
against ticks, as well as some other parasitic species. Although there has been no 
evidence of a homologue of Bm86 in D. gallinae, an immunisation trial has been 
performed that involved injecting hens with Gavac™ and a recombinant form of 
subolesin from the tick Amblyomma hebraeum. In these vaccinated hens, antibodies 
against Bm86 but not against subolesin were detected on Western blots. Blood from 
immunised hens was fed to mites in an in vitro feeding assay. The mortality of the 
mites fed blood from Bm86 immunised hens ranged from 0 % to 84.6 %, which was 
not significantly different from the mortality of the mites fed control blood. The 
mortality of the mites fed blood from hens immunised with subolesin ranged from  
25 % to 78.6 % and were statistically different from the control group (Harrington et 
al., 2009a). Subolesin has the potential to be a vaccine candidate and more of the 
potential vaccine antigenic candidates from different parasitic species need to be 
investigated. One candidate could be Bm95, a homologue of Bm86 in an 
Argentinean strain of R. microplus, strain A, which is resistant to Gavac™. The 
recombinant form of the protein offered 58 % efficacy against strain A (Garcia-
Garcia et al., 2000). Another candidate would be the salivary protein 64P, truncated 
recombinant forms of which were used to immunise guinea pigs against  
R. sanguineus, resulting in an 80 % mortality of the ticks (Trimnell et al., 2005). 
Cysteine proteases might also be potential vaccine candidates, as they have been 
found to play a key role in the feeding mechanisms of the fluke  
F. hepatica. The recombinant form of the fluke cysteine protease cathepsin L was 
used to vaccinate mice, which were then challenged with fluke parasites. The 
immune response generated reduced the parasitic burden by up to 80 % (Kesik et al., 
2007). Since the success of Bm86 has not been repeated, and no other single antigen 
has been identified that has as high a degree of efficacy (Willadsen, 2008). Future 
vaccines may have to be composed of multiple antigens in a cocktail that together 
generate a protective immune response capable of reducing the parasite population. 
A further possibility would be to target different life stages of the parasite with either 
a combination of proteins common to all stages or different proteins that target each 





A vaccine, either with a single antigen or a cocktail of antigens, would probably have 
to be used in combination with acaracides to reduce the levels of D. gallinae 
infestation of poultry units to a manageable level. This would reduce the use of 
potentially harmful chemicals (de la Fuente et al., 2007) and target mites that have 
developed resistance to acaracides. This approach has been successful in Cuba where 
the use of Gavac™ in combination with acaracides reduced the number of chemical 
treatments by 60 % (de la Fuente et al., 1999). The combination control strategy 
could be implemented at the introduction of a new flock to a poultry house. All the 
hens would be vaccinated and the cages sprayed with a chemical to initially reduce 
the mite population. After this initial combined regime a limited number of sprayed 
chemical treatments throughout the laying period of the flock could restrict the build 
up of mite numbers. The reduction in chemical treatments could slow the 
development of resistance in D. gallinae and reduce costs to the farmer. This has 
been shown in R. microplus, where Gavac™ was used to reduce a population of ticks 
resistant to amidine acaracides to zero after 83 days (Redondo et al., 1999). Using a 
vaccine and chemicals in combination to control D. gallinae could mean that the 
vaccine would not have to be as effective as TickGARD™. As stated previously,  
D. gallinae is a source of great economic loss to the poultry farmer through blood 
spots on the eggs and reduced performance of the parasitized hens due to blood loss 
and irritation. Feeding antibodies to mites raised against the PBS-soluble protein 
fraction reduces the population by 39 %. In practice, a reduction in population by this 
amount would mean there would be less blood-spotting and increased productivity of 
the hens, thereby increasing profit margins. 
 
As described in the general introduction, the development of resistance to chemical 
compounds is an increasing problem (Beugnet et al., 1997). Vaccination would 
circumvent this resistance issue, and, arguably there is little likelihood of the mite 
becoming non-responsive to the vaccine, since most proteins have multiple epitopes 
to which an antibody can bind. For a parasite to develop resistance, the native protein 
would have to have multiple mutations in the DNA encoding these epitopes, 
changing the amino acid sequence and configuration but without changing function. 




proteins and possibly lethal changes. The development of resistance to a vaccine 
based on targeting “hidden” or “exposed” antigens is probably less likely than the 
development of resistance to chemicals, which can occur with single nucleotide 
polymorphisms (SNPs). For example, resistance against the benzimidasole class of 
anthelmintic, which interrupts the tubulin-microtubule equilibrium in the cell 
cytoskeleton in gastrointestinal nematodes, is thought to be caused by up to three 
SNPs that alter the amino acid sequence of the protein β-tubulin at bases 167, 198 
and 200. These changes to the β-tubulin amino acid sequence do not allow the drug 
to bind and disrupt the tubulin-microtubules equilibrium (Von Samson-
Himmelstjerna et al., 2007). The antibody raised against a vaccine may bind to an 
external epitope that is under no selective pressure to mutate, so the SNP would be 
less likely to occur. However, in D. gallinae there could be significant differences 
between strains. An Argentinean strain of R. microplus, strain A, has been shown to 
be resistant to the vaccine Gavac™ (Garcia-Garcia et al., 1999). The homologous 
protein to Bm86 in this strain of tick, which was called Bm95, had up to 21 amino 
acid differences to Bm86  (Garcia-Garcia et al., 2000). Strain differences and SNPs 
may be present in potential vaccine candidate genes from D. gallinae, since 
differences have been found in the cytochrome oxidase I gene in mites from 
populations in European countries (Marangi et al., 2009b). A potential vaccine 
antigen would have to be tested against different populations of mites to ensure its 
efficacy and potential to be used against D. gallinae infestations in the UK, in 
Europe and, ideally, world-wide. 
  
In the present study, the rational approach to vaccine candidate identification was 
also employed, where genetic sequencing approaches were used to identify vaccine 
candidates, homologues of which have been used successfully to protect against 
other pathogenic species. Expressed sequence tag (EST) databases were generated 
that could be mined for vaccine candidates. Two databases were generated to 
produce over 13,000 contigs using material derived from total RNA (chapter 4). A 
third EST database was generated using a suppression subtractive hybridisation 
(SSH) library to identify genes that were differentially expressed between fed and 




sequencing to quantitatively analyse the differentially expressed genes between fed 
and starved mites. There were genes in the SSH EST database that were shown to be 
up-regulated in the Illumina Solexa dataset. All four datasets identified proteins that 
could be possible vaccine candidates against D. gallinae. 
 
Two such proteins are paramyosin and tropomyosin, which are proteins of the 
cellular cytoskeleton (Maroto et al., 1995; Perry, 1985). These proteins have been 
shown to generate an anti-parasitic immune response in endoparasites. A native form 
of paramyosin has been successfully employed as a vaccine that reduces the burden 
of Schistosoma japonicum in mice by up to 86 % (Ramirez et al., 1996). When 
expressed as a recombinant protein it reduced the burden of S. japonicum in mice by 
up to 39.9 % (Zhang et al., 2006). Native and recombinant versions of tropomyosin 
have been used to reduce the burden of Acanthocheilonema viteae, a filarial 
nematode, in jirds by 64.4 % and 35 % respectively (Hartmann et al., 1997; 
Hartmann et al., 2006). Paramyosin has also previously been identified as a potential 
vaccine candidate against Psoroptes ovis, the sheep scab mite, (Nisbet et al., 2006b)  
and tropomyosin has been identified in D. gallinae (Nisbet et al., 2006a). 
Paramyosin, which was partially sequenced by Roche 454 sequencing, and 
tropomyosin, which had been sequenced and cloned previously (Nisbet et al., 2006a), 
were expressed and used in an immunisation study to raise antibodies, which were 
tested using the in vitro feeding assay. This experiment demonstrated that the 
antibodies generated caused a mite mortality of 33 % in paramyosin groups and 28 % 
in tropomyosin groups, compared to a mortality of 9 % in the control group (chapter 
5). Although antibodies to these proteins had anti-mite properties when tested in the 
in vitro feeding assay individually, time did not allow the investigation of whether a 
combination of these antibodies would have resulted in an enhanced mortality. 
Clearly, it would be important to determine whether the average of 30 % mortality in 
the mite population with each protein could be increased with a combination of 
antibodies, as has been previously suggested during studies for developing vaccines 
(Willadsen, 2008). An average mortality of 30 % was also achieved with the PBS-




required to define the active antigen in the complex mixture, and to establish whether 
multiple protein antigens will enhance the efficacy of a vaccine. 
 
An in vivo study was performed in which hens were injected with a recombinant 
protein cocktail, which included paramyosin and tropomyosin along with histamine 
release factor, cathepsin L and cathepsin D, all of which were identified in the EST 
database generated using Roche 454 sequencing technology. These were categorised 
in the post-translational modification, protein turnover or chaperones group (chapter 
4). The hens were then challenged with live D. gallinae. The PBS-soluble protein 
fraction was also used to immunise hens (chapter 6). The in vivo experiment did not 
provide a definitive answer as to whether the immune response generated by either 
the recombinant protein cocktail or the PBS-soluble protein fraction was protective 
against a mite challenge. The mites that were used in the challenge were freshly 
collected from a commercial poultry farm and introduced to the hens a day later. 
Clearly the initial mite challenge of approximately 500 mites per hen was 
insufficient, in the time allowed, to establish a stable colony. So a second challenge 
of mites, which was greater than 10,000 mites per cage, was added to the experiment. 
There are two critical factors that would need investigation before future 
immunisation studies are performed. These are 1) the number of mites introduced to 
the cages would have to be optimised and 2) the mites added could be conditioned 
before challenge for at least a week to allow the bloodmeal from hens on the 
commercial farm to be digested. As discussed above, the number of mites used to 
start a challenge is crucial, as too many mites could overload the system and cause 
welfare issues for the experimental hens, whereas too few mites would result in the 
challenge not being established. The conditioning of mites allows the bloodmeal to 
be digested and for the next stage of the life cycle to be completed, whether that is 
moulting, reproducing or laying eggs. If the majority of the mites used in the 
challenge were female adults that contain a clutch of eggs, then the number of mites 
in the challenge would be much higher than estimated. If the mites were conditioned 
they would have to feed on the hens to complete their life cycle. The population of 




feeding on the immunised hens would decrease due to the antibodies generated 
against the injected antigen. 
 
There are several important factors which are involved in the development of a 
successful vaccine. These include not only the most effective antigen target, but the 
dose, route of inoculation, the adjuvant employed and the frequency of vaccination. 
In addition, a vaccine produced to combat D. gallinae would have to be applied to 
the flock using a system that can be easily managed. Most poultry farms have a strict 
vaccination schedule that starts soon after the chick is hatched. The hens are 
vaccinated against various diseases before they are housed. These included a vaccine 
against Marek‟s Disease, which is injected subcutaneously in the back of the neck 
(Baigent et al., 2006),  and vaccines against Newcastle Disease and Infectious Bursal 
Disease (Sharma, 1999), which can be administered in either the water supply or as a 
whole flock spray. It may be possible to combine a vaccine against D. gallinae with 
one of these other vaccines to reduce the stress and expense caused by another 
injection. The use of non-invasive application strategies, such as introducing the 
vaccine to the water supply, may be of use. However, these spray and water-borne 
applications are most effective for live vaccines, and immunisations for inert protein 
antigens are likely to require injection. Stability of the vaccine is of paramount 
importance, and factors such as resistance to enzymic digestion may all be relevant. 
For example, if the vaccine consists of a cocktail of antigens and one of them is the 
active form of a digestive enzyme, the other proteins may be digested during storage, 
potentially rendering the vaccine ineffective. 
 
Further work to develop a vaccine against D. gallinae is required. A second 
challenge trial would be necessary to properly assess the potential of the PBS-soluble 
protein fraction (from D. gallinae) as a vaccine. In any further study, the number of 
mites used to populate the cages would have to be closely regulated. The mites 
should be partially conditioned before being introduced to the cages to ensure that 
they take a bloodmeal from the hens in the study. The immunoreactive proteins from 
this study should then be identified, e.g. using 2D Western blots and MALDI-ToF 




immunisations trials. The antibodies generated during future trials can be tested in 
the in vitro feeding assay before challenge studies using large numbers of hens. As 
discussed previously, there are a number of issues that require addressing, which are 
the determination of the relationship between IgY titre and anti-mite efficacy, the 
number of injections and the timing of these to optimise protection, and the adjuvant 
required. These issues will all need to be defined before any vaccine candidate is 
licensed for production. Moreover, also of high importance will be the demonstration 
that the effector antibodies are safe for human consumption. The development of 
TickGARD™ took 13 years, which was considered a short period for a novel 
vaccine. It went through four stages demonstration of feasibility in the laboratory, 
demonstration of feasibility in field trials, proof of efficacy, safely and applicability 
and integration of product into commercial market (Willadsen et al., 1995). 
Registration of a vaccine in the EU has to be ratified by the European Medicines 
Evaluation Agency (Meeusen et al., 2007). Although antibodies are inactivated by 
acid in the stomach or degraded by proteases in the gut, their lack of reactivity with 
similar or cross-reactive epitopes in human tissues would need to be demonstrated. 
 
This thesis described the initial studies towards the production of a vaccine against 
the poultry red mite, D. gallinae. The pragmatic approach employed in this study 
suggested that the PBS-soluble antigen from D. gallinae was capable of increasing 
the mortality of mites in an in vitro assay. The rational approach was also employed, 
and by use of genetic sequencing tools produced a database of thousands of contigs 
and another database containing differentially expressed genes between populations 
of fed and starved D. gallinae mites. Two previously identified vaccine candidates, 
tropomyosin and paramyosin, that had an effect against other parasitic species, were 
shown to elicit the production of antibodies in hens that increased the mortality of 
mites in the in vitro feeding assay. An in vivo trial was performed in which the PBS-
soluble protein fraction, identified using the pragmatic approach, and five 
recombinant proteins, which included paramyosin and tropomyosin, identified using 
a rational approach, were injected into hens that were subsequently challenged with 
live D. gallinae. As described earlier, the experiment was not successful in producing 




implemented. A successful vaccine, combined with chemical control methods for 
maximum efficiency, would have a direct and lasting effect on the poultry industry, 
in particular for egg production. Quality of life and productivity of laying hens would 
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Contig Length Nos. of EST Contig identity/Putative function P value Species Database 
DBC003 354 3 Similar to CG30375-PA Peptidase_S1_S6 2E-07 Drosophila melanogaster  KEGG 
DBC027 391 1 Similar to spicule matrix protein SM29 8E-04 Strongylocentrotus purpuratus KEGG 
DBC032 321 1 Eukaryotic translation initiation factor 3 2E-20 Xenopus tropicalis KEGG 
DBC037 352 1 K05868 cyclin B 8E-15 Xenopus laevis  KEGG 
DBC039 643 1 Hypothetical protein  3E-07 Saccharum officinarum  KEGG 
DBC048 291 1 3-oxoacid CoA-transferase subunit A  2E-14 Fugu rubripes  KEGG 
DBC050 710 1 Similar to CG1746-PA ATPase C chain family, isoform A 1E-05 D.melanogaster KEGG 
DBC052 495 18 Hypothetical protein 8E-03 Arabidopsis thaliana  KEGG 
DBC063 592 1 zgc:136473 8E-19 Danio rerio  KEGG 
DBC066 548 1 tRNA (cytosine-5-)-methyltransferase 6E-32 Oryzias latipes KEGG 
DBC067 603 5 Hypothetical protein 7E-04 Plasmodium falciparum KEGG 
DBC074 391 1 Similar to spicule matrix protein SM29 2E-03 Strongylocentrotus purpuratus KEGG 
DBC077 359 9 NEWSINFRUG00000126286 9E-03 P. falciparum KEGG 
DBC078 295 1 Similar to 2300006N05Rik protein keratin high-sulfur matrix protein IIIA  5E-04 mouse KEGG 
DBC087 320 1 Protein tyrosine phosphatase, receptor type, D  3E-05 Oryzias latipes KEGG 
DBC094 652 1 Methylmalonyl-CoA epimerase 6E-40 D. melanogaster KEGG 
DBC099 483 3 NPC2; Niemann-Pick disease, type C2 5E-07 Sus scrofa  KEGG 
DBC107 306 6 Similar to CG4769-PA  1E-29 D. melanogaster  KEGG 
DBC110 648 4 Hypothetical protein 9E-03 Homo sapiens KEGG 
DBC111 367 3 Hypothetical protein 3E-10 Malassezia globosa KEGG 
DBC113 457 1 Predicted protein; K08776 puromycin-sensitive aminopeptidase 1E-12 Nematostella vectensis KEGG 
DBC116 368 1 Mannose-6-phosphate protein p76  5E-16 Bos taurus  KEGG 
DBC117 242 1 Similar to aldehyde dehydrogenase 7 family, member A1  3E-34 Tribolium castaneum  KEGG 
DBC119 270 6 Similar to CG10686-PA Cellular component: transcription factor complex  1E-10 D. melanogaster  KEGG 








Contig Length Nos. of EST Contig identity/Putative function P value Species Database 
DBC136 347 1 Hypothetical protein; Interacting selectively with any nucleic acid. 7E-03 Monosiga brevicollis KEGG 
DBC138 443 1 Annexin x 1E-16 Aedes_aegypti KEGG 
DBC142 254 1 GE24263-RA 3E-05 D. yakuba KEGG 
DBC144 405 2 U1 small nuclear ribonucleoprotein A U2 B 2E-06 Anopheles_Apis KEGG 
DBC151 470 3 GI15535-RA 5E-03 D. mojavensis KEGG 
DBC159 257 1 Similar to MGC80934 protein coatomer protein complex, subunit beta 1 2E-22 Xenopus laevis KEGG 
DBC160 469 1 GA20895 gene product from transcript GA20895-RA 7E-11 D. pseudoobscura KEGG 
DBC163 418 3 Rab proteins geranylgeranyltransferase component A 1 8E-07 Homo sapiens KEGG 
DBC164 520 1 Sphingomyelin phosphodiesterase 1 4E-14 Mus musculus  KEGG 
DBC182 731 1 Hypothetical protein 8E-05 Podospora anserina KEGG 
DBC184 452 1 GF19153-RA 6E-04 Drosophila ananassae KEGG 
DBC190 490 1 Hypothetical; solute carrier family 38, member 8 2E-17 Strongylocentrotus purpuratus KEGG 
DBC204 338 1 K02132 F-type H+-transporting ATPase alpha chain 7E-14 A. gambiae KEGG 
DBC210 224 1 GF10431-RA 1E-02 
 
KEGG 
DBC214 449 1 Similar to vacuolar protein sorting 35 4E-32 Tribolium castaneum KEGG 
DBC219 269 1 GH17039-RA 3E-05 D. grimshawi KEGG 
DBC223 311 1 K02920 large subunit ribosomal protein L36e 5E-28 C.merolae KEGG 
DBC229 279 1 NEMVEDRAFT_v1g244189; predicted protein 2E-21 Nematostella vectensis KEGG 
DBC237 326 1 Hypothetical protein 5E-03 Paramecium tetraurelia KEGG 
DBC238 274 1 Hypothetical protein 7E-11 Homo sapiens KEGG 
DBC239 215 1 Hypothetical LOC579671 ; K01870 isoleucyl-tRNA synthetase 3E-19 C.merolae KEGG 
DBC240 512 1 DeliriumA, putative 2E-04 Tetrahymena thermophila KEGG 
DBC242 403 1 Cathepsin D ; K01379  6E-20 Macaca mulatta KEGG 
DBC244 428 1 Similar to lethal 35Di 2E-20 Tribolium castaneum KEGG 








Contig Length Nos. of EST Contig identity/Putative function P value Species Database 
DBC250 379 1 Isoform A amylo-1,6-glucosidase  4E-17 Tribolium castaneum KEGG 
DBC254 751 1 SET domain and mariner transposase fusion gene       3E-04 Pan troglodytes KEGG 
DBC261 520 1 GE18641-RA 4E-10 Drosophila KEGG 
DBC263 419 1 Acyl-CoA synthetase long-chain fatty-acid-CoA ligase 1E-08 Acinetobacter  KEGG 
DBC264 727 1 Hypothetical protein 9E-03 
 
KEGG 
DBC266 659 1 Predicted protein  1E-07 Nematostella vectensis KEGG 
DBC270 462 1 GI18840-RA 6E-26 D. mojavensis KEGG 
DBC271 218 1 Carboxylesterase 2E-23 Xanthomonas campestris KEGG 
DBC275 356 1 Pold2-prov protein;  DNA polymerase delta subunit 2 6E-17 Brugia malayi KEGG 
DBC276 536 1 Serine/threonine protein kinase 5E-03 Frankia  KEGG 
DBC281 507 1 Similar to CG13625-PA 5E-17 D. melanogaster KEGG 
DBC283 435 1 Alpha-L-fucosidase 6E-55 Bombyx mori KEGG 
DBC286 535 1 Cysteine proteinase, putative                           1E-25 G.gallus KEGG 
DBC288 452 1 BMP binding endothelial regulator 9E-03 Bos taurus KEGG 
DBC290 203 1 Adenosylhomocysteinase 2E-06 Caenorhabditis elegans KEGG 
DBC295 449 1 Similar to proteasome 20S proteasome subunit alpha 1 2E-10 Tribolium castaneum KEGG 
DBC296 809 3 Dihydrolipoamide succinyltransferase 1E-07 Caenorhabditis elegans KEGG 
DBC297 318 1 GJ11095-RA 1E-18 D. melanogaster KEGG 
DBC298 316 1 Similar to Protein C14orf166 2E-09 Homo sapiens KEGG 
DBC301 333 1 Carboxypeptidase A4  2E-07 Mus musculus KEGG 
DBC306 256 1 Hypothetical protein cathepsin L   2E-03 Mus musculus KEGG 
DBC308 363 1 Alpha-glucosidase 4E-06 D. melanogaster KEGG 
DBC322 315 1 Protein disulfide isomerase family A, member 3 3E-06 D. melanogaster KEGG 
DBC323 822 1 Glutathione S-transferase M2  1E-19 Homo sapiens KEGG 
DBC324 228 
 








Contig Length Nos. of EST Contig identity/Putative function P value Species Database 
DBC328 471 1 Hexosaminidase B ; K01207 beta-N-acetylhexosaminidase 5E-35 Mus musculus KEGG 
DBC001 356 1 Similar to hydroxyacyl-coenzyme A dehydrogenase 5E-28 Tribolium castaneum NCBI nr 
DBC005 508 21 GP80 precursor  9E-13 Boophilus microplus NCBI nr 
DBC019 822 12 Vitellogenin 9E-24 Dermacentor variabilis NCBI nr 
DBC021 722 2 Mariner transposase  5E-41 Homo sapiens NCBI nr 
DBC022 282 1 ATP synthase D chain  4E-13 Ornithodoros parkeri NCBI nr 
DBC047 435 2 Cathepsin D-like aspartic protease 4E-40 Opisthorchis viverrini NCBI nr 
DBC057 423 2 Similar to CG13310-PA  3E-28 Apis mellifera NCBI nr 
DBC059 287 1 Protein disulfide isomerase-1 4E-32 Haemaphysalis longicornis NCBI nr 
DBC075 675 22 Vitellogenin structural genes (yolk protein genes) protein 2, isoform a 1E-11 Caenorhabditis elegans NCBI nr 
DBC086 433 4 Vitellogenin  2E-12 Dermacentor variabilis NCBI nr 
DBC090 463 1 Aspartic protease  5E-20 Haemaphysalis longicornis NCBI nr 
DBC100 543 1 Ribosomal protein L30  3E-11 Ornithodoros parkeri NCBI nr 
DBC105 472 4 RNA (guanine-9-)-methyltransferase domain-containing protein 1 homolog 1E-20 Tribolium castaneum NCBI nr 
DBC106 660 4 Vitellogenin 4E-33 Dermacentor variabilis NCBI nr 
DBC108 573 3 Vitellogenin C2  6E-08 Culex pipiens quinquefasciatus NCBI nr 
DBC112 562 9 Similar to CG13313-PA (Spermadhesin, CUB domain) 8E-17 Apis mellifera NCBI nr 
DBC115 778 2 GP80 precursor  4E-12 Boophilus microplus NCBI nr 
DBC121 242 2 Similar to granulin  2E-09 Strongylocentrotus purpuratus NCBI nr 
DBC129 384 1 Arginine kinase 2E-51 Dermatophagoides farinae NCBI nr 
DBC132 710 3 Similar to mitochondrial ribosomal protein L53 CG30481-PA 3E-14 Tribolium castaneum NCBI nr 
DBC139 216 1 Similar to ENSANGP00000030885 3E-08 Nasonia vitripennis NCBI nr 
DBC143 224 1 Hypothetical protein CBG14484 (Protein disulphide isomerase) 4E-27 Caenorhabditis briggsae NCBI nr 
DBC146 337 1 p27BBP/eIF6 (LOC398731 protein) 3E-48 Xenopus laevis NCBI nr 








Contig Length Nos. of EST Contig identity/Putative function P value Species Database 
DBC165 321 2 Similar to 2-oxoglutarate dehydrogenase  8E-26 Nasonia vitripennis NCBI nr 
DBC179 567 1 Calreticulin 8E-79 Ixodes jellisoni NCBI nr 
DBC180 610 2 Protein disulfide isomerase-2 1E-10 Haemaphysalis longicornis NCBI nr 
DBC195 506 1 Vitellogenin  3E-22 Dermacentor variabilis NCBI nr 
DBC213 452 3 Nucleoside diphosphate kinase  6E-56 Ornithodoros parkeri NCBI nr 
DBC217 344 1 Branched chain keto acid dehydrogenase E1, beta polypeptide  3E-15 Rattus norvegicus NCBI nr 
DBC225 485 1 Sorting nexin associated golgi protein 1 6E-10 Xenopus laevis NCBI nr 
DBC233 364 1 Phosphatidylethanolamine binding protein isoform 1  7E-12 Bombyx mori NCBI nr 
DBC241 288 1 Vitellogenin  9E-09 Dermacentor variabilis NCBI nr 
DBC292 745 1 Glycoprotein 93 similar to CG5520-PA  1E-76 Nasonia vitripennis NCBI nr 
DBC326 300 1 ATP/ADP translocase  3E-16 Marsupenaeus japonicus NCBI nr 
DBC327 173 1 FUN14 family protein  2E-07 Ixodes scapularis NCBI nr 
DBC006 416 13 Vitellogenin_N 
  
InterProScan 
DBC011 177 1 Ribosomal protein S14 
  
InterProScan 
DBC042 514 3 Immunoglobulin/major histocompatibility complex, conserved site 
  
InterProScan 
DBC056 398 1 Zinc finger C2H2-type 
  
InterProScan 
DBC060 398 1 Zinc finger C2H2-type 
  
InterProScan 
DBC061 671 10 Vitellogenin_N,  
  
InterProScan 
DBC093 260 1 Vitellogenin_N,  
  
InterProScan 
DBC114 620 1 PROTEIN DISULFIDE ISOMERASE 
  
InterProScan 
DBC126 240 1 GTP cyclohydrolase I feedback regulatory protein 
  
InterProScan 
DBC149 232 2 Short-chain dehydrogenase/reductase SDR,  
  
InterProScan 
DBC154 248 1 Nucleotidyltransferase,  
  
InterProScan 
DBC167 325 2 Gonadotropin, beta chain 
  
InterProScan 










Contig Length Nos. of EST Contig identity/Putative function P value Species Database 
DBC211 566 1 Protein translocase SEC61 complex gamma subunit,  
  
InterProScan 
DBC232 283 1 Aldehyde dehydrogenase conserved site 
  
InterProScan 
DBC268 448 1 Zinc finger FYVE/PHD-type 
  
InterProScan 
DBC279 313 1 Cysteine proteinases 
  
InterProScan 
DBC291 271 1 Scramblase, PHOSPHOLIPID SCRAMBLASE 1, 2 
  
InterProScan 
DBC299 770 1 EGF-like region conserved site,  
  
InterProScan 











Appendix 2:  
 






COG major and sub classifications 
INFORMATION STORAGE AND PROCESSING (I) 
J Translation, ribosomal structure and biogenesis  
A RNA processing and modification  
K Transcription  
L Replication, recombination and repair  
B Chromatin structure and dynamics  
  CELLULAR PROCESSES AND SIGNALING (C) 
D Cell cycle control, cell division, chromosome partitioning  
Y Nuclear structure  
V Defense mechanisms  
T Signal transduction mechanisms  
M Cell wall/membrane/envelope biogenesis  
N Cell motility  
Z Cytoskeleton  
W Extracellular structures  
U Intracellular trafficking, secretion, and vesicular transport  
O Posttranslational modification, protein turnover, chaperones  
  METABOLISM (M)  
C Energy production and conversion  
G Carbohydrate transport and metabolism  
E Amino acid transport and metabolism  
F Nucleotide transport and metabolism  
H Coenzyme transport and metabolism  
I Lipid transport and metabolism  
P Inorganic ion transport and metabolism  





Cellular Processes and Signaling 
Contig BLAST result e value Class 
contig11065 gi|62425774|ref|ZP_00380905.1| COG0642: Signal transduction hist...    33   9.6 M 
contig12124 gi|156388121|ref|XP_001634550.1| predicted protein [Nematostella...    33   9.6 U 
contig09226 gi|125858048|gb|AAI29157.1| Importin 9 [Danio rerio] >gnl|BL_ORD...    33   9.6 UY 
contig07751 gi|195393016|ref|XP_002055150.1| GJ19212 [Drosophila virilis] >g...    33   9.6 V 
contig03882 gi|194385568|dbj|BAG65161.1| unnamed protein product [Homo sapiens]    33   9.6 YU 
contig08944 gi|123498833|ref|XP_001327486.1| SH3 domain containing protein [...    33   9.5 T 
contig06368 gi|159490555|ref|XP_001703240.1| hypothetical protein CHLREDRAFT...    33   9.5 U 
contig07940 gi|115751468|ref|XP_785198.2| PREDICTED: similar to laminin B2 [...    33   9.5 W 
contig01667 gi|167384655|ref|XP_001737041.1| hypothetical protein, conserved...    33   9.4 O 
contig07931 gi|195430620|ref|XP_002063352.1| GK21858 [Drosophila willistoni]...    33   9.4 O 
contig00791 gi|187039719|emb|CAP21397.1| Hypothetical protein CBG24893 [Caen...    33   9.4 T 
contig06188 gi|195573070|ref|XP_002104518.1| GD21002 [Drosophila simulans] >...    33   9.4 T 
contig04878 gi|50546493|ref|XP_500716.1| hypothetical protein [Yarrowia lipo...    33   9.4 TR 
contig05214 gi|119622371|gb|EAX01966.1| phosphodiesterase 8A, isoform CRA_b ...    33   9.4 TV 
contig03416 gi|47218346|emb|CAG04178.1| unnamed protein product [Tetraodon n...    33   9.4 W 
contig06533 gi|195583169|ref|XP_002081396.1| GD25734 [Drosophila simulans] >...    33   9.4 Z 
contig08538 gi|47209492|emb|CAG13281.1| unnamed protein product [Tetraodon n...    33   9.3 O 
contig04794 gi|72124879|ref|XP_792408.1| PREDICTED: hypothetical protein [St...    33   9.3 T 
contig07762 gi|52076835|dbj|BAD45777.1| hypothetical protein [Oryza sativa J...    33   9.2 U 
contig02035 gi|167536190|ref|XP_001749767.1| predicted protein [Monosiga bre...    33   8.5 T 
contig00341 gi|70951758|ref|XP_745094.1| hypothetical protein PC000597.02.0 ...    33   8 YU 
contig01036 gi|157136025|ref|XP_001656733.1| axis inhibition protein, axin [...    33   7.3 O 
contig01290 gi|56204188|emb|CAI23045.1| mitogen-activated protein kinase kin...    33   7.3 T 
contig11202 gi|167457373|ref|ZP_02323586.1| hypothetical protein A2cp1DRAFT_...    33   7.3 T 
contig10533 gi|126290333|ref|XP_001372442.1| PREDICTED: similar to mKIAA0284...    33   7.3 U 
contig03404 gi|118091717|ref|XP_001231608.1| PREDICTED: hypothetical protein...    33   7.3 W 
contig09639 gi|170049792|ref|XP_001870929.1| conserved hypothetical protein ...    33   7.3 YU 
contig01561 gi|33325642|gb|AAQ08323.1| complement component 3-like protein [...    33   7.2 D 
contig10900 gi|145478439|ref|XP_001425242.1| hypothetical protein GSPATT0002...    33   7.2 NTZ 
contig06835 gi|195377152|ref|XP_002047356.1| GJ11977 [Drosophila virilis] >g...    33   7.2 O 
contig10182 gi|17560520|ref|NP_505945.1| Temporarily Assigned Gene name fami...    33   7.2 O 
contig10375 gi|156546060|ref|XP_001600638.1| PREDICTED: hypothetical protein...    33   7.2 O 
contig00698 gi|124512590|ref|XP_001349428.1| hypothetical protein, conserved...    33   7.2 T 
contig04761 gi|166998782|ref|ZP_02264636.1| hypothetical protein BmalP_02679...    33   7.2 T 
contig01924 gi|115473629|ref|NP_001060413.1| Os07g0639000 [Oryza sativa (jap...    33   7.2 V 
contig06943 gi|195398411|ref|XP_002057815.1| GJ18339 [Drosophila virilis] >g...    33   7.2 W 
contig11746 gi|161526028|ref|YP_001581040.1| phosphoglycolate phosphatase [B...    33   7.2 W 
contig01056 gi|118099423|ref|XP_415413.2| PREDICTED: similar to quiescin Q6-...    33   7.1 D 
contig09411 gi|114555498|ref|XP_001167189.1| PREDICTED: claspin isoform 1 [P...    33   7.1 DT 
contig04263 gi|157353201|emb|CAO45124.1| unnamed protein product [Vitis vini...    33   7.1 MOT 
contig11057 gi|195119648|ref|XP_002004342.1| GI19880 [Drosophila mojavensis]...    33   7.1 O 
contig11121 gi|148675478|gb|EDL07425.1| DnaJ (Hsp40) homolog, subfamily C, m...    33   7.1 O 
contig00923 gi|156543188|ref|XP_001606169.1| PREDICTED: similar to slingshot...    33   7.1 T 
contig06241 gi|118361871|ref|XP_001014163.1| hypothetical protein TTHERM_002...    33   7.1 T 
contig07193 gi|114707159|ref|ZP_01440057.1| hypothetical protein FP2506_0461...    33   7.1 U 
contig03953 gi|71980924|ref|NP_001021005.1| Dauer or Aging adult Overexpress...    33   7.1 Y 
contig12789 gi|186491181|ref|NP_564696.2| microtubule motor [Arabidopsis tha...    33   7.1 Z 
contig11123 gi|198133265|gb|EAL29168.2| GA11151 [Drosophila pseudoobscura ps...    35   6.5 U 




Contig BLAST result e value Class 
contig03923 gi|145254746|ref|XP_001398733.1| hypothetical protein An18g02740...    33   5.6 O 
contig07268 gi|182418304|ref|ZP_02949599.1| heat-inducible transcription rep...    33   5.6 O 
contig05496 gi|168180139|ref|ZP_02614803.1| hypothetical protein CBN_1627 [C...    33   5.6 T 
contig06502 gi|118353053|ref|XP_001009797.1| hypothetical protein TTHERM_001...    33   5.6 T 
contig09832 gi|194221935|ref|XP_001492983.2| PREDICTED: similar to suppresso...    33   5.6 T 
contig11851 gi|167947380|ref|ZP_02534454.1| Fe-S cluster domain protein [End...    33   5.6 T 
contig12665 gi|120602788|ref|YP_967188.1| methionine aminopeptidase, type I ...    33   5.6 U 
contig01680 gi|170070231|ref|XP_001869508.1| conserved hypothetical protein ...    33   5.5 O 
contig00864 gi|109480404|ref|XP_001079928.1| PREDICTED: hypothetical protein...    33   5.5 T 
contig11588 gi|116060559|emb|CAL55895.1| unnamed protein product [Ostreococc...    33   5.5 T 
contig04187 gi|50251904|dbj|BAD27842.1| hypothetical protein [Oryza sativa J...    33   5.5 Z 
contig03434 gi|184155519|ref|YP_001843859.1| methyltransferase [Lactobacillu...    33   5.4 D 
contig12069 gi|170578730|ref|XP_001894520.1| hypothetical protein Bm1_15300 ...    33   5.4 O 
contig12829 gi|171695622|ref|XP_001912735.1| unnamed protein product [Podosp...    33   5.4 T 
contig00029 gi|177665666|ref|ZP_02941465.1| Tetratricopeptide TPR_2 repeat p...    33   5.4 Z 
contig01420 gi|169203868|ref|XP_001714781.1| PREDICTED: hypothetical protein...    34   5.2 O 
contig12651 gi|157749721|ref|XP_001678574.1| Hypothetical protein CBG00733 [...    34   4.4 D 
contig10527 gi|67153366|ref|ZP_00415111.1| Polysaccharide biosynthesis prote...    34   4.3 NTZ 
contig01008 gi|169844679|ref|XP_001829060.1| hypothetical protein CC1G_01740...    34   4.3 O 
contig08300 gi|156548302|ref|XP_001602506.1| PREDICTED: similar to protein p...    34   4.3 O 
contig10555 gi|198249428|gb|ACH85021.1| ABC-2 type transporter, NodJ family ...    34   4.3 O 
contig01382 gi|119113210|ref|XP_309461.3| Toll-like receptor (AGAP011186-PA)...    34   4.3 T 
contig09507 gi|125559499|gb|EAZ05035.1| hypothetical protein OsI_026267 [Ory...    34   4.3 T 
contig09272 gi|126335686|ref|XP_001370682.1| PREDICTED: hypothetical protein...    34   4.3 U 
contig11466 gi|126297966|ref|XP_001371704.1| PREDICTED: hypothetical protein...    34   4.3 U 
contig05274 gi|156406751|ref|XP_001641208.1| predicted protein [Nematostella...    34   4.3 Z 
contig01994 gi|109123769|ref|XP_001112843.1| PREDICTED: hypothetical protein...    34   4.2 D 
contig00683 gi|197749971|ref|YP_002173498.1| ABC superfamily ATP binding cas...    34   4.2 MW 
contig02065 gi|118581641|ref|YP_902891.1| transglutaminase domain-containing...    34   4.2 O 
contig03181 gi|170699244|ref|ZP_02890295.1| hypothetical protein BamIOP4010D...    34   4.2 O 
contig10672 gi|25013159|gb|AAN71692.1| SD22693p [Drosophila melanogaster]          34   4.2 O 
contig11262 gi|91093683|ref|XP_970017.1| PREDICTED: similar to AGAP007113-PA...    34   4.2 O 
contig05761 gi|195590932|ref|XP_002085198.1| GD14667 [Drosophila simulans] >...    34   4.2 OU 
contig00062 gi|73993564|ref|XP_534544.2| PREDICTED: similar to protein tyros...    34   4.2 T 
contig01618 gi|77919765|ref|YP_357580.1| adenylylating enzyme for glutamine ...    34   4.2 T 
contig04530 gi|111225915|ref|YP_716709.1| signal peptidase-like protein [Fra...    34   4.2 T 
contig05567 gi|125549301|gb|EAY95123.1| hypothetical protein OsI_016356 [Ory...    34   4.2 T 
contig05732 gi|71659287|ref|XP_821367.1| hypothetical protein Tc00.104705351...    34   4.2 T 
contig07731 gi|126734799|ref|ZP_01750545.1| branched-chain amino acid ABC tr...    34   4.2 T 
contig12612 gi|153838997|ref|ZP_01991664.1| ATPase component of ABC transpor...    34   4.2 T 
contig07030 gi|57864805|gb|AAW56980.1| homocitrate synthase [Cyanothece sp. ...    34   4.2 TV 
contig12342 gi|193643513|ref|XP_001943927.1| PREDICTED: similar to AGAP01087...    34   4.2 TV 
contig05860 gi|190405189|gb|EDV08456.1| COPII coat of secretory pathway vesi...    34   4.2 U 
contig06965 gi|169597363|ref|XP_001792105.1| hypothetical protein SNOG_01467...    34   4.2 U 
contig04105 gi|70944395|ref|XP_742133.1| hypothetical protein PC104452.00.0 ...    34   4.1 T 
contig09582 gi|34393988|dbj|BAC84012.1| hypothetical protein [Oryza sativa J...    34   3.3 D 
contig08032 gi|71001204|ref|XP_755283.1| eukaryotic translation initiation f...    34   3.3 DZ 
contig03622 gi|191161587|ref|ZP_03023469.1| hypothetical protein GM21DRAFT_0...    34   3.3 M 
contig08889 gi|193678945|ref|XP_001949533.1| PREDICTED: similar to CG10542 C...    34   3.3 O 
contig00125 gi|156606|gb|AAA28264.1| SpId                                          34   3.3 T 




Contig BLAST result e value Class 
contig06216 gi|145507812|ref|XP_001439861.1| hypothetical protein GSPATT0000...    34   3.3 Z 
contig08151 gi|157746539|ref|XP_001668365.1| Hypothetical protein CBG12357 [...    34   3.2 D 
contig06479 gi|45198890|ref|NP_985919.1| AFR372Wp [Ashbya gossypii ATCC 1089...    34   3.2 DZ 
contig04538 gi|195398873|ref|XP_002058045.1| GJ15706 [Drosophila virilis] >g...    34   3.2 O 
contig02639 gi|124262623|ref|YP_001023093.1| hypothetical protein Mpe_B0079 ...    34   3.2 T 
contig04570 gi|118375060|ref|XP_001020716.1| hypothetical protein TTHERM_012...    34   3.2 T 
contig11265 gi|67924417|ref|ZP_00517844.1| Hydrogenase maturation protein Hy...    34   3.2 T 
contig02220 gi|167624360|ref|YP_001674654.1| hypothetical protein Shal_2437 ...    34   3.2 TR 
contig05803 gi|170070484|ref|XP_001869596.1| phosphatidylinositol 4-kinase [...    34   3.2 TU 
contig03821 gi|6320452|ref|NP_010532.1| One of 10 subunits of the transport ...    34   3.2 U 
contig11166 gi|195111456|ref|XP_002000294.1| GI10149 [Drosophila mojavensis]...    36   3.2 U 
contig04131 gi|195034401|ref|XP_001988888.1| GH11411 [Drosophila grimshawi] ...    34   3.2 W 
contig11258 gi|156398596|ref|XP_001638274.1| predicted protein [Nematostella...    34   3.2 W 
contig08501 gi|195174473|ref|XP_002027998.1| GL16648 [Drosophila persimilis]...    34   3.2 YU 
contig04516 gi|118360810|ref|XP_001013636.1| hypothetical protein TTHERM_008...    34   3.2 Z 
contig06995 gi|147919261|ref|YP_687003.1| Holliday junction DNA helicase B [...    34   3.2 Z 
contig08805 gi|57241961|ref|ZP_00369901.1| conserved hypothetical protein TI...    34   3.2 Z 
contig11596 gi|439289|emb|CAA81388.1| verprolin [Saccharomyces cerevisiae]         37   3.2 Z 
contig05015 gi|90080692|dbj|BAE89827.1| unnamed protein product [Macaca fasc...    34   3.2 ZU 
contig08129 gi|198150934|gb|EAL30012.2| GA20934 [Drosophila pseudoobscura ps...    35   3.1 T 
contig01201 gi|157736697|ref|YP_001489380.1| hypothetical protein Abu_0436 [...    35   3.1 W 
contig08723 gi|58267468|ref|XP_570890.1| eukaryotic translation initiation f...    35   2.5 D 
contig09025 gi|68468367|ref|XP_721743.1| hypothetical protein CaO19.1666 [Ca...    35   2.5 D 
contig09784 gi|53792183|dbj|BAD52816.1| vegetative cell wall protein gp1 -li...    35   2.5 D 
contig00608 gi|170095453|ref|XP_001878947.1| predicted protein [Laccaria bic...    35   2.5 DO 
contig05039 gi|85691079|ref|XP_965939.1| hypothetical protein ECU01_1030 [En...    35   2.5 DZ 
contig07600 gi|149242348|ref|XP_001526452.1| hypothetical protein LELG_03010...    35   2.5 M 
contig00477 gi|156402682|ref|XP_001639719.1| predicted protein [Nematostella...    35   2.5 O 
contig10935 gi|67538958|ref|XP_663253.1| hypothetical protein AN5649.2 [Aspe...    35   2.5 O 
contig12429 gi|114052162|ref|NP_001040460.1| proteasome beta 3 subunit [Bomb...    35   2.5 O 
contig00827 gi|195121432|ref|XP_002005224.1| GI20375 [Drosophila mojavensis]...    37   2.5 T 
contig03803 gi|196185300|gb|EDX80276.1| Pyridine nucleotide-disulphide oxido...    35   2.5 T 
contig09595 gi|58265682|ref|XP_569997.1| DNA supercoiling [Cryptococcus neof...    35   2.5 T 
contig09599 gi|170117594|ref|XP_001889983.1| predicted protein [Laccaria bic...    35   2.5 T 
contig10388 gi|145528738|ref|XP_001450163.1| hypothetical protein GSPATT0001...    35   2.5 T 
contig11059 gi|195432721|ref|XP_002064365.1| GK19733 [Drosophila willistoni]...    35   2.5 T 
contig11341 gi|118082345|ref|XP_416047.2| PREDICTED: similar to SRrp129 [Gal...    35   2.5 T 
contig07512 gi|149999616|ref|NP_073293.2| protein LORF2 [Meleagrid herpesvir...    35   2.5 TR 
contig01591 gi|17569677|ref|NP_509052.1| T07H6.4 [Caenorhabditis elegans] >g...    35   2.5 TV 
contig07496 gi|147768721|emb|CAN62675.1| hypothetical protein [Vitis vinifera]     35   2.5 TZR 
contig04020 gi|70935360|ref|XP_738775.1| hypothetical protein PC401526.00.0 ...    35   2.5 W 
contig12458 gi|83749245|ref|ZP_00946245.1| Carbon monoxide oxygenase (cytoch...    35   2.5 W 
contig06431 gi|145522165|ref|XP_001446932.1| hypothetical protein GSPATT0001...    35   2.5 Z 
contig09292 gi|170059945|ref|XP_001865583.1| something about silencing prote...    35   2.5 Z 
contig07542 gi|6323273|ref|NP_013345.1| Methionine aminopeptidase, catalyzes...    35   2.4 O 
contig01144 gi|156842348|ref|XP_001644542.1| hypothetical protein Kpol_1052p...    35   2.4 V 
contig12682 gi|169218160|ref|XP_001719783.1| PREDICTED: similar to KLHL23 pr...    27   2.2 TR 
contig00416 gi|67603978|ref|XP_666583.1| hypothetical protein Chro.70593 [Cr...    39   2.1 U 
contig01278 gi|195434521|ref|XP_002065251.1| GK15350 [Drosophila willistoni]...    37   2 O 
contig03680 gi|72387830|ref|XP_844339.1| hypothetical protein, conserved [Tr...    35   1.9 D 




Contig BLAST result e value Class 
contig00259 gi|161507977|ref|YP_001577941.1| putative ATP-dependent helicase...    35   1.9 O 
contig01558 gi|110769117|ref|XP_394836.3| PREDICTED: similar to ubiquitin sp...    35   1.9 O 
contig04787 gi|194759065|ref|XP_001961770.1| GF14762 [Drosophila ananassae] ...    35   1.9 O 
contig07232 gi|147900295|ref|NP_001083439.1| hypothetical protein LOC398926 ...    35   1.9 O 
contig08465 gi|121593982|ref|YP_985878.1| hypothetical protein Ajs_1609 [Aci...    35   1.9 O 
contig10701 gi|156550335|ref|XP_001603253.1| PREDICTED: similar to 26S prote...    35   1.9 O 
contig12910 gi|156399835|ref|XP_001638706.1| predicted protein [Nematostella...    35   1.9 O 
contig13073 gi|156392707|ref|XP_001636189.1| predicted protein [Nematostella...    35   1.9 O 
contig02661 gi|188026387|ref|ZP_02997884.1| hypothetical protein PROSTU_0397...    35   1.9 T 
contig04865 gi|167525154|ref|XP_001746912.1| predicted protein [Monosiga bre...    30   1.9 T 
contig07719 gi|194895594|ref|XP_001978292.1| GG17765 [Drosophila erecta] >gn...    35   1.9 T 
contig00598 gi|190574310|ref|YP_001972155.1| putative two-component response...    35   1.9 TZ 
contig03948 gi|195388260|ref|XP_002052801.1| GJ19836 [Drosophila virilis] >g...    35   1.9 U 
contig01264 gi|194766886|ref|XP_001965555.1| GF22554 [Drosophila ananassae] ...    35   1.5 D 
contig05034 gi|46110719|ref|XP_382417.1| hypothetical protein FG02241.1 [Gib...    35   1.5 O 
contig07484 gi|194367365|ref|YP_002029975.1| hypothetical protein Smal_3593 ...    35   1.5 O 
contig08622 gi|148680449|gb|EDL12396.1| mCG125898 [Mus musculus]                   35   1.5 O 
contig09236 gi|193787650|dbj|BAG52856.1| unnamed protein product [Homo sapiens]    35   1.5 O 
contig11714 gi|67522775|ref|XP_659448.1| hypothetical protein AN1844.2 [Aspe...    35   1.5 O 
contig01340 gi|77022988|ref|XP_888938.1| hypothetical protein CaO19_1346 [Ca...    37   1.5 OT 
contig00676 gi|195576554|ref|XP_002078140.1| GD22701 [Drosophila simulans] >...    35   1.5 T 
contig07290 gi|50550919|ref|XP_502933.1| hypothetical protein [Yarrowia lipo...    35   1.5 T 
contig11279 gi|67901420|ref|XP_680966.1| hypothetical protein AN7697.2 [Aspe...    35   1.5 T 
contig04177 gi|89897355|ref|YP_520842.1| putative oxidoreductase iron-sulfur...    35   1.5 TU 
contig11852 gi|170699604|ref|ZP_02890643.1| conserved hypothetical protein [...    35   1.5 W 
contig02884 gi|13487281|gb|AAK27473.1| polyketide synthase; SvKS [Streptomyc...    35   1.5 Z 
contig02569 gi|194697734|gb|ACF82951.1| unknown [Zea mays]                         37   1.4 MW 
contig13298 gi|115455821|ref|NP_001051511.1| Os03g0789600 [Oryza sativa (jap...    38   1.4 N 
contig06288 gi|195131669|ref|XP_002010268.1| GI14785 [Drosophila mojavensis]...    35   1.4 T 
contig11172 gi|76162433|gb|AAX30253.2| SJCHGC02429 protein [Schistosoma japo...    30   1.4 T 
contig05814 gi|73988191|ref|XP_542325.2| PREDICTED: similar to centaurin del...    35   1.4 TU 
contig03391 gi|19718366|ref|NP_604435.1| phosphoprotein [Human parainfluenza...    35   1.4 TZ 
contig01838 gi|204787|gb|AAA41396.1| Immunoglobulin kappa-chain VJ precursor       35   1.4 U 
contig09717 gi|167386146|ref|XP_001737636.1| hypothetical protein, conserved...    35   1.4 U 
contig04048 gi|156554278|ref|XP_001602116.1| PREDICTED: similar to ENSANGP00...    35   1.4 W 
contig04916 gi|126002135|ref|XP_001352272.1| GA14535-PA [Drosophila pseudoob...    28   1.3 M 
contig03638 gi|125591112|gb|EAZ31462.1| hypothetical protein OsJ_014945 [Ory...    38   1.3 W 
contig03608 gi|195344163|ref|XP_002038658.1| GM10939 [Drosophila sechellia] ...    37   1.3 Z 
contig05694 gi|195574457|ref|XP_002105205.1| GD21359 [Drosophila simulans] >...    36   1.1 O 
contig12078 gi|158289547|ref|XP_311247.4| AGAP000713-PA [Anopheles gambiae s...    36   1.1 O 
contig01095 gi|162454494|ref|YP_001616861.1| hypothetical protein sce6214 [S...    36   1.1 T 
contig02428 gi|116492183|ref|YP_803918.1| x-prolyl-dipeptidyl aminopeptidase...    36   1.1 T 
contig06549 gi|164661015|ref|XP_001731630.1| hypothetical protein MGL_0898 [...    36   1.1 T 
contig03290 gi|156546770|ref|XP_001605588.1| PREDICTED: similar to rap55 [Na...    36   1.1 U 
contig06597 gi|47216957|emb|CAG04899.1| unnamed protein product [Tetraodon n...    36   1.1 U 
contig08524 gi|159481730|ref|XP_001698931.1| hypothetical protein CHLREDRAFT...    36   1.1 U 
contig03324 gi|193702277|ref|XP_001948755.1| PREDICTED: similar to AGAP00204...    36   1.1 V 
contig10773 gi|19115005|ref|NP_594093.1| nucleoporin Nup189 [Schizosaccharom...    36   1.1 YU 
contig05865 gi|195161123|ref|XP_002021419.1| GL25318 [Drosophila persimilis]...    36   1.1 Z 
contig08209 gi|70798578|gb|AAZ08999.1| immunoglobulin heavy chain variable r...    36   1.1 Z 




Contig BLAST result e value Class 
contig03270 gi|116793592|gb|ABK26801.1| unknown [Picea sitchensis]                 37   0.9 T 
contig08553 gi|156383791|ref|XP_001633016.1| predicted protein [Nematostella...    36   0.87 O 
contig02900 gi|85090533|ref|XP_958462.1| hypothetical protein NCU09955 [Neur...    36   0.86 O 
contig01757 gi|114615998|ref|XP_001135989.1| PREDICTED: plexin A4, A isoform...    36   0.86 T 
contig06286 gi|169640128|gb|ACA61137.1| cellulase [uncultured microorganism]       36   0.86 T 
contig10563 gi|73965496|ref|XP_548054.2| PREDICTED: similar to C1q-related f...    36   0.86 T 
contig12323 gi|124504889|ref|XP_001351187.1| putative protein kinase [Plasmo...    36   0.86 W 
contig10528 gi|157676123|emb|CAP08065.1| m21 protein [Murine cytomegalovirus...    36   0.85 O 
contig03058 gi|197925298|ref|ZP_03190244.1| hypothetical protein SpriA_20024...    36   0.85 T 
contig05959 gi|193681063|ref|XP_001950378.1| PREDICTED: similar to chromaffi...    36   0.85 U 
contig08521 gi|156366295|ref|XP_001627074.1| predicted protein [Nematostella...    36   0.85 U 
contig10018 gi|152989514|ref|YP_001346511.1| hypothetical protein PSPA7_1125...    36   0.85 W 
contig00739 gi|116198151|ref|XP_001224887.1| hypothetical protein CHGG_07231...    36   0.85 Z 
contig04127 gi|170575044|ref|XP_001893074.1| Twik (KCNK-like) family of pota...    36   0.84 M 
contig00264 gi|156359643|ref|XP_001624876.1| predicted protein [Nematostella...    36   0.84 O 
contig00075 gi|42761547|gb|AAS45365.1| similar to Plasmodium falciparum. Hyp...    38   0.77 Z 
contig12607 gi|157865433|ref|XP_001681424.1| hypothetical protein, conserved...    39   0.73 TZ 
contig05086 gi|168031786|ref|XP_001768401.1| predicted protein [Physcomitrel...    28   0.7 O 
contig07878 gi|145253362|ref|XP_001398194.1| hypothetical protein An16g08960...    37   0.66 D 
contig13323 gi|119719782|ref|YP_920277.1| hypothetical protein Tpen_0873 [Th...    37   0.66 O 
contig00491 gi|195386888|ref|XP_002052136.1| GJ17388 [Drosophila virilis] >g...    37   0.66 T 
contig01028 gi|114625625|ref|XP_001151769.1| PREDICTED: similar to basic pro...    37   0.66 T 
contig10520 gi|170585792|ref|XP_001897666.1| Protein kinase c protein 2, iso...    37   0.66 T 
contig12170 gi|182680179|ref|YP_001834325.1| hypothetical protein Bind_3276 ...    37   0.65 O 
contig13052 gi|73955932|ref|XP_863640.1| PREDICTED: similar to ubiquitin B p...    37   0.65 OR 
contig04523 gi|148706314|gb|EDL38261.1| EGF-like module containing, mucin-li...    37   0.65 T 
contig11739 gi|153833093|ref|ZP_01985760.1| hypothetical protein A1Q_1062 [V...    37   0.65 T 
contig05894 gi|115379274|ref|ZP_01466387.1| glutamine synthetase [Stigmatell...    37   0.65 Z 
contig01483 gi|66814134|ref|XP_641246.1| hypothetical protein DDBDRAFT_02182...    37   0.64 D 
contig01088 gi|198139346|gb|EAL33262.2| GA13628 [Drosophila pseudoobscura ps...    37   0.64 O 
contig08922 gi|169860246|ref|XP_001836758.1| hypothetical protein CC1G_04071...    37   0.64 OU 
contig01623 gi|167357703|ref|ZP_02292367.1| methyltransferase-like protein [...    37   0.64 U 
contig07023 gi|157125996|ref|XP_001654485.1| hypothetical protein AaeL_AAEL0...    31   0.62 T 
contig00475 gi|18027726|gb|AAL55824.1|AF318317_1 unknown [Homo sapiens]            28   0.6 T 
contig12885 gi|149919653|ref|ZP_01908132.1| hypothetical protein PPSIR1_0726...    38   0.52 T 
contig03576 gi|157344388|emb|CAO69771.1| unnamed protein product [Vitis vini...    37   0.51 D 
contig08022 gi|169170317|ref|XP_001718125.1| PREDICTED: hypothetical protein...    28   0.51 T 
contig08382 gi|189534684|ref|XP_001919656.1| PREDICTED: similar to zinc fing...    37   0.51 T 
contig12728 gi|117957263|gb|ABK59062.1| polymerase [Human adenovirus 37]           37   0.5 O 
contig01782 gi|119873111|ref|YP_931118.1| saccharopine dehydrogenase [Pyroba...    37   0.5 T 
contig07215 gi|115894447|ref|XP_780669.2| PREDICTED: similar to DBC2 protein...    37   0.5 TZ 
contig04534 gi|110761227|ref|XP_001122167.1| PREDICTED: similar to CG4030-PA...    37   0.5 U 
contig05499 gi|147845679|emb|CAN80589.1| hypothetical protein [Vitis vinifera]     37   0.5 U 
contig06902 gi|194757768|ref|XP_001961134.1| GF11157 [Drosophila ananassae] ...    37   0.5 U 
contig00284 gi|45184624|gb|AAS55564.1| MST84DC [Drosophila mauritiana] >gnl|...    37   0.5 W 
contig03233 gi|12249142|ref|NP_065432.2| NADH dehydrogenase subunit 6 [Schis...    37   0.49 T 
contig01823 gi|1335202|emb|CAA56130.1| beta2/S laminin chain [Homo sapiens]        37   0.46 W 
contig08825 gi|157136051|ref|XP_001656746.1| signal recognition particle [Ae...    37   0.39 U 
contig11680 gi|123504770|ref|XP_001328828.1| LIM domain containing protein [...    37   0.39 W 
contig09447 gi|156548864|ref|XP_001606345.1| PREDICTED: similar to MGC80357 ...    37   0.38 T 




Contig BLAST result e value Class 
contig11661 gi|71749482|ref|XP_828080.1| hypothetical protein Tb10.61.0160 [...    37   0.38 Z 
contig12765 gi|125591402|gb|EAZ31752.1| hypothetical protein OsJ_015235 [Ory...    40   0.31 D 
contig01255 gi|189237968|ref|XP_001811946.1| PREDICTED: similar to CG8155 CG...    38   0.3 T 
contig02256 gi|189202442|ref|XP_001937557.1| conserved hypothetical protein ...    38   0.3 U 
contig07132 gi|195491533|ref|XP_002093601.1| ida [Drosophila yakuba] >gnl|BL...    38   0.29 DO 
contig06957 gi|29841035|gb|AAP06048.1| similar to NM_017284 proteasome (pros...    38   0.29 O 
contig03938 gi|169173427|ref|XP_001717734.1| PREDICTED: hypothetical protein...    38   0.29 T 
contig09368 gi|157123175|ref|XP_001660044.1| cd36 antigen [Aedes aegypti] >g...    38   0.29 T 
contig02786 gi|189523564|ref|XP_001920789.1| PREDICTED: hypothetical protein...    38   0.29 TV 
contig01211 gi|125586705|gb|EAZ27369.1| hypothetical protein OsJ_010852 [Ory...    40   0.26 TV 
contig04335 gi|194218680|ref|XP_001494740.2| PREDICTED: similar to Actin-rel...    38   0.24 Z 
contig10538 gi|167523042|ref|XP_001745858.1| predicted protein [Monosiga bre...    38   0.23 DZU 
contig00231 gi|156550801|ref|XP_001600558.1| PREDICTED: similar to FTP3 [Nas...    38   0.23 O 
contig05696 gi|168067485|ref|XP_001785646.1| predicted protein [Physcomitrel...    38   0.23 O 
contig09541 gi|170033288|ref|XP_001844510.1| olygosaccharyltransferase alpha...    38   0.23 O 
contig00118 gi|125531144|gb|EAY77709.1| hypothetical protein OsI_031668 [Ory...    38   0.23 T 
contig02828 gi|194761414|ref|XP_001962924.1| GF15679 [Drosophila ananassae] ...    39   0.23 T 
contig05395 gi|149616040|ref|XP_001510974.1| PREDICTED: similar to hCG204480...    39   0.23 T 
contig05780 gi|161661029|gb|ABX75381.1| cysteine and glycine-rich protein [L...    38   0.23 TZ 
contig03739 gi|148668868|gb|EDL01036.1| mCG129264 [Mus musculus]                   38   0.22 DZU 
contig03206 gi|156387705|ref|XP_001634343.1| predicted protein [Nematostella...    38   0.22 O 
contig05189 gi|114612501|ref|XP_518982.2| PREDICTED: basic leucine zipper an...    38   0.22 O 
contig03327 gi|154757410|gb|AAI51785.1| DIAPH3 protein [Bos taurus]                38   0.22 T 
contig07147 gi|195480495|ref|XP_002101281.1| GE17532 [Drosophila yakuba] >gn...    38   0.22 T 
contig12673 gi|195168069|ref|XP_002024854.1| GL17883 [Drosophila persimilis]...    40   0.22 T 
contig09674 gi|156385188|ref|XP_001633513.1| predicted protein [Nematostella...    38   0.22 U 
contig01224 gi|195029723|ref|XP_001987721.1| GH19811 [Drosophila grimshawi] ...    38   0.22 Z 
contig11426 gi|198145779|gb|EAL32566.2| GA22026 [Drosophila pseudoobscura ps...    40   0.21 T 
contig11599 gi|157117680|ref|XP_001658884.1| polybromo-1 [Aedes aegypti] >gn...    39   0.19 O 
contig01915 gi|4886294|emb|CAB43342.1| Lamin [Astropecten brasiliensis]            39   0.17 DY 
contig08072 gi|195152453|ref|XP_002017151.1| GL22150 [Drosophila persimilis]...    39   0.17 O 
contig09138 gi|187608119|ref|NP_001120050.1| hypothetical protein LOC1001450...    39   0.17 O 
contig10875 gi|126323246|ref|XP_001376008.1| PREDICTED: similar to scaffold ...    39   0.17 O 
contig10154 gi|183987808|gb|ACC65888.1| Down syndrome cell adhesion molecule...    39   0.17 T 
contig11014 gi|67845963|dbj|BAE00009.1| LDL receptor [Seriola quinqueradiata]      39   0.17 T 
contig11182 gi|147901940|ref|NP_001090248.1| hypothetical protein LOC779153 ...    39   0.17 T 
contig07097 gi|116871854|ref|YP_848635.1| hypothetical protein lwe0434 [List...    39   0.17 Y 
contig07550 gi|118378274|ref|XP_001022313.1| Kinesin motor domain containing...    39   0.17 Z 
contig07635 gi|115958669|ref|XP_001194281.1| PREDICTED: hypothetical protein...    39   0.17 Z 
contig13245 gi|30023940|ref|NP_835282.1| polymerase [Indian peanut clump virus]    39   0.16 T 
contig06692 gi|46559756|ref|NP_956213.2| adaptor-related protein complex 2, ...    32   0.15 U 
contig00333 gi|54400522|ref|NP_001006010.1| hypothetical protein LOC449989 [...    39   0.13 DV 
contig06046 gi|68063199|ref|XP_673609.1| hypothetical protein PB405521.00.0 ...    39   0.13 M 
contig05828 gi|91092020|ref|XP_970897.1| PREDICTED: similar to putative cath...    39   0.13 O 
contig07211 gi|93003312|tpd|FAA00239.1| TPA: zinc finger protein [Ciona inte...    39   0.13 O 
contig08440 gi|158292142|ref|XP_001237526.2| AGAP004413-PA [Anopheles gambia...    39   0.13 O 
contig04678 gi|114685214|ref|XP_001157109.1| PREDICTED: hypothetical protein...    39   0.13 T 
contig00929 gi|195453690|ref|XP_002073897.1| GK14360 [Drosophila willistoni]...    39   0.13 U 
contig13254 gi|151337348|gb|ABS01106.1| D-hordein [Hordeum chilense]               40   0.13 V 
contig07893 gi|126338312|ref|XP_001373693.1| PREDICTED: hypothetical protein...    39   0.13 W 




Contig BLAST result e value Class 
contig01861 gi|47221621|emb|CAF97886.1| unnamed protein product [Tetraodon n...    39   0.13 Z 
contig05576 gi|170581235|ref|XP_001895597.1| tubulin alpha-2 chain [Brugia m...    39   0.13 Z 
contig03647 gi|5052414|gb|AAD38537.1|AF145029_1 transportin-SR [Homo sapiens]      35   0.12 U 
contig06590 gi|118785594|ref|XP_314763.3| AGAP008664-PA [Anopheles gambiae s...    39   0.1 M 
contig03512 gi|156546773|ref|XP_001607297.1| PREDICTED: similar to ubiquitin...    39   0.1 O 
contig05102 gi|195483891|ref|XP_002090473.1| GE12790 [Drosophila yakuba] >gn...    39   0.1 T 
contig11339 gi|116669193|ref|YP_830126.1| nuclear export factor GLE1 [Arthro...    39   0.1 T 
contig07353 gi|159472306|ref|XP_001694292.1| predicted protein [Chlamydomona...    39   0.1 TR 
contig02973 gi|194206111|ref|XP_001491687.2| PREDICTED: similar to Mitochond...    39   0.1 U 
contig12070 gi|193643549|ref|XP_001948352.1| PREDICTED: similar to rab6 isof...    39   0.1 U 
contig05482 gi|167525597|ref|XP_001747133.1| predicted protein [Monosiga bre...    39   0.1 W 
contig07698 gi|91091176|ref|XP_971655.1| PREDICTED: similar to S1 RNA bindin...    39   0.1 WV 
contig08555 gi|47205490|emb|CAF90253.1| unnamed protein product [Tetraodon n...    39   0.10 DZU 
contig08637 gi|189233774|ref|XP_001814482.1| PREDICTED: similar to MGC80357 ...    39   0.10 T 
contig03121 gi|115770339|ref|XP_001176616.1| PREDICTED: similar to egg bindi...    40   0.08 T 
contig10036 gi|198138857|gb|EAL34132.2| GA19606 [Drosophila pseudoobscura ps...    40   0.08 T 
contig09100 gi|21593914|gb|AAM65879.1| unknown [Arabidopsis thaliana]              40   0.08 MOU 
contig03378 gi|123477829|ref|XP_001322080.1| hypothetical protein TVAG_25938...    40   0.08 T 
contig12024 gi|156451854|ref|ZP_02058228.1| formate dehydrogenase, alpha sub...    40   0.08 O 
contig10609 gi|133777115|gb|AAH91093.2| GRN protein [Xenopus tropicalis]           40   0.08 T 
contig04859 gi|118101636|ref|XP_417771.2| PREDICTED: similar to Arginine/pro...    40   0.06 Z 
contig10399 gi|170034430|ref|XP_001845077.1| 26S proteasome non-ATPase regul...    40   0.06 O 
contig08563 gi|91095293|ref|XP_967766.1| PREDICTED: similar to calcyclin bin...    40   0.06 T 
contig04026 gi|67469205|ref|XP_650594.1| RNA methyltransferase, putative [En...    40   0.06 T 
contig05609 gi|115371999|ref|ZP_01459311.1| FHA domain protein [Stigmatella ...    41   0.06 W 
contig08195 gi|189530984|ref|XP_001920524.1| PREDICTED: intersectin like [Da...    40   0.05 O 
contig03194 gi|119912012|ref|XP_001256523.1| PREDICTED: similar to tetratric...    40   0.05 Z 
contig09035 gi|169768980|ref|XP_001818960.1| hypothetical protein [Aspergill...    40   0.05 T 
contig07655 gi|91092816|ref|XP_967541.1| PREDICTED: similar to AGAP002470-PA...    40   0.05 W 
contig06135 gi|153812578|ref|ZP_01965246.1| hypothetical protein RUMOBE_0297...    42   0.04 T 
contig12862 gi|194753720|ref|XP_001959158.1| GF12744 [Drosophila ananassae] ...    41   0.04 YU 
contig11360 gi|33112616|gb|AAF37724.3|AF238234_1 diaphanous protein [Entamoe...    42   0.04 W 
contig02805 gi|195135429|ref|XP_002012135.1| GI16804 [Drosophila mojavensis]...    41   0.04 O 
contig01236 gi|123989726|gb|ABM83891.1| mitogen-activated protein-binding pr...    41   0.04 T 
contig02975 gi|149264699|ref|XP_001475752.1| PREDICTED: hypothetical protein...    41   0.04 T 
contig05292 gi|196002321|ref|XP_002111028.1| hypothetical protein TRIADDRAFT...    41   0.04 U 
contig01728 gi|170044717|ref|XP_001849983.1| puromycin-sensitive aminopeptid...    41   0.04 Z 
contig05843 gi|118085859|ref|XP_001235427.1| PREDICTED: hypothetical protein...    41   0.04 Z 
contig11827 gi|160213448|gb|ABX10976.1| Rho GTPase activating protein 4 (pre...    41   0.04 Z 
contig02733 gi|30681147|ref|NP_172416.2| haspin-related [Arabidopsis thalian...    41   0.03 D 
contig08295 gi|168013032|ref|XP_001759205.1| predicted protein [Physcomitrel...    41   0.03 T 
contig09596 gi|156552361|ref|XP_001602164.1| PREDICTED: similar to IP17403p ...    41   0.03 T 
contig09310 gi|91081667|ref|XP_969700.1| PREDICTED: similar to AGAP000550-PA...    41   0.03 W 
contig02951 gi|149287066|gb|ABR23432.1| alpha crystallin [Ornithodoros parkeri]    42   0.03 O 
contig09458 gi|47215439|emb|CAG05726.1| unnamed protein product [Tetraodon n...    41   0.03 T 
contig01380 gi|197246549|gb|AAI68475.1| Unknown (protein for MGC:172737) [Xe...    41   0.03 T 
contig09956 gi|193673870|ref|XP_001944375.1| PREDICTED: similar to alpha Cat...    41   0.03 W 
contig02558 gi|197128346|gb|ACH44844.1| putative dynein cytoplasmic light pe...    43   0.02 Z 
contig07791 gi|62857002|dbj|BAD95886.1| Ca/calmodulin-dependent protein kina...    42   0.02 T 
contig11765 gi|196000721|ref|XP_002110228.1| expressed hypothetical protein ...    42   0.02 T 




Contig BLAST result e value Class 
contig00809 gi|157114115|ref|XP_001652166.1| abc transporter [Aedes aegypti]...    42   0.02 U 
contig11549 gi|145503637|ref|XP_001437793.1| hypothetical protein GSPATT0003...    43   0.02 W 
contig08356 gi|110750886|ref|XP_395543.3| PREDICTED: similar to dalao CG7055...    42   0.02 O 
contig10447 gi|159060|gb|AAA29140.1| mu-glutathione transferase [Fasciola he...    42   0.02 O 
contig12559 gi|195567675|ref|XP_002107384.1| GD17434 [Drosophila simulans] >...    44   0.02 T 
contig04548 gi|193664496|ref|XP_001943041.1| PREDICTED: similar to short sto...    42   0.02 Z 
contig03656 gi|195108637|ref|XP_001998899.1| GI24219 [Drosophila mojavensis]...    43   0.02 T 
contig05325 gi|195047032|ref|XP_001992258.1| GH24301 [Drosophila grimshawi] ...    42   0.02 T 
contig09169 gi|76801260|ref|YP_326268.1| chromosome partition protein [Natro...    42   0.02 Z 
contig10090 gi|152996239|ref|YP_001341074.1| hypothetical protein Mmwyl1_221...    45   0.01 O 
contig08827 gi|58332124|ref|NP_001011214.1| cathepsin S [Xenopus (Silurana) ...    42   0.01 O 
contig08880 gi|194668814|ref|XP_590284.4| PREDICTED: similar to MPN domain-c...    36   0.01 O 
contig04139 gi|156337939|ref|XP_001619924.1| hypothetical protein NEMVEDRAFT...    42   0.01 T 
contig00401 gi|156386140|ref|XP_001633771.1| predicted protein [Nematostella...    42   0.01 U 
contig07786 gi|91094489|ref|XP_971063.1| PREDICTED: similar to CG2095 CG2095...    42   0.01 U 
contig11380 gi|170030690|ref|XP_001843221.1| filamin [Culex quinquefasciatus...    42   0.01 Z 
contig01078 gi|198145578|gb|EDY72179.1| GA22956 [Drosophila pseudoobscura ps...    44   0.01 V 
contig01447 gi|156552511|ref|XP_001599980.1| PREDICTED: similar to cathepsin...    43   0.01 O 
contig03077 gi|170067598|ref|XP_001868545.1| phosphatase and actin regulator...    43   0.01 O 
contig08275 gi|196008375|ref|XP_002114053.1| hypothetical protein TRIADDRAFT...    43   0.01 O 
contig08476 gi|156553970|ref|XP_001602910.1| PREDICTED: similar to ENSANGP00...    40   0.01 T 
contig08986 gi|14647143|gb|AAK71863.1|AF339157_1 mannose-6-phosphate/insulin...    43   0.01 TU 
contig09642 gi|195438034|ref|XP_002066942.1| GK24746 [Drosophila willistoni]...    43   0.01 YU 
contig01564 gi|91094875|ref|XP_972773.1| PREDICTED: similar to CG7394 CG7394...    43   0.01 O 
contig02620 gi|149371336|ref|ZP_01890822.1| oligopeptidase (protease II) [un...    43   0.01 O 
contig08690 gi|156365829|ref|XP_001626845.1| predicted protein [Nematostella...    43   0.01 O 
contig10431 gi|169217053|ref|XP_001714101.1| PREDICTED: similar to ubiquitin...    43   0.01 O 
contig05787 gi|195553265|ref|XP_002076633.1| GD15097 [Drosophila simulans] >...    43   0.01 T 
contig03258 gi|118088968|ref|XP_419917.2| PREDICTED: similar to CUB and Sush...    43   0.01 TV 
contig01233 gi|149445072|ref|XP_001518993.1| PREDICTED: hypothetical protein...    43   0.01 U 
contig09428 gi|195132985|ref|XP_002010920.1| GI21806 [Drosophila mojavensis]...    44   0.01 DO 
contig03565 gi|159184548|ref|NP_353970.2| hypothetical protein Atu0950 [Agro...    44   0.01 O 
contig05837 gi|50295084|ref|XP_449953.1| hypothetical protein CAGL0M14003g [...    44   0.01 O 
contig09403 gi|156379923|ref|XP_001631705.1| predicted protein [Nematostella...    44   0.01 O 
contig06804 gi|149056871|gb|EDM08302.1| protein kinase D2 [Rattus norvegicus]      44   0.01 T 
contig01162 gi|47217245|emb|CAF96768.1| unnamed protein product [Tetraodon n...    44   0.01 U 
contig05737 gi|195440772|ref|XP_002068214.1| GK10106 [Drosophila willistoni]...    44   0.01 Z 
contig02758 gi|72030199|ref|XP_780027.1| PREDICTED: similar to MGC80929 prot...    44   0.00 O 
contig04135 gi|67597810|ref|XP_666173.1| hypothetical protein Chro.10099 [Cr...    44   0.00 O 
contig09154 gi|156401589|ref|XP_001639373.1| predicted protein [Nematostella...    44   0.00 O 
contig04486 gi|156551402|ref|XP_001603645.1| PREDICTED: similar to 28S ribos...    44   0.00 D 
contig05185 gi|195452950|ref|XP_002073572.1| GK13074 [Drosophila willistoni]...    44   0.00 D 
contig01066 gi|47227523|emb|CAG04671.1| unnamed protein product [Tetraodon n...    44   0.00 T 
contig10187 gi|195996897|ref|XP_002108317.1| hypothetical protein TRIADDRAFT...    44   0.00 T 
contig02735 gi|195479726|ref|XP_002101004.1| GE17372 [Drosophila yakuba] >gn...    44   0.00 U 
contig08957 gi|110767589|ref|XP_001121853.1| PREDICTED: similar to Transloca...    44   0.00 U 
contig08856 gi|159475749|ref|XP_001695981.1| flagellar associated protein, p...    44   0.00 V 
contig05991 gi|126329141|ref|XP_001367459.1| PREDICTED: similar to proteasom...    45   0.00 O 
contig06638 gi|115687856|ref|XP_001196828.1| PREDICTED: similar to BRCA1/BRC...    45   0.00 O 
contig06688 gi|156551191|ref|XP_001604758.1| PREDICTED: similar to phosphati...    45   0.00 O 
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contig08063 gi|196000721|ref|XP_002110228.1| expressed hypothetical protein ...    45   0.00 T 
contig09751 gi|154335798|ref|XP_001564135.1| hypothetical protein LbrM19_V2....    45   0.00 T 
contig12371 gi|149723703|ref|XP_001489791.1| PREDICTED: granulin [Equus caba...    45   0.00 T 
contig10604 gi|114431574|gb|ABI74628.1| beta-catenin [Podocoryne carnea]           45   0.00 TZ 
contig04157 gi|170036955|ref|XP_001846326.1| gamma-soluble nsf attachment pr...    45   0.00 U 
contig05450 gi|89258423|gb|ABD65435.1| Rab11 [Suberites domuncula]                 45   0.00 U 
contig08623 gi|91084541|ref|XP_972999.1| PREDICTED: similar to vacuolar prot...    45   0.00 U 
contig10812 gi|47229714|emb|CAG06910.1| unnamed protein product [Tetraodon n...    45   0.00 Z 
contig09115 gi|169641795|gb|AAI60392.1| Unknown (protein for IMAGE:7548775) ...    46   0.00 D 
contig10842 gi|170059103|ref|XP_001865214.1| VPRBP protein [Culex quinquefas...    45   0.00 D 
contig08711 gi|149635870|ref|XP_001513294.1| PREDICTED: similar to asparagin...    45   0.00 M 
contig07478 gi|93003048|tpd|FAA00107.1| TPA: zinc finger protein [Ciona inte...    46   0.00 O 
contig11516 gi|170035373|ref|XP_001845544.1| conserved hypothetical protein ...    46   0.00 T 
contig05568 gi|170571409|ref|XP_001891717.1| hypothetical protein Bm1_00995 ...    45   0.00 U 
contig07874 gi|91090696|ref|XP_974756.1| PREDICTED: similar to cop-coated ve...    46   0.00 U 
contig01910 gi|50540242|ref|NP_001002588.1| SEC63-like protein [Danio rerio]...    46   0.00 UO 
contig06735 gi|156551334|ref|XP_001602109.1| PREDICTED: similar to ENSANGP00...    46   0.00 Z 
contig07678 gi|195338965|ref|XP_002036092.1| GM13447 [Drosophila sechellia] ...    35   9E-04 O 
contig11351 gi|118101683|ref|XP_417788.2| PREDICTED: similar to CSMD2 protei...    48   9E-04 TV 
contig07633 gi|195051586|ref|XP_001993128.1| GH13251 [Drosophila grimshawi] ...    46   8E-04 M 
contig07570 gi|156546249|ref|XP_001605335.1| PREDICTED: similar to ubiquitin...    46   8E-04 O 
contig05687 gi|110763741|ref|XP_394054.3| PREDICTED: similar to MAP kinase k...    46   8E-04 T 
contig11281 gi|158299368|ref|XP_319468.3| AGAP010276-PA [Anopheles gambiae s...    44   8E-04 T 
contig02232 gi|5833948|gb|AAD53751.1|AF172845_1 death-associated LIM only pr...    46   8E-04 TZ 
contig07278 gi|91086435|ref|XP_968298.1| PREDICTED: similar to HIF prolyl hy...    47   6E-04 T 
contig00391 gi|41055654|ref|NP_956490.1| hypothetical protein LOC393165 isof...    47   6E-04 TZ 
contig12145 gi|156254836|gb|ABU62829.1| serpin-2 [Spodoptera exigua]               47   6E-04 V 
contig08682 gi|156385392|ref|XP_001633614.1| predicted protein [Nematostella...    47   5E-04 D 
contig05867 gi|170064305|ref|XP_001867470.1| cathepsin l [Culex quinquefasci...    47   5E-04 O 
contig07982 gi|170047354|ref|XP_001851189.1| conserved hypothetical protein ...    47   5E-04 O 
contig09608 gi|195119099|ref|XP_002004069.1| GI18251 [Drosophila mojavensis]...    47   5E-04 O 
contig02208 gi|17555058|ref|NP_499811.1| T12D8.8 [Caenorhabditis elegans] >g...    47   5E-04 OT 
contig10805 gi|21539615|ref|NP_081110.1| hypothetical protein LOC68768 [Mus ...    47   5E-04 W 
contig05438 gi|157105151|ref|XP_001648739.1| kinesin-like protein Klp10A [Ae...    47   5E-04 Z 
contig09078 gi|195502445|ref|XP_002098227.1| GE24065 [Drosophila yakuba] >gn...    47   4E-04 M 
contig01198 gi|45386075|gb|AAS59855.1| KOG1656-like protein [Ornithodoros mo...    47   4E-04 U 
contig02293 gi|157120931|ref|XP_001659800.1| slit protein [Aedes aegypti] >g...    47   4E-04 WT 
contig09920 gi|198138224|gb|EDY70016.1| GA25794 [Drosophila pseudoobscura ps...    34   4E-04 Z 
contig02685 gi|72027916|ref|XP_779916.1| PREDICTED: similar to MGC81823 prot...    48   3E-04 O 
contig00512 gi|156547498|ref|XP_001605935.1| PREDICTED: similar to ENSANGP00...    48   3E-04 OT 
contig05631 gi|170047098|ref|XP_001851073.1| serine/threonine protein kinase...    48   3E-04 T 
contig03542 gi|27369487|ref|NP_765985.1| LIM domain containing 2 [Mus muscul...    48   3E-04 TZ 
contig01692 gi|67782245|gb|AAY81965.1| importin beta 1 [Aplysia californica]       48   3E-04 YU 
contig03786 gi|145235872|ref|XP_001390584.1| unnamed protein product [Asperg...    49   2E-04 D 
contig01624 gi|109829212|sp|P0C1J6|FKBP4_RHIOR FK506-binding protein 4 (Pept...    49   2E-04 O 
contig05800 gi|114582838|ref|XP_001157111.1| PREDICTED: similar to KIAA2012 ...    48   2E-04 O 
contig09522 gi|195573566|ref|XP_002104763.1| GD18276 [Drosophila simulans] >...    48   2E-04 O 
contig07727 gi|118778060|ref|XP_308434.3| AGAP007398-PA [Anopheles gambiae s...    49   2E-04 OU 
contig04133 gi|47228546|emb|CAG05366.1| unnamed protein product [Tetraodon n...    49   2E-04 T 
contig11053 gi|169145619|emb|CAQ14613.1| notch homolog 2 [Danio rerio]             48   2E-04 T 
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contig05518 gi|91077500|ref|XP_969314.1| PREDICTED: similar to exocyst compl...    48   2E-04 U 
contig09437 gi|156548143|ref|XP_001606718.1| PREDICTED: similar to signal re...    49   2E-04 U 
contig10659 gi|193584811|ref|XP_001949052.1| PREDICTED: similar to membrin [...    48   2E-04 U 
contig10988 gi|194227296|ref|XP_001491209.2| PREDICTED: similar to acyl-Coen...    48   2E-04 U 
contig01514 gi|195474225|ref|XP_002089392.1| GE19081 [Drosophila yakuba] >gn...    39   2E-04 V 
contig10999 gi|110758166|ref|XP_623577.2| PREDICTED: similar to sallimus CG1...    52   2E-04 Z 
contig05227 gi|194909250|ref|XP_001981914.1| GG12306 [Drosophila erecta] >gn...    50   1E-04 D 
contig03672 gi|91091294|ref|XP_970147.1| PREDICTED: similar to AGAP001802-PA...    49   1E-04 O 
contig03833 gi|28302342|gb|AAH46690.1| LOC398495 protein [Xenopus laevis]          49   1E-04 O 
contig08335 gi|193641094|ref|XP_001948739.1| PREDICTED: similar to acylpepti...    49   1E-04 O 
contig09574 gi|158286268|ref|XP_308650.4| AGAP007107-PA [Anopheles gambiae s...    49   1E-04 O 
contig10138 gi|115783450|ref|XP_790411.2| PREDICTED: similar to Usp16 protei...    49   1E-04 O 
contig10577 gi|66499725|ref|XP_397154.2| PREDICTED: similar to CG31915-PA [A...    49   1E-04 O 
contig05376 gi|114606743|ref|XP_518409.2| PREDICTED: inositol 1,4,5-triphosp...    49   1E-04 T 
contig07284 gi|115951942|ref|XP_001184423.1| PREDICTED: similar to alpha-2-m...    49   1E-04 T 
contig04841 gi|149757279|ref|XP_001503441.1| PREDICTED: similar to longevity...    49   1E-04 U 
contig08992 gi|195035974|ref|XP_001989446.1| GH18809 [Drosophila grimshawi] ...    44   1E-04 WT 
contig06665 gi|193582389|ref|XP_001948175.1| PREDICTED: similar to short win...    49   1E-04 Z 
contig07425 gi|195328617|ref|XP_002031011.1| GM24264 [Drosophila sechellia] ...    49   1E-04 Z 
contig02695 gi|74096307|ref|NP_001027766.1| HR-29-like protein [Ciona intest...    50   8E-05 O 
contig08120 gi|170571605|ref|XP_001891790.1| alpha-1,3-mannosyltransferase [...    50   7E-05 M 
contig08789 gi|156546249|ref|XP_001605335.1| PREDICTED: similar to ubiquitin...    50   7E-05 O 
contig04554 gi|168823548|ref|NP_001108403.1| hypothetical protein LOC1001413...    50   7E-05 U 
contig02624 gi|91083805|ref|XP_973263.1| PREDICTED: similar to importin subu...    50   7E-05 YU 
contig12249 gi|194679896|ref|XP_584352.4| PREDICTED: similar to inner centro...    50   6E-05 D 
contig07713 gi|57530768|ref|NP_001006370.1| protein disulfide isomerase fami...    50   6E-05 O 
contig05681 gi|156543770|ref|XP_001606220.1| PREDICTED: similar to CG7422-PB...    33   6E-05 T 
contig11463 gi|119640054|gb|ABL85461.1| Wiskott-Aldrich syndrome protein [Su...    50   6E-05 TZ 
contig12526 gi|91087669|ref|XP_973734.1| PREDICTED: similar to putative myos...    41   6E-05 Z 
contig05375 gi|115629176|ref|XP_786317.2| PREDICTED: hypothetical protein [S...    47   5E-05 O 
contig11054 gi|66500390|ref|XP_623298.1| PREDICTED: similar to Tropomyosin 1...    51   5E-05 Z 
contig02176 gi|194741252|ref|XP_001953103.1| GF17600 [Drosophila ananassae] ...    50   4E-05 O 
contig06912 gi|195446934|ref|XP_002070989.1| GK25553 [Drosophila willistoni]...    51   3E-05 T 
contig08029 gi|123445530|ref|XP_001311524.1| conserved hypothetical protein ...    51   3E-05 T 
contig07963 gi|862467|dbj|BAA06909.1| limulus intracellular coagulation inhi...    51   3E-05 V 
contig08255 gi|126327982|ref|XP_001370272.1| PREDICTED: similar to facilitat...    51   3E-05 YU 
contig11078 gi|47212600|emb|CAF93042.1| unnamed protein product [Tetraodon n...    51   3E-05 Z 
contig08725 gi|156537388|ref|XP_001606740.1| PREDICTED: similar to cell divi...    52   2E-05 D 
contig02274 gi|109497997|ref|XP_001070833.1| PREDICTED: hypothetical protein...    52   2E-05 O 
contig03387 gi|56159969|gb|AAV80796.1| putative secreted salivary gland pept...    52   2E-05 O 
contig10252 gi|119588531|gb|EAW68125.1| low density lipoprotein receptor cla...    54   2E-05 O 
contig05389 gi|149064402|gb|EDM14605.1| casein kinase 1, alpha 1, isoform CR...    52   2E-05 T 
contig10475 gi|148231426|ref|NP_001080095.1| growth hormone inducible transm...    52   2E-05 T 
contig04419 gi|156545080|ref|XP_001601330.1| PREDICTED: similar to Nicastrin...    52   2E-05 TO 
contig00812 gi|66518227|ref|XP_393502.2| PREDICTED: similar to CG10686-PA [A...    56   2E-05 U 
contig05943 gi|157124457|ref|XP_001660469.1| low-density lipoprotein recepto...    52   1E-05 T 
contig03751 gi|158299275|ref|XP_554113.3| AGAP010206-PA [Anopheles gambiae s...    40   1E-05 U 
contig08782 gi|170037865|ref|XP_001846775.1| transport protein sec23 [Culex ...    52   1E-05 U 
contig02333 gi|156549624|ref|XP_001603995.1| PREDICTED: similar to conserved...    52   1E-05 YU 
contig09695 gi|91091320|ref|XP_971490.1| PREDICTED: similar to proteasome su...    53   9E-06 O 
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contig12188 gi|114051792|ref|NP_001039436.1| serine peptidase inhibitor, Kun...    53   9E-06 O 
contig11075 gi|197103110|ref|NP_001126096.1| transmembrane BAX inhibitor mot...    53   9E-06 T 
contig03610 gi|126179667|ref|YP_001047632.1| beta-Ig-H3/fasciclin [Methanocu...    53   7E-06 MW 
contig04971 gi|148704620|gb|EDL36567.1| proteasome (prosome, macropain) subu...    53   7E-06 O 
contig07427 gi|189515588|ref|XP_001922908.1| PREDICTED: similar to frizzy-re...    54   5E-06 DO 
contig10282 gi|110766269|ref|XP_624567.2| PREDICTED: similar to fizzy CG4274...    54   5E-06 DO 
contig00915 gi|170040091|ref|XP_001847845.1| maternal tudor protein [Culex q...    54   5E-06 T 
contig02528 gi|189237968|ref|XP_001811946.1| PREDICTED: similar to CG8155 CG...    54   5E-06 T 
contig03043 gi|195546839|ref|NP_001124248.1| hypothetical protein LOC562169 ...    54   5E-06 U 
contig06655 gi|189237585|ref|XP_975030.2| PREDICTED: similar to importin alp...    54   5E-06 U 
contig11757 gi|66560412|ref|XP_624981.1| PREDICTED: similar to SLIT-ROBO Rho...    54   5E-06 Z 
contig11816 gi|33348836|gb|AAQ16118.1| cathepsin L-like cysteine proteinase ...    54   4E-06 O 
contig09904 gi|158291648|ref|XP_313165.4| AGAP004246-PA [Anopheles gambiae s...    54   4E-06 T 
contig12278 gi|149720830|ref|XP_001490387.1| PREDICTED: similar to RIO kinas...    54   4E-06 T 
contig06011 gi|157120691|ref|XP_001659725.1| vacuolar protein sorting-associ...    54   4E-06 U 
contig04861 gi|48118518|ref|XP_396430.1| PREDICTED: similar to CG14211-PB [A...    54   4E-06 V 
contig05756 gi|115609883|ref|XP_795679.2| PREDICTED: similar to ANAPC2 prote...    48   3E-06 DO 
contig09133 gi|114052713|ref|NP_001040543.1| proteasome 26S non-ATPase subun...    54   3E-06 O 
contig04036 gi|158297644|ref|XP_317844.3| AGAP011463-PA [Anopheles gambiae s...    54   3E-06 T 
contig06963 gi|82754297|gb|ABB89946.1| ace1 type acetylcholinesterase [Blatt...    54   3E-06 T 
contig00742 gi|149010993|ref|ZP_01832298.1| argininosuccinate synthase [Stre...    57   3E-06 TV 
contig02199 gi|190571419|ref|YP_001975777.1| signal recognition particle pro...    54   3E-06 U 
contig06028 gi|47211513|emb|CAF90309.1| unnamed protein product [Tetraodon n...    54   3E-06 U 
contig08380 gi|170044582|ref|XP_001849921.1| mitochondrial import receptor s...    54   3E-06 U 
contig09366 gi|195441430|ref|XP_002068512.1| GK20379 [Drosophila willistoni]...    54   3E-06 Z 
contig07043 gi|149755241|ref|XP_001495972.1| PREDICTED: zinc finger, CCHC do...    55   2E-06 D 
contig08196 gi|148232744|ref|NP_001081724.1| wee1 homolog [Xenopus laevis] >...    55   2E-06 D 
contig07585 gi|116055404|emb|CAL58072.1| polyubiquitin 2 (ISS) [Ostreococcus...    55   2E-06 DO 
contig04062 gi|91091796|ref|XP_970426.1| PREDICTED: similar to dynactin P62 ...    55   2E-06 N 
contig02757 gi|48113502|ref|XP_396350.1| PREDICTED: similar to Peptidylglyci...    55   2E-06 O 
contig07025 gi|16768432|gb|AAL28435.1| GM04535p [Drosophila melanogaster]          55   2E-06 O 
contig10511 gi|196009778|ref|XP_002114754.1| hypothetical protein TRIADDRAFT...    55   2E-06 YU 
contig06162 gi|19114087|ref|NP_593175.1| actin binding protein, coronin Crn1...    55   2E-06 Z 
contig01259 gi|91093707|ref|XP_967114.1| PREDICTED: similar to sex-determini...    55   1E-06 M 
contig01257 gi|156401011|ref|XP_001639085.1| predicted protein [Nematostella...    56   1E-06 O 
contig05898 gi|91077894|ref|XP_973141.1| PREDICTED: similar to predicted pro...    55   1E-06 O 
contig07163 gi|91093697|ref|XP_966486.1| PREDICTED: similar to ADAM metallop...    53   1E-06 O 
contig08800 gi|194883632|ref|XP_001975905.1| GG20306 [Drosophila erecta] >gn...    55   1E-06 T 
contig05944 gi|126323512|ref|XP_001364194.1| PREDICTED: similar to adaptor-r...    55   1E-06 U 
contig07178 gi|170036594|ref|XP_001846148.1| importin subunit beta [Culex qu...    55   1E-06 YU 
contig11328 gi|74927078|sp|Q86GF7|CRUST_PANBO Crustapain precursor (NsCys) >...    56   8E-07 O 
contig09675 gi|108998743|ref|XP_001096957.1| PREDICTED: similar to PTEN indu...    56   8E-07 T 
contig12386 gi|25148442|ref|NP_741323.1| K08D12.3a [Caenorhabditis elegans] ...    40   6E-07 O 
contig00781 gi|115638628|ref|XP_784181.2| PREDICTED: similar to high affinit...    57   6E-07 T 
contig01475 gi|63259175|gb|AAY40292.1| replicase [Porcine circovirus 2]            57   6E-07 T 
contig00329 gi|156398162|ref|XP_001638058.1| predicted protein [Nematostella...    57   6E-07 U 
contig05873 gi|115720191|ref|XP_792773.2| PREDICTED: similar to Wu:fc30a11 p...    57   6E-07 U 
contig05190 gi|28932704|gb|AAO60046.1| midgut cysteine proteinase 3 [Rhipice...    57   5E-07 O 
contig09173 gi|194224024|ref|XP_001917420.1| PREDICTED: sema domain, seven t...    57   5E-07 T 
contig10385 gi|156374335|ref|XP_001629763.1| predicted protein [Nematostella...    57   5E-07 T 




Contig BLAST result e value Class 
contig06405 gi|157118247|ref|XP_001653133.1| mbp-1 interacting protein-2a [A...    57   5E-07 U 
contig11589 gi|157310311|emb|CAN43867.1| outer membrane protein 25b [Brucell...    57   4E-07 OR 
contig04193 gi|195332648|ref|XP_002033009.1| GM21084 [Drosophila sechellia] ...    57   4E-07 T 
contig04802 gi|194384828|dbj|BAG60820.1| unnamed protein product [Homo sapiens]    57   4E-07 TZ 
contig02563 gi|156548151|ref|XP_001606762.1| PREDICTED: similar to microtubu...    57   4E-07 Z 
contig08064 gi|110768018|ref|XP_623323.2| PREDICTED: similar to zipper CG157...    57   4E-07 Z 
contig00694 gi|72043691|ref|XP_791396.1| PREDICTED: hypothetical protein [St...    58   3E-07 O 
contig02704 gi|156384849|ref|XP_001633345.1| predicted protein [Nematostella...    60   3E-07 O 
contig12714 gi|194212734|ref|XP_001502891.2| PREDICTED: ubiquitination facto...    59   2E-07 O 
contig07417 gi|157104296|ref|XP_001648341.1| growth hormone inducible transm...    59   2E-07 T 
contig08164 gi|148231247|ref|NP_001079938.1| proto-oncogene tyrosine-protein...    58   2E-07 T 
contig08184 gi|115977127|ref|XP_001179234.1| PREDICTED: similar to Sip-prov ...    59   2E-07 T 
contig09394 gi|66499366|ref|XP_393243.2| PREDICTED: similar to Syndapin CG33...    58   2E-07 TUZ 
contig02944 gi|170047259|ref|XP_001851146.1| conserved hypothetical protein ...    58   2E-07 U 
contig05691 gi|47214953|emb|CAG10775.1| unnamed protein product [Tetraodon n...    53   2E-07 U 
contig05982 gi|110762380|ref|XP_391944.3| PREDICTED: similar to rhea CG6831-...    59   2E-07 Z 
contig10304 gi|168055852|ref|XP_001779937.1| predicted protein [Physcomitrel...    58   2E-07 Z 
contig02366 gi|71997077|ref|NP_001022985.1| Tubulin Tyrosine Ligase Like fam...    48   1E-07 O 
contig10668 gi|20090338|ref|NP_616413.1| heat shock protein 40 [Methanosarci...    59   1E-07 O 
contig02056 gi|15487298|dbj|BAB64539.1| natriuretic-peptide receptor A [Rana...    50   1E-07 T 
contig09019 gi|157773297|ref|XP_001664713.1| hypothetical protein CBG09108 [...    59   1E-07 T 
contig11613 gi|158286904|ref|XP_308996.3| AGAP006746-PA [Anopheles gambiae s...    60   1E-07 Z 
contig03172 gi|163838684|ref|NP_001106225.1| ubiquinol-cytochrome c reductas...    59   9E-08 O 
contig07671 gi|156351062|ref|XP_001622345.1| predicted protein [Nematostella...    59   9E-08 O 
contig10596 gi|195133496|ref|XP_002011175.1| GI16393 [Drosophila mojavensis]...    59   9E-08 TU 
contig10500 gi|156537586|ref|XP_001607692.1| PREDICTED: similar to Sorting n...    59   9E-08 ZUD 
contig03869 gi|169646700|ref|NP_613056.2| zinc finger, CCHC domain containin...    60   7E-08 O 
contig02825 gi|110760264|ref|XP_393691.3| PREDICTED: similar to Serine/threo...    60   7E-08 T 
contig10409 gi|115742433|ref|XP_001198028.1| PREDICTED: similar to MGC80624 ...    60   7E-08 U 
contig08971 gi|115647121|ref|XP_783397.2| PREDICTED: similar to phosphatidyl...    46   6E-08 MO 
contig06588 gi|91083895|ref|XP_974479.1| PREDICTED: similar to ATPase family...    60   6E-08 O 
contig10325 gi|83701157|gb|ABC41138.1| small heat shock protein p26 [Artemia...    60   6E-08 O 
contig04318 gi|194225289|ref|XP_001494645.2| PREDICTED: similar to Fibulin 5...    60   6E-08 T 
contig06047 gi|195575320|ref|XP_002105627.1| GD21583 [Drosophila simulans] >...    60   6E-08 U 
contig08453 gi|148235839|ref|NP_001080187.1| p47 [Xenopus laevis] >gnl|BL_OR...    60   6E-08 Y 
contig09181 gi|91083247|ref|XP_973990.1| PREDICTED: similar to O-fucosyltran...    60   5E-08 O 
contig05180 gi|158301431|ref|XP_321122.4| AGAP001939-PA [Anopheles gambiae s...    60   5E-08 U 
contig10350 gi|17540400|ref|NP_501169.1| F42C5.9 [Caenorhabditis elegans] >g...    60   5E-08 Z 
contig08194 gi|110764542|ref|XP_395416.3| PREDICTED: similar to PCI domain c...    60   4E-08 D 
contig11035 gi|50746643|ref|XP_420590.1| PREDICTED: similar to cyclin I [Gal...    60   4E-08 D 
contig01120 gi|50400849|sp|P84032|PN16_PHONI Venom protein PN16C3                  62   4E-08 MW 
contig03262 gi|170577734|ref|XP_001894118.1| Cathepsin L-like precursor [Bru...    60   4E-08 O 
contig04169 gi|29841011|gb|AAP06024.1| SJCHGC09407 protein [Schistosoma japo...    60   4E-08 O 
contig07149 gi|160774139|gb|AAI55471.1| Unknown (protein for IMAGE:7725043) ...    60   4E-08 O 
contig10922 gi|60302732|ref|NP_001012558.1| tubulin tyrosine ligase-like fam...    60   4E-08 O 
contig10445 gi|170047146|ref|XP_001851095.1| meiotic checkpoint regulator cu...    61   3E-08 DO 
contig09690 gi|47211865|emb|CAF95367.1| unnamed protein product [Tetraodon n...    61   3E-08 DZ 
contig07900 gi|170571908|ref|XP_001891914.1| ThiF family protein [Brugia mal...    61   3E-08 O 
contig09514 gi|194755154|ref|XP_001959857.1| GF13077 [Drosophila ananassae] ...    61   3E-08 O 
contig09984 gi|195427169|ref|XP_002061651.1| GK17108 [Drosophila willistoni]...    61   3E-08 O 




Contig BLAST result e value Class 
contig05377 gi|170073474|ref|XP_001870381.1| tomosyn [Culex quinquefasciatus...    61   3E-08 U 
contig08101 gi|91092748|ref|XP_973348.1| PREDICTED: similar to pyrazinamidas...    61   3E-08 V 
contig08959 gi|189233780|ref|XP_001814557.1| PREDICTED: similar to Kinesin-7...    61   3E-08 Z 
contig09244 gi|156538078|ref|XP_001607596.1| PREDICTED: similar to beta chai...    61   3E-08 Z 
contig08097 gi|193659754|ref|XP_001946896.1| PREDICTED: similar to mystery 4...    62   2E-08 DZ 
contig03004 gi|196476658|gb|ACG76195.1| alpha-2-macroglobulin [Amblyomma ame...    62   2E-08 O 
contig03114 gi|34539117|gb|AAQ74442.1| glutathione S-transferase [Rhipicepha...    61   2E-08 O 
contig04479 gi|47219312|emb|CAG10941.1| unnamed protein product [Tetraodon n...    42   2E-08 O 
contig09370 gi|164655843|ref|XP_001729050.1| hypothetical protein MGL_3838 [...    62   2E-08 O 
contig10245 gi|149571552|ref|XP_001518754.1| PREDICTED: similar to Protein p...    62   2E-08 OT 
contig06815 gi|45361393|ref|NP_989274.1| protein phosphatase 2 (formerly 2A)...    62   2E-08 T 
contig00314 gi|189241696|ref|XP_970104.2| PREDICTED: similar to LIM protein ...    61   2E-08 TZ 
contig05858 gi|91089831|ref|XP_969724.1| PREDICTED: similar to formin 1,2/ca...    61   2E-08 TZ 
contig10790 gi|156391901|ref|XP_001635788.1| predicted protein [Nematostella...    62   1E-08 D 
contig11423 gi|194755108|ref|XP_001959834.1| GF13064 [Drosophila ananassae] ...    62   1E-08 D 
contig02943 gi|163843912|ref|YP_001628316.1| O-sialoglycoprotein endopeptida...    62   1E-08 O 
contig07367 gi|118085702|ref|XP_418609.2| PREDICTED: similar to dnaJ-like pr...    62   1E-08 O 
contig11634 gi|149032841|gb|EDL87696.1| rCG42109, isoform CRA_a [Rattus norv...    62   1E-08 O 
contig12028 gi|170573427|ref|XP_001892466.1| hypothetical protein Bm1_04940 ...    62   1E-08 O 
contig00552 gi|115702407|ref|XP_001177220.1| PREDICTED: similar to LOC615074...    62   1E-08 T 
contig00758 gi|91079328|ref|XP_968347.1| PREDICTED: similar to AGAP009901-PA...    62   1E-08 T 
contig07052 gi|66517761|ref|XP_392905.2| PREDICTED: similar to cAMP-dependen...    62   1E-08 T 
contig07729 gi|62466117|gb|AAX83388.1| Sds [Schistosoma mansoni]                   62   1E-08 T 
contig06206 gi|170033357|ref|XP_001844544.1| conserved hypothetical protein ...    62   1E-08 U 
contig12279 gi|22164300|gb|AAM93655.1|AF483733_1 putative 4.3 kDa secreted p...    62   1E-08 U 
contig08548 gi|114153202|gb|ABI52767.1| serpin [Argas monolakensis]                62   1E-08 V 
contig01414 gi|114153294|gb|ABI52813.1| GGY domain protein [Argas monolakensis]    64   1E-08 YU 
contig07301 gi|6682319|emb|CAB64662.1| myosin heavy chain [Mytilus galloprov...    62   1E-08 Z 
contig04829 gi|91081971|ref|XP_967978.1| PREDICTED: similar to tumor endothe...    63   8E-09 W 
contig06326 gi|114864933|gb|ABI83786.1| Arp2/3 complex subunit ARPC5 [Anophe...    63   8E-09 Z 
contig02882 gi|193596505|ref|XP_001945593.1| PREDICTED: similar to 26S prote...    63   7E-09 O 
contig06458 gi|157813218|gb|ABV81354.1| putative 26S proteasome non-ATPase r...    63   7E-09 O 
contig11935 gi|118638258|gb|ABL09302.1| allergen Aca s 8 [Acarus siro]             64   7E-09 O 
contig08441 gi|197692443|dbj|BAG70185.1| protein phosphatase 1A isoform 1 [H...    63   7E-09 T 
contig06303 gi|195388318|ref|XP_002052827.1| GJ19747 [Drosophila virilis] >g...    63   7E-09 U 
contig01803 gi|2570145|dbj|BAA22991.1| cyclin A [Hemicentrotus pulcherrimus]       66   5E-09 D 
contig00286 gi|48138650|ref|XP_393416.1| PREDICTED: similar to Downstream of...    64   5E-09 T 
contig07954 gi|170062766|ref|XP_001866812.1| integrin-linked protein kinase ...    64   5E-09 T 
contig01738 gi|33440467|gb|AAH56211.1| Platelet-activating factor acetylhydr...    64   5E-09 TV 
contig08910 gi|197322816|gb|ACH69159.1| myosin heavy chain [Bombyx mori]           64   5E-09 Z 
contig02955 gi|193606239|ref|XP_001950033.1| PREDICTED: similar to anaphase ...    64   4E-09 DO 
contig01310 gi|33667928|gb|AAQ24541.1| Blo t 1 allergen [Blomia tropicalis]        64   4E-09 O 
contig02815 gi|72030199|ref|XP_780027.1| PREDICTED: similar to MGC80929 prot...    64   4E-09 O 
contig06695 gi|167518423|ref|XP_001743552.1| predicted protein [Monosiga bre...    64   4E-09 U 
contig08012 gi|115655549|ref|XP_789920.2| PREDICTED: similar to CG1599-PA [S...    64   4E-09 U 
contig06980 gi|156544772|ref|XP_001606200.1| PREDICTED: similar to ubiquitin...    64   3E-09 O 
contig09009 gi|114053293|ref|NP_001039853.1| heat shock 70kDa protein 14 [Bo...    64   3E-09 O 
contig09576 gi|196000510|ref|XP_002110123.1| hypothetical protein TRIADDRAFT...    64   3E-09 O 
contig03319 gi|170046387|ref|XP_001850749.1| peroxisomal biogenesis factor 1...    64   3E-09 U 
contig07895 gi|50513239|gb|AAT77811.1| calpain B [Gecarcinus lateralis]            58   2E-09 OT 
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contig06095 gi|156543205|ref|XP_001606305.1| PREDICTED: similar to SD02996p ...    65   2E-09 T 
contig07452 gi|156366264|ref|XP_001627059.1| predicted protein [Nematostella...    65   2E-09 T 
contig07748 gi|149714295|ref|XP_001504277.1| PREDICTED: similar to Fas apopt...    65   2E-09 T 
contig08601 gi|91092436|ref|XP_968632.1| PREDICTED: similar to laminin gamma...    65   2E-09 W 
contig09125 gi|158297035|ref|XP_317338.4| AGAP008118-PA [Anopheles gambiae s...    65   1E-09 D 
contig01568 gi|121543943|gb|ABM55636.1| putative apolipoprotein D [Maconelli...    67   1E-09 M 
contig03969 gi|47222375|emb|CAG05124.1| unnamed protein product [Tetraodon n...    65   1E-09 O 
contig04104 gi|115668711|ref|XP_791717.2| PREDICTED: similar to conserved hy...    66   1E-09 O 
contig05360 gi|139000435|dbj|BAF51711.1| tick legumain [Haemaphysalis longic...    65   1E-09 O 
contig05941 gi|195384621|ref|XP_002051013.1| GJ22461 [Drosophila virilis] >g...    66   1E-09 O 
contig06104 gi|91078536|ref|XP_970577.1| PREDICTED: similar to ganglioside-i...    65   1E-09 O 
contig07738 gi|156543233|ref|XP_001606546.1| PREDICTED: similar to ENSANGP00...    65   1E-09 O 
contig11776 gi|168003405|ref|XP_001754403.1| predicted protein [Physcomitrel...    66   1E-09 O 
contig01722 gi|189233683|ref|XP_970087.2| PREDICTED: similar to Delta [Tribo...    66   1E-09 T 
contig05547 gi|83272632|gb|ABC00801.1| LOC402870-like protein [Pomacentrus m...    65   1E-09 T 
contig06390 gi|195050911|ref|XP_001992994.1| GH13339 [Drosophila grimshawi] ...    65   1E-09 Z 
contig08044 gi|148725190|emb|CAN88398.1| novel protein (zgc:56161) [Danio re...    66   8E-10 D 
contig06652 gi|156365518|ref|XP_001626692.1| predicted protein [Nematostella...    66   8E-10 O 
contig07811 gi|170591296|ref|XP_001900406.1| Coronin-like protein [Brugia ma...    66   8E-10 Z 
contig11630 gi|193643604|ref|XP_001943670.1| PREDICTED: similar to predicted...    67   6E-10 O 
contig11170 gi|144925078|gb|ABP03876.1| Hly-III related proteins [Medicago t...    67   6E-10 RT 
contig02246 gi|91080341|ref|XP_974659.1| PREDICTED: similar to GA19895-PA [T...    67   6E-10 T 
contig06908 gi|189237088|ref|XP_969702.2| PREDICTED: similar to GA17645-PA [...    67   6E-10 T 
contig07905 gi|156384880|ref|XP_001633360.1| predicted protein [Nematostella...    67   6E-10 YU 
contig06168 gi|189234407|ref|XP_975060.2| PREDICTED: similar to myosin vi [T...    67   5E-10 Z 
contig09471 gi|157133635|ref|XP_001662951.1| endoplasmin [Aedes aegypti] >gn...    67   3E-10 O 
contig10492 gi|193613058|ref|XP_001952614.1| PREDICTED: similar to Y48C3A.16...    67   3E-10 O 
contig10658 gi|41054301|ref|NP_956052.1| ariadne ubiquitin-conjugating enzym...    68   3E-10 O 
contig07749 gi|189523269|ref|XP_687578.3| PREDICTED: similar to Rap guanine ...    68   3E-10 T 
contig10263 gi|189234212|ref|XP_970946.2| PREDICTED: similar to adducin [Tri...    68   3E-10 TZ 
contig03007 gi|156383838|ref|XP_001633039.1| predicted protein [Nematostella...    67   3E-10 U 
contig07411 gi|193664496|ref|XP_001943041.1| PREDICTED: similar to short sto...    68   3E-10 Z 
contig00703 gi|159155128|gb|AAI54789.1| Proteasome (prosome, macropain) 26S ...    68   2E-10 O 
contig04640 gi|66546020|ref|XP_623947.1| PREDICTED: similar to Probable 26S ...    68   2E-10 O 
contig11458 gi|156543740|ref|XP_001605962.1| PREDICTED: similar to tripeptid...    70   2E-10 O 
contig08039 gi|156384222|ref|XP_001633230.1| predicted protein [Nematostella...    69   2E-10 OW 
contig07989 gi|165972429|ref|NP_001107093.1| hypothetical protein LOC570768 ...    68   2E-10 TR 
contig02431 gi|158287103|ref|XP_309162.4| AGAP000969-PA [Anopheles gambiae s...    65   2E-10 Z 
contig06634 gi|91085145|ref|XP_966691.1| PREDICTED: similar to choline/ethan...    69   1E-10 M 
contig03937 gi|146163744|ref|XP_001471259.1| cathepsin z [Tetrahymena thermo...    69   1E-10 O 
contig11629 gi|189234978|ref|XP_001807535.1| PREDICTED: similar to lysosomal...    69   1E-10 O 
contig02754 gi|91089445|ref|XP_966341.1| PREDICTED: similar to rho guanine d...    69   1E-10 T 
contig03763 gi|193662043|ref|XP_001949462.1| PREDICTED: similar to proto-onc...    69   1E-10 T 
contig06847 gi|156550147|ref|XP_001606081.1| PREDICTED: similar to ENSANGP00...    69   9E-11 M 
contig07760 gi|193787078|dbj|BAG51901.1| unnamed protein product [Homo sapiens]    69   9E-11 M 
contig01285 gi|156545036|ref|XP_001600401.1| PREDICTED: similar to conserved...    69   9E-11 O 
contig08237 gi|158285616|ref|XP_308398.3| AGAP007474-PA [Anopheles gambiae s...    69   9E-11 Z 
contig00710 gi|91090252|ref|XP_969934.1| PREDICTED: similar to maggie CG1498...    70   8E-11 U 
contig09487 gi|170033703|ref|XP_001844716.1| cell division protease ftsH [Cu...    70   7E-11 O 
contig04834 gi|196006640|ref|XP_002113186.1| hypothetical protein TRIADDRAFT...    70   7E-11 T 




Contig BLAST result e value Class 
contig11498 gi|197129867|gb|ACH46365.1| putative septin 11 [Taeniopygia gutt...    70   4E-11 D 
contig07756 gi|156365829|ref|XP_001626845.1| predicted protein [Nematostella...    70   4E-11 O 
contig07432 gi|91091170|ref|XP_971489.1| PREDICTED: similar to huntingtin in...    59   3E-11 Z 
contig05905 gi|156552545|ref|XP_001600397.1| PREDICTED: similar to protein a...    71   2E-11 D 
contig05969 gi|156379089|ref|XP_001631291.1| predicted protein [Nematostella...    72   2E-11 O 
contig10950 gi|47085937|ref|NP_998328.1| autocrine motility factor receptor ...    52   2E-11 O 
contig08458 gi|149052895|gb|EDM04712.1| rCG33182, isoform CRA_b [Rattus norv...    71   2E-11 OR 
contig01714 gi|66525845|ref|XP_623057.1| PREDICTED: similar to CG5315-PA, is...    71   2E-11 RT 
contig06810 gi|156376991|ref|XP_001630641.1| predicted protein [Nematostella...    72   2E-11 T 
contig07112 gi|194208555|ref|XP_001490275.2| PREDICTED: similar to vacuolar ...    72   2E-11 U 
contig10302 gi|158291370|ref|XP_312883.3| AGAP003185-PA [Anopheles gambiae s...    71   2E-11 U 
contig01024 gi|157116832|ref|XP_001652865.1| nsfl1 cofactor P47 [Aedes aegyp...    74   2E-11 Y 
contig10714 gi|198150846|gb|EAL29947.2| GA21581 [Drosophila pseudoobscura ps...    72   2E-11 Z 
contig04804 gi|170038740|ref|XP_001847206.1| phospholipid scramblase 1 [Cule...    72   1E-11 M 
contig06488 gi|195481167|ref|XP_002101542.1| GE15568 [Drosophila yakuba] >gn...    72   1E-11 O 
contig09209 gi|170033167|ref|XP_001844450.1| ribosomal protein S6 kinase [Cu...    72   1E-11 RT 
contig07647 gi|66561016|ref|XP_392778.2| PREDICTED: similar to CG40494-PA.3 ...    72   1E-11 T 
contig00517 gi|114153200|gb|ABI52766.1| Defensin [Argas monolakensis]              72   1E-11 TR 
contig08079 gi|150416761|gb|ABR68850.1| synaptotagmin [Platynereis dumerilii]      72   1E-11 TU 
contig09042 gi|115608248|ref|XP_779975.2| PREDICTED: hypothetical protein [S...    72   1E-11 U 
contig09384 gi|115947191|ref|XP_784884.2| PREDICTED: similar to karyopherin ...    72   1E-11 U 
contig10022 gi|157813190|gb|ABV81340.1| putative signal recognition particle...    72   1E-11 U 
contig02149 gi|156544131|ref|XP_001605898.1| PREDICTED: similar to ENSANGP00...    72   1E-11 Z 
contig02939 gi|71896827|ref|NP_001025946.1| COP9 complex subunit 7a [Gallus ...    56   9E-12 OT 
contig02089 gi|157093349|gb|ABV22329.1| ubiquitin-conjugating enzyme E2, cat...    73   8E-12 O 
contig10665 gi|91089713|ref|XP_974951.1| PREDICTED: similar to ubiquitin spe...    73   8E-12 O 
contig05394 gi|148233314|ref|NP_001087108.1| ubiquilin 2 [Xenopus laevis] >g...    73   8E-12 OR 
contig11410 gi|55785689|dbj|BAD72613.1| granulin-like peptide precursor [Miz...    73   8E-12 T 
contig09088 gi|149640886|ref|XP_001512501.1| PREDICTED: similar to Exportin ...    73   8E-12 YU 
contig10056 gi|82698821|gb|ABB89211.1| troponin I protein [Rhipicephalus hae...    73   8E-12 Z 
contig00292 gi|115748979|ref|XP_784731.2| PREDICTED: similar to Syvn1 protei...    73   6E-12 O 
contig10116 gi|193580107|ref|XP_001944348.1| PREDICTED: similar to tep3, par...    73   6E-12 O 
contig04781 gi|158289383|ref|XP_311125.4| AGAP000037-PA [Anopheles gambiae s...    74   5E-12 T 
contig10692 gi|196012014|ref|XP_002115870.1| hypothetical protein TRIADDRAFT...    74   5E-12 U 
contig02693 gi|91081971|ref|XP_967978.1| PREDICTED: similar to tumor endothe...    74   5E-12 W 
contig05209 gi|58385719|ref|XP_314156.2| AGAP005246-PD [Anopheles gambiae st...    75   4E-12 V 
contig03620 gi|119615295|gb|EAW94889.1| capping protein (actin filament) mus...    75   4E-12 Z 
contig09938 gi|189241293|ref|XP_975097.2| PREDICTED: similar to conserved hy...    74   3E-12 O 
contig10082 gi|126305110|ref|XP_001362347.1| PREDICTED: hypothetical protein...    74   3E-12 O 
contig06999 gi|156547498|ref|XP_001605935.1| PREDICTED: similar to ENSANGP00...    50   3E-12 OT 
contig04160 gi|193783717|dbj|BAG53822.1| unnamed protein product [Homo sapiens]    74   3E-12 TZ 
contig10216 gi|193713573|ref|XP_001950161.1| PREDICTED: similar to AGAP00448...    74   3E-12 V 
contig04851 gi|198145466|gb|EAL32378.2| GA14896 [Drosophila pseudoobscura ps...    75   2E-12 O 
contig05743 gi|91080775|ref|XP_968281.1| PREDICTED: similar to rab gdp-disso...    75   2E-12 O 
contig06107 gi|67083917|gb|AAY66893.1| SCF ubiquitin ligase complex [Ixodes ...    75   2E-12 O 
contig10559 gi|195123633|ref|XP_002006308.1| GI18640 [Drosophila mojavensis]...    75   2E-12 O 
contig02018 gi|156366264|ref|XP_001627059.1| predicted protein [Nematostella...    76   2E-12 T 
contig03283 gi|115815405|ref|XP_794440.2| PREDICTED: hypothetical protein [S...    75   2E-12 T 
contig07922 gi|161661029|gb|ABX75381.1| cysteine and glycine-rich protein [L...    75   2E-12 TZ 
contig00597 gi|121309135|dbj|BAF43802.1| galectin [Ornithodoros moubata] >gn...    76   2E-12 W 




Contig BLAST result e value Class 
contig01204 gi|163869040|ref|YP_001610271.1| chaperonin GroEL [Bartonella tr...    75   1E-12 O 
contig07787 gi|17563052|ref|NP_503322.1| R09E12.3 [Caenorhabditis elegans] >...    76   1E-12 O 
contig03567 gi|126331533|ref|XP_001377752.1| PREDICTED: hypothetical protein...    76   1E-12 TU 
contig10123 gi|194380362|dbj|BAG63948.1| unnamed protein product [Homo sapiens]    75   1E-12 TV 
contig08965 gi|118780654|ref|XP_310308.5| AGAP003769-PA [Anopheles gambiae s...    75   1E-12 YU 
contig12098 gi|112143898|gb|ABI13158.1| putative cysteine protease [Emiliani...    76   7E-13 O 
contig09790 gi|66472542|ref|NP_001018438.1| phosphatidylinositol-4-phosphate...    76   7E-13 T 
contig04045 gi|72112336|ref|XP_789626.1| PREDICTED: hypothetical protein [St...    76   7E-13 TR 
contig11023 gi|189536402|ref|XP_700411.3| PREDICTED: si:dkeyp-1e8.1 [Danio r...    76   7E-13 TR 
contig03061 gi|157428048|ref|NP_001098932.1| ATPase family, AAA domain conta...    77   6E-13 O 
contig03711 gi|115377235|ref|ZP_01464446.1| maleylacetoacetate isomerase [St...    77   6E-13 O 
contig05834 gi|91079624|ref|XP_967576.1| PREDICTED: similar to dodo [Triboli...    77   6E-13 O 
contig11157 gi|156537009|ref|XP_001608297.1| PREDICTED: similar to prefoldin...    77   6E-13 O 
contig13341 gi|195439884|ref|XP_002067789.1| GK12524 [Drosophila willistoni]...    77   6E-13 U 
contig01683 gi|71896055|ref|NP_001025616.1| pcmt1 protein [Xenopus tropicali...    77   4E-13 O 
contig01372 gi|156400070|ref|XP_001638823.1| predicted protein [Nematostella...    80   4E-13 T 
contig00466 gi|74096057|ref|NP_001027676.1| sec61 protein [Ciona intestinali...    64   4E-13 U 
contig01544 gi|156553544|ref|XP_001601721.1| PREDICTED: similar to sorting n...    77   4E-13 U 
contig09214 gi|156553544|ref|XP_001601721.1| PREDICTED: similar to sorting n...    77   4E-13 U 
contig04898 gi|91089973|ref|XP_973833.1| PREDICTED: similar to Exportin 1, C...    77   4E-13 YU 
contig02910 gi|158297830|ref|XP_318008.4| AGAP004801-PA [Anopheles gambiae s...    77   4E-13 Z 
contig01596 gi|195023701|ref|XP_001985734.1| GH20962 [Drosophila grimshawi] ...    78   3E-13 DR 
contig01091 gi|196008825|ref|XP_002114278.1| hypothetical protein TRIADDRAFT...    78   3E-13 DZ 
contig05220 gi|148236500|ref|NP_001083999.1| similar to proteasome (prosome,...    77   3E-13 O 
contig06212 gi|54261597|gb|AAH84600.1| LOC495281 protein [Xenopus laevis]          78   3E-13 O 
contig09454 gi|126343155|ref|XP_001372015.1| PREDICTED: similar to inhibitor...    77   3E-13 OT 
contig02577 gi|194318571|gb|ACF47675.1| guanine nucleotide-binding protein a...    77   3E-13 T 
contig06706 gi|193580220|ref|XP_001945916.1| PREDICTED: similar to myotonin-...    77   3E-13 T 
contig10622 gi|189235622|ref|XP_970209.2| PREDICTED: similar to map kinase-i...    78   3E-13 T 
contig01214 gi|91087807|ref|XP_967674.1| PREDICTED: similar to vacuolar prot...    78   3E-13 U 
contig02369 gi|157124488|ref|XP_001654070.1| ran-binding protein [Aedes aegy...    78   3E-13 U 
contig08216 gi|66549728|ref|XP_392990.2| PREDICTED: similar to ADP ribosylat...    78   3E-13 U 
contig11349 gi|72077602|ref|XP_797023.1| PREDICTED: similar to serpin 1 prec...    77   3E-13 V 
contig02362 gi|195443760|ref|XP_002069562.1| GK11508 [Drosophila willistoni]...    77   3E-13 YU 
contig02189 gi|170031478|ref|XP_001843612.1| tep3 [Culex quinquefasciatus] >...    78   2E-13 O 
contig03901 gi|11079190|dbj|BAB17604.1| peroxiredoxin [Haemaphysalis longico...    78   2E-13 O 
contig05892 gi|91087035|ref|XP_974421.1| PREDICTED: similar to synoviolin [T...    78   2E-13 O 
contig02162 gi|170029149|ref|XP_001842456.1| tyrosine-protein kinase btk29a ...    78   2E-13 T 
contig04164 gi|170030314|ref|XP_001843034.1| mystery 45A [Culex quinquefasci...    59   1E-13 DZ 
contig03413 gi|156395766|ref|XP_001637281.1| predicted protein [Nematostella...    60   1E-13 O 
contig09305 gi|158293614|ref|XP_314956.4| AGAP008822-PA [Anopheles gambiae s...    55   1E-13 O 
contig05148 gi|197128799|gb|ACH45297.1| putative RAB14 member RAS oncogene f...    67   1E-13 U 
contig10998 gi|161671318|gb|ABX75511.1| myosin light polypeptide 6 [Lycosa s...    79   1E-13 Z 
contig09141 gi|62857965|ref|NP_001016573.1| hypothetical protein LOC549327 [...    79   9E-14 D 
contig03006 gi|115951487|ref|XP_001189418.1| PREDICTED: similar to KIAA0369 ...    80   7E-14 DZ 
contig00065 gi|170031478|ref|XP_001843612.1| tep3 [Culex quinquefasciatus] >...    80   7E-14 O 
contig07773 gi|197129911|gb|ACH46409.1| putative NSFL1 cofactor [Taeniopygia...    80   7E-14 Y 
contig09981 gi|156541807|ref|XP_001602555.1| PREDICTED: similar to GH01576p ...    80   5E-14 YU 
contig08936 gi|156547617|ref|XP_001603638.1| PREDICTED: similar to ATP-depen...    80   4E-14 O 
contig04168 gi|156549579|ref|XP_001602959.1| PREDICTED: similar to calpain B...    80   4E-14 OT 




Contig BLAST result e value Class 
contig05563 gi|139949068|ref|NP_001077235.1| protein tyrosine phosphatase ty...    80   4E-14 T 
contig03016 gi|108742460|gb|ABG01866.1| putative accessory gland protein [Gr...    54   3E-14 O 
contig04354 gi|193594276|ref|XP_001945478.1| PREDICTED: similar to proteasom...    81   3E-14 O 
contig04389 gi|170579699|ref|XP_001894945.1| Ulp1 protease family, C-termina...    81   3E-14 O 
contig00754 gi|195028748|ref|XP_001987238.1| GH21807 [Drosophila grimshawi] ...    82   3E-14 V 
contig00964 gi|195391043|ref|XP_002054175.1| GJ24294 [Drosophila virilis] >g...    81   2E-14 D 
contig05885 gi|156544752|ref|XP_001606012.1| PREDICTED: similar to ENSANGP00...    81   2E-14 DO 
contig02323 gi|195539750|gb|AAI68042.1| Unknown (protein for MGC:185359) [Xe...    81   2E-14 O 
contig07964 gi|170064267|ref|XP_001867454.1| conserved hypothetical protein ...    82   2E-14 O 
contig11545 gi|21263742|sp|Q9I8F9|HSP71_ORYLA Heat shock 70 kDa protein 1 (H...    82   2E-14 O 
contig04245 gi|41053487|ref|NP_956984.1| hypothetical protein LOC393663 [Dan...    81   2E-14 U 
contig06827 gi|91086141|ref|XP_969127.1| PREDICTED: similar to protein trans...    82   2E-14 U 
contig01466 gi|66508940|ref|XP_397201.2| PREDICTED: similar to CG6459-PA [Ap...    83   2E-14 V 
contig02380 gi|194219245|ref|XP_001490868.2| PREDICTED: similar to ubiquitin...    82   1E-14 O 
contig04680 gi|124487744|gb|ABN11959.1| putative chaperonin subunit 6a zeta ...    82   1E-14 O 
contig06472 gi|91077894|ref|XP_973141.1| PREDICTED: similar to predicted pro...    82   1E-14 O 
contig04497 gi|156537007|ref|XP_001608296.1| PREDICTED: similar to conserved...    82   1E-14 OT 
contig08448 gi|115670856|ref|XP_781475.2| PREDICTED: hypothetical protein [S...    82   1E-14 T 
contig01409 gi|156546010|ref|XP_001607952.1| PREDICTED: similar to conserved...    82   1E-14 Z 
contig01807 gi|66513484|ref|XP_395374.2| PREDICTED: similar to CG5871-PA [Ap...    83   8E-15 O 
contig07583 gi|151301141|ref|NP_001093092.1| proteasome beta subunit [Bombyx...    83   8E-15 O 
contig01384 gi|115713356|ref|XP_001204091.1| PREDICTED: similar to glycine t...    83   8E-15 T 
contig02931 gi|34850473|dbj|BAC87840.1| Armadillo [Achaearanea tepidariorum]       83   8E-15 TZ 
contig05528 gi|115700014|ref|XP_791516.2| PREDICTED: hypothetical protein [S...    83   6E-15 U 
contig06678 gi|56267941|gb|AAV85443.1| reverse transcriptase-like protein [A...    83   6E-15 U 
contig11012 gi|149639872|ref|XP_001510959.1| PREDICTED: hypothetical protein...    86   5E-15 T 
contig02947 gi|118094562|ref|XP_422476.2| PREDICTED: similar to zinc finger,...    84   4E-15 D 
contig01602 gi|195389480|ref|XP_002053404.1| GJ23355 [Drosophila virilis] >g...    84   4E-15 O 
contig07872 gi|153008177|ref|YP_001369392.1| ATP-dependent protease ATP-bind...    84   4E-15 O 
contig08037 gi|154338918|ref|XP_001565681.1| hypothetical protein LbrM25_V2....    57   3E-15 O 
contig05510 gi|71896903|ref|NP_001025928.1| heat shock 70kD protein binding ...    84   3E-15 OT 
contig00395 gi|47207591|emb|CAG02332.1| unnamed protein product [Tetraodon n...    84   3E-15 T 
contig11190 gi|170037319|ref|XP_001846506.1| TBC1 domain family [Culex quinq...    84   3E-15 T 
contig10136 gi|189241310|ref|XP_001815658.1| PREDICTED: similar to AGAP00480...    84   3E-15 TZ 
contig04258 gi|91083677|ref|XP_968528.1| PREDICTED: similar to dynein light ...    85   2E-15 N 
contig01045 gi|193596448|ref|XP_001951792.1| PREDICTED: similar to Hsc70Cb C...    86   2E-15 O 
contig05048 gi|156401011|ref|XP_001639085.1| predicted protein [Nematostella...    85   2E-15 O 
contig06558 gi|170064323|ref|XP_001867478.1| brain tumor protein [Culex quin...    85   2E-15 O 
contig10237 gi|156551295|ref|XP_001601373.1| PREDICTED: similar to ENSANGP00...    85   2E-15 O 
contig02748 gi|194218564|ref|XP_001917008.1| PREDICTED: low density lipoprot...    87   2E-15 T 
contig07826 gi|31198799|ref|XP_308347.1| AGAP007532-PA [Anopheles gambiae st...    85   2E-15 W 
contig03409 gi|23491588|dbj|BAC16746.1| myosin heavy chain [Branchiostoma be...    85   2E-15 Z 
contig03562 gi|161669254|gb|ABX75479.1| myosin heavy chain [Lycosa singorien...    85   2E-15 Z 
contig01519 gi|195588777|ref|XP_002084134.1| GD14099 [Drosophila simulans] >...    86   1E-15 O 
contig03414 gi|149898803|gb|ABR27863.1| Sec61 protein translocation complex ...    87   1E-15 O 
contig06455 gi|148231811|ref|NP_001080017.1| hypothetical protein LOC379708 ...    86   1E-15 TW 
contig09761 gi|156547359|ref|XP_001603094.1| PREDICTED: similar to ENSANGP00...    86   9E-16 O 
contig12144 gi|50734130|ref|XP_418980.1| PREDICTED: similar to Leukocyte ela...    87   8E-16 V 
contig02417 gi|47206961|emb|CAF90782.1| unnamed protein product [Tetraodon n...    88   7E-16 O 
contig04028 gi|115638630|ref|XP_790132.2| PREDICTED: similar to GABA neurotr...    86   7E-16 T 
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contig03158 gi|47218173|emb|CAG10093.1| unnamed protein product [Tetraodon n...    87   6E-16 U 
contig05986 gi|72091589|ref|XP_791815.1| PREDICTED: hypothetical protein [St...    87   5E-16 OR 
contig06442 gi|193707017|ref|XP_001952867.1| PREDICTED: similar to septin [A...    87   4E-16 DZU 
contig07741 gi|47206576|emb|CAF94013.1| unnamed protein product [Tetraodon n...    87   4E-16 O 
contig04458 gi|156542512|ref|XP_001600274.1| PREDICTED: similar to glucosida...    87   4E-16 T 
contig05410 gi|148222958|ref|NP_001085021.1| hypothetical protein LOC432085 ...    87   3E-16 O 
contig02941 gi|156538200|ref|XP_001601553.1| PREDICTED: similar to GA10497-P...    87   3E-16 T 
contig11338 gi|157106589|ref|XP_001649392.1| coatomer beta subunit [Aedes ae...    87   3E-16 U 
contig01157 gi|162415911|gb|ABX89274.1| serpin peptidase inhibitor, clade B,...    87   3E-16 V 
contig07835 gi|110756556|ref|XP_396810.3| PREDICTED: similar to Nucleoporin ...    87   3E-16 YU 
contig02817 gi|67083885|gb|AAY66877.1| nonmuscle myosin essential light chai...    87   3E-16 Z 
contig04801 gi|156555332|ref|XP_001604103.1| PREDICTED: similar to parvin [N...    87   3E-16 Z 
contig07723 gi|194670334|ref|XP_612559.2| PREDICTED: acidic (leucine-rich) n...    88   2E-16 DR 
contig02622 gi|189540623|ref|XP_684202.3| PREDICTED: similar to Ubiquitin sp...    88   2E-16 O 
contig08640 gi|126304111|ref|XP_001381909.1| PREDICTED: similar to FrzA [Mon...    88   2E-16 T 
contig02331 gi|149380781|gb|ABR24785.1| glutathione S-transferase mu class [...    89   1E-16 O 
contig03943 gi|6318665|gb|AAF06994.1|AF167366_1 T-complex protein 1 gamma su...    89   1E-16 O 
contig10839 gi|195479503|ref|XP_002100910.1| GE15910 [Drosophila yakuba] >gn...    89   1E-16 O 
contig10311 gi|158299486|ref|XP_319605.4| AGAP008863-PA [Anopheles gambiae s...    89   1E-16 T 
contig03892 gi|156402263|ref|XP_001639510.1| predicted protein [Nematostella...    89   1E-16 U 
contig10172 gi|156554310|ref|XP_001602669.1| PREDICTED: similar to CG6775-PC...    89   1E-16 U 
contig03228 gi|195457232|ref|XP_002075484.1| GK18337 [Drosophila willistoni]...    89   8E-17 O 
contig04998 gi|142976617|ref|NP_001073358.2| selenophosphate synthetase 2 [R...    89   8E-17 T 
contig07532 gi|156554719|ref|XP_001605102.1| PREDICTED: similar to conserved...    90   7E-17 T 
contig00107 gi|114842185|dbj|BAF32577.1| cytoplasmic actin [Varroa destructor]     90   6E-17 Z 
contig01051 gi|94734234|emb|CAK11350.1| novel protein (zgc:66267) [Danio rerio]    91   4E-17 O 
contig12479 gi|157745561|ref|XP_001667877.1| Hypothetical protein CBG14979 [...    94   4E-17 O 
contig03120 gi|34539117|gb|AAQ74442.1| glutathione S-transferase [Rhipicepha...    91   3E-17 O 
contig07628 gi|195457050|ref|XP_002075403.1| GK17732 [Drosophila willistoni]...    91   3E-17 T 
contig08978 gi|156554755|ref|XP_001605584.1| PREDICTED: similar to ras-relat...    91   3E-17 TU 
contig09646 gi|189241915|ref|XP_971248.2| PREDICTED: similar to Putative GTP...    91   3E-17 TU 
contig11500 gi|54400522|ref|NP_001006010.1| hypothetical protein LOC449989 [...    91   2E-17 DV 
contig09144 gi|158297247|ref|XP_317515.4| AGAP007957-PA [Anopheles gambiae s...    92   2E-17 M 
contig01114 gi|194853503|ref|XP_001968175.1| GG24722 [Drosophila erecta] >gn...    92   2E-17 O 
contig09962 gi|71659830|ref|XP_821635.1| proteasome beta 2 subunit, putative...    88   2E-17 O 
contig00898 gi|158289971|ref|XP_311569.4| AGAP010376-PA [Anopheles gambiae s...    92   2E-17 T 
contig01553 gi|121309135|dbj|BAF43802.1| galectin [Ornithodoros moubata] >gn...    92   2E-17 W 
contig09402 gi|195454473|ref|XP_002074253.1| GK18416 [Drosophila willistoni]...    92   2E-17 YU 
contig06609 gi|156057557|ref|XP_001594702.1| conserved hypothetical protein ...    92   2E-17 Z 
contig09779 gi|109104620|ref|XP_001110230.1| PREDICTED: similar to Tubulin a...    92   2E-17 Z 
contig04686 gi|55926117|ref|NP_001007498.1| bub3 protein [Xenopus tropicalis...    92   1E-17 D 
contig06446 gi|194764889|ref|XP_001964560.1| GF22987 [Drosophila ananassae] ...    92   1E-17 O 
contig01892 gi|156555566|ref|XP_001604721.1| PREDICTED: similar to calcineur...    92   1E-17 T 
contig02566 gi|193669177|ref|XP_001945333.1| PREDICTED: similar to AGAP00302...    92   1E-17 U 
contig07422 gi|194213458|ref|XP_001496149.2| PREDICTED: similar to RAB6A, me...    92   1E-17 U 
contig08607 gi|91079294|ref|XP_966628.1| PREDICTED: similar to CG8707 CG8707...    92   1E-17 U 
contig11289 gi|195429527|ref|XP_002062810.1| GK19497 [Drosophila willistoni]...    93   1E-17 U 
contig00318 gi|114052272|ref|NP_001040465.1| tropomyosin isoform 2 [Bombyx m...    92   1E-17 Z 
contig04037 gi|156394055|ref|XP_001636642.1| predicted protein [Nematostella...    93   8E-18 O 
contig05755 gi|91093675|ref|XP_969585.1| PREDICTED: similar to AGAP004340-PA...    93   8E-18 T 




Contig BLAST result e value Class 
contig05883 gi|195964871|gb|ACG60423.1| heat shock protein 70-2 [Tetranychus...    60   7E-18 O 
contig03321 gi|91088981|ref|XP_966828.1| PREDICTED: similar to CG4165 CG4165...    93   6E-18 O 
contig07206 gi|47218760|emb|CAG02746.1| unnamed protein product [Tetraodon n...    93   6E-18 O 
contig08582 gi|189234451|ref|XP_967488.2| PREDICTED: similar to blue cheese ...    93   6E-18 TU 
contig06440 gi|156537015|ref|XP_001608302.1| PREDICTED: similar to chaperoni...    94   3E-18 O 
contig09565 gi|156555726|ref|XP_001601862.1| PREDICTED: similar to paraplegi...    94   3E-18 O 
contig09743 gi|195457695|ref|XP_002075674.1| GK23547 [Drosophila willistoni]...    94   3E-18 O 
contig05090 gi|118091839|ref|XP_421224.2| PREDICTED: similar to vesicle tran...    94   3E-18 U 
contig02798 gi|170585966|ref|XP_001897752.1| Ubiquitin-conjugating enzyme E2...    95   2E-18 O 
contig05521 gi|189525365|ref|XP_001341326.2| PREDICTED: similar to ubiquitin...    95   2E-18 O 
contig11390 gi|118793755|ref|XP_321060.3| AGAP001999-PA [Anopheles gambiae s...    95   2E-18 T 
contig02139 gi|124487934|gb|ABN12050.1| putative ribophorin II [Maconellicoc...    96   1E-18 O 
contig07256 gi|183979376|dbj|BAG30740.1| muscle myosin heavy chain [Papilio ...    96   1E-18 Z 
contig07267 gi|2947316|gb|AAC05388.1| fibulin-1, isoform C precursor [Gallus...    96   9E-19 T 
contig09580 gi|193685937|ref|XP_001952603.1| PREDICTED: similar to sarcalume...    96   9E-19 TU 
contig06290 gi|66565839|ref|XP_395065.2| PREDICTED: similar to Clathrin ligh...    96   9E-19 U 
contig04475 gi|33598988|gb|AAP51387.1| constitutive heat shock protein HSC70...    64   8E-19 O 
contig02453 gi|58390289|ref|XP_317621.2| AGAP007871-PA [Anopheles gambiae st...    98   6E-19 U 
contig10970 gi|156543740|ref|XP_001605962.1| PREDICTED: similar to tripeptid...    97   5E-19 O 
contig05415 gi|3913717|sp|O16118|GNAS_HOMAM Guanine nucleotide-binding prote...    97   5E-19 T 
contig05989 gi|193624646|ref|XP_001952092.1| PREDICTED: similar to muscle my...    95   5E-19 Z 
contig01112 gi|170581201|ref|XP_001895580.1| ubiquitin C-terminal hydrolase ...    97   3E-19 O 
contig04551 gi|149412083|ref|XP_001510215.1| PREDICTED: hypothetical protein...    98   2E-19 T 
contig08850 gi|72017227|ref|XP_791019.1| PREDICTED: similar to MGC82152 prot...    98   2E-19 T 
contig09376 gi|168278389|dbj|BAG11074.1| coatomer subunit alpha [synthetic c...    98   2E-19 U 
contig13287 gi|126323523|ref|XP_001364576.1| PREDICTED: hypothetical protein...    98   2E-19 U 
contig01433 gi|156553669|ref|XP_001602360.1| PREDICTED: similar to beta-tubu...    98   2E-19 Z 
contig08500 gi|148235319|ref|NP_001080290.1| ubiquitin-conjugating enzyme E2...    73   1E-19 O 
contig10643 gi|147905141|ref|NP_001086744.1| G protein-coupled receptor 89 [...    99   1E-19 T 
contig11655 gi|196000721|ref|XP_002110228.1| expressed hypothetical protein ...    99   1E-19 T 
contig04567 gi|193587329|ref|XP_001949579.1| PREDICTED: similar to CG14232 C...    99   1E-19 U 
contig00217 gi|195435101|ref|XP_002065540.1| GK14617 [Drosophila willistoni]...    99   8E-20 O 
contig07687 gi|109079105|ref|XP_001094909.1| PREDICTED: ring finger protein ...    99   8E-20 O 
contig02840 gi|195384084|ref|XP_002050748.1| GJ20037 [Drosophila virilis] >g...   100   7E-20 T 
contig03407 gi|114637619|ref|XP_508413.2| PREDICTED: proteasome 26S ATPase s...    90   6E-20 O 
contig06623 gi|110751295|ref|XP_623197.2| PREDICTED: similar to GDP dissocia...   100   6E-20 O 
contig08754 gi|183979249|dbj|BAG30786.1| similar to CG2708-PA [Papilio xuthus]    100   6E-20 ODR 
contig03192 gi|148231189|ref|NP_001085042.1| hypothetical protein LOC432109 ...   100   6E-20 Z 
contig07454 gi|195553249|ref|XP_002076630.1| GD15163 [Drosophila simulans] >...   100   5E-20 T 
contig04869 gi|198138224|gb|EDY70016.1| GA25794 [Drosophila pseudoobscura ps...   100   4E-20 Z 
contig11791 gi|193783623|dbj|BAG53534.1| unnamed protein product [Homo sapiens]   100   3E-20 O 
contig12186 gi|195150723|ref|XP_002016300.1| GL10567 [Drosophila persimilis]...    61   3E-20 T 
contig05295 gi|170067248|ref|XP_001868406.1| translocon-associated protein s...    88   3E-20 U 
contig00543 gi|170596615|ref|XP_001902831.1| FKBP-type peptidyl-prolyl cis-t...   103   2E-20 O 
contig06494 gi|196000965|ref|XP_002110350.1| hypothetical protein TRIADDRAFT...   101   2E-20 U 
contig02766 gi|170029190|ref|XP_001842476.1| myosin heavy chain [Culex quinq...   101   2E-20 Z 
contig10612 gi|156538817|ref|XP_001607965.1| PREDICTED: similar to ubiquitin...   102   1E-20 O 
contig01945 gi|113204600|gb|ABI34002.1| high-affinity serotonin transporter ...   102   1E-20 T 
contig00795 gi|198138224|gb|EDY70016.1| GA25794 [Drosophila pseudoobscura ps...   102   1E-20 Z 
contig06823 gi|158298304|ref|XP_554420.3| AGAP004023-PA [Anopheles gambiae s...   102   1E-20 ZU 




Contig BLAST result e value Class 
contig02992 gi|91092996|ref|XP_968315.1| PREDICTED: similar to Cysteine-rich...   102   7E-21 Z 
contig08545 gi|107910630|gb|ABF85673.1| 70 kD heat shock protein [Rimicaris ...    73   4E-21 O 
contig04194 gi|37925239|gb|AAP59794.1| slow muscle myosin S1 heavy chain [Ho...    73   4E-21 Z 
contig08013 gi|71896679|ref|NP_001026142.1| phosphatidylinositol-4-phosphate...   104   3E-21 T 
contig01256 gi|114153122|gb|ABI52727.1| ADP ribosylation factor 79F [Argas m...    64   3E-21 U 
contig02164 gi|115643098|ref|XP_001191223.1| PREDICTED: similar to suppresso...   103   3E-21 U 
contig13056 gi|37903435|gb|AAO38846.1| actin [Danio rerio] >gnl|BL_ORD_ID|29...   104   3E-21 Z 
contig13123 gi|37903435|gb|AAO38846.1| actin [Danio rerio] >gnl|BL_ORD_ID|29...   104   3E-21 Z 
contig03884 gi|156553628|ref|XP_001600123.1| PREDICTED: hypothetical protein...   104   2E-21 O 
contig11432 gi|66566513|ref|XP_395605.2| PREDICTED: similar to CG7830-PA [Ap...   104   2E-21 O 
contig01265 gi|195020142|ref|XP_001985130.1| GH16896 [Drosophila grimshawi] ...   104   2E-21 Z 
contig00991 gi|198137562|gb|EDY69675.1| GA25293 [Drosophila pseudoobscura ps...   105   1E-21 O 
contig11560 gi|158288915|ref|XP_310731.4| AGAP000378-PA [Anopheles gambiae s...   107   1E-21 T 
contig12416 gi|67083891|gb|AAY66880.1| D-dopachrome tautomerase [Ixodes scap...   107   1E-21 V 
contig05448 gi|110759783|ref|XP_395212.3| PREDICTED: similar to Spectrin bet...   105   1E-21 Z 
contig02282 gi|47229652|emb|CAG06848.1| unnamed protein product [Tetraodon n...   105   9E-22 O 
contig12224 gi|115655582|ref|XP_780679.2| PREDICTED: similar to granulin [St...   106   9E-22 T 
contig03250 gi|91082327|ref|XP_974606.1| PREDICTED: similar to prohibitin pr...   106   7E-22 O 
contig02525 gi|26891614|gb|AAN78379.1| CG10174 protein [Drosophila melanogas...   106   7E-22 U 
contig04765 gi|82621739|gb|ABB86551.1| proteosome PSMB6/9 protein [Branchios...   106   5E-22 O 
contig05490 gi|91077138|ref|XP_971446.1| PREDICTED: similar to DnaJ homolog ...   107   4E-22 O 
contig05522 gi|91075936|ref|XP_967560.1| PREDICTED: similar to AGAP002481-PA...   107   4E-22 O 
contig08749 gi|49474021|ref|YP_032063.1| protease II [Bartonella quintana st...    97   4E-22 O 
contig08798 gi|193617698|ref|XP_001948523.1| PREDICTED: similar to GA18789-P...   107   4E-22 O 
contig09165 gi|66533395|ref|XP_393300.2| PREDICTED: similar to CG7033-PA, is...    68   4E-22 O 
contig07757 gi|189525403|ref|XP_001921194.1| PREDICTED: similar to inositol ...   107   4E-22 T 
contig06227 gi|4322296|gb|AAD16002.1| cAMP-dependent protein kinase catalyti...   107   3E-22 T 
contig02836 gi|157111247|ref|XP_001651451.1| BRI1-KD interacting protein, pu...   107   3E-22 U 
contig08586 gi|66553034|ref|XP_396707.2| PREDICTED: similar to Serine/threon...   108   2E-22 D 
contig03707 gi|195457320|ref|XP_002075523.1| GK18527 [Drosophila willistoni]...   110   2E-22 O 
contig05250 gi|193594276|ref|XP_001945478.1| PREDICTED: similar to proteasom...   108   2E-22 O 
contig08559 gi|72012370|ref|XP_781234.1| PREDICTED: similar to p70 ribosomal...   108   2E-22 RT 
contig01750 gi|123469147|ref|XP_001317787.1| AGC family protein kinase [Tric...   108   1E-22 D 
contig05305 gi|146284648|ref|YP_001165601.1| cobyrinic acid a,c-diamide synt...   108   1E-22 D 
contig00365 gi|195394999|ref|XP_002056124.1| GJ10398 [Drosophila virilis] >g...   108   1E-22 O 
contig06195 gi|7416829|dbj|BAA94076.1| ubiquitin-activating enzyme E1 [Caras...   108   1E-22 O 
contig10729 gi|156377225|ref|XP_001630757.1| predicted protein [Nematostella...   108   1E-22 O 
contig03356 gi|58382750|ref|XP_312147.2| AGAP002777-PA [Anopheles gambiae st...   108   1E-22 T 
contig05211 gi|156545774|ref|XP_001605636.1| PREDICTED: similar to Sec24B pr...   109   8E-23 U 
contig12767 gi|160420131|ref|NP_001080570.1| dual specificity phosphatase 1 ...   109   8E-23 V 
contig01933 gi|156375039|ref|XP_001629890.1| predicted protein [Nematostella...   110   6E-23 D 
contig02789 gi|170043539|ref|XP_001849441.1| grpE [Culex quinquefasciatus] >...   109   6E-23 O 
contig03560 gi|116488307|gb|ABJ98722.1| heat shock protein 71 [Perna viridis...   106   6E-23 O 
contig04358 gi|139000435|dbj|BAF51711.1| tick legumain [Haemaphysalis longic...   109   6E-23 O 
contig12259 gi|91082187|ref|XP_971460.1| PREDICTED: similar to conserved hyp...   113   6E-23 O 
contig03280 gi|46048731|ref|NP_990565.1| hippocalcin-like 1 [Gallus gallus] ...    95   6E-23 T 
contig04005 gi|62554177|dbj|BAD95607.1| WNT8C [Gallus gallus]                     109   6E-23 T 
contig07142 gi|193627205|ref|XP_001952587.1| PREDICTED: similar to AGAP00926...   109   6E-23 T 
contig02883 gi|119352599|gb|ABL63902.1| capping protein beta subunit [Xenopu...   109   6E-23 Z 
contig10158 gi|72064509|ref|XP_780270.1| PREDICTED: similar to chaperonin is...   110   4E-23 O 




Contig BLAST result e value Class 
contig08540 gi|195450889|ref|XP_002072676.1| GK13729 [Drosophila willistoni]...   110   3E-23 Z 
contig02122 gi|157132324|ref|XP_001655999.1| cathepsin l [Aedes aegypti] >gn...   111   2E-23 O 
contig04751 gi|91091652|ref|XP_971071.1| PREDICTED: similar to mitochondrial...   111   2E-23 O 
contig11044 gi|66813248|ref|XP_640803.1| hypothetical protein DDBDRAFT_02039...   104   2E-23 O 
contig04083 gi|126324876|ref|XP_001379073.1| PREDICTED: similar to clathrin ...   111   2E-23 U 
contig05088 gi|189526748|ref|XP_694714.3| PREDICTED: similar to Golgi-specif...   111   2E-23 U 
contig05429 gi|156542546|ref|XP_001599253.1| PREDICTED: similar to probable ...   111   2E-23 UO 
contig10851 gi|19074903|ref|NP_586409.1| PROTEASOME REGULATORY SUBUNIT YTA6 ...   112   1E-23 O 
contig11670 gi|91093707|ref|XP_967114.1| PREDICTED: similar to sex-determini...   112   1E-23 OT 
contig06681 gi|189537228|ref|XP_001921364.1| PREDICTED: similar to AP-3 comp...   112   1E-23 U 
contig02564 gi|154814668|gb|ABS87368.1| lospin 16 [Amblyomma americanum]           71   1E-23 V 
contig07322 gi|91076138|ref|XP_970159.1| PREDICTED: similar to actin binding...   112   1E-23 W 
contig10020 gi|156368061|ref|XP_001627515.1| predicted protein [Nematostella...   112   9E-24 O 
contig01025 gi|193657081|ref|XP_001945441.1| PREDICTED: similar to ubiquitin...   112   8E-24 O 
contig02263 gi|51011554|gb|AAT92186.1| heat shock protein 10 [Ixodes pacificus]   114   7E-24 O 
contig12574 gi|109104965|ref|XP_001091374.1| PREDICTED: cathepsin D isoform ...   112   7E-24 O 
contig07517 gi|189234922|ref|XP_970841.2| PREDICTED: similar to myosin light...   112   7E-24 Z 
contig09419 gi|149633775|ref|XP_001513271.1| PREDICTED: similar to ubiquitin...   113   5E-24 O 
contig09046 gi|7330345|gb|AAB24072.2| G-protein alpha i subunit [Homarus ame...   113   4E-24 DT 
contig10352 gi|110771394|ref|XP_001123288.1| PREDICTED: similar to Insulin-d...   113   4E-24 O 
contig01567 gi|148558491|ref|YP_001257246.1| chaperonin GroEL [Brucella ovis...   114   3E-24 O 
contig06860 gi|165905471|dbj|BAF99000.1| atypical protein kinase C [Hemicent...   110   3E-24 T 
contig00572 gi|91081923|ref|XP_970724.1| PREDICTED: similar to DnaJ (Hsp40) ...   114   2E-24 O 
contig00664 gi|58377313|ref|XP_309539.2| glutaredoxin (AGAP011107-PA) [Anoph...   114   2E-24 O 
contig07580 gi|194758635|ref|XP_001961567.1| GF14871 [Drosophila ananassae] ...   114   2E-24 T 
contig08536 gi|156549535|ref|XP_001602657.1| PREDICTED: similar to GA19430-P...   114   2E-24 T 
contig13087 gi|42476045|ref|NP_599161.2| cathepsin D [Rattus norvegicus] >gn...   115   1E-24 O 
contig07958 gi|193629709|ref|XP_001948291.1| PREDICTED: hypothetical protein...   115   1E-24 T 
contig05337 gi|91081955|ref|XP_967420.1| PREDICTED: similar to cullin [Tribo...   115   8E-25 D 
contig01368 gi|196004168|ref|XP_002111951.1| hypothetical protein TRIADDRAFT...   116   8E-25 Z 
contig08436 gi|91077186|ref|XP_972614.1| PREDICTED: similar to cyclin-K [Tri...   116   7E-25 D 
contig05122 gi|47216266|emb|CAG05962.1| unnamed protein product [Tetraodon n...    73   7E-25 O 
contig09333 gi|65332126|gb|AAY42205.1| troponin T [Haemaphysalis qinghaiensis]    101   7E-25 Z 
contig10687 gi|193624646|ref|XP_001952092.1| PREDICTED: similar to muscle my...   116   7E-25 Z 
contig06781 gi|156374072|ref|XP_001629633.1| predicted protein [Nematostella...   116   6E-25 D 
contig07660 gi|156352097|ref|XP_001622605.1| predicted protein [Nematostella...   116   6E-25 O 
contig03145 gi|56412194|gb|AAV88596.1| Sparc [Schistocerca gregaria]              116   6E-25 W 
contig11037 gi|71834414|ref|NP_001025299.1| dynamin 2 [Danio rerio] >gnl|BL_...   116   5E-25 UR 
contig05915 gi|189234352|ref|XP_973750.2| PREDICTED: similar to spectrin [Tr...   116   5E-25 Z 
contig12620 gi|170063951|ref|XP_001867326.1| lysosomal aspartic protease [Cu...   117   4E-25 O 
contig10034 gi|29134779|dbj|BAC66140.1| projectin [Procambarus clarkii]           117   4E-25 Z 
contig10243 gi|115654526|ref|XP_001176817.1| PREDICTED: similar to Structura...   117   3E-25 D 
contig01287 gi|158298637|ref|XP_318831.4| AGAP009747-PA [Anopheles gambiae s...   119   2E-25 O 
contig11938 gi|161788938|dbj|BAF95090.1| 2nd tick legumain [Haemaphysalis lo...    77   2E-25 O 
contig04423 gi|189239939|ref|XP_001813596.1| PREDICTED: similar to Myosin he...   117   2E-25 Z 
contig01212 gi|75029909|sp|Q4PMC9|PNO1_IXOSC RNA-binding protein pno1 >gnl|B...   118   1E-25 O 
contig08163 gi|112983414|ref|NP_001036985.1| heat shock protein hsp21.4 [Bom...   118   1E-25 O 
contig10087 gi|195349292|ref|XP_002041179.1| GM15181 [Drosophila sechellia] ...   119   1E-25 O 
contig02167 gi|73966641|ref|XP_867227.1| PREDICTED: similar to Clathrin heav...    71   1E-25 U 
contig09818 gi|195129812|ref|XP_002009348.1| GI15281 [Drosophila mojavensis]...   118   1E-25 Z 




Contig BLAST result e value Class 
contig10404 gi|156537047|ref|XP_001601463.1| PREDICTED: similar to GA15568-P...   119   6E-26 DO 
contig04255 gi|114051682|ref|NP_001040173.1| calcium-binding protein p22 [Bo...   119   6E-26 T 
contig11382 gi|66501010|ref|XP_392587.2| PREDICTED: similar to alien CG9556-...   120   4E-26 OT 
contig01177 gi|148608643|gb|ABQ95654.1| mitogen-activated protein kinase kin...   120   3E-26 T 
contig05765 gi|47215026|emb|CAG01850.1| unnamed protein product [Tetraodon n...   120   3E-26 T 
contig00126 gi|157123632|ref|XP_001660237.1| cyclin B3 [Aedes aegypti] >gnl|...   121   2E-26 D 
contig02950 gi|110665909|gb|ABG81495.1| ubiquitin [Mayetiola destructor]          121   2E-26 O 
contig05161 gi|126327605|ref|XP_001376365.1| PREDICTED: hypothetical protein...   122   2E-26 O 
contig01116 gi|66500538|ref|XP_392119.2| PREDICTED: similar to Phosphatidyli...   122   2E-26 T 
contig06056 gi|121543726|gb|ABM55548.1| putative peptidyl-prolyl cis-trans i...   122   9E-27 O 
contig01608 gi|91078858|ref|XP_972061.1| PREDICTED: similar to thymus-specif...   122   9E-27 OR 
contig04919 gi|170049784|ref|XP_001870925.1| mitochondrial import inner memb...   122   7E-27 U 
contig06806 gi|37651156|dbj|BAC98949.1| beta-tubulin [Octopus vulgaris]           122   7E-27 Z 
contig06184 gi|110761364|ref|XP_001121589.1| PREDICTED: similar to Alpha-act...   106   6E-27 Z 
contig00156 gi|118104159|ref|XP_425038.2| PREDICTED: similar to cathepsin L ...    96   5E-27 O 
contig12240 gi|33348836|gb|AAQ16118.1| cathepsin L-like cysteine proteinase ...   123   5E-27 O 
contig03683 gi|158287647|ref|XP_309631.4| AGAP004079-PA [Anopheles gambiae s...   123   5E-27 T 
contig01298 gi|156549140|ref|XP_001607681.1| PREDICTED: similar to microtubu...   123   5E-27 TR 
contig11663 gi|109127465|ref|XP_001094589.1| PREDICTED: TNF receptor-associa...   124   3E-27 O 
contig03395 gi|195453988|ref|XP_002074034.1| GK12822 [Drosophila willistoni]...   124   2E-27 M 
contig08973 gi|195111606|ref|XP_002000369.1| GI22559 [Drosophila mojavensis]...   124   2E-27 O 
contig04961 gi|110763838|ref|XP_395927.3| PREDICTED: similar to Lk6 CG17342-...   124   2E-27 T 
contig11832 gi|189238236|ref|XP_972123.2| PREDICTED: similar to AGAP009953-P...   124   2E-27 T 
contig04384 gi|193620299|ref|XP_001944741.1| PREDICTED: similar to ring fing...   125   1E-27 O 
contig06643 gi|170045205|ref|XP_001850207.1| past-1 [Culex quinquefasciatus]...   125   1E-27 TU 
contig07977 gi|148228813|ref|NP_001086997.1| N-ethylmaleimide-sensitive fact...   125   1E-27 U 
contig03684 gi|193683746|ref|XP_001950805.1| PREDICTED: similar to alpha act...   125   1E-27 Z 
contig02722 gi|159112802|ref|XP_001706629.1| Peptidyl-prolyl cis-trans isome...   104   9E-28 O 
contig10117 gi|125980157|ref|XP_001354111.1| GA19652-PA [Drosophila pseudoob...   125   8E-28 O 
contig04642 gi|110761559|ref|XP_395279.3| PREDICTED: similar to Darkener of ...   125   8E-28 T 
contig04253 gi|156542889|ref|XP_001600957.1| PREDICTED: similar to stromal a...   126   6E-28 D 
contig05790 gi|193690576|ref|XP_001944217.1| PREDICTED: similar to CG34352 C...   126   6E-28 T 
contig03791 gi|156541797|ref|XP_001602382.1| PREDICTED: similar to SD01613p ...   126   5E-28 O 
contig11656 gi|47550797|ref|NP_999924.1| legumain [Danio rerio] >gnl|BL_ORD_...   126   5E-28 O 
contig06758 gi|189239939|ref|XP_001813596.1| PREDICTED: similar to Myosin he...    79   4E-28 Z 
contig00048 gi|193599208|ref|XP_001947519.1| PREDICTED: similar to meningiom...   128   3E-28 O 
contig00342 gi|193643700|ref|XP_001950340.1| PREDICTED: similar to homologue...   121   3E-28 O 
contig03374 gi|195996309|ref|XP_002108023.1| hypothetical protein TRIADDRAFT...   128   2E-28 M 
contig00202 gi|195399558|ref|XP_002058386.1| GJ14386 [Drosophila virilis] >g...   129   2E-28 O 
contig08261 gi|118092150|ref|XP_421350.2| PREDICTED: hypothetical protein [G...   128   2E-28 U 
contig03612 gi|157168009|ref|XP_001663284.1| adenylyl cyclase-associated pro...   128   2E-28 ZT 
contig02349 gi|124487748|gb|ABN11961.1| putative T-complex protein 1 subunit...   129   1E-28 O 
contig03276 gi|118593492|ref|ZP_01550872.1| Esterase/lipase/thioesterase, ac...   128   1E-28 O 
contig03868 gi|194043678|ref|XP_001925937.1| PREDICTED: proteasome (prosome,...   128   1E-28 O 
contig00355 gi|145499164|ref|XP_001435568.1| hypothetical protein GSPATT0003...   130   9E-29 RT 
contig08385 gi|170579335|ref|XP_001894786.1| DnaJ homolog subfamily B member...   129   7E-29 O 
contig03904 gi|195146696|ref|XP_002014320.1| GL19137 [Drosophila persimilis]...    99   5E-29 YU 
contig00617 gi|149428150|ref|XP_001511081.1| PREDICTED: similar to p85 beta ...   130   4E-29 T 
contig04880 gi|195572192|ref|XP_002104080.1| GD20772 [Drosophila simulans] >...   130   4E-29 U 
contig00276 gi|195029561|ref|XP_001987640.1| GH19845 [Drosophila grimshawi] ...   131   3E-29 O 




Contig BLAST result e value Class 
contig06586 gi|112983414|ref|NP_001036985.1| heat shock protein hsp21.4 [Bom...   130   3E-29 O 
contig11024 gi|309462|gb|AAA39948.1| protein kinase                               132   2E-29 D 
contig06040 gi|126333982|ref|XP_001364360.1| PREDICTED: similar to DnaJ-like...   131   2E-29 O 
contig07051 gi|193699959|ref|XP_001951177.1| PREDICTED: similar to cytochrom...   131   2E-29 O 
contig09684 gi|193621494|ref|XP_001952471.1| PREDICTED: similar to oligosacc...   131   2E-29 O 
contig12697 gi|139439837|ref|ZP_01773214.1| Hypothetical protein COLAER_0224...    79   2E-29 T 
contig03373 gi|189234352|ref|XP_973750.2| PREDICTED: similar to spectrin [Tr...   130   2E-29 Z 
contig05234 gi|126293910|ref|XP_001363445.1| PREDICTED: similar to ubiquitin...   133   1E-29 O 
contig10060 gi|91080285|ref|XP_973904.1| PREDICTED: similar to B-box type zi...   132   1E-29 O 
contig12120 gi|189517055|ref|XP_001341446.2| PREDICTED: similar to heat shoc...   132   1E-29 O 
contig01525 gi|170595779|ref|XP_001902516.1| Transmembrane protein [Brugia m...   132   1E-29 U 
contig12011 gi|195381281|ref|XP_002049382.1| GJ20779 [Drosophila virilis] >g...   133   5E-30 T 
contig08026 gi|156454274|gb|ABU63810.1| heat shock protein 70 [Hesiolyra bergi]   128   4E-30 O 
contig00031 gi|161661029|gb|ABX75381.1| cysteine and glycine-rich protein [L...   136   4E-30 TZ 
contig03985 gi|47086637|ref|NP_997868.1| hypoxia up-regulated 1 [Danio rerio...   134   2E-30 O 
contig06312 gi|67083917|gb|AAY66893.1| SCF ubiquitin ligase complex [Ixodes ...   135   1E-30 O 
contig07304 gi|158293554|ref|XP_314892.4| AGAP008768-PA [Anopheles gambiae s...   135   1E-30 O 
contig12285 gi|72062512|ref|XP_796204.1| PREDICTED: similar to ENSANGP000000...   135   1E-30 O 
contig01521 gi|193683394|ref|XP_001944981.1| PREDICTED: similar to AGAP00627...   135   1E-30 T 
contig02095 gi|156550987|ref|XP_001604363.1| PREDICTED: similar to endomembr...   135   1E-30 U 
contig06031 gi|91087767|ref|XP_975031.1| PREDICTED: similar to Vacuolar prot...    73   1E-30 U 
contig06256 gi|170032989|ref|XP_001844362.1| adiponectin receptor protein 2 ...   135   8E-31 RT 
contig05963 gi|146189553|emb|CAM91778.1| hypothetical protein [Platynereis d...   137   2E-31 Z 
contig01638 gi|126336219|ref|XP_001366393.1| PREDICTED: similar to nuclear r...    83   1E-31 T 
contig04666 gi|110756153|ref|XP_001120355.1| PREDICTED: similar to Arpc3B CG...   131   1E-31 Z 
contig06110 gi|156374137|ref|XP_001629665.1| predicted protein [Nematostella...   140   7E-32 U 
contig03367 gi|161661029|gb|ABX75381.1| cysteine and glycine-rich protein [L...   142   5E-32 TZ 
contig05354 gi|115655402|ref|XP_796587.2| PREDICTED: hypothetical protein [S...   140   4E-32 U 
contig10346 gi|91087807|ref|XP_967674.1| PREDICTED: similar to vacuolar prot...   140   4E-32 U 
contig11738 gi|189236765|ref|XP_975383.2| PREDICTED: similar to CG14407 CG14...   142   3E-32 O 
contig06424 gi|82906177|ref|XP_890535.1| PREDICTED: similar to ubiquitin-con...   140   2E-32 O 
contig00093 gi|158294130|ref|XP_315412.4| AGAP005402-PA [Anopheles gambiae s...   142   1E-32 RD 
contig00799 gi|115712025|ref|XP_787000.2| PREDICTED: similar to apoptosis-li...   142   1E-32 T 
contig01126 gi|157118476|ref|XP_001659125.1| calponin/transgelin [Aedes aegy...   144   1E-32 Z 
contig02679 gi|149409055|ref|XP_001508583.1| PREDICTED: similar to Sp6 trans...   142   8E-33 O 
contig09223 gi|91086195|ref|XP_971475.1| PREDICTED: similar to protein trans...   142   6E-33 U 
contig05265 gi|156399594|ref|XP_001638586.1| predicted protein [Nematostella...   143   5E-33 T 
contig11090 gi|118789340|ref|XP_317352.3| AGAP008105-PA [Anopheles gambiae s...   143   4E-33 D 
contig03663 gi|110751295|ref|XP_623197.2| PREDICTED: similar to GDP dissocia...   143   4E-33 O 
contig00984 gi|126330898|ref|XP_001376794.1| PREDICTED: hypothetical protein...   144   4E-33 T 
contig05075 gi|194219924|ref|XP_001917962.1| PREDICTED: similar to protein p...   143   4E-33 T 
contig05930 gi|156544986|ref|XP_001607995.1| PREDICTED: similar to clathrin ...   143   4E-33 U 
contig02834 gi|193714972|ref|XP_001951659.1| PREDICTED: similar to Ring fing...   144   3E-33 O 
contig11795 gi|91077294|ref|XP_968496.1| PREDICTED: similar to thymosin beta...   146   2E-33 N 
contig03132 gi|194766555|ref|XP_001965390.1| GF20636 [Drosophila ananassae] ...   144   2E-33 O 
contig12035 gi|91082073|ref|XP_966419.1| PREDICTED: similar to 26S proteasom...   144   2E-33 O 
contig05230 gi|195394485|ref|XP_002055873.1| GJ10528 [Drosophila virilis] >g...   144   2E-33 T 
contig11223 gi|47216032|emb|CAG11363.1| unnamed protein product [Tetraodon n...   145   2E-33 T 
contig07735 gi|161661029|gb|ABX75381.1| cysteine and glycine-rich protein [L...   145   2E-33 TZ 
contig02930 gi|66546674|ref|XP_395448.2| PREDICTED: similar to Cbl CG7037-PB...   144   2E-33 V 




Contig BLAST result e value Class 
contig10153 gi|189236779|ref|XP_967166.2| PREDICTED: similar to reticulon/no...   146   1E-33 U 
contig11103 gi|58389525|ref|XP_317088.2| thioester-containing protein (AGAP0...   147   8E-34 O 
contig07176 gi|28422163|gb|AAH46839.1| Plk-prov protein [Xenopus laevis]          147   6E-34 D 
contig00996 gi|24652326|ref|NP_724885.1| 14-3-3zeta CG17870-PA, isoform A [D...   146   6E-34 O 
contig08628 gi|193678945|ref|XP_001949533.1| PREDICTED: similar to CG10542 C...   146   6E-34 O 
contig05200 gi|189234077|ref|XP_001812066.1| PREDICTED: similar to fimbrin/p...   146   6E-34 Z 
contig03698 gi|170040959|ref|XP_001848248.1| integrin beta-PS [Culex quinque...    92   5E-34 TW 
contig08387 gi|195331895|ref|XP_002032634.1| GM20894 [Drosophila sechellia] ...   146   5E-34 U 
contig06929 gi|156548783|ref|XP_001604963.1| PREDICTED: similar to vacuolar ...   146   4E-34 U 
contig04517 gi|110759191|ref|XP_393334.3| PREDICTED: similar to Myosin heavy...   146   4E-34 Z 
contig11697 gi|157114579|ref|XP_001652323.1| calponin/transgelin [Aedes aegy...   147   4E-34 Z 
contig01474 gi|157112080|ref|XP_001651784.1| proteasome subunit alpha type [...   148   2E-34 O 
contig03196 gi|50756599|ref|XP_415234.1| PREDICTED: similar to Kelch-like 22...   147   2E-34 TR 
contig04944 gi|114153202|gb|ABI52767.1| serpin [Argas monolakensis]               148   1E-34 V 
contig03375 gi|114153122|gb|ABI52727.1| ADP ribosylation factor 79F [Argas m...   149   9E-35 U 
contig06587 gi|194388764|dbj|BAG60350.1| unnamed protein product [Homo sapiens]   149   7E-35 O 
contig03215 gi|196476637|gb|ACG76186.1| thioredoxin peroxidase [Amblyomma am...   151   4E-35 O 
contig06208 gi|189241320|ref|XP_966927.2| PREDICTED: similar to CG5871 CG587...   151   2E-35 O 
contig03260 gi|195153445|ref|XP_002017636.1| GL17205 [Drosophila persimilis]...   153   2E-35 U 
contig00571 gi|189531123|ref|XP_001920415.1| PREDICTED: similar to nuclear p...   150   2E-35 YU 
contig00106 gi|157779728|gb|ABV71392.1| actin [Haemaphysalis longicornis]         151   2E-35 Z 
contig00990 gi|24584702|ref|NP_724004.1| Myosin heavy chain CG17927-PD, isof...    89   2E-35 Z 
contig12237 gi|167683074|gb|ABZ91679.1| actin [Uloborus diversus]                 151   2E-35 Z 
contig13014 gi|126291135|ref|XP_001371416.1| PREDICTED: hypothetical protein...   154   2E-35 Z 
contig03988 gi|156390723|ref|XP_001635419.1| predicted protein [Nematostella...   152   1E-35 D 
contig01246 gi|110756772|ref|XP_001121636.1| PREDICTED: similar to peanut CG...   152   1E-35 DZU 
contig11905 gi|167387323|ref|XP_001738112.1| cysteine proteinase 3 precursor...   153   9E-36 O 
contig01431 gi|156388328|ref|XP_001634653.1| predicted protein [Nematostella...   155   6E-36 O 
contig09966 gi|66511475|ref|XP_394621.2| PREDICTED: similar to -Adaptin CG42...   152   6E-36 U 
contig01872 gi|110762076|ref|XP_625049.2| PREDICTED: similar to CG2862-PA, i...   114   4E-36 T 
contig04299 gi|157132436|ref|XP_001662562.1| cytochrome c oxidase assembly p...   154   2E-36 O 
contig06481 gi|146285369|gb|ABQ18260.1| protein serine/threonine phosphatase...   154   2E-36 TR 
contig03333 gi|156371405|ref|XP_001628754.1| predicted protein [Nematostella...   155   1E-36 O 
contig07191 gi|125807245|ref|XP_001360320.1| GA13759-PA [Drosophila pseudoob...   157   4E-37 O 
contig07219 gi|12060812|gb|AAG48248.1|AF282407_1 p70 ribosomal protein S6 ki...   144   3E-37 RT 
contig06802 gi|58332574|ref|NP_001011361.1| CDC-like kinase 2 [Xenopus tropi...   158   1E-37 T 
contig10329 gi|118781781|ref|XP_311856.3| AGAP003021-PA [Anopheles gambiae s...   158   1E-37 U 
contig12027 gi|82698821|gb|ABB89211.1| troponin I protein [Rhipicephalus hae...   160   1E-37 Z 
contig11605 gi|73975640|ref|XP_858570.1| PREDICTED: similar to calumenin iso...   162   5E-38 TU 
contig04584 gi|19112602|ref|NP_595810.1| chaperonin-containing T-complex gam...   162   1E-38 O 
contig03977 gi|194673970|ref|XP_001255255.2| PREDICTED: similar to MAP kinas...   162   1E-38 T 
contig00030 gi|161661029|gb|ABX75381.1| cysteine and glycine-rich protein [L...   166   8E-39 TZ 
contig11290 gi|62178034|gb|AAX73177.1| putative heat shock 70 kDa protein [E...   162   6E-39 O 
contig03652 gi|147907369|ref|NP_001087937.1| mec-12 protein [Xenopus laevis]...    90   5E-39 Z 
contig05077 gi|66523378|ref|XP_394044.2| PREDICTED: similar to Cullin-1 (CUL...   165   1E-39 D 
contig10928 gi|91086477|ref|XP_975920.1| PREDICTED: similar to microtubule-a...   165   1E-39 DZ 
contig11334 gi|156538136|ref|XP_001608256.1| PREDICTED: similar to proteasom...   166   1E-39 O 
contig08487 gi|71897157|ref|NP_001026081.1| ubiquitination factor E4A [Gallu...   165   9E-40 O 
contig05064 gi|66499186|ref|XP_395748.2| PREDICTED: similar to FK506-binding...   136   4E-40 O 
contig05049 gi|125842482|ref|XP_690505.2| PREDICTED: wu:fc07b10 [Danio rerio]     167   3E-40 O 




Contig BLAST result e value Class 
contig00861 gi|39725991|gb|AAR29947.1| calreticulin [Haemaphysalis leporispa...   170   1E-40 O 
contig03762 gi|161669254|gb|ABX75479.1| myosin heavy chain [Lycosa singorien...   168   1E-40 Z 
contig13074 gi|47230018|emb|CAG10432.1| unnamed protein product [Tetraodon n...   169   6E-41 O 
contig05373 gi|189236792|ref|XP_966417.2| PREDICTED: similar to protein phos...   170   3E-41 TR 
contig02093 gi|53828193|emb|CAH58743.1| putative glutahione S-transferase, d...   174   1E-41 O 
contig02957 gi|156404512|ref|XP_001640451.1| predicted protein [Nematostella...   102   1E-41 U 
contig08269 gi|91083895|ref|XP_974479.1| PREDICTED: similar to ATPase family...   172   6E-42 O 
contig00103 gi|81096421|ref|ZP_00874766.1| hypothetical protein SsuiDRAFT_16...   104   6E-42 W 
contig00913 gi|38147395|gb|AAR12010.1| cathepsin L-like proteinase [Triatoma...   117   3E-42 O 
contig06687 gi|156398911|ref|XP_001638431.1| predicted protein [Nematostella...   174   3E-42 ZT 
contig04180 gi|67083919|gb|AAY66894.1| defender against cell death 1 [Ixodes...   175   2E-42 DO 
contig01697 gi|147901313|ref|NP_001080849.1| von Hippel-Lindau binding prote...   134   2E-42 O 
contig11291 gi|147905905|ref|NP_001082504.1| similar to ribophorin I [Xenopu...   154   2E-42 O 
contig11904 gi|33667952|gb|AAQ24553.1| Blo t profilin allergen [Blomia tropi...   178   1E-42 Z 
contig02392 gi|197127389|gb|ACH43887.1| putative Proteasome subunit alpha ty...   176   5E-43 O 
contig01633 gi|91077058|ref|XP_968505.1| PREDICTED: similar to karyopherin a...   176   5E-43 U 
contig12506 gi|55168340|gb|AAV44205.1| unknow protein [Oryza sativa (japonic...   115   5E-43 W 
contig01541 gi|168002792|ref|XP_001754097.1| predicted protein [Physcomitrel...   177   4E-43 O 
contig13129 gi|118429511|gb|ABK91803.1| aspartic protease precursor [Clonorc...   177   3E-43 O 
contig03055 gi|193702351|ref|XP_001949887.1| PREDICTED: similar to integrin ...   177   3E-43 TW 
contig02580 gi|22901939|gb|AAN10129.1| alpha-2-macroglobulin precursor splic...   180   2E-43 O 
contig13020 gi|158634610|gb|ABW76151.1| myosin II regulatory light chain [Av...   181   6E-44 Z 
contig04294 gi|189241696|ref|XP_970104.2| PREDICTED: similar to LIM protein ...   136   5E-44 TZ 
contig02421 gi|189238186|ref|XP_966734.2| PREDICTED: similar to GA21791-PA [...   134   5E-44 Z 
contig05027 gi|158294889|ref|XP_315883.4| AGAP005857-PA [Anopheles gambiae s...   180   4E-44 Z 
contig02509 gi|91077396|ref|XP_975299.1| PREDICTED: similar to chaperonin [T...   148   2E-44 O 
contig02749 gi|194389846|dbj|BAG60439.1| unnamed protein product [Homo sapiens]   183   2E-44 U 
contig03517 gi|170585438|ref|XP_001897491.1| Tubulin alpha chain [Brugia mal...   181   2E-44 Z 
contig13173 gi|1389604|gb|AAC59905.1| acetylcholinesterase                        186   9E-45 T 
contig05955 gi|91081399|ref|XP_972623.1| PREDICTED: similar to cyclin a [Tri...   184   8E-45 D 
contig01281 gi|195110563|ref|XP_001999849.1| GI22847 [Drosophila mojavensis]...   186   1E-45 U 
contig00176 gi|67083759|gb|AAY66814.1| selenium dependent salivary glutathio...   188   6E-46 O 
contig13272 gi|195472863|ref|XP_002088718.1| GE11255 [Drosophila yakuba] >gn...   190   5E-46 T 
contig11526 gi|114051243|ref|NP_001040382.1| FK506-binding protein [Bombyx m...   189   2E-46 O 
contig04115 gi|194889394|ref|XP_001977075.1| GG18832 [Drosophila erecta] >gn...   191   7E-47 O 
contig02365 gi|195436762|ref|XP_002066324.1| GK18232 [Drosophila willistoni]...   189   6E-47 Z 
contig03783 gi|193617734|ref|XP_001946433.1| PREDICTED: similar to zinc fing...   189   5E-47 O 
contig12063 gi|118102310|ref|XP_419249.2| PREDICTED: hypothetical protein [G...   191   3E-47 Z 
contig04858 gi|170038216|ref|XP_001846948.1| dolichyl-diphosphooligosacchari...   192   2E-47 O 
contig11169 gi|41393177|ref|NP_958915.1| mitogen-activated protein kinase 3 ...   191   2E-47 T 
contig12263 gi|156551872|ref|XP_001603255.1| PREDICTED: similar to GA12600-P...   193   2E-47 V 
contig11552 gi|45822201|emb|CAE47497.1| cathepsin L-like proteinase [Diabrot...   151   1E-47 O 
contig11512 gi|161671310|gb|ABX75507.1| cofilin [Lycosa singoriensis]             196   1E-47 Z 
contig00949 gi|156547852|ref|XP_001605005.1| PREDICTED: similar to ENSANGP00...   195   7E-48 U 
contig03140 gi|187177323|ref|NP_001119639.1| Sec61 alpha 1 subunit [Acyrthos...   194   6E-48 UO 
contig01889 gi|114153020|gb|ABI52676.1| Ca2+ calmodulin dependent protein ki...   194   3E-48 T 
contig07057 gi|58257644|dbj|BAA07894.2| KIAA0098 protein [Homo sapiens]           194   2E-48 O 
contig00449 gi|147905680|ref|NP_001080243.1| proteasome (prosome, macropain)...   196   1E-48 O 
contig00144 gi|197246922|gb|AAI69141.1| Aurora kinase A [Xenopus tropicalis]      197   8E-49 D 
contig04218 gi|77166828|gb|ABA62390.1| phospholipid-hydroperoxide glutathion...   196   8E-49 O 
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contig11136 gi|195036412|ref|XP_001989664.1| GH18918 [Drosophila grimshawi] ...   200   3E-49 U 
contig01790 gi|195046036|ref|XP_001992076.1| GH24410 [Drosophila grimshawi] ...   197   3E-49 Z 
contig00691 gi|156537928|ref|XP_001608152.1| PREDICTED: similar to ENSANGP00...   198   2E-49 O 
contig12330 gi|94966875|ref|NP_001035631.1| ubiquitin carboxyl-terminal este...   199   2E-49 O 
contig04016 gi|110768448|ref|XP_624843.2| PREDICTED: similar to cheerio CG39...   197   2E-49 Z 
contig09395 gi|74190898|dbj|BAE28230.1| unnamed protein product [Mus musculus]    112   1E-49 U 
contig01456 gi|196011966|ref|XP_002115846.1| phosphatase 2A [Trichoplax adha...   200   7E-50 T 
contig01363 gi|18043133|gb|AAH19682.1| Ctsd protein [Mus musculus]                202   1E-50 O 
contig03692 gi|91078920|ref|XP_973689.1| PREDICTED: similar to ubiquitin-con...   202   7E-51 O 
contig11163 gi|72136076|ref|XP_781152.1| PREDICTED: similar to thioredoxin f...   203   4E-51 O 
contig02719 gi|147907369|ref|NP_001087937.1| mec-12 protein [Xenopus laevis]...   205   1E-51 Z 
contig01425 gi|66503873|ref|XP_624697.1| PREDICTED: similar to 26S proteasom...   205   8E-52 O 
contig00340 gi|3435078|gb|AAD05373.1| cholinesterase 1 [Branchiostoma floridae]   209   8E-52 T 
contig04978 gi|193676530|ref|XP_001945130.1| PREDICTED: similar to four and ...   206   5E-52 TZR 
contig01611 gi|126632812|emb|CAM56654.1| novel protein (zgc:55818) [Danio re...   208   4E-52 O 
contig12269 gi|90820032|gb|ABD98773.1| putative GABA-A receptor associated p...   211   3E-52 Z 
contig03618 gi|156547544|ref|XP_001607621.1| PREDICTED: similar to ENSANGP00...   209   6E-53 O 
contig02452 gi|73962301|ref|XP_537355.2| PREDICTED: similar to Legumain prec...   152   2E-53 O 
contig11297 gi|110759191|ref|XP_393334.3| PREDICTED: similar to Myosin heavy...   199   1E-53 Z 
contig04274 gi|66541426|ref|XP_624341.1| PREDICTED: similar to Proteasome su...   213   7E-54 O 
contig00256 gi|109255261|ref|YP_654538.1| replicase [Cytoplasmic citrus lepr...   220   1E-54 WV 
contig12280 gi|156367369|ref|XP_001627390.1| predicted protein [Nematostella...   216   6E-55 T 
contig13090 gi|167683074|gb|ABZ91679.1| actin [Uloborus diversus]                 218   1E-55 Z 
contig01313 gi|91078924|ref|XP_973781.1| PREDICTED: similar to actin [Tribol...   218   9E-56 Z 
contig12809 gi|149287016|gb|ABR23407.1| putative ubiquitin-conjugating enzym...   219   7E-56 O 
contig05900 gi|161788938|dbj|BAF95090.1| 2nd tick legumain [Haemaphysalis lo...   199   3E-56 O 
contig01948 gi|55140565|gb|AAV41826.1| myosin alkali light chain protein [Ha...   223   1E-56 Z 
contig01511 gi|114153168|gb|ABI52750.1| signal peptidase complex I [Argas mo...   224   4E-57 U 
contig06281 gi|91078858|ref|XP_972061.1| PREDICTED: similar to thymus-specif...   224   2E-57 OR 
contig07074 gi|193643451|ref|XP_001946772.1| PREDICTED: similar to uridine c...   225   2E-57 TZ 
contig04812 gi|110757619|ref|XP_001120141.1| PREDICTED: similar to Arflike a...   225   1E-57 U 
contig00721 gi|136050|sp|P15159|TNNC_TACTR Troponin C >gnl|BL_ORD_ID|766147 ...   228   7E-58 T 
contig04645 gi|198145382|gb|EAL32343.2| GA13115 [Drosophila pseudoobscura ps...   162   7E-58 Z 
contig02656 gi|2443346|dbj|BAA22382.1| beta-tubulin [Halocynthia roretzi]         226   6E-58 Z 
contig03733 gi|148695032|gb|EDL26979.1| proteasome (prosome, macropain) 26S ...   227   3E-58 O 
contig09816 gi|110760400|ref|XP_396948.3| PREDICTED: similar to misshapen CG...   228   2E-58 T 
contig12602 gi|47213256|emb|CAF92917.1| unnamed protein product [Tetraodon n...   232   7E-59 D 
contig04217 gi|18031682|gb|AAK31583.1| heat shock protein 70 [Ambystoma mexi...   145   7E-59 O 
contig03835 gi|148717303|dbj|BAF63637.1| glucose-regulated protein 94 [Crass...   229   6E-59 O 
contig02455 gi|15428288|gb|AAK97814.1|AF209911_1 glutathione peroxidase [Ixo...   229   5E-59 O 
contig04556 gi|194385190|dbj|BAG61001.1| unnamed protein product [Homo sapiens]   230   3E-59 Z 
contig00410 gi|170574536|ref|XP_001892857.1| Oligosaccharyl transferase STT3...   231   1E-59 O 
contig00825 gi|156394193|ref|XP_001636711.1| predicted protein [Nematostella...   231   1E-59 TR 
contig01548 gi|156373877|ref|XP_001629536.1| predicted protein [Nematostella...   232   8E-60 O 
contig03011 gi|91087761|ref|XP_974991.1| PREDICTED: similar to predicted pro...   236   2E-60 O 
contig05653 gi|158299538|ref|XP_319643.4| AGAP008896-PA [Anopheles gambiae s...   236   6E-61 UR 
contig03208 gi|148717317|dbj|BAF63672.1| protein disulfide isomerase-1 [Haem...   241   5E-62 O 
contig07241 gi|68161644|emb|CAG44455.1| cAMP-dependent protein kinase cataly...   241   1E-62 T 
contig00347 gi|18542438|gb|AAL75583.1|AF467697_1 clathrin-adaptor protein [D...   242   1E-62 U 
contig04870 gi|183979376|dbj|BAG30740.1| muscle myosin heavy chain [Papilio ...   244   7E-63 Z 




Contig BLAST result e value Class 
contig00873 gi|2665388|dbj|BAA23764.1| cyclophilin G [Tachypleus tridentatus]     251   5E-65 O 
contig00611 gi|195059281|ref|XP_001995602.1| GH17842 [Drosophila grimshawi] ...   251   4E-65 O 
contig03366 gi|156545571|ref|XP_001607375.1| PREDICTED: similar to proteasom...   252   7E-66 O 
contig03909 gi|46370306|gb|AAS89952.1| GroEL [Bartonella phoceensis]              185   2E-66 O 
contig12625 gi|17647231|ref|NP_523710.1| Calmodulin CG8472-PA, isoform A [Dr...   234   1E-66 T 
contig12116 gi|182701796|ref|ZP_02955128.1| conserved hypothetical protein [...   182   8E-67 O 
contig01081 gi|91089049|ref|XP_969998.1| PREDICTED: similar to AGAP011768-PA...   256   5E-67 T 
contig03864 gi|193657249|ref|XP_001950152.1| PREDICTED: similar to rab32 [Ac...   259   3E-67 T 
contig02379 gi|66513481|ref|XP_394434.2| PREDICTED: similar to Ubiquitin act...   259   1E-67 O 
contig00773 gi|189241320|ref|XP_966927.2| PREDICTED: similar to CG5871 CG587...   224   5E-69 O 
contig13125 gi|115715524|ref|XP_780580.2| PREDICTED: similar to cathepsin l ...   231   5E-71 O 
contig12685 gi|193643435|ref|XP_001945057.1| PREDICTED: similar to transport...   271   3E-71 U 
contig01569 gi|91085931|ref|XP_970194.1| PREDICTED: similar to proteasome su...   272   2E-71 O 
contig03808 gi|156549531|ref|XP_001602213.1| PREDICTED: similar to ubiquitin...   272   2E-71 O 
contig05159 gi|17391080|gb|AAH18459.1| Cct6a protein [Mus musculus]               271   1E-71 O 
contig03303 gi|112983370|ref|NP_001037628.1| transport protein Sec61 alpha s...   272   5E-72 UO 
contig04106 gi|148717305|dbj|BAF63638.1| calnexin [Crassostrea gigas]             234   7E-73 O 
contig00331 gi|195113909|ref|XP_002001510.1| GI10836 [Drosophila mojavensis]...   276   4E-73 U 
contig11484 gi|156544337|ref|XP_001607303.1| PREDICTED: similar to CG17927-P...   192   4E-73 Z 
contig12438 gi|194757347|ref|XP_001960926.1| GF13608 [Drosophila ananassae] ...   244   7E-74 O 
contig01172 gi|65332126|gb|AAY42205.1| troponin T [Haemaphysalis qinghaiensis]    285   5E-75 Z 
contig04987 gi|91090858|ref|XP_967143.1| PREDICTED: similar to annexin B13a ...   286   2E-75 U 
contig13301 gi|194354483|gb|ACF54724.1| beta-actin [Mantichorula semenowi]        284   1E-75 Z 
contig02485 gi|66524917|ref|XP_393112.2| PREDICTED: similar to 26S proteasom...   219   7E-76 O 
contig00438 gi|51011504|gb|AAT92161.1| myosin regulatory light chain [Ixodes...   219   1E-76 Z 
contig03511 gi|157121273|ref|XP_001659895.1| ran [Aedes aegypti] >gnl|BL_ORD...   291   2E-77 U 
contig11475 gi|55925548|ref|NP_001007314.1| protein phosphatase 1A, magnesiu...   167   1E-77 T 
contig13176 gi|24646906|ref|NP_731941.1| effete CG7425-PA [Drosophila melano...   302   2E-80 O 
contig13051 gi|57163957|ref|NP_001009202.1| polyubiquitin [Ovis aries] >gnl|...   301   2E-80 OR 
contig12133 gi|154183745|gb|ABS70713.1| cathepsin L-like cysteine proteinase...   176   1E-80 O 
contig02861 gi|66513649|ref|XP_623691.1| PREDICTED: similar to Spectrin alph...   302   7E-81 Z 
contig01798 gi|156361252|ref|XP_001625432.1| predicted protein [Nematostella...   308   2E-82 O 
contig00453 gi|156381354|ref|XP_001632230.1| predicted protein [Nematostella...   309   2E-82 TU 
contig01747 gi|91085175|ref|XP_971032.1| PREDICTED: similar to ubiquitin con...   313   4E-83 O 
contig11327 gi|152205934|dbj|BAF73714.1| valosin containing protein [Haemaph...   313   1E-83 O 
contig11660 gi|22901939|gb|AAN10129.1| alpha-2-macroglobulin precursor splic...   319   3E-85 O 
contig12493 gi|73958240|ref|XP_537920.2| PREDICTED: similar to protein kinas...   323   1E-86 T 
contig12243 gi|39725977|gb|AAR29940.1| calreticulin [Boophilus microplus]         323   7E-87 O 
contig00197 gi|149287010|gb|ABR23404.1| thioredoxin peroxidase [Ornithodoros...   326   2E-87 O 
contig02000 gi|91087475|ref|XP_967673.1| PREDICTED: similar to 26S protease ...   324   2E-87 O 
contig11566 gi|156407426|ref|XP_001641545.1| predicted protein [Nematostella...   332   6E-89 U 
contig06778 gi|197322816|gb|ACH69159.1| myosin heavy chain [Bombyx mori]          339   9E-92 Z 
contig00679 gi|189234306|ref|XP_971669.2| PREDICTED: similar to protein disu...   347   1E-93 O 
contig11995 gi|13562118|ref|NP_110454.1| low density lipoprotein receptor-re...   188   2E-94 T 
contig00399 gi|195972560|emb|CAQ77161.1| histamine release factor [Dermanyss...   350   1E-94 DZ 
contig02474 gi|67083703|gb|AAY66786.1| mitochondrial truncated thioredoxin-d...   350   9E-95 O 
contig00786 gi|109114958|ref|XP_001094505.1| PREDICTED: proteasome 26S non-A...   257   4E-99 O 
contig03320 gi|94448674|emb|CAI91575.1| cathepsin L2 [Lubomirskia baicalensis]    369   1E-100 O 
contig00670 gi|72008176|ref|XP_780713.1| PREDICTED: similar to cathepsin L [...   377   1E-102 O 
contig04310 gi|158287073|ref|XP_309120.3| AGAP000935-PA [Anopheles gambiae s...   305   1E-104 O 




Contig BLAST result e value Class 
contig13343 gi|156553657|ref|XP_001600604.1| PREDICTED: similar to ENSANGP00...   386   1E-105 O 
contig02395 gi|195390229|ref|XP_002053771.1| GJ24070 [Drosophila virilis] >g...   387   1E-106 O 
contig00995 gi|48097086|ref|XP_391841.1| PREDICTED: similar to 14-3-3-like p...   254   1E-108 O 
contig00320 gi|83308265|emb|CAJ44440.1| tropomyosin [Dermanyssus gallinae]        410   1E-112 Z 
contig11792 gi|146217394|gb|ABQ10739.1| cathepsin L [Penaeus monodon]             413   1E-113 O 
contig12527 gi|157131971|ref|XP_001662386.1| prohibitin [Aedes aegypti] >gnl...   411   1E-113 O 
contig13094 gi|28932702|gb|AAO60045.1| midgut cysteine proteinase 2 [Rhipice...   416   1E-118 O 
contig01604 gi|110734697|gb|ABG88953.1| elongation factor-1 gamma [Diguetia ...   434   1E-119 O 
contig12925 gi|50539738|ref|NP_001002335.1| karyopherin alpha 2 (RAG cohort ...   439   1E-121 U 
contig00293 gi|83319201|dbj|BAE53722.1| aspartic protease [Haemaphysalis lon...   451   1E-125 O 
contig03441 gi|18542438|gb|AAL75583.1|AF467697_1 clathrin-adaptor protein [D...   450   1E-125 U 
contig02172 gi|170015974|ref|NP_001116163.1| thioredoxin reductase 2 [Gallus...   330   1E-129 O 
contig11932 gi|118102310|ref|XP_419249.2| PREDICTED: hypothetical protein [G...   286   1E-130 Z 
contig03245 gi|74211237|dbj|BAE37687.1| unnamed protein product [Mus musculus]    431   1E-132 T 
contig02198 gi|195128571|ref|XP_002008736.1| GI11652 [Drosophila mojavensis]...   353   1E-147 O 
contig00018 gi|149287130|gb|ABR23464.1| G protein beta subunit-like protein ...   525   1E-147 T 
contig11091 gi|111380719|gb|ABH09735.1| heat shock cognate 70 protein [Trich...   358   1E-149 O 
contig12961 gi|60302774|ref|NP_001012581.1| chaperonin containing TCP1, subu...   308   1E-152 O 
contig00224 gi|39725965|gb|AAR29934.1| calreticulin [Amblyomma cooperi]           546   1E-153 O 
contig11293 gi|148717315|dbj|BAF63671.1| protein disulfide isomerase-2 [Haem...   385   1E-160 O 
contig01323 gi|87042250|gb|ABD16189.1| protein disulfide isomerase [Amblyomm...   333   1E-173 O 
contig01178 gi|115748959|ref|XP_784913.2| PREDICTED: similar to Chaperonin c...   617   1E-175 O 
contig00147 gi|150034859|gb|ABR66910.1| heat shock protein 90 [Metapenaeus e...  1038   0E+00 O 
contig00200 gi|112982828|ref|NP_001036892.1| heat shock cognate protein [Bom...   969   0 O 
contig00472 gi|66547450|ref|XP_392899.2| PREDICTED: similar to 60 kDa heat s...   819   0 O 
contig00639 gi|156540734|ref|XP_001599525.1| PREDICTED: similar to CG8542-PA...   883   0 O 
contig02359 gi|91086235|ref|XP_966692.1| PREDICTED: similar to transitional ...   818   0 O 
contig02363 gi|29825445|gb|AAO92283.1| 26S proteasome regulatory subunit [De...   484   0 O 
contig12143 gi|158147455|emb|CAL68992.1| heat shock protein 70 kDa [Xantho i...   664   0 O 
contig00452 gi|170034793|ref|XP_001845257.1| conserved hypothetical protein ...  1177   0 OR 
contig12705 gi|189208430|ref|XP_001940548.1| laccase-1 precursor [Pyrenophor...    26   0 T 
contig11712 gi|183987114|gb|ACC65584.1| paramyosin [Sarcoptes scabiei]            634   0 Z 
contig13015 gi|10242160|gb|AAG15315.1|AF255553_1 beta tubulin [Notothenia co...   680   0 Z 
contig13080 gi|45269081|gb|AAS55945.1| actin [Ornithodoros moubata]               742   0 Z 
contig13115 gi|83318905|emb|CAJ38791.1| alpha tubulin protein [Platynereis d...   848   0 Z 
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Cellular processes and signaling and Metabolism 
Contig BLAST result e value Class 
contig01361 gi|19172975|ref|NP_597526.1| GOLGI MEMBRANE PROTEIN [Encephalito...    34   8.10 GOU 
contig04295 gi|183985269|ref|YP_001853560.1| osmoprotectant transport ATP-bi...    33   7.40 TG 
contig12716 gi|167526593|ref|XP_001747630.1| predicted protein [Monosiga bre...    33   7.10 PT 
contig09594 gi|170065803|ref|XP_001868034.1| activin receptor type II [Culex...    34   4.30 PT 
contig00895 gi|195341800|ref|XP_002037493.1| GM18293 [Drosophila sechellia] ...    34   4.20 OC 
contig00657 gi|94264824|ref|ZP_01288600.1| Oxidoreductase FAD/NAD(P)-binding...    34   3.20 PT 
contig03144 gi|148557003|ref|YP_001264585.1| hypothetical protein Swit_4104 ...    34   3.20 IT 
contig06119 gi|116056702|emb|CAL52991.1| Zn-binding protein Push (ISS) [Ostr...    34   3.20 GOU 
contig01658 gi|55962840|emb|CAI17143.1| calcium channel, voltage-dependent, ...    35   2.50 PT 
contig01334 gi|168044085|ref|XP_001774513.1| predicted protein [Physcomitrel...    35   1.50 GOT 
contig00243 gi|187478146|ref|YP_786170.1| LysR-family transcriptional regula...    36   1.10 PT 
contig05456 gi|15341234|dbj|BAB63947.1| Ser/Thr protein phosphatase [Caenorh...    37   0.80 GT 
contig02753 gi|196014576|ref|XP_002117147.1| hypothetical protein TRIADDRAFT...    37   0.66 NI 
contig13213 gi|195112951|ref|XP_002001035.1| GI22201 [Drosophila mojavensis]...    37   0.65 GO 
contig06251 gi|195171619|ref|XP_002026601.1| GL11802 [Drosophila persimilis]...    38   0.63 PT 
contig07412 gi|170061586|ref|XP_001866297.1| endophilin a [Culex quinquefasc...    38   0.29 IT 
contig12340 gi|171685035|ref|XP_001907459.1| unnamed protein product [Podosp...    38   0.29 OE 
contig05729 gi|66826615|ref|XP_646662.1| hypothetical protein DDBDRAFT_01909...    38   0.23 PT 
contig10284 gi|157106778|ref|XP_001649477.1| o-linked n-acetylglucosamine tr...    38   0.22 GOT 
contig13200 gi|111220888|ref|YP_711682.1| 1-hydroxy-2-methyl-2-(E)-butenyl 4...    43   0.05 EO 
contig13357 gi|162149485|ref|YP_001603946.1| HlyD family secretion protein [...    43   0.04 PT 
contig01068 gi|156545822|ref|XP_001606135.1| PREDICTED: similar to LD41494p ...    50   4E-05 OC 
contig05888 gi|160333701|ref|NP_001103872.1| UDP-glucose dehydrogenase [Dani...    54   4E-06 GT 
contig00433 gi|91090053|ref|XP_968775.1| PREDICTED: similar to neural stem c...    54   3E-06 IOT 
contig05365 gi|73951761|ref|XP_536218.2| PREDICTED: similar to Alpha-2-macro...    57   9E-07 OUTIV 
contig10993 gi|118792081|ref|XP_001238258.1| AGAP012412-PA [Anopheles gambia...    57   6E-07 IM 
contig11601 gi|193596507|ref|XP_001944612.1| PREDICTED: similar to AGAP00572...    59   2E-07 EO 
contig06102 gi|147906564|ref|NP_001086043.1| MGC81801 protein [Xenopus laevi...    60   7E-08 GMO 
contig01197 gi|158294663|ref|XP_556379.3| AGAP005728-PA [Anopheles gambiae s...    63   7E-09 EO 
contig10084 gi|156552278|ref|XP_001600652.1| PREDICTED: similar to Na/Ca exc...    64   4E-09 PT 
contig08219 gi|195120496|ref|XP_002004760.1| GI20092 [Drosophila mojavensis]...    64   3E-09 OE 
contig03559 gi|156404336|ref|XP_001640363.1| predicted protein [Nematostella...    53   2E-10 PT 
contig08759 gi|126352610|ref|NP_001075382.1| transferrin receptor [Equus cab...    72   1E-11 OPR 
contig04697 gi|190339135|gb|AAI63301.1| Unknown (protein for MGC:194608) [Da...    74   5E-12 GMO 
contig05197 gi|47215938|emb|CAF96340.1| unnamed protein product [Tetraodon n...    71   5E-14 GOU 
contig05762 gi|193674143|ref|XP_001949237.1| PREDICTED: similar to CG9342 CG...    81   3E-14 IU 
contig03934 gi|170573720|ref|XP_001892576.1| Voltage-gated calcium channel, ...    88   2E-16 PT 
contig10389 gi|156546630|ref|XP_001602950.1| PREDICTED: similar to retinoid-...    89   9E-17 OE 
contig04969 gi|156544540|ref|XP_001607806.1| PREDICTED: similar to CG5269-PA...    90   5E-17 IT 
contig11936 gi|158294663|ref|XP_556379.3| AGAP005728-PA [Anopheles gambiae s...    80   6E-20 EO 
contig10249 gi|167525465|ref|XP_001747067.1| predicted protein [Monosiga bre...   101   2E-20 IOVE 
contig05012 gi|118092771|ref|XP_426509.2| PREDICTED: similar to polycystin-L...   102   1E-20 PT 
contig01270 gi|189240987|ref|XP_001809298.1| PREDICTED: similar to potassium...   104   3E-21 PT 
contig01418 gi|156550327|ref|XP_001600741.1| PREDICTED: similar to pra1 prot...   105   1E-21 ET 
contig05889 gi|193627424|ref|XP_001947931.1| PREDICTED: similar to endophili...   109   6E-23 IT 
contig12172 gi|154500170|ref|ZP_02038208.1| hypothetical protein BACCAP_0383...   116   5E-25 PT 
contig00919 gi|114051728|ref|NP_001040176.1| NADH dehydrogenase (ubiquinone)...   120   2E-25 CD 
contig03190 gi|67083971|gb|AAY66920.1| possible succinate-ubiquinone reducta...   128   4E-28 CU 
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contig03031 gi|149634049|ref|XP_001511641.1| PREDICTED: similar to putative ...   133   4E-30 OE 
contig04546 gi|110765015|ref|XP_624669.2| PREDICTED: similar to Serine/threo...   140   3E-32 GT 
contig02211 gi|158290203|ref|XP_311781.3| AGAP001058-PA [Anopheles gambiae s...   147   3E-34 IO 
contig04478 gi|17559180|ref|NP_504655.1| F46E10.9 [Caenorhabditis elegans] >...   204   1E-50 OC 
contig01195 gi|198149515|gb|EAL31307.2| GA10064 [Drosophila pseudoobscura ps...   262   2E-68 EO 
contig11372 gi|193631919|ref|XP_001951188.1| PREDICTED: similar to Myotubula...   286   8E-76 IU 
contig12048 gi|195490422|ref|XP_002093133.1| GE21157 [Drosophila yakuba] >gn...   106   4E-96 EO 
contig11836 gi|40548304|ref|NP_954972.1| carboxypeptidase, vitellogenic-like...   303   1E-122 OE 
contig00933 No hits found 
 
GM 
contig04448 No hits found 
 
PT 
contig07497 No hits found 
 
GM 
contig09113 No hits found 
 
PET 








Information storage and processing 
Contig BLAST result e value Class 
contig05124 gi|194374455|dbj|BAG57123.1| unnamed protein product [Homo sapiens]    33   9.600 B 
contig02671 gi|121603509|ref|YP_980838.1| FAD linked oxidase domain-containi...    33   9.500 L 
contig05610 gi|91777106|ref|YP_546862.1| protein translocase subunit yidC [M...    33   9.500 K 
contig08230 gi|189518188|ref|XP_683042.3| PREDICTED: Scm-like with four mbt ...    33   9.500 K 
contig09627 gi|89071147|ref|ZP_01158342.1| Siderophore-interacting protein [...    33   9.500 J 
contig10633 gi|149923996|ref|ZP_01912380.1| hypothetical protein PPSIR1_0653...    33   9.500 J 
contig01810 gi|152978930|ref|YP_001344559.1| formate dehydrogenase, alpha su...    33   9.400 J 
contig04050 gi|160013866|sp|Q5AB15.2|IPI3_CANAL Pre-rRNA-processing protein ...    33   9.400 K 
contig04103 gi|157104671|ref|XP_001648516.1| mediator complex, subunit, puta...    33   9.400 KL 
contig04545 gi|195478403|ref|XP_002100505.1| GE17103 [Drosophila yakuba] >gn...    33   9.400 L 
contig13113 gi|47458915|ref|YP_015777.1| putative rRNA methylase [Mycoplasma...    33   9.400 K 
contig01011 gi|20072170|gb|AAH26177.1| MGC27348 protein [Homo sapiens]             33   9.300 J 
contig13154 gi|42559896|sp|Q9U5M4|TPM2_PODCA Tropomyosin-2 >gnl|BL_ORD_ID|85...    33   8.200 K 
contig05004 gi|195035285|ref|XP_001989108.1| GH10228 [Drosophila grimshawi] ...    33   7.300 K 
contig06330 gi|84500302|ref|ZP_00998568.1| hypothetical protein OB2597_10179...    33   7.300 K 
contig06343 gi|67521968|ref|XP_659045.1| hypothetical protein AN1441.2 [Aspe...    33   7.300 A 
contig09697 gi|192759134|gb|EDV73629.1| lava lamp protein [Culex quinquefasc...    33   7.300 A 
contig00038 gi|194225212|ref|XP_001490986.2| PREDICTED: similar to Jun dimer...    33   7.200 K 
contig02382 gi|119899016|ref|YP_934229.1| flagellar biosynthesis protein Fli...    33   7.200 K 
contig03226 gi|32398950|emb|CAD98415.1| PAN domain protein [Cryptosporidium ...    33   7.200 A 
contig03976 gi|123478136|ref|XP_001322232.1| hypothetical protein TVAG_12818...    33   7.200 J 
contig05651 gi|17536939|ref|NP_496560.1| Y17G7B.12 [Caenorhabditis elegans] ...    33   7.200 L 
contig06092 gi|126342708|ref|XP_001365584.1| PREDICTED: similar to histidine...    33   7.200 K 
contig06727 gi|125538332|gb|EAY84727.1| hypothetical protein OsI_005960 [Ory...    33   7.200 K 
contig07061 gi|19547871|gb|AAL87457.1| serine/threonine protein kinase pk23 ...    33   7.200 J 
contig10055 gi|120602907|ref|YP_967307.1| DNA polymerase III, delta [Desulfo...    33   7.200 A 
contig03002 gi|62859687|ref|NP_001016716.1| hypothetical protein LOC549470 [...    33   7.100 B 
contig12996 gi|195436782|ref|XP_002066334.1| GK18240 [Drosophila willistoni]...    33   7.100 J 
contig00056 gi|194748797|ref|XP_001956829.1| GF10124 [Drosophila ananassae] ...    33   5.600 L 
contig02842 gi|170043937|ref|XP_001849622.1| conserved hypothetical protein ...    33   5.600 B 
contig09941 gi|164660100|ref|XP_001731173.1| hypothetical protein MGL_1356 [...    33   5.600 L 
contig10035 gi|74003268|ref|XP_857479.1| PREDICTED: similar to Translation i...    33   5.600 J 
contig11353 gi|149190975|ref|ZP_01869237.1| hypothetical protein VSAK1_26575...    33   5.600 K 
contig12382 gi|195043683|ref|XP_001991668.1| GH11938 [Drosophila grimshawi] ...    33   5.600 K 
contig02300 gi|121710258|ref|XP_001272745.1| HECT domain protein [Aspergillu...    33   5.500 J 
contig05646 gi|194227065|ref|XP_001915913.1| PREDICTED: similar to Zinc fing...    33   5.500 K 
contig07387 gi|161761242|pdb|3BGV|A Chain A, The Crystals Structure Of Mrna ...    33   5.500 A 
contig08134 gi|45359004|ref|NP_988561.1| molybdopterin-guanine dinucleotide ...    33   5.500 J 
contig08734 gi|147835330|emb|CAN67672.1| hypothetical protein [Vitis vinifera]     33   5.500 J 
contig12081 gi|163700748|ref|ZP_02119601.1| glycosyl transferase, group 1 [M...    33   5.500 K 
contig12141 gi|167034074|ref|YP_001669305.1| ArsR family transcriptional reg...    33   5.500 K 
contig10948 gi|149632421|ref|XP_001510539.1| PREDICTED: hypothetical protein...    33   5.400 L 
contig12181 gi|195567395|ref|XP_002107246.1| GD17354 [Drosophila simulans] >...    32   5.400 K 
contig12690 gi|67772310|gb|AAY79377.1| hch [Fusarium proliferatum]                 34   4.800 B 
contig00196 gi|66816547|ref|XP_642283.1| putative extracellular matrix prote...    34   4.300 K 
contig00987 gi|161870105|ref|YP_001599275.1| hypothetical protein NMCC_1144 ...    34   4.300 K 
contig01117 gi|149586739|ref|XP_001516059.1| PREDICTED: similar to p28 ING5 ...    34   4.300 B 
contig01339 gi|198151499|gb|EAL30533.2| GA16795 [Drosophila pseudoobscura ps...    34   4.300 J 




Contig BLAST result e value Class 
contig05350 gi|126541150|emb|CAM45911.1| novel protein [Mus musculus]              34   4.300 B 
contig08499 gi|170096352|ref|XP_001879396.1| predicted protein [Laccaria bic...    34   4.300 L 
contig09937 gi|19112932|ref|NP_596140.1| 40S ribosomal protein S0A (p40) [Sc...    34   4.300 J 
contig12545 gi|116003975|ref|NP_001070347.1| smoothelin [Bos taurus] >gnl|BL...    34   4.300 K 
contig00511 gi|170114445|ref|XP_001888419.1| predicted protein [Laccaria bic...    34   4.200 AR 
contig00829 gi|148234927|ref|NP_001083333.1| hypothetical protein LOC398871 ...    34   4.200 A 
contig01345 gi|188590827|ref|YP_001795427.1| putative HIPPURATE HYDROLASE [C...    34   4.200 J 
contig01408 gi|126731378|ref|ZP_01747185.1| glucose-6-phosphate isomerase [S...    34   4.200 B 
contig01691 gi|45387885|ref|NP_991303.1| BarH-like 2 [Danio rerio] >gnl|BL_O...    34   4.200 K 
contig02783 gi|195487951|ref|XP_002092108.1| GE11845 [Drosophila yakuba] >gn...    34   4.200 K 
contig02868 gi|194665922|ref|XP_875648.3| PREDICTED: similar to Splicing fac...    34   4.200 A 
contig11473 gi|167524793|ref|XP_001746732.1| predicted protein [Monosiga bre...    34   4.200 K 
contig12764 gi|118088246|ref|XP_419583.2| PREDICTED: similar to Cog2 protein...    34   4.200 K 
contig05851 gi|115379616|ref|ZP_01466701.1| hypothetical protein STIAU_8201 ...    34   4.100 K 
contig02542 gi|58583085|ref|YP_202101.1| abortive infection bacteriophage re...    35   3.500 K 
contig02555 gi|149634900|ref|XP_001509468.1| PREDICTED: similar to serine/ar...    34   3.300 AR 
contig04247 gi|195391078|ref|XP_002054190.1| GJ24302 [Drosophila virilis] >g...    34   3.300 BK 
contig11452 gi|73959522|ref|XP_853674.1| PREDICTED: similar to Endonuclease ...    34   3.300 L 
contig12355 gi|68086434|gb|AAH93108.2| Programmed cell death 7 [Danio rerio]       34   3.300 BK 
contig02516 gi|190894294|ref|YP_001984588.1| oxygen-independent coprophorphy...    34   3.200 A 
contig03691 gi|157767564|ref|XP_001667262.1| Hypothetical protein CBG16055 [...    34   3.200 A 
contig04508 gi|85076351|ref|XP_955914.1| hypothetical protein NCU04456 [Neur...    34   3.200 A 
contig05279 gi|104782107|ref|YP_608605.1| non-ribosomal peptide synthetase, ...    34   3.200 K 
contig05747 gi|60117201|ref|YP_209535.1| hypothetical chloroplast RF2 [Huper...    34   3.200 K 
contig06762 gi|18411789|ref|NP_567106.1| C2 domain-containing protein [Arabi...    34   3.200 L 
contig08846 gi|17557646|ref|NP_504838.1| C05C8.5 [Caenorhabditis elegans] >g...    34   3.200 L 
contig00265 gi|195151592|ref|XP_002016723.1| GL10349 [Drosophila persimilis]...    35   2.500 AR 
contig01677 gi|195996431|ref|XP_002108084.1| hypothetical protein TRIADDRAFT...    35   2.500 L 
contig01824 gi|110777050|ref|XP_001123116.1| PREDICTED: similar to Tetratric...    35   2.500 K 
contig03898 gi|195116507|ref|XP_002002796.1| GI11029 [Drosophila mojavensis]...    35   2.500 A 
contig05998 gi|198251761|gb|EDY76076.1| hypothetical protein OA307_1098 [Oct...    35   2.500 L 
contig06606 gi|159486775|ref|XP_001701413.1| phosphofructokinase [Chlamydomo...    35   2.500 B 
contig07381 gi|114550513|ref|XP_001143253.1| PREDICTED: similar to bHLH fact...    35   2.500 K 
contig07473 gi|195059412|ref|XP_001995632.1| GH17861 [Drosophila grimshawi] ...    35   2.500 B 
contig08434 gi|63054602|ref|NP_594222.2| mitochondrial ribosomal protein sub...    35   2.500 J 
contig08454 gi|66805733|ref|XP_636588.1| hypothetical protein DDBDRAFT_01880...    35   2.500 K 
contig09018 gi|148239740|ref|YP_001225127.1| hypothetical protein SynWH7803_...    35   2.500 A 
contig09254 gi|170036541|ref|XP_001846122.1| conserved hypothetical protein ...    35   2.500 BK 
contig12748 gi|114675075|ref|XP_001146978.1| PREDICTED: similar to transform...    35   2.500 K 
contig07765 gi|115631503|ref|XP_793321.2| PREDICTED: similar to Nuclear rece...    35   2.400 K 
contig10530 gi|146310031|ref|YP_001175105.1| methyl-accepting chemotaxis sen...    35   2.400 K 
contig03207 gi|118360979|ref|XP_001013720.1| hypothetical protein TTHERM_004...    35   2.300 A 
contig13260 gi|6012073|gb|AAB82017.2| microfilarial sheath protein SHP3 [Lit...    38   2.100 L 
contig02454 gi|86156144|gb|ABC86790.1| ribonucleotide reductase alpha subuni...    35   1.900 K 
contig06574 gi|157770618|ref|XP_001677129.1| Hypothetical protein CBG16774 [...    35   1.900 K 
contig08409 gi|76154922|gb|AAX26319.2| SJCHGC08564 protein [Schistosoma japo...    35   1.900 B 
contig08652 gi|37525042|ref|NP_928386.1| hypothetical protein plu1057 [Photo...    35   1.900 A 
contig09477 gi|34597230|gb|AAQ77190.1| elongation factor 2 [Sphaerotherium p...    35   1.900 J 
contig10602 gi|6015452|dbj|BAA85169.1| dopamine receptor D4 [Hylobates agilis]     35   1.900 BK 
contig12695 gi|149409316|ref|XP_001509568.1| PREDICTED: similar to hCG199415...    35   1.900 L 




Contig BLAST result e value Class 
contig10854 gi|66519677|ref|XP_393827.2| PREDICTED: similar to Big brother C...    29   1.700 K 
contig03917 gi|47204164|emb|CAG13473.1| unnamed protein product [Tetraodon n...    35   1.500 K 
contig05206 gi|72162076|ref|YP_289733.1| hypothetical protein Tfu_1675 [Ther...    35   1.500 K 
contig11921 gi|153816219|ref|ZP_01968887.1| hypothetical protein RUMTOR_0246...    35   1.500 K 
contig12274 gi|21357063|ref|NP_649548.1| Snm1 CG10018-PA [Drosophila melanog...    35   1.500 L 
contig12946 gi|42628974|ref|ZP_00154525.1| COG1629: Outer membrane receptor ...    37   1.500 L 
contig13064 gi|94496764|ref|ZP_01303339.1| type III secretion system ATPase ...    35   1.500 K 
contig13119 gi|116059360|emb|CAL55067.1| unnamed protein product [Ostreococc...    35   1.500 A 
contig02185 gi|156397119|ref|XP_001637739.1| predicted protein [Nematostella...    35   1.400 K 
contig04417 gi|169211998|ref|XP_001719409.1| PREDICTED: hypothetical protein...    35   1.400 L 
contig05176 gi|49475135|ref|YP_033176.1| Phage protein gp17 [Bartonella hens...    35   1.400 BK 
contig02250 gi|72388412|ref|XP_844630.1| hypothetical protein, conserved [Tr...    38   1.300 J 
contig13234 gi|159038238|ref|YP_001537491.1| cytochrome P450 [Salinispora ar...    37   1.300 J 
contig01829 gi|115487600|ref|NP_001066287.1| Os12g0174300 [Oryza sativa (jap...    34   1.200 K 
contig00372 gi|148677083|gb|EDL09030.1| microtubule-associated protein 4, is...    39   1.100 BK 
contig05128 gi|149737471|ref|XP_001498017.1| PREDICTED: similar to ATP-depen...    36   1.100 A 
contig06548 gi|116630025|ref|YP_815197.1| Signal transduction histidine kina...    36   1.100 K 
contig06783 gi|154275406|ref|XP_001538554.1| E3 ubiquitin--protein ligase pu...    36   1.100 K 
contig08272 gi|194903420|ref|XP_001980865.1| GG17394 [Drosophila erecta] >gn...    36   1.100 J 
contig09546 gi|194374955|dbj|BAG62592.1| unnamed protein product [Homo sapiens]    36   1.100 A 
contig11026 gi|149052886|gb|EDM04703.1| nuclear receptor co-repressor 1, iso...    36   1.100 K 
contig12267 gi|194223682|ref|XP_001914731.1| PREDICTED: bromodomain containi...    36   1.100 K 
contig12437 gi|47213666|emb|CAF95619.1| unnamed protein product [Tetraodon n...    36   1.100 K 
contig03754 gi|125600956|gb|EAZ40532.1| hypothetical protein OsJ_024015 [Ory...    36   0.860 A 
contig06389 gi|116668953|ref|YP_829886.1| hypothetical protein Arth_0385 [Ar...    36   0.860 J 
contig06715 gi|120603669|ref|YP_968069.1| hypothetical protein Dvul_2630 [De...    36   0.860 K 
contig04224 gi|71004404|ref|XP_756868.1| hypothetical protein UM00721.1 [Ust...    36   0.850 L 
contig11331 gi|110289435|gb|AAP54676.2| methyltransferase family protein, ex...    36   0.850 A 
contig12149 gi|168227042|ref|ZP_02652273.1| hypothetical protein Sententeric...    36   0.850 J 
contig12247 gi|154332073|ref|XP_001561853.1| microtubule-associated protein,...    36   0.850 A 
contig12401 gi|66824905|ref|XP_645807.1| hypothetical protein DDBDRAFT_02029...    36   0.850 L 
contig05798 gi|197246418|gb|AAI68833.1| Unknown (protein for IMAGE:8859384) ...    36   0.840 J 
contig11944 gi|91084937|ref|XP_971098.1| PREDICTED: similar to Spt5 CG7626-P...    36   0.840 K 
contig02769 gi|77359943|ref|YP_339518.1| translation initiation factor IF-2 ...    39   0.680 A 
contig06082 gi|126335335|ref|XP_001371550.1| PREDICTED: similar to splicing ...    37   0.660 A 
contig10584 gi|39975039|ref|XP_368910.1| predicted protein [Magnaporthe gris...    37   0.660 K 
contig05949 gi|115707349|ref|XP_001199817.1| PREDICTED: similar to retinitis...    37   0.650 K 
contig12157 gi|159466738|ref|XP_001691555.1| predicted protein [Chlamydomona...    37   0.650 A 
contig01071 gi|134280916|ref|ZP_01767626.1| hypothetical protein BURPS305_37...    39   0.540 A 
contig06703 gi|152983013|ref|YP_001355143.1| Tn7-like transposition protein ...    37   0.510 J 
contig11652 gi|77553198|gb|ABA95994.1| hypothetical protein LOC_Os12g08490 [...    37   0.510 A 
contig02192 gi|91080713|ref|XP_975329.1| PREDICTED: similar to bicoid stabil...    37   0.500 A 
contig03547 gi|164427354|ref|XP_956464.2| hypothetical protein NCU03355 [Neu...    37   0.500 K 
contig04856 gi|194671056|ref|XP_001788407.1| PREDICTED: similar to YLP motif...    37   0.500 BK 
contig08106 gi|6225541|sp|O77210.1|IF4E_APLCA Eukaryotic translation initiat...    37   0.500 J 
contig00607 gi|193652714|ref|XP_001950832.1| PREDICTED: similar to predicted...    38   0.490 A 
contig07088 gi|195043294|ref|XP_001991590.1| GH12742 [Drosophila grimshawi] ...    35   0.440 J 
contig01333 gi|115471039|ref|NP_001059118.1| Os07g0195900 [Oryza sativa (jap...    39   0.420 B 
contig04598 gi|193643332|ref|XP_001942760.1| PREDICTED: similar to AGAP00225...    37   0.390 L 
contig11064 gi|153815791|ref|ZP_01968459.1| hypothetical protein RUMTOR_0203...    37   0.390 K 




Contig BLAST result e value Class 
contig05853 gi|56118378|ref|NP_001008144.1| La ribonucleoprotein domain fami...    37   0.380 L 
contig13358 gi|195402857|ref|XP_002060016.1| GJ15500 [Drosophila virilis] >g...    37   0.380 K 
contig06914 gi|195115399|ref|XP_002002244.1| GI17279 [Drosophila mojavensis]...    38   0.340 K 
contig07075 gi|147679178|ref|YP_001213393.1| CTP synthetase [Pelotomaculum t...    38   0.300 K 
contig02638 gi|47217572|emb|CAG02499.1| unnamed protein product [Tetraodon n...    38   0.290 J 
contig06142 gi|77548411|gb|ABA91208.1| expressed protein [Oryza sativa (japo...    38   0.290 A 
contig08713 gi|124360603|gb|ABN08602.1| Phosphoinositide-binding clathrin ad...    38   0.290 K 
contig06044 gi|148690326|gb|EDL22273.1| serine/arginine repetitive matrix 2 ...    39   0.230 A 
contig00560 gi|193582536|ref|XP_001946023.1| PREDICTED: similar to CG11486 C...    38   0.220 A 
contig05453 gi|156555067|ref|XP_001604099.1| PREDICTED: similar to smooth [N...    38   0.220 A 
contig11725 gi|114053047|ref|NP_001040027.1| glutamyl-tRNA(Gln) amidotransfe...    38   0.220 L 
contig08306 gi|145252814|ref|XP_001397920.1| hypothetical protein An16g06160...    29   0.210 K 
contig11553 gi|194207332|ref|XP_001915885.1| PREDICTED: Fanconi anemia, comp...    40   0.160 L 
contig12900 gi|158337389|ref|YP_001518564.1| type I secretion target repeat-...    41   0.150 B 
contig06496 gi|189491618|ref|NP_001121625.1| timeless [Ovis aries] >gnl|BL_O...    39   0.130 L 
contig08268 gi|37220738|gb|AAQ89710.1| rhoptry associated membrane antigen [...    39   0.130 J 
contig03293 gi|66806449|ref|XP_636947.1| leucine-rich repeat-containing prot...    39   0.100 K 
contig08061 gi|169616167|ref|XP_001801499.1| hypothetical protein SNOG_11257...    39   0.100 B 
contig12391 gi|37521692|ref|NP_925069.1| hypothetical protein gll2123 [Gloeo...    39   0.100 K 
contig04052 gi|195380001|ref|XP_002048759.1| GJ21226 [Drosophila virilis] >g...    39   0.099 J 
contig08298 gi|49256131|gb|AAH73031.1| Unknown (protein for MGC:82639) [Xeno...    40   0.078 A 
contig09224 gi|157953923|ref|YP_001498814.1| hypothetical protein AR158_C733...    40   0.078 A 
contig03246 gi|156376942|ref|XP_001630617.1| predicted protein [Nematostella...    40   0.077 J 
contig04572 gi|157116290|ref|XP_001652808.1| hypothetical protein AaeL_AAEL0...    40   0.077 K 
contig03717 gi|76156698|gb|AAX27852.2| SJCHGC03298 protein [Schistosoma japo...    40   0.063 J 
contig06684 gi|141795258|gb|AAI39520.1| Im:7151572 protein [Danio rerio]           40   0.059 A 
contig01075 gi|149028968|gb|EDL84287.1| rCG63087 [Rattus norvegicus]               40   0.058 A 
contig07909 gi|54038332|gb|AAH84673.1| LOC495249 protein [Xenopus laevis]          40   0.058 AR 
contig03179 gi|1237202|emb|CAA65612.1| histidine kinase [Dictyostelium disco...    39   0.055 L 
contig02570 gi|158315983|ref|YP_001508491.1| alpha/beta hydrolase domain-con...    40   0.045 J 
contig10798 gi|115699072|ref|XP_781418.2| PREDICTED: similar to DNA polymera...    40   0.045 L 
contig09757 gi|156552292|ref|XP_001600496.1| PREDICTED: similar to ENSANGP00...    40   0.044 J 
contig11253 gi|193216773|ref|YP_002000015.1| massive surface protein MspC [M...    44   0.037 L 
contig12095 gi|170040091|ref|XP_001847845.1| maternal tudor protein [Culex q...    44   0.035 K 
contig03099 gi|195452550|ref|XP_002073403.1| GK14107 [Drosophila willistoni]...    41   0.034 K 
contig03382 gi|148702332|gb|EDL34279.1| DEAD (Asp-Glu-Ala-Asp) box polypepti...    41   0.034 A 
contig09398 gi|109130171|ref|XP_001086342.1| PREDICTED: hypothetical protein...    41   0.034 A 
contig10593 gi|194669470|ref|XP_615781.4| PREDICTED: similar to jumonji doma...    41   0.034 L 
contig12468 gi|48139121|ref|XP_393443.1| PREDICTED: similar to mitochondrial...    41   0.034 J 
contig00242 gi|195457344|ref|XP_002075533.1| GK18547 [Drosophila willistoni]...    42   0.032 L 
contig10049 gi|156370098|ref|XP_001628309.1| predicted protein [Nematostella...    42   0.021 A 
contig02922 gi|16197971|gb|AAL13756.1| LD23445p [Drosophila melanogaster]          42   0.020 A 
contig07769 gi|195586770|ref|XP_002083143.1| GD13507 [Drosophila simulans] >...    42   0.020 A 
contig10091 gi|195128859|ref|XP_002008877.1| GI11570 [Drosophila mojavensis]...    42   0.020 A 
contig08528 gi|148708536|gb|EDL40483.1| activating signal cointegrator 1 com...    42   0.016 K 
contig11141 gi|157126535|ref|XP_001660916.1| sterol regulatory element-bindi...    42   0.015 K 
contig05517 gi|115458062|ref|NP_001052631.1| Os04g0388600 [Oryza sativa (jap...    43   0.009 A 
contig09216 gi|195572497|ref|XP_002104232.1| GD18561 [Drosophila simulans] >...    43   0.009 J 
contig03842 gi|156553460|ref|XP_001604505.1| PREDICTED: similar to translati...    43   0.007 J 
contig05252 gi|31745178|ref|NP_853634.1| SWI/SNF-related matrix-associated a...    43   0.007 BK 




Contig BLAST result e value Class 
contig12218 gi|195539327|ref|NP_001124190.1| argonaute 1 [Strongylocentrotus...    43   0.007 J 
contig02715 gi|72127019|ref|XP_792641.1| PREDICTED: similar to RNA pseudouri...    44   0.005 A 
contig05850 gi|145611424|ref|XP_368851.2| hypothetical protein MGG_00393 [Ma...    44   0.005 B 
contig06764 gi|91093050|ref|XP_967369.1| PREDICTED: similar to RpI12 CG13418...    44   0.005 K 
contig00263 gi|145253539|ref|XP_001398282.1| hypothetical protein An17g00530...    33   0.004 K 
contig00835 gi|51090781|dbj|BAD35259.1| unknown protein [Oryza sativa Japoni...    44   0.004 A 
contig04049 gi|193676340|ref|XP_001948540.1| PREDICTED: similar to DNA topoi...    44   0.004 B 
contig05302 gi|195433847|ref|XP_002064918.1| GK15187 [Drosophila willistoni]...    44   0.004 B 
contig06002 gi|157116527|ref|XP_001658535.1| ribosomal pseudouridine synthas...    44   0.004 A 
contig10330 gi|167517733|ref|XP_001743207.1| predicted protein [Monosiga bre...    44   0.004 J 
contig10698 gi|156547804|ref|XP_001606248.1| PREDICTED: hypothetical protein...    44   0.004 K 
contig04714 gi|170033323|ref|XP_001844527.1| far upstream binding protein [C...    45   0.003 A 
contig07710 gi|67084083|gb|AAY66976.1| possible mitochondrial ribosomal prot...    44   0.003 J 
contig02630 gi|156545235|ref|XP_001604531.1| PREDICTED: similar to replicati...    45   0.002 L 
contig03506 gi|195129479|ref|XP_002009183.1| GI11400 [Drosophila mojavensis]...    45   0.002 J 
contig06339 gi|154684978|ref|YP_001420139.1| YdcI [Bacillus amyloliquefacien...    45   0.002 K 
contig07177 gi|115916105|ref|XP_781769.2| PREDICTED: similar to KIAA1218 pro...    45   0.002 B 
contig07409 gi|196010159|ref|XP_002114944.1| hypothetical protein TRIADDRAFT...    45   0.002 J 
contig07448 gi|194679733|ref|XP_001788248.1| PREDICTED: similar to Pre-mRNA ...    45   0.002 A 
contig08253 gi|195032827|ref|XP_001988569.1| GH11234 [Drosophila grimshawi] ...    45   0.002 A 
contig10041 gi|115758159|ref|XP_793245.2| PREDICTED: similar to KIAA1404 pro...    45   0.002 L 
contig00109 gi|194222651|ref|XP_001497265.2| PREDICTED: eIF4GI protein [Equu...    48   0.001 J 
contig01552 gi|126324882|ref|XP_001379147.1| PREDICTED: similar to Mitochond...    45   0.001 J 
contig03887 gi|50513542|pdb|1SGL|A Chain A, The Three-Dimensional Structure ...    45   0.001 A 
contig05574 gi|149424585|ref|XP_001520526.1| PREDICTED: similar to MGC21874 ...    46   0.001 B 
contig10650 gi|47212288|emb|CAF92859.1| unnamed protein product [Tetraodon n...    46   0.001 A 
contig11149 gi|119574612|gb|EAW54227.1| AT rich interactive domain 5B (MRF1-...    46   0.001 K 
contig00404 gi|47208448|emb|CAF93102.1| unnamed protein product [Tetraodon n...    47   8E-04 J 
contig01876 gi|110748834|ref|XP_623721.2| PREDICTED: similar to mitochondria...    46   8E-04 J 
contig09496 gi|72006586|ref|XP_782916.1| PREDICTED: similar to SET domain an...    46   8E-04 BK 
contig12768 gi|196236958|ref|ZP_03135749.1| conserved hypothetical protein [...    49   7E-04 K 
contig06572 gi|195048072|ref|XP_001992465.1| GH24190 [Drosophila grimshawi] ...    47   6E-04 J 
contig08332 gi|195503187|ref|XP_002098546.1| GE23879 [Drosophila yakuba] >gn...    47   6E-04 A 
contig09868 gi|110759186|ref|XP_396401.3| PREDICTED: similar to GLE1 RNA exp...    47   5E-04 A 
contig02142 gi|91083973|ref|XP_975149.1| PREDICTED: similar to splicing fact...    47   4E-04 A 
contig05266 gi|115627983|ref|XP_001176368.1| PREDICTED: hypothetical protein...    47   4E-04 A 
contig09300 gi|50740707|ref|XP_419536.1| PREDICTED: similar to histone methy...    47   4E-04 B 
contig06370 gi|115927400|ref|XP_782196.2| PREDICTED: similar to putative RNA...    49   3E-04 A 
contig04441 gi|157105173|ref|XP_001648750.1| S1 RNA binding domain protein, ...    49   2E-04 K 
contig05205 gi|195121564|ref|XP_002005290.1| GI20404 [Drosophila mojavensis]...    48   2E-04 L 
contig08027 gi|112983080|ref|NP_001037670.1| Rsf1 [Bombyx mori] >gnl|BL_ORD_...    48   2E-04 A 
contig10786 gi|115965534|ref|XP_001194862.1| PREDICTED: similar to rapamycin...    48   2E-04 L 
contig05847 gi|156543392|ref|XP_001600067.1| PREDICTED: similar to ATP-depen...    49   1E-04 A 
contig09977 gi|37362208|gb|AAQ91232.1| origin recognition complex, subunit 3...    49   1E-04 L 
contig09444 gi|195444815|ref|XP_002070042.1| GK11236 [Drosophila willistoni]...    50   7E-05 L 
contig00270 gi|91078526|ref|XP_970233.1| PREDICTED: similar to CRSP complex ...    50   6E-05 K 
contig01533 gi|56159959|gb|AAV80791.1| putative secreted salivary gland pept...    50   6E-05 A 
contig02446 gi|114052735|ref|NP_001040494.1| U2 small nuclear ribonucleoprot...    50   6E-05 A 
contig12255 gi|56283929|ref|NP_523475.3| Salivary gland secretion 1 CG3047-P...    53   5E-05 A 
contig10347 gi|157761629|ref|XP_001673157.1| Hypothetical protein CBG01314 [...    50   4E-05 J 




Contig BLAST result e value Class 
contig05024 gi|147901564|ref|NP_001081653.1| ligase I [Xenopus laevis] >gnl|...    51   3E-05 L 
contig07389 gi|156368841|ref|XP_001627900.1| predicted protein [Nematostella...    51   3E-05 K 
contig05011 gi|154721379|gb|ABS84820.1| polyprotein [Honey bee slow paralysi...    52   2E-05 J 
contig05178 gi|110757968|ref|XP_394707.3| PREDICTED: similar to M-phase phos...    52   2E-05 A 
contig07634 gi|194381256|dbj|BAG58582.1| unnamed protein product [Homo sapiens]    52   2E-05 K 
contig03134 gi|158298514|ref|XP_318687.4| AGAP009650-PA [Anopheles gambiae s...    52   1E-05 K 
contig04017 gi|112983034|ref|NP_001037070.1| putative H3K9 methyltransferase...    52   1E-05 B 
contig06337 gi|170047547|ref|XP_001851279.1| quaking protein A [Culex quinqu...    52   1E-05 A 
contig03734 gi|73981226|ref|XP_540261.2| PREDICTED: similar to WD-repeat pro...    53   9E-06 A 
contig06534 gi|147899310|ref|NP_001085393.1| MGC79017 protein [Xenopus laevi...    53   9E-06 L 
contig01228 gi|74136739|ref|NP_001028175.1| basic transcription factor 3 [Ci...    55   8E-06 K 
contig03455 gi|197632259|gb|ACH70853.1| eukaryotic translation initiation fa...    53   7E-06 J 
contig04303 gi|156408277|ref|XP_001641783.1| predicted protein [Nematostella...    53   7E-06 A 
contig04979 gi|170091308|ref|XP_001876876.1| predicted protein [Laccaria bic...    53   7E-06 J 
contig06877 gi|169158574|emb|CAQ15578.1| novel protein similar to H.sapiens ...    54   5E-06 J 
contig06964 gi|198151133|gb|EAL30213.2| GA15241 [Drosophila pseudoobscura ps...    54   5E-06 J 
contig05988 gi|157128864|ref|XP_001655231.1| DNA repair protein xp-e [Aedes ...    54   4E-06 L 
contig09396 gi|196007374|ref|XP_002113553.1| hypothetical protein TRIADDRAFT...    54   4E-06 K 
contig04464 gi|41054625|ref|NP_955870.1| splicing factor, arginine/serine-ri...    54   3E-06 A 
contig07230 gi|170040111|ref|XP_001847855.1| elongation factor G 1, mitochon...    54   3E-06 J 
contig07745 gi|195401220|ref|XP_002059212.1| GJ16153 [Drosophila virilis] >g...    54   3E-06 K 
contig10652 gi|187469812|gb|AAI67080.1| Unknown (protein for IMAGE:8363520) ...    54   3E-06 L 
contig01465 gi|196476795|gb|ACG76261.1| small nuclear ribonucleoprotein G [A...    55   2E-06 A 
contig02953 gi|170084049|ref|XP_001873248.1| predicted protein [Laccaria bic...    55   2E-06 J 
contig11631 gi|125583414|gb|EAZ24345.1| hypothetical protein OsJ_007828 [Ory...    55   2E-06 B 
contig11635 gi|82249026|sp|Q9YGX5|CPEB1_BRARE Cytoplasmic polyadenylation el...    55   2E-06 J 
contig01711 gi|193678853|ref|XP_001945895.1| PREDICTED: similar to Eukaryoti...    56   1E-06 J 
contig02143 gi|170070381|ref|XP_001869559.1| histone-lysine n-methyltransfer...    56   1E-06 BK 
contig05304 gi|148234716|ref|NP_001080984.1| flap endonuclease 1 [Xenopus la...    52   1E-06 L 
contig08532 gi|195552807|ref|XP_002076543.1| GD17572 [Drosophila simulans] >...    56   8E-07 J 
contig12761 gi|115968078|ref|XP_001189793.1| PREDICTED: similar to dpy-30-li...    56   8E-07 K 
contig09466 gi|126334326|ref|XP_001377008.1| PREDICTED: hypothetical protein...    46   7E-07 L 
contig01879 gi|194223833|ref|XP_001492097.2| PREDICTED: splicing factor, arg...    57   6E-07 A 
contig07782 gi|47210503|emb|CAF90142.1| unnamed protein product [Tetraodon n...    57   6E-07 J 
contig00143 gi|195972757|dbj|BAG68513.1| histone 4 [Drosophila takahashii]         57   5E-07 B 
contig10392 gi|195032188|ref|XP_001988454.1| GH11175 [Drosophila grimshawi] ...    57   5E-07 J 
contig07924 gi|195112849|ref|XP_002000984.1| GI22233 [Drosophila mojavensis]...    57   4E-07 A 
contig02602 gi|195398566|ref|XP_002057892.1| GJ17848 [Drosophila virilis] >g...    60   3E-07 K 
contig01115 gi|58396614|ref|XP_322026.2| AGAP001135-PA [Anopheles gambiae st...    41   2E-07 L 
contig01659 gi|189536204|ref|XP_001335519.2| PREDICTED: similar to mKIAA0191...    58   2E-07 A 
contig04995 gi|156377136|ref|XP_001630713.1| predicted protein [Nematostella...    59   1E-07 J 
contig11061 gi|125985901|ref|XP_001356714.1| GA15004-PA [Drosophila pseudoob...    59   1E-07 A 
contig02553 gi|156551437|ref|XP_001604411.1| PREDICTED: similar to fetal glo...    59   9E-08 K 
contig09577 gi|118404512|ref|NP_001072914.1| mitochondrial ribosomal protein...    59   9E-08 J 
contig06417 gi|156540682|ref|XP_001599742.1| PREDICTED: similar to conserved...    61   8E-08 J 
contig01064 gi|114561793|ref|YP_749306.1| DEAD/DEAH box helicase domain-cont...    60   7E-08 A 
contig06775 gi|66509028|ref|XP_396048.2| PREDICTED: similar to damage specif...    60   7E-08 L 
contig10430 gi|194745508|ref|XP_001955230.1| GF16340 [Drosophila ananassae] ...    60   7E-08 A 
contig10781 gi|189238915|ref|XP_969200.2| PREDICTED: similar to DNA polymera...    60   6E-08 L 
contig06284 gi|50744652|ref|XP_419816.1| PREDICTED: similar to Activating si...    48   5E-08 A 




Contig BLAST result e value Class 
contig07676 gi|114051417|ref|NP_001040314.1| DNA-damage inducible protein [B...    60   4E-08 L 
contig10509 gi|126304454|ref|XP_001382178.1| PREDICTED: similar to homolog o...    60   4E-08 L 
contig05940 gi|195479102|ref|XP_002100763.1| GE17244 [Drosophila yakuba] >gn...    61   3E-08 K 
contig08405 gi|189236986|ref|XP_001810629.1| PREDICTED: similar to General t...    61   3E-08 K 
contig12471 gi|57525409|ref|NP_001006243.1| minichromosome maintenance compl...    61   3E-08 L 
contig04650 gi|156547291|ref|XP_001606432.1| PREDICTED: similar to cysteinyl...    62   2E-08 J 
contig05054 gi|149427386|ref|XP_001521089.1| PREDICTED: similar to cap bindi...    62   2E-08 A 
contig05706 gi|156554094|ref|XP_001601319.1| PREDICTED: similar to tata-bind...    62   2E-08 K 
contig10755 gi|148231815|ref|NP_001082292.1| ARC105 protein [Xenopus laevis]...    62   2E-08 K 
contig03296 gi|194332576|ref|NP_001123777.1| hypothetical protein LOC1001705...    62   1E-08 L 
contig07789 gi|156361828|ref|XP_001625486.1| predicted protein [Nematostella...    62   1E-08 A 
contig07802 gi|158300342|ref|XP_320293.4| AGAP012249-PA [Anopheles gambiae s...    62   1E-08 J 
contig11178 gi|114052779|ref|NP_001040341.1| mitochondrial ribosomal protein...    54   1E-08 J 
contig00336 gi|168000575|ref|XP_001752991.1| argonaute family member [Physco...    63   8E-09 J 
contig01434 gi|112983360|ref|NP_001037644.1| polyadenylate binding protein 2...    65   8E-09 A 
contig02240 gi|115727635|ref|XP_789513.2| PREDICTED: similar to MGC82596 pro...    63   8E-09 A 
contig03867 gi|156406660|ref|XP_001641163.1| predicted protein [Nematostella...    51   8E-09 J 
contig02781 gi|189234753|ref|XP_974490.2| PREDICTED: similar to STE20-like k...    63   6E-09 A 
contig07124 gi|118100342|ref|XP_001235387.1| PREDICTED: hypothetical protein...    63   6E-09 A 
contig03082 gi|195035783|ref|XP_001989351.1| GH11680 [Drosophila grimshawi] ...    64   5E-09 J 
contig07329 gi|195586452|ref|XP_002082988.1| GD24941 [Drosophila simulans] >...    64   5E-09 K 
contig13058 gi|156399409|ref|XP_001638494.1| predicted protein [Nematostella...    57   5E-09 J 
contig09302 gi|125818968|ref|XP_695864.2| PREDICTED: similar to SWI/SNF-rela...    64   4E-09 B 
contig10283 gi|118101846|ref|XP_417852.2| PREDICTED: hypothetical protein [G...    64   4E-09 J 
contig07511 gi|189241033|ref|XP_971712.2| PREDICTED: similar to AGAP012195-P...    65   2E-09 J 
contig00575 gi|170581661|ref|XP_001895780.1| transcription elongation factor...    67   1E-09 K 
contig02904 gi|56269784|gb|AAH86970.1| Top2a protein [Danio rerio] >gnl|BL_O...    66   1E-09 B 
contig02948 gi|194224218|ref|XP_001497231.2| PREDICTED: similar to nucleolar...    65   1E-09 AJ 
contig05461 gi|189235069|ref|XP_974729.2| PREDICTED: similar to nocturnin CG...    65   1E-09 K 
contig08377 gi|66534191|ref|XP_624580.1| PREDICTED: similar to Chromatin ass...    58   1E-09 B 
contig08722 gi|170051312|ref|XP_001861707.1| translation machinery-associate...    66   1E-09 J 
contig13178 gi|189353843|ref|YP_001949470.1| hypothetical protein BMULJ_0509...    66   1E-09 K 
contig03723 gi|195583628|ref|XP_002081619.1| GD25618 [Drosophila simulans] >...    66   8E-10 L 
contig07492 gi|118100644|ref|XP_417395.2| PREDICTED: similar to KIAA1404 pro...    66   8E-10 L 
contig00640 gi|194222435|ref|XP_001500218.2| PREDICTED: splicing factor 3b, ...    67   6E-10 A 
contig01565 gi|48101238|ref|XP_392654.1| PREDICTED: similar to mitochondrial...    67   6E-10 J 
contig05405 gi|158286351|ref|XP_308698.4| AGAP007065-PA [Anopheles gambiae s...    67   6E-10 K 
contig02102 gi|157339020|emb|CAO42371.1| unnamed protein product [Vitis vini...    67   4E-10 A 
contig06393 gi|62078847|ref|NP_001014079.1| tRNA splicing endonuclease 2 hom...    67   4E-10 J 
contig02702 gi|61651808|ref|NP_001013344.1| hypothetical protein LOC503748 [...    68   3E-10 L 
contig07722 gi|126297559|ref|XP_001362254.1| PREDICTED: similar to Polymeras...    68   3E-10 K 
contig09861 gi|47210231|emb|CAF95218.1| unnamed protein product [Tetraodon n...    64   3E-10 J 
contig00813 gi|115663128|ref|XP_795489.2| PREDICTED: similar to THO complex ...    68   2E-10 K 
contig04890 gi|126321954|ref|XP_001366911.1| PREDICTED: similar to E2F-3 tra...    48   2E-10 K 
contig05203 gi|170043518|ref|XP_001849432.1| puff-specific protein Bx42 [Cul...    69   2E-10 AB 
contig09508 gi|91087083|ref|XP_974948.1| PREDICTED: similar to AGAP008405-PA...    68   2E-10 J 
contig12019 gi|188593364|emb|CAO78751.1| Oikopleura cytoplasmic RNAse III en...    70   2E-10 A 
contig10724 gi|196006696|ref|XP_002113214.1| hypothetical protein TRIADDRAFT...    69   1E-10 A 
contig04250 gi|156550801|ref|XP_001600558.1| PREDICTED: similar to FTP3 [Nas...    69   9E-11 A 
contig07470 gi|66557991|ref|XP_625041.1| PREDICTED: similar to CG11265-PA, i...    70   7E-11 L 




Contig BLAST result e value Class 
contig13342 gi|194385764|dbj|BAG65257.1| unnamed protein product [Homo sapiens]    70   7E-11 A 
contig00489 gi|187023422|emb|CAP37383.1| C. briggsae CBR-TOP-1 protein [Caen...    70   5E-11 L 
contig10645 gi|163868323|ref|YP_001609532.1| DNA polymerase III subunit delt...    70   5E-11 L 
contig08873 gi|58383228|ref|XP_312466.2| AGAP002472-PA [Anopheles gambiae st...    70   4E-11 L 
contig12936 gi|197127145|gb|ACH43643.1| putative ribosomal protein S11 [Taen...    70   4E-11 J 
contig01555 gi|170571964|ref|XP_001891933.1| piwi domain containing protein ...    71   3E-11 J 
contig03855 gi|156545501|ref|XP_001607052.1| PREDICTED: similar to cleavage ...    71   3E-11 A 
contig02888 gi|189233619|ref|XP_970422.2| PREDICTED: similar to arylhydrocar...    71   2E-11 K 
contig08901 gi|110762326|ref|XP_001120377.1| PREDICTED: similar to CG8232-PA...    71   2E-11 L 
contig03389 gi|66505576|ref|XP_393347.2| PREDICTED: similar to CG3527-PA [Ap...    72   1E-11 J 
contig03504 gi|189467630|ref|ZP_03016415.1| hypothetical protein BACINT_0402...    72   1E-11 A 
contig04293 gi|158290481|ref|XP_312084.4| AGAP002829-PA [Anopheles gambiae s...    72   1E-11 A 
contig06499 gi|193704612|ref|XP_001945957.1| PREDICTED: similar to DNA repli...    72   1E-11 L 
contig06840 gi|156537721|ref|XP_001608262.1| PREDICTED: similar to GA15333-P...    72   1E-11 J 
contig11474 gi|110756942|ref|XP_395357.3| PREDICTED: similar to Rox8 CG5422-...    72   1E-11 AJ 
contig13289 gi|77736399|ref|NP_001029899.1| X-box binding protein 1 [Bos tau...    73   1E-11 K 
contig00439 gi|157674639|gb|ABV60408.1| RNA polymerase II transcriptional co...    52   7E-12 K 
contig05288 gi|193610701|ref|XP_001951408.1| PREDICTED: similar to U3 small ...    73   6E-12 A 
contig07141 gi|157104333|ref|XP_001648358.1| mitochondrial 28S ribosomal pro...    73   6E-12 J 
contig11421 gi|195470256|ref|XP_002087424.1| GE16791 [Drosophila yakuba] >gn...    73   6E-12 B 
contig02115 gi|193683845|ref|XP_001950620.1| PREDICTED: similar to CG17838 C...    74   5E-12 A 
contig04630 gi|165972435|ref|NP_001107069.1| eukaryotic translation initiati...    74   5E-12 J 
contig05536 gi|193718435|ref|XP_001949512.1| PREDICTED: similar to conserved...    74   5E-12 J 
contig07189 gi|195436461|ref|XP_002066186.1| GK22226 [Drosophila willistoni]...    74   5E-12 A 
contig04542 gi|157127307|ref|XP_001654915.1| Srb7p: RNA polymerase II holoen...    74   4E-12 K 
contig02195 gi|48094369|ref|XP_392115.1| PREDICTED: similar to eIF6 CG17611-...    74   3E-12 J 
contig04031 gi|170038522|ref|XP_001847098.1| mitochondrial 28S ribosomal pro...    74   3E-12 J 
contig12959 gi|189238875|ref|XP_973671.2| PREDICTED: similar to DNA replicat...    74   3E-12 L 
contig00994 gi|156547287|ref|XP_001606343.1| PREDICTED: similar to RE29053p ...    75   2E-12 J 
contig01282 gi|110764913|ref|XP_624290.2| PREDICTED: similar to eukaryotic t...    75   2E-12 J 
contig05441 gi|156548556|ref|XP_001605611.1| PREDICTED: similar to eukaryoti...    75   2E-12 J 
contig00337 gi|47211075|emb|CAF89690.1| unnamed protein product [Tetraodon n...    78   1E-12 J 
contig03634 gi|189517411|ref|XP_001922483.1| PREDICTED: similar to MGC84354 ...    76   1E-12 A 
contig06960 gi|126305772|ref|XP_001375367.1| PREDICTED: similar to NOL1/NOP2...    75   1E-12 J 
contig09037 gi|170050832|ref|XP_001861489.1| tRNA methyltransferase [Culex q...    75   1E-12 J 
contig10244 gi|170031954|ref|XP_001843848.1| U4/U6 small nuclear ribonucleop...    76   7E-13 A 
contig06580 gi|34785805|gb|AAH57529.1| Supt5h protein [Danio rerio]                77   6E-13 K 
contig07992 gi|73981244|ref|XP_540263.2| PREDICTED: similar to Tryptophanyl-...    77   6E-13 J 
contig03895 gi|15891751|ref|NP_357423.1| ABC transporter, substrate binding ...    77   3E-13 K 
contig05364 gi|71021341|ref|XP_760901.1| hypothetical protein UM04754.1 [Ust...    77   3E-13 A 
contig00361 gi|82249026|sp|Q9YGX5|CPEB1_BRARE Cytoplasmic polyadenylation el...    79   2E-13 J 
contig01574 gi|170028476|ref|XP_001842121.1| conserved hypothetical protein ...    78   2E-13 A 
contig06467 gi|156389050|ref|XP_001634805.1| predicted protein [Nematostella...    78   2E-13 L 
contig11590 gi|149287022|gb|ABR23410.1| p8 nuclear protein [Ornithodoros par...    80   2E-13 K 
contig11032 gi|156555684|ref|XP_001602582.1| PREDICTED: hypothetical protein...    79   1E-13 A 
contig11219 gi|170035603|ref|XP_001845658.1| gar2 [Culex quinquefasciatus] >...    79   1E-13 J 
contig12333 gi|158300914|ref|XP_320713.3| AGAP011802-PA [Anopheles gambiae s...    79   9E-14 J 
contig06202 gi|156552643|ref|XP_001603250.1| PREDICTED: similar to CG6049-PB...    80   7E-14 K 
contig09288 gi|195375100|ref|XP_002046341.1| GJ12560 [Drosophila virilis] >g...    80   7E-14 J 
contig05577 gi|47221361|emb|CAF97279.1| unnamed protein product [Tetraodon n...    70   6E-14 J 




Contig BLAST result e value Class 
contig05166 gi|125977188|ref|XP_001352627.1| GA13435-PA [Drosophila pseudoob...    80   5E-14 J 
contig12287 gi|118097495|ref|XP_414612.2| PREDICTED: similar to CCR4-NOT tra...    80   5E-14 K 
contig09047 gi|46129443|ref|XP_389073.1| hypothetical protein FG08897.1 [Gib...    80   4E-14 A 
contig07299 gi|194440948|gb|ACF70735.1| eukaryotic translation elongation fa...    81   3E-14 J 
contig12004 gi|193603617|ref|XP_001950573.1| PREDICTED: similar to eukaryoti...    84   3E-14 J 
contig01996 gi|149286958|gb|ABR23378.1| 60S ribosomal protein L29 [Ornithodo...    81   2E-14 J 
contig05028 gi|172051058|gb|ACB70304.1| histone 1 [Ornithodoros coriaceus]         82   2E-14 B 
contig05698 gi|195383944|ref|XP_002050685.1| GJ20075 [Drosophila virilis] >g...    82   2E-14 J 
contig08617 gi|115687312|ref|XP_793463.2| PREDICTED: similar to Lysyl-tRNA s...    81   2E-14 J 
contig09083 gi|195425857|ref|XP_002061179.1| GK10341 [Drosophila willistoni]...    82   2E-14 J 
contig09914 gi|91082415|ref|XP_970120.1| PREDICTED: similar to tRNA-dihydrou...    82   2E-14 J 
contig11563 gi|172051058|gb|ACB70304.1| histone 1 [Ornithodoros coriaceus]         84   2E-14 B 
contig02713 gi|110770107|ref|XP_001123058.1| PREDICTED: similar to Rbp1-like...    83   1E-14 A 
contig04498 gi|195438186|ref|XP_002067018.1| GK24781 [Drosophila willistoni]...    82   1E-14 A 
contig07339 gi|122890852|emb|CAM12938.1| poly(A) polymerase gamma [Danio rerio]    82   1E-14 A 
contig12018 gi|194500479|gb|ACF75502.1| histone H2B [Philodina roseola]            82   1E-14 B 
contig03464 gi|193634355|ref|XP_001949691.1| PREDICTED: similar to eukaryoti...    83   8E-15 J 
contig12593 gi|115618688|ref|XP_793195.2| PREDICTED: hypothetical protein [S...    83   6E-15 K 
contig00254 gi|156555067|ref|XP_001604099.1| PREDICTED: similar to smooth [N...    84   5E-15 A 
contig08266 gi|170035806|ref|XP_001845758.1| ATP-dependent RNA helicase p62 ...    84   5E-15 A 
contig01672 gi|125980520|ref|XP_001354284.1| GA11463-PA [Drosophila pseudoob...    84   4E-15 J 
contig02633 gi|195447052|ref|XP_002071043.1| GK25580 [Drosophila willistoni]...    84   3E-15 J 
contig05163 gi|4691352|emb|CAB41634.1| iron regulatory protein 1-like protei...    84   3E-15 AJ 
contig12034 gi|41055136|ref|NP_957497.1| HIV TAT specific factor 1 [Danio re...    84   3E-15 K 
contig09958 gi|118100214|ref|XP_423183.2| PREDICTED: similar to putative chr...    85   2E-15 A 
contig03575 gi|114153222|gb|ABI52777.1| conserved arthropod protein [Argas m...    87   1E-15 K 
contig06654 gi|170590770|ref|XP_001900144.1| Brix domain containing protein ...    86   1E-15 A 
contig09238 gi|45361635|ref|NP_989393.1| hypothetical protein LOC395030 [Xen...    86   9E-16 L 
contig09401 gi|58332582|ref|NP_001011365.1| cysteinyl-tRNA synthetase [Xenop...    86   9E-16 J 
contig04141 gi|156358627|ref|XP_001624618.1| predicted protein [Nematostella...    86   7E-16 A 
contig10297 gi|115677476|ref|XP_001203441.1| PREDICTED: similar to DEAH (Asp...    86   7E-16 A 
contig09185 gi|169260671|gb|ACA52061.1| vasa [Anopheles gambiae]                   87   6E-16 A 
contig03872 gi|195114712|ref|XP_002001911.1| GI17096 [Drosophila mojavensis]...    87   5E-16 J 
contig00508 gi|195442109|ref|XP_002068802.1| GK17973 [Drosophila willistoni]...    87   4E-16 A 
contig04075 gi|194385024|dbj|BAG60918.1| unnamed protein product [Homo sapiens]    87   4E-16 JK 
contig06701 gi|193598839|ref|XP_001949841.1| PREDICTED: similar to ATP-depen...    87   4E-16 A 
contig06273 gi|114052923|ref|NP_001040037.1| asparaginyl-tRNA synthetase [Bo...    88   2E-16 J 
contig06482 gi|148224586|ref|NP_001085709.1| MGC80562 protein [Xenopus laevi...    76   2E-16 A 
contig09227 gi|193617855|ref|XP_001949062.1| PREDICTED: similar to smooth CG...    89   1E-16 A 
contig03531 gi|148223529|ref|NP_001086279.1| MGC84435 protein [Xenopus laevi...    89   8E-17 B 
contig13282 gi|197210363|gb|ACH48189.1| alternative splicing factor SRp20/9G...    93   6E-17 A 
contig03621 gi|2352418|gb|AAC05332.1| extra sex combs [Schistocerca americana]     62   5E-17 K 
contig04437 gi|149633871|ref|XP_001512293.1| PREDICTED: hypothetical protein...    90   5E-17 A 
contig08331 gi|193627300|ref|XP_001946602.1| PREDICTED: similar to twist [Ac...    90   5E-17 K 
contig10867 gi|156549811|ref|XP_001606554.1| PREDICTED: hypothetical protein...    90   5E-17 A 
contig07373 gi|66516301|ref|XP_623215.1| PREDICTED: similar to egalitarian C...    91   4E-17 L 
contig02322 gi|156545066|ref|XP_001601066.1| PREDICTED: similar to mediator ...    92   2E-17 K 
contig04035 gi|158301455|ref|XP_321146.4| AGAP001917-PA [Anopheles gambiae s...    92   2E-17 BK 
contig05127 gi|196006025|ref|XP_002112879.1| hypothetical protein TRIADDRAFT...    91   2E-17 J 
contig08119 gi|194381198|dbj|BAG64167.1| unnamed protein product [Homo sapiens]    92   2E-17 A 




Contig BLAST result e value Class 
contig00689 gi|149286900|gb|ABR23349.1| 40S ribosomal protein S28 [Ornithodo...    92   1E-17 J 
contig03566 gi|195398847|ref|XP_002058032.1| GJ15858 [Drosophila virilis] >g...    92   1E-17 J 
contig03761 gi|156398337|ref|XP_001638145.1| predicted protein [Nematostella...    94   9E-18 A 
contig06432 gi|50761009|ref|XP_425893.1| PREDICTED: similar to ATF family tr...    93   8E-18 K 
contig01759 gi|66519677|ref|XP_393827.2| PREDICTED: similar to Big brother C...    93   6E-18 K 
contig04487 gi|74004026|ref|XP_545326.2| PREDICTED: similar to Phenylalanyl-...    93   6E-18 J 
contig06505 gi|91088779|ref|XP_967442.1| PREDICTED: similar to SD10981p [Tri...    93   6E-18 J 
contig07151 gi|195447876|ref|XP_002071410.1| GK25783 [Drosophila willistoni]...    93   6E-18 J 
contig03282 gi|118343958|ref|NP_001071803.1| transcription factor protein [C...    57   5E-18 K 
contig11682 gi|194225519|ref|XP_001495451.2| PREDICTED: similar to Nuclear c...    95   5E-18 A 
contig02042 gi|115938145|ref|XP_786336.2| PREDICTED: hypothetical protein [S...    94   3E-18 A 
contig02045 gi|154091255|gb|ABS57437.1| ribosomal protein P2 [Heliconius mel...    95   3E-18 J 
contig06620 gi|115696664|ref|XP_001199006.1| PREDICTED: similar to Eukaryoti...    94   3E-18 J 
contig02871 gi|163868316|ref|YP_001609525.1| 30S ribosomal protein S4 [Barto...    95   2E-18 J 
contig05621 gi|193603584|ref|XP_001948892.1| PREDICTED: similar to DNA polym...    84   2E-18 L 
contig11745 gi|115614630|ref|XP_001199821.1| PREDICTED: similar to fetal glo...    95   2E-18 K 
contig00807 gi|188529679|gb|ACD62526.1| Vasa short form [Silurus meridionalis]     96   9E-19 A 
contig03635 gi|149641567|ref|XP_001511623.1| PREDICTED: hypothetical protein...    96   9E-19 J 
contig03921 gi|195570494|ref|XP_002103242.1| GD20313 [Drosophila simulans] >...    96   9E-19 B 
contig04658 gi|167525803|ref|XP_001747236.1| predicted protein [Monosiga bre...    96   9E-19 J 
contig11018 gi|195445281|ref|XP_002070256.1| GK11133 [Drosophila willistoni]...    96   9E-19 J 
contig05852 gi|189237999|ref|XP_001812951.1| PREDICTED: similar to Mediator ...    96   7E-19 K 
contig12348 gi|115941338|ref|XP_001196755.1| PREDICTED: similar to SAS10 [St...    97   5E-19 B 
contig07653 gi|66499810|ref|XP_624522.1| PREDICTED: similar to nudix (nucleo...    97   3E-19 A 
contig10376 gi|156537177|ref|XP_001604206.1| PREDICTED: similar to ribosome ...    97   3E-19 J 
contig10759 gi|118404292|ref|NP_001072455.1| protein inhibitor of activated ...    75   3E-19 K 
contig00238 gi|91090322|ref|XP_972497.1| PREDICTED: similar to AGAP012204-PA...    98   2E-19 A 
contig00533 gi|195377858|ref|XP_002047704.1| dead box protein 80 [Drosophila...    98   2E-19 A 
contig02033 gi|157117813|ref|XP_001653048.1| hypothetical protein AaeL_AAEL0...    98   2E-19 K 
contig04340 gi|158298472|ref|XP_318643.3| AGAP009613-PA [Anopheles gambiae s...    98   2E-19 J 
contig04491 gi|91087281|ref|XP_975549.1| PREDICTED: similar to conserved hyp...    98   2E-19 L 
contig06096 gi|194222435|ref|XP_001500218.2| PREDICTED: splicing factor 3b, ...    98   2E-19 A 
contig10617 gi|47215698|emb|CAG04782.1| unnamed protein product [Tetraodon n...    98   2E-19 KLB 
contig13219 gi|156397042|ref|XP_001637701.1| predicted protein [Nematostella...    99   2E-19 J 
contig01400 gi|193599122|ref|XP_001948282.1| PREDICTED: similar to chromodom...    99   1E-19 K 
contig05379 gi|149898916|gb|ABR27968.1| putative elongation factor 1 beta [T...    99   1E-19 K 
contig05458 gi|157138343|ref|XP_001657254.1| hypothetical protein AaeL_AAEL0...    99   8E-20 K 
contig00948 gi|158120678|gb|ABW16870.1| ribosomal protein P0 [Haemaphysalis ...   100   7E-20 J 
contig06201 gi|193582379|ref|XP_001951043.1| PREDICTED: similar to conserved...   100   6E-20 AR 
contig06682 gi|10121857|gb|AAG13401.1|AF285155_1 topoisomerase II alpha-2 [G...   100   5E-20 B 
contig07732 gi|110765057|ref|XP_397167.3| PREDICTED: similar to pitchoune CG...   100   5E-20 A 
contig06809 gi|110763164|ref|XP_001122465.1| PREDICTED: similar to Stem-loop...   100   4E-20 A 
contig04267 gi|25027443|ref|NP_737497.1| hypothetical protein CE0887 [Coryne...   100   3E-20 K 
contig09360 gi|47210118|emb|CAF91684.1| unnamed protein product [Tetraodon n...   100   3E-20 K 
contig12217 gi|115447849|ref|NP_001047704.1| Os02g0672200 [Oryza sativa (jap...    74   3E-20 J 
contig02463 gi|195381389|ref|XP_002049435.1| GJ21579 [Drosophila virilis] >g...   101   2E-20 J 
contig03519 gi|156538236|ref|XP_001602268.1| PREDICTED: similar to helicase ...   101   2E-20 L 
contig09970 gi|170592815|ref|XP_001901160.1| Yeast mcm [Brugia malayi] >gnl|...   101   2E-20 L 
contig08633 gi|193702205|ref|XP_001943193.1| PREDICTED: similar to bifunctio...   102   1E-20 J 
contig12241 gi|91084417|ref|XP_967827.1| PREDICTED: similar to chromobox-lik...   104   8E-21 B 




Contig BLAST result e value Class 
contig08764 gi|193290168|ref|NP_001123270.1| pitchoune [Nasonia vitripennis]      103   6E-21 A 
contig09517 gi|194039507|ref|XP_001927776.1| PREDICTED: mortality factor 4 l...   103   6E-21 BK 
contig04492 gi|189237154|ref|XP_973939.2| PREDICTED: similar to igf2 mRNA bi...   104   3E-21 AR 
contig09075 gi|163868076|ref|YP_001609280.1| trigger factor [Bartonella trib...   103   3E-21 A 
contig02435 gi|156551567|ref|XP_001601734.1| PREDICTED: similar to helicase ...   104   2E-21 K 
contig02801 gi|196015281|ref|XP_002117498.1| hypothetical protein TRIADDRAFT...    92   2E-21 A 
contig05795 gi|193589588|ref|XP_001948328.1| PREDICTED: similar to eukaryoti...    88   2E-21 J 
contig07711 gi|170029969|ref|XP_001842863.1| snrnp sm protein [Culex quinque...   104   2E-21 A 
contig08083 gi|156385388|ref|XP_001633612.1| predicted protein [Nematostella...   104   2E-21 A 
contig08903 gi|17986801|ref|NP_539435.1| cold shock protein CSPA [Brucella m...   105   2E-21 J 
contig13269 gi|67083849|gb|AAY66859.1| ribosomal protein L28 [Ixodes scapula...   105   2E-21 J 
contig01314 gi|157108382|ref|XP_001650201.1| seryl-tRNA synthetase [Aedes ae...   105   1E-21 J 
contig03669 gi|195477424|ref|XP_002086336.1| GE22920 [Drosophila yakuba] >gn...   106   1E-21 J 
contig00297 gi|115908623|ref|XP_783274.2| PREDICTED: similar to MGC83105 pro...   106   5E-22 A 
contig01429 gi|153009303|ref|YP_001370518.1| 30S ribosomal protein S5 [Ochro...   106   5E-22 J 
contig04286 gi|47087413|ref|NP_998606.1| repressor of RNA polymerase III tra...   106   5E-22 K 
contig05966 gi|115627171|ref|XP_001188174.1| PREDICTED: similar to Cleavage ...   106   5E-22 A 
contig03398 gi|193806389|sp|A6N9N3.1|RL38_ORNPR 60S ribosomal protein L38 >g...   107   4E-22 J 
contig00158 gi|114153052|gb|ABI52692.1| ribosomal protein LP1 [Argas monolak...   107   3E-22 J 
contig03406 gi|110767088|ref|XP_395451.3| PREDICTED: similar to CG40351-PA.3...   107   2E-22 BK 
contig05763 gi|47215025|emb|CAG01849.1| unnamed protein product [Tetraodon n...   107   2E-22 J 
contig07471 gi|115717870|ref|XP_781450.2| PREDICTED: hypothetical protein [S...   107   2E-22 J 
contig08030 gi|156543507|ref|XP_001602171.1| PREDICTED: similar to CG8144-PK...   107   2E-22 AR 
contig12947 gi|91087549|ref|XP_970604.1| PREDICTED: similar to pterin-4a-car...   107   2E-22 K 
contig03876 gi|91086147|ref|XP_969343.1| PREDICTED: similar to CG1972 CG1972...    78   1E-22 A 
contig04639 gi|194390836|dbj|BAG62177.1| unnamed protein product [Homo sapiens]   108   1E-22 J 
contig03514 gi|156550205|ref|XP_001601191.1| PREDICTED: similar to conserved...   110   6E-23 KA 
contig03796 gi|170053997|ref|XP_001862928.1| mitochondrial ribosomal protein...   110   5E-23 J 
contig11079 gi|115744100|ref|XP_001197420.1| PREDICTED: hypothetical protein...   111   5E-23 J 
contig08574 gi|156398094|ref|XP_001638024.1| predicted protein [Nematostella...   100   4E-23 L 
contig12282 gi|75029844|sp|Q4PM64|RS21_IXOSC 40S ribosomal protein S21 >gnl|...    72   4E-23 J 
contig06631 gi|157128943|ref|XP_001661560.1| ribosomal RNA small subunit met...   110   3E-23 A 
contig02269 gi|91082895|ref|XP_972070.1| PREDICTED: similar to lupus la ribo...   111   2E-23 A 
contig10466 gi|126341698|ref|XP_001380514.1| PREDICTED: similar to p300/CBP-...    94   2E-23 BK 
contig00708 gi|110761892|ref|XP_391934.3| PREDICTED: similar to CG8636-PA [A...   113   1E-23 J 
contig11771 gi|148560314|ref|YP_001259646.1| leucyl-tRNA synthetase [Brucell...   112   9E-24 J 
contig02872 gi|189235571|ref|XP_001812213.1| PREDICTED: similar to wd-repeat...   112   7E-24 B 
contig02031 gi|160871558|ref|ZP_02061690.1| DNA gyrase, B subunit [Rickettsi...   113   6E-24 B 
contig05684 gi|156383769|ref|XP_001633005.1| predicted protein [Nematostella...   113   5E-24 L 
contig11337 gi|66559524|ref|XP_393057.2| PREDICTED: similar to Eukaryotic in...    85   4E-24 J 
contig03690 gi|156553460|ref|XP_001604505.1| PREDICTED: similar to translati...   114   3E-24 J 
contig11586 gi|91086921|ref|XP_971865.1| PREDICTED: similar to Probable mito...   115   3E-24 J 
contig00218 gi|149286942|gb|ABR23370.1| 60S ribosomal protein L22 [Ornithodo...   115   2E-24 J 
contig07272 gi|118790039|ref|XP_317984.3| AGAP004824-PA [Anopheles gambiae s...   114   2E-24 J 
contig00380 gi|156548880|ref|XP_001606467.1| PREDICTED: similar to conserved...   115   1E-24 L 
contig01332 gi|134948671|ref|NP_001077096.1| small nuclear ribonucleoprotein...   115   1E-24 A 
contig07569 gi|189238701|ref|XP_968537.2| PREDICTED: similar to Rs1 CG2173-P...   115   1E-24 A 
contig11708 gi|158187762|gb|ABW23170.1| ribosomal protein rpl14 [Arenicola m...   115   1E-24 J 
contig13237 gi|114152964|gb|ABI52648.1| ubiquitin/40S ribosomal protein S27a...   116   1E-24 J 
contig04809 gi|156538399|ref|XP_001605688.1| PREDICTED: similar to GA17927-P...   115   9E-25 J 




Contig BLAST result e value Class 
contig01646 gi|196000174|ref|XP_002109955.1| hypothetical protein TRIADDRAFT...   116   5E-25 J 
contig01929 gi|148298659|ref|NP_001091811.1| mitochondrial ribosomal protein...   116   5E-25 J 
contig07995 gi|194670338|ref|XP_877614.3| PREDICTED: similar to transducin-l...   116   5E-25 B 
contig08203 gi|126272991|ref|XP_001372133.1| PREDICTED: similar to PD2 prote...   116   5E-25 K 
contig04672 gi|194679131|ref|XP_001254710.2| PREDICTED: similar to topoisome...   117   3E-25 B 
contig05578 gi|156385037|ref|XP_001633438.1| predicted protein [Nematostella...   119   1E-25 J 
contig11128 gi|110754971|ref|XP_396833.3| PREDICTED: similar to euchromatic ...    90   1E-25 BK 
contig13007 gi|192447401|ref|NP_001122187.1| hypothetical protein LOC563448 ...   118   1E-25 A 
contig01436 gi|149287094|gb|ABR23446.1| 40S ribosomal protein S29 [Ornithodo...   120   7E-26 J 
contig10939 gi|194036047|ref|XP_001928886.1| PREDICTED: similar to Mitochond...   120   7E-26 J 
contig13239 gi|15213826|gb|AAK92188.1|AF400216_1 ribosomal protein S19 [Spod...   119   6E-26 J 
contig09529 gi|162287117|ref|NP_001104751.1| wu:fb18g03 [Danio rerio] >gnl|B...   120   4E-26 K 
contig02451 gi|119874619|gb|ABM05786.1| dyskerin [Triops longicaudatus]           120   3E-26 J 
contig03772 gi|62083517|gb|AAX62483.1| mitochondrial ribosomal protein L17 [...   120   3E-26 J 
contig10126 gi|166797029|gb|AAI59199.1| Ddx5 protein [Danio rerio]                121   2E-26 A 
contig11454 gi|198149604|gb|EAL31227.2| GA19033 [Drosophila pseudoobscura ps...   121   2E-26 A 
contig00324 gi|189239335|ref|XP_973573.2| PREDICTED: similar to pasilla CG16...   122   1E-26 AR 
contig02746 gi|163868077|ref|YP_001609281.1| aspartyl/glutamyl-tRNA amidotra...   105   1E-26 J 
contig11340 gi|156544606|ref|XP_001602203.1| PREDICTED: similar to EN10 [Nas...   122   7E-27 J 
contig12939 gi|91083327|ref|XP_974883.1| PREDICTED: similar to 39S ribosomal...   123   5E-27 J 
contig01997 gi|193657279|ref|XP_001951507.1| PREDICTED: similar to 67 kDa po...   123   4E-27 JK 
contig00421 gi|159145658|gb|ABW90366.1| putative ribosomal protein L35 [Sipu...   124   2E-27 J 
contig04460 gi|166215964|sp|A2BHJ4.1|CNO6L_DANRE CCR4-NOT transcription comp...   124   2E-27 K 
contig07504 gi|170042852|ref|XP_001849125.1| 39S ribosomal protein L45 [Cule...   125   1E-27 J 
contig04188 gi|66544546|ref|XP_623093.1| PREDICTED: similar to RAD23a homolo...   125   8E-28 L 
contig00677 gi|47550803|ref|NP_999933.1| superkiller viralicidic activity 2-...   126   7E-28 A 
contig05802 gi|91087799|ref|XP_967345.1| PREDICTED: similar to RH56418p [Tri...   126   6E-28 J 
contig11627 gi|156544840|ref|XP_001606830.1| PREDICTED: similar to GA13644-P...   126   5E-28 K 
contig02691 gi|197129949|gb|ACH46447.1| putative LSM4 homolog U6 small nucle...   127   4E-28 A 
contig05067 gi|196007484|ref|XP_002113608.1| hypothetical protein TRIADDRAFT...   127   3E-28 BK 
contig11171 gi|91083589|ref|XP_968607.1| PREDICTED: similar to mitochondrial...   115   3E-28 J 
contig05781 gi|110759283|ref|XP_397014.3| PREDICTED: similar to absent, smal...   128   2E-28 BK 
contig00203 gi|169931071|gb|ACB05775.1| 60S ribosomal protein L37a [Artemia ...   129   1E-28 J 
contig06069 gi|47218337|emb|CAG04169.1| unnamed protein product [Tetraodon n...   129   7E-29 A 
contig06299 gi|31127036|gb|AAF26656.2|AF139006_1 RNA polymerase II largest s...   129   7E-29 K 
contig01687 gi|156540001|ref|XP_001599059.1| PREDICTED: similar to enhancer ...   129   6E-29 K 
contig01748 gi|91085659|ref|XP_971350.1| PREDICTED: similar to Intron-bindin...   129   6E-29 L 
contig04857 gi|195998546|ref|XP_002109141.1| hypothetical protein TRIADDRAFT...   130   6E-29 J 
contig10077 gi|1351179|sp|P49696|SYV_FUGRU Valyl-tRNA synthetase (Valine--tR...   129   6E-29 J 
contig12445 gi|67083895|gb|AAY66882.1| ribosomal protein S25 [Ixodes scapula...   129   6E-29 J 
contig04440 gi|193683638|ref|XP_001952518.1| PREDICTED: similar to mitochond...    98   5E-29 J 
contig04072 gi|195568479|ref|XP_002102243.1| GD19602 [Drosophila simulans] >...   130   3E-29 J 
contig08726 gi|170039954|ref|XP_001847781.1| conserved hypothetical protein ...   130   3E-29 K 
contig06234 gi|153009283|ref|YP_001370498.1| elongation factor G [Ochrobactr...   131   2E-29 J 
contig00115 gi|156349201|ref|XP_001621959.1| hypothetical protein NEMVEDRAFT...   135   9E-30 A 
contig13226 gi|160948300|emb|CAO94751.1| putative ribosomal protein L37 [Pom...   133   5E-30 J 
contig05504 gi|189234959|ref|XP_973320.2| PREDICTED: similar to nonsense-med...   133   4E-30 A 
contig09269 gi|156552599|ref|XP_001601647.1| PREDICTED: similar to 5-3 exori...   134   3E-30 LA 
contig00141 gi|197215705|gb|ACH53093.1| CCR4-NOT transcription complex, subu...   134   2E-30 K 
contig03982 gi|149636761|ref|XP_001505482.1| PREDICTED: hypothetical protein...   134   2E-30 KL 




Contig BLAST result e value Class 
contig08305 gi|91093851|ref|XP_970554.1| PREDICTED: similar to pre-mRNA-spli...   134   2E-30 A 
contig08512 gi|156543001|ref|XP_001603257.1| PREDICTED: similar to RNA-bindi...   134   2E-30 A 
contig01835 gi|149639779|ref|XP_001510132.1| PREDICTED: similar to MGC97718 ...   135   8E-31 A 
contig13042 gi|49619137|gb|AAT68153.1| eukaryotic translation initiation fac...   137   5E-31 J 
contig02573 gi|197129764|gb|ACH46262.1| putative H3 histone family 3B varian...   137   4E-31 B 
contig11750 gi|124487974|gb|ABN12070.1| putative RNA-dependent helicase p68 ...   139   4E-31 A 
contig05561 gi|189234539|ref|XP_973056.2| PREDICTED: similar to AGAP001195-P...    94   3E-31 A 
contig01453 gi|112982956|ref|NP_001037676.1| splicing factor arginine/serine...   139   2E-31 A 
contig12235 gi|83644429|ref|YP_432864.1| hypothetical protein HCH_10036 [Hah...   137   2E-31 K 
contig07323 gi|115767175|ref|XP_798957.2| PREDICTED: similar to Eukaryotic t...   138   1E-31 J 
contig02597 gi|197131003|gb|ACH47049.1| target of rapamycin [Blattella germa...   139   9E-32 L 
contig07360 gi|195589302|ref|XP_002084391.1| GD14248 [Drosophila simulans] >...   139   9E-32 KL 
contig07552 gi|168062615|ref|XP_001783274.1| predicted protein [Physcomitrel...   139   7E-32 J 
contig08491 gi|157103157|ref|XP_001647846.1| elongin b [Aedes aegypti] >gnl|...   139   7E-32 K 
contig08505 gi|198146545|gb|EDY72729.1| GA29178 [Drosophila pseudoobscura ps...   139   7E-32 A 
contig10348 gi|149408557|ref|XP_001513499.1| PREDICTED: similar to G elongat...   139   7E-32 J 
contig11150 gi|157128852|ref|XP_001655225.1| cytoplasmic polyadenylation ele...   142   7E-32 J 
contig07616 gi|110758526|ref|XP_394712.3| PREDICTED: similar to Chip CG3924-...   140   6E-32 K 
contig01682 gi|197210381|gb|ACH48198.1| translation initiation factor 5A [Or...   141   2E-32 J 
contig05282 gi|187936050|gb|ACD37546.1| mitochondrial ribosomal protein s22 ...   141   2E-32 J 
contig11608 gi|169153890|emb|CAQ14784.1| novel protein similar to vertebrate...    96   2E-32 BK 
contig00335 gi|195359243|ref|XP_002045323.1| GM23254 [Drosophila sechellia] ...   145   1E-32 J 
contig02049 gi|110758526|ref|XP_394712.3| PREDICTED: similar to Chip CG3924-...   141   1E-32 K 
contig05055 gi|91086675|ref|XP_968460.1| PREDICTED: similar to seryl-tRNA sy...   141   1E-32 J 
contig05347 gi|51571949|ref|NP_001003978.1| G1 to S phase transition 1 [Ratt...   142   7E-33 J 
contig02071 gi|91088509|ref|XP_971592.1| PREDICTED: similar to pre-mRNA-spli...   142   6E-33 A 
contig11441 gi|148657070|ref|YP_001277275.1| putative endoribonuclease L-PSP...   143   5E-33 J 
contig04975 gi|38490438|emb|CAD57737.1| extradenticle 1 [Cupiennius salei]        143   4E-33 K 
contig12937 gi|48142237|ref|XP_397314.1| PREDICTED: similar to ribosomal pro...   143   4E-33 J 
contig03090 gi|195120149|ref|XP_002004591.1| GI20015 [Drosophila mojavensis]...   144   3E-33 J 
contig00612 gi|170043665|ref|XP_001849498.1| RNA and export factor binding p...   147   2E-33 A 
contig03593 gi|66546305|ref|XP_394723.2| PREDICTED: similar to DEAD (Asp-Glu...   145   1E-33 A 
contig12632 gi|73976787|ref|XP_857499.1| PREDICTED: similar to poly(A) bindi...   145   1E-33 AJ 
contig12271 gi|195582973|ref|XP_002081300.1| GD10948 [Drosophila simulans] >...   145   8E-34 J 
contig03838 gi|170047758|ref|XP_001851377.1| DNA topoisomerase 2 [Culex quin...   146   6E-34 B 
contig10306 gi|195570991|ref|XP_002103487.1| GD18948 [Drosophila simulans] >...   146   6E-34 K 
contig02425 gi|158256662|dbj|BAF84304.1| unnamed protein product [Homo sapiens]   147   3E-34 L 
contig06780 gi|193669397|ref|XP_001951491.1| PREDICTED: similar to AGAP00308...   149   7E-35 J 
contig01963 gi|156548548|ref|XP_001604962.1| PREDICTED: similar to ENSANGP00...   150   4E-35 K 
contig01034 gi|91081091|ref|XP_975490.1| PREDICTED: similar to barrier-to-au...   152   3E-35 BL 
contig11477 gi|70909783|emb|CAJ17317.1| ribosomal protein L24e [Julodis onop...   150   3E-35 J 
contig00227 gi|67084045|gb|AAY66957.1| ribosomal protein L40 [Ixodes scapula...   152   2E-35 J 
contig13121 gi|90419459|ref|ZP_01227369.1| conserved hypothetical protein [A...   151   2E-35 K 
contig11835 gi|114145437|ref|NP_001041456.1| transcription factor [Ciona int...   151   1E-35 B 
contig12873 gi|4689134|gb|AAD27776.1|AF077043_1 60S ribosomal protein L36 [H...   153   5E-36 J 
contig02584 gi|124504396|gb|AAI28806.1| Phenylalanyl-tRNA synthetase, alpha ...   153   4E-36 J 
contig11556 gi|71151998|sp|Q8AWF2|NACA_ORENI Nascent polypeptide-associated ...   158   9E-37 K 
contig11522 gi|156539055|ref|XP_001599770.1| PREDICTED: similar to ENSANGP00...   157   7E-37 B 
contig02663 gi|51965690|emb|CAG29667.1| translation initiation factor 2 gamm...   156   6E-37 J 
contig00386 gi|170041583|ref|XP_001848537.1| ebna2 binding protein P100 [Cul...   158   5E-37 K 




Contig BLAST result e value Class 
contig13232 gi|66506394|ref|XP_624700.1| PREDICTED: similar to CG31618-PA [A...   160   3E-37 B 
contig05104 gi|194374871|dbj|BAG62550.1| unnamed protein product [Homo sapiens]   159   1E-37 L 
contig11352 gi|149287044|gb|ABR23421.1| elongation factor 1-beta [Ornithodor...   144   8E-38 K 
contig02367 gi|157124837|ref|XP_001660547.1| hypothetical protein AaeL_AAEL0...   159   5E-38 J 
contig11006 gi|156554609|ref|XP_001604785.1| PREDICTED: similar to sigma DNA...   162   3E-38 L 
contig11529 gi|194223075|ref|XP_001498098.2| PREDICTED: similar to Hist1h4c ...   162   3E-38 B 
contig11919 gi|156538234|ref|XP_001602190.1| PREDICTED: similar to ENSANGP00...   119   2E-38 K 
contig12810 gi|114675653|ref|XP_001170388.1| PREDICTED: deoxyribonuclease II...   119   2E-38 L 
contig00230 gi|159145788|gb|ABW90431.1| putative ribosomal protein S27 [Bare...   162   1E-38 J 
contig03800 gi|148223485|ref|NP_001085851.1| MGC80911 protein [Xenopus laevi...   162   8E-39 J 
contig04100 gi|115970958|ref|XP_001194184.1| PREDICTED: similar to WD repeat...   164   2E-39 A 
contig06768 gi|70909867|emb|CAJ17420.1| ribosomal protein L35Ae [Carabus gra...   164   2E-39 J 
contig07213 gi|194382944|dbj|BAG59028.1| unnamed protein product [Homo sapiens]   166   7E-40 A 
contig11370 gi|121512010|gb|ABM55456.1| S10e ribosomal protein [Xenopsylla c...   167   6E-40 J 
contig00172 gi|114153130|gb|ABI52731.1| 40S ribosomal protein S24 [Argas mon...   167   4E-40 J 
contig00153 gi|149287152|gb|ABR23475.1| 60s ribosomal protein L34 [Ornithodo...   167   3E-40 J 
contig05901 gi|170575130|ref|XP_001893112.1| Probable ATP-dependent RNA heli...   168   1E-40 A 
contig01043 gi|110757770|ref|XP_393239.3| PREDICTED: similar to Eukaryotic t...   110   8E-41 J 
contig01965 gi|60115445|dbj|BAD90013.1| p68 RNA helicase [Tubifex tubifex]        169   8E-41 A 
contig01870 gi|110766548|ref|XP_623580.2| PREDICTED: similar to eIF3-S8 CG49...   171   5E-41 J 
contig00004 gi|159145778|gb|ABW90426.1| putative ribosomal protein S20 [Bare...   171   2E-41 J 
contig00711 gi|67083893|gb|AAY66881.1| ribosomal protein L27A [Ixodes scapul...   171   2E-41 J 
contig00451 gi|67083795|gb|AAY66832.1| protein translation factor SUI1-like ...   175   6E-42 J 
contig06217 gi|66558122|ref|XP_396907.2| PREDICTED: similar to Nhp2 non-hist...   119   3E-42 AJ 
contig12482 gi|149287166|gb|ABR23482.1| 40S ribosomal protein S12 [Ornithodo...   177   1E-42 J 
contig11987 gi|196476807|gb|ACG76267.1| histone 2B [Amblyomma americanum]         178   6E-43 B 
contig00706 gi|118083778|ref|XP_001232842.1| PREDICTED: hypothetical protein...   177   3E-43 J 
contig02242 gi|112984062|ref|NP_001036824.1| Multiprotein bridging factor 1 ...   179   3E-43 K 
contig01190 gi|72159025|ref|XP_790770.1| PREDICTED: similar to ribosomal pro...   179   1E-43 J 
contig03232 gi|195051695|ref|XP_001993152.1| GH13236 [Drosophila grimshawi] ...   179   1E-43 J 
contig09267 gi|115739074|ref|XP_783189.2| PREDICTED: similar to DPH5 homolog...   178   1E-43 J 
contig12594 gi|158296283|ref|XP_001237856.2| AGAP006668-PA [Anopheles gambia...   183   8E-44 A 
contig02863 gi|92081444|dbj|BAE93269.1| RNA helicase [Tubifex tubifex]            182   5E-44 A 
contig00188 gi|196476807|gb|ACG76267.1| histone 2B [Amblyomma americanum]         182   4E-44 B 
contig00946 gi|24266986|gb|AAN52389.1| ribosomal protein S17 [Branchiostoma ...   180   3E-44 J 
contig11433 gi|156550927|ref|XP_001603100.1| PREDICTED: similar to transcrip...   180   3E-44 K 
contig03135 gi|54400666|ref|NP_001006082.1| eukaryotic translation initiatio...   183   1E-44 J 
contig01347 gi|126321316|ref|XP_001379079.1| PREDICTED: similar to RRS1 ribo...   184   9E-45 J 
contig03939 gi|126332314|ref|XP_001376996.1| PREDICTED: similar to nucleolar...   186   4E-46 AJ 
contig02046 gi|172051200|gb|ACB70375.1| translation elongation factor EF-1 a...   187   2E-46 J 
contig00085 gi|72088524|ref|XP_780039.1| PREDICTED: similar to Ribosomal pro...   188   1E-46 J 
contig00529 gi|195453932|ref|XP_002074008.1| GK14409 [Drosophila willistoni]...   190   3E-47 K 
contig00473 gi|196003590|ref|XP_002111662.1| hypothetical protein TRIADDRAFT...   191   2E-47 AJ 
contig02006 gi|195450945|ref|XP_002072700.1| GK13546 [Drosophila willistoni]...   194   2E-47 B 
contig13040 gi|67083805|gb|AAY66837.1| eukaryotic translation initiation fac...   196   1E-48 J 
contig00166 gi|149287034|gb|ABR23416.1| 60S ribosomal protein L44 [Ornithodo...   140   6E-49 J 
contig00151 gi|51011522|gb|AAT92170.1| ribosomal protein L6 [Ixodes pacificus]    199   3E-49 J 
contig00003 gi|148704906|gb|EDL36853.1| basic leucine zipper and W2 domains ...   201   2E-49 J 
contig11364 gi|149733277|ref|XP_001502820.1| PREDICTED: chromodomain helicas...   197   2E-49 K 
contig02310 gi|170053486|ref|XP_001862696.1| Histone H3c [Culex quinquefasci...   177   1E-49 B 
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contig07684 gi|158286472|ref|XP_308774.4| AGAP006996-PA [Anopheles gambiae s...   198   1E-49 J 
contig13197 gi|51011530|gb|AAT92174.1| ribosomal protein L30 [Ixodes pacific...   198   1E-49 J 
contig13246 gi|65332270|gb|AAY42210.1| ribosomal protein L23 [Haemaphysalis ...   201   4E-50 J 
contig01792 gi|156541180|ref|XP_001600613.1| PREDICTED: similar to histone d...   200   3E-50 B 
contig06542 gi|157105268|ref|XP_001648792.1| pre-mrna cleavage factor im, 25...   202   9E-51 A 
contig08403 gi|156549876|ref|XP_001603892.1| PREDICTED: similar to ribosomal...   203   4E-51 J 
contig03668 gi|157119079|ref|XP_001659326.1| elongation factor tu (ef-tu) [A...   205   3E-51 J 
contig07546 gi|91087871|ref|XP_969564.1| PREDICTED: similar to ribosomal pro...   204   3E-51 J 
contig00199 gi|114153170|gb|ABI52751.1| 40S ribosomal protein S26 [Argas mon...   209   7E-53 J 
contig08490 gi|195055839|ref|XP_001994820.1| GH13965 [Drosophila grimshawi] ...   211   4E-53 J 
contig00384 gi|149286948|gb|ABR23373.1| 40S ribosomal protein S14 [Ornithodo...   214   9E-54 J 
contig02763 gi|51467966|ref|NP_001003860.1| maternal G10 transcript [Danio r...   147   1E-54 K 
contig00406 gi|62122748|ref|NP_001014311.1| eukaryotic translation initiatio...   222   1E-55 J 
contig12199 gi|91086117|ref|XP_968147.1| PREDICTED: similar to S7e ribosomal...   223   1E-56 J 
contig01362 gi|62083461|gb|AAX62455.1| ribosomal protein L13 [Lysiphlebus te...   223   8E-57 J 
contig12195 gi|149689024|gb|ABR27827.1| 40S ribosomal protein S15/S22 [Triat...   227   4E-58 J 
contig01756 gi|121952302|sp|Q09JW2.1|RL17_ARGMO 60S ribosomal protein L17 >g...   228   3E-58 J 
contig00105 gi|83028352|ref|XP_892120.1| PREDICTED: hypothetical protein [Mu...   166   2E-58 J 
contig11850 gi|161661035|gb|ABX75384.1| 40s ribosomal protein S15 [Lycosa si...   233   6E-60 J 
contig02391 gi|149286992|gb|ABR23395.1| ribosomal protein S18 [Ornithodoros ...   235   2E-60 J 
contig03221 gi|67083925|gb|AAY66897.1| ribosomal protein S16 [Ixodes scapula...   235   2E-60 J 
contig12746 gi|67083927|gb|AAY66898.1| ribosomal protein L18a [Ixodes scapul...   236   1E-60 J 
contig03725 gi|48102797|ref|XP_395432.1| PREDICTED: similar to Transcription...   160   3E-61 K 
contig11917 gi|197210381|gb|ACH48198.1| translation initiation factor 5A [Or...   241   1E-61 J 
contig01003 gi|67084019|gb|AAY66944.1| ribosomal protein L21 [Ixodes scapula...   240   4E-62 J 
contig00545 gi|67083991|gb|AAY66930.1| ribosomal protein L19 [Ixodes scapula...   243   1E-62 J 
contig00769 gi|149287142|gb|ABR23470.1| 60s ribosomal protein L18 [Ornithodo...   243   1E-62 J 
contig13085 gi|156548621|ref|XP_001608164.1| PREDICTED: hypothetical protein...   244   5E-63 B 
contig01585 gi|2253411|gb|AAB62936.1| PP2A inhibitor [Tetraodon fluviatilis]      251   4E-65 L 
contig01300 gi|193647951|ref|XP_001943223.1| PREDICTED: similar to eukaryoti...   251   1E-65 J 
contig04011 gi|157118999|ref|XP_001659287.1| DEAD box ATP-dependent RNA heli...   243   5E-66 A 
contig00673 gi|149757872|ref|XP_001492034.1| PREDICTED: similar to ribosomal...   255   3E-66 J 
contig06564 gi|47228339|emb|CAG07734.1| unnamed protein product [Tetraodon n...   254   1E-66 A 
contig12581 gi|161661015|gb|ABX75375.1| 60S ribosomal protein L13A [Lycosa s...   256   9E-67 J 
contig02866 gi|121543837|gb|ABM55583.1| putative 60S ribosomal protein L23 [...   256   6E-67 J 
contig12216 gi|156548621|ref|XP_001608164.1| PREDICTED: hypothetical protein...   265   3E-69 B 
contig11515 gi|194210878|ref|XP_001491419.2| PREDICTED: similar to histone H...   268   3E-70 B 
contig12264 gi|110748814|ref|XP_001120211.1| PREDICTED: similar to arrest CG...   273   2E-71 A 
contig00159 gi|61369380|gb|AAX43326.1| ribosomal protein S13 [synthetic cons...   276   5E-73 J 
contig00535 gi|67083817|gb|AAY66843.1| ribosomal protein S8 [Ixodes scapularis]   278   3E-73 J 
contig13097 gi|91089607|ref|XP_967635.1| PREDICTED: similar to S9e ribosomal...   280   9E-74 J 
contig00187 gi|41054585|ref|NP_955885.1| eukaryotic translation initiation f...   237   3E-74 J 
contig00014 gi|149287182|gb|ABR23490.1| 60S ribosomal protein L9 [Ornithodor...   281   2E-74 J 
contig01669 gi|66511248|ref|XP_623444.1| PREDICTED: similar to CG5684-PA, is...   223   3E-76 A 
contig00229 gi|54039492|sp|Q86FP7|RS23_DERVA 40S ribosomal protein S23 >gnl|...   290   4E-77 J 
contig12388 gi|51011506|gb|AAT92162.1| Shwachman-Bodian-Diamond syndrome-lik...   236   2E-82 J 
contig11602 gi|67084007|gb|AAY66938.1| ribosomal protein L11 [Ixodes scapula...   313   4E-84 J 
contig12503 gi|149287168|gb|ABR23483.1| 40S ribosomal protein SA [Ornithodor...   316   3E-84 J 
contig11880 gi|67083987|gb|AAY66928.1| ribosomal protein L7-like [Ixodes sca...   317   7E-85 J 
contig00163 gi|12848978|dbj|BAB28159.1| unnamed protein product [Mus musculus]    230   2E-85 J 
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contig13196 gi|47214750|emb|CAG01285.1| unnamed protein product [Tetraodon n...   330   1E-88 J 
contig13150 gi|67083973|gb|AAY66921.1| ribosomal protein L15 [Ixodes scapula...   336   1E-90 J 
contig04097 gi|91087957|ref|XP_972849.1| PREDICTED: similar to eIF3-S9 [Trib...   337   6E-91 J 
contig00008 gi|66533098|ref|XP_397307.2| PREDICTED: similar to Ribosomal pro...   338   2E-91 J 
contig01013 gi|67083831|gb|AAY66850.1| 60S acidic ribosomal protein P0 [Ixod...   236   2E-91 J 
contig00649 gi|91080647|ref|XP_974536.1| PREDICTED: similar to DEAD box ATP-...   345   4E-93 A 
contig02376 gi|115735325|ref|XP_798852.2| PREDICTED: similar to Staphylococc...   346   3E-93 K 
contig01129 gi|118403668|ref|NP_001072159.1| hypothetical protein LOC447981 ...   348   5E-94 J 
contig11833 gi|189238197|ref|XP_001807880.1| PREDICTED: similar to translati...   353   2E-95 J 
contig00577 gi|156406016|ref|XP_001641027.1| predicted protein [Nematostella...   261   1E-98 AJ 
contig01777 gi|195055139|ref|XP_001994478.1| GH17270 [Drosophila grimshawi] ...   363   9E-99 A 
contig00211 gi|29825585|gb|AAO92286.1| 40S ribosomal protein S5 [Dermacentor...   369   1E-100 J 
contig00715 gi|67083829|gb|AAY66849.1| 60s ribosomal protein L10 [Ixodes sca...   370   1E-101 J 
contig11420 gi|91087657|ref|XP_973536.1| PREDICTED: similar to eIF2 alpha su...   373   1E-101 J 
contig12622 gi|114153002|gb|ABI52667.1| 40S ribosomal protein S3a [Argas mon...   385   1E-105 J 
contig12743 gi|156536919|ref|XP_001608023.1| PREDICTED: similar to ribosomal...   300   1E-106 A 
contig00763 gi|170059336|ref|XP_001865319.1| eukaryotic translation initiati...   399   1E-109 J 
contig00209 gi|149286910|gb|ABR23354.1| 40S ribosomal protein S2/30S [Ornith...   407   1E-112 J 
contig11568 gi|149689084|gb|ABR27873.1| 60S ribosomal protein L8 [Triatoma i...   292   1E-112 J 
contig00468 gi|132983|sp|P15125|RL5A_XENLA 60S ribosomal protein L5-A >gnl|B...   411   1E-113 J 
contig01885 gi|156392861|ref|XP_001636266.1| predicted protein [Nematostella...   419   1E-115 J 
contig00327 gi|168983901|emb|CAQ09737.1| HLA-B associated transcript 1 [Homo...   426   1E-117 A 
contig00250 gi|75029893|sp|Q4PMB3|RS4_IXOSC 40S ribosomal protein S4 >gnl|BL...   431   1E-119 J 
contig11256 gi|51965682|emb|CAG29663.1| translation initiation factor 2 gamm...   495   1E-151 J 
contig11504 gi|157118999|ref|XP_001659287.1| DEAD box ATP-dependent RNA heli...   484   1E-152 A 
contig00656 gi|145974737|gb|ABQ00072.1| PL10A [Fenneropenaeus chinensis]          601   1E-169 A 
contig01288 gi|66551115|ref|XP_623285.1| PREDICTED: similar to Eukaryotic in...   612   1E-173 J 
contig11541 gi|156554128|ref|XP_001604076.1| PREDICTED: similar to poly A bi...   545   1E-177 AJ 
contig11801 gi|66566113|ref|XP_624821.1| PREDICTED: similar to Ribosomal pro...   633   1E-179 J 
contig00411 gi|66508439|ref|XP_392691.2| PREDICTED: similar to Elongation fa...  1369   0 J 
contig10489 gi|125536477|gb|EAY82965.1| hypothetical protein OsI_036924 [Ory...    23   0 K 
contig12874 gi|40786900|gb|AAR89978.1| putative elongation factor 1-alpha [H...   492   0 J 
contig00023 No hits found 
 
L 
contig00675 No hits found 
 
K 
contig02487 No hits found 
 
J 
contig02803 No hits found 
 
J 
contig02913 No hits found 
 
B 
contig03286 No hits found 
 
B 
contig03568 No hits found 
 
K 
contig04390 No hits found 
 
J 
contig04846 No hits found 
 
K 
contig05208 No hits found 
 
K 
contig05879 No hits found 
 
J 
contig06237 No hits found 
 
K 
contig06425 No hits found 
 
K 
contig06427 No hits found 
 
B 
contig06814 No hits found 
 
J 
contig06982 No hits found 
 
L 
contig07053 No hits found 
 
J 
contig07096 No hits found 
 
J 






Contig BLAST result e value Class 
contig08265 No hits found 
 
K 
contig08384 No hits found 
 
J 
contig08412 No hits found 
 
A 
contig08927 No hits found 
 
K 
contig10054 No hits found 
 
BK 
contig10332 No hits found 
 
K 
contig10586 No hits found 
 
L 
contig11922 No hits found 
 
J 
contig12219 No hits found 
 
K 
contig12456 No hits found 
 
A 
contig12551 No hits found 
 
J 
contig12642 No hits found 
 
L 
contig12692 No hits found 
 
A 








Information storage and processing and Cellular processes and signaling 
Contig BLAST result e value Classification 
contig01496 gi|91078036|ref|XP_966313.1| PREDICTED: similar to casein kinase...   388   1E-106 TDK 
contig11184 gi|47575810|ref|NP_001001249.1| nucleosome assembly protein 1-li...   225   8E-57 BD 
contig04557 gi|91080113|ref|XP_967415.1| PREDICTED: similar to eukaryotic tr...   218   1E-55 JT 
contig02965 gi|170649627|gb|ACB21214.1| host cell factor 1 (predicted) [Call...   218   2E-55 DK 
contig07437 gi|157134878|ref|XP_001656487.1| protein arginine n-methyltransf...   124   8E-51 OKT 
contig07785 gi|193591939|ref|XP_001945590.1| PREDICTED: similar to histone-a...   182   7E-45 OK 
contig03451 gi|194377638|dbj|BAG57767.1| unnamed protein product [Homo sapiens]   135   8E-31 OK 
contig08662 gi|126327443|ref|XP_001367742.1| PREDICTED: similar to replicati...   128   2E-28 DL 
contig05679 gi|157110270|ref|XP_001651031.1| mothers against dpp protein [Ae...   128   2E-28 TK 
contig11538 gi|67084061|gb|AAY66965.1| 40S ribosomal protein S30 [Ixodes sca...   112   6E-27 JO 
contig09762 gi|47220687|emb|CAG11756.1| unnamed protein product [Tetraodon n...   119   8E-26 KT 
contig02077 gi|195571923|ref|XP_002103950.1| GD20702 [Drosophila simulans] >...   118   1E-25 OKT 
contig09011 gi|197215681|gb|ACH53070.1| host cell factor 1 (predicted) [Otol...   107   3E-22 DK 
contig02837 gi|156379827|ref|XP_001631657.1| predicted protein [Nematostella...   101   6E-20 TK 
contig03397 gi|27882339|gb|AAH44511.1| CDC5 cell division cycle 5-like (S. p...    97   4E-19 AD 
contig08303 gi|170041711|ref|XP_001848597.1| mitosis protein dim1 [Culex qui...    88   2E-16 AD 
contig07657 gi|114051800|ref|NP_001040433.1| eukaryotic translation initiati...    66   2E-15 JT 
contig06403 gi|110758541|ref|XP_001120794.1| PREDICTED: similar to HECT, UBA...    85   2E-15 OK 
contig08113 gi|119351872|gb|ABL63639.1| STAT [Hyphantria cunea]                    81   3E-14 KT 
contig02338 gi|48141041|ref|XP_397181.1| PREDICTED: similar to signal transd...    79   1E-13 KT 
contig06544 gi|72016481|ref|XP_779912.1| PREDICTED: similar to replication f...    78   2E-13 DL 
contig00699 gi|149411128|ref|XP_001515279.1| PREDICTED: similar to Rb1-induc...    75   1E-12 KRT 
contig01550 gi|110757972|ref|XP_001120878.1| PREDICTED: similar to delangin ...    74   3E-12 BDL 
contig09339 gi|131328778|gb|AAH35143.2| Tigger transposable element derived ...    62   7E-12 BD 
contig03005 gi|19920938|ref|NP_609217.1| CG17293 CG17293-PA [Drosophila mela...    70   5E-11 ABO 
contig09494 gi|1709741|sp|Q11208|PARP_SARPE Poly [ADP-ribose] polymerase (PA...    69   1E-10 KLO 
contig06844 gi|110749415|ref|XP_624477.2| PREDICTED: similar to Poly [ADP-ri...    67   3E-10 KLO 
contig07159 gi|154273336|ref|XP_001537520.1| hypothetical protein HCAG_07829...    65   1E-09 BD 
contig01721 gi|51889790|gb|AAU12852.1| GCIP-interacting protein [Xenopus tro...    63   6E-09 DA 
contig06563 gi|115625818|ref|XP_785475.2| PREDICTED: similar to CK2 alpha su...    62   2E-08 TDK 
contig07788 gi|115496982|ref|NP_001069134.1| microspherule protein 1 [Bos ta...    60   6E-08 KT 
contig10266 gi|48141041|ref|XP_397181.1| PREDICTED: similar to signal transd...    59   1E-07 KT 
contig00718 gi|194669355|ref|XP_585794.4| PREDICTED: structural maintenance ...    57   6E-07 BDL 
contig02422 gi|154937332|ref|NP_001073186.1| ubinuclein 1 [Gallus gallus]          57   6E-07 KT 
contig05571 gi|170053161|ref|XP_001862547.1| poly [Culex quinquefasciatus] >...    51   3E-05 KLO 
contig09156 gi|115757018|ref|XP_001199118.1| PREDICTED: hypothetical protein...    50   4E-05 KLO 
contig01740 gi|195135210|ref|XP_002012027.1| GI16655 [Drosophila mojavensis]...    47   5E-04 AD 
contig03503 gi|91081917|ref|XP_970376.1| PREDICTED: similar to chromaffin gr...    45   0.002 BD 
contig10161 gi|170590714|ref|XP_001900116.1| SMC proteins Flexible Hinge Dom...    45   0.002 BD 
contig05296 gi|189241940|ref|XP_971495.2| PREDICTED: similar to Serine-prote...    42   0.016 TBLD 
contig02557 gi|156546691|ref|XP_001604244.1| PREDICTED: similar to ENSANGP00...    41   0.026 OJ 
contig09786 gi|194745504|ref|XP_001955228.1| GF16341 [Drosophila ananassae] ...    41   0.035 KRT 
contig13221 gi|85857568|gb|ABC86319.1| IP15837p [Drosophila melanogaster]          44   0.037 BD 
contig09502 gi|170064093|ref|XP_001867382.1| myosin I [Culex quinquefasciatu...    40   0.059 AD 
contig06627 gi|111026197|ref|YP_708480.1| acyl-CoA transferase, N-terminal [...    41   0.073 KTDL 
contig10956 gi|50545761|ref|XP_500419.1| hypothetical protein [Yarrowia lipo...    40   0.078 DK 
contig12823 gi|170574743|ref|XP_001892943.1| Heat shock factor binding prote...    39   0.130 KO 
contig07810 gi|159037567|ref|YP_001536820.1| hypothetical protein Sare_1944 ...    37   0.38 TK 




Contig BLAST result e value Classification 
contig01636 gi|18420415|ref|NP_568409.1| La domain-containing protein / prol...    37   0.650 OJ 
contig12931 gi|194678652|ref|XP_596969.4| PREDICTED: similar to Nuclear enve...    36   0.860 BD 
contig13091 gi|194678652|ref|XP_596969.4| PREDICTED: similar to Nuclear enve...    36   1.100 BD 
contig00281 gi|3641289|gb|AAC36334.1| RF-C/activator 1 homolog [Homo sapiens]      36   1.100 DL 
contig02982 gi|119586334|gb|EAW65930.1| neuronal PAS domain protein 3 [Homo ...    35   1.9 TK 






Information storage and processing, Cellular processes and signaling and 
Metabolism 
Contig BLAST result e value Class 
contig10844 gi|149732126|ref|XP_001497982.1| PREDICTED: similar to Inositol ...    35   2.500 KIT  
contig04618 gi|170066943|ref|XP_001868285.1| amidase [Culex quinquefasciatus...    44   0.004 JIT 
contig05502 gi|156369693|ref|XP_001628109.1| predicted protein [Nematostella...    56   8E-07 JIT 
contig02010 No hits found 
 
OKIT 
contig05236 No hits found 
 
OKIT 








Information storage and processing and Metabolism 
Contig BLAST result e value Class 
contig07805 gi|162287117|ref|NP_001104751.1| wu:fb18g03 [Danio rerio] >gnl|B...    35   2.4 EJ 







Contig BLAST result e value Class 
contig06672 gi|170761567|ref|YP_001787246.1| integrase [Clostridium botulinu...    33   9.600 C 
contig04226 gi|167627306|ref|YP_001677806.1| glycosyltransferase [Francisell...    33   9.400 C 
contig06618 gi|5882239|gb|AAD55259.1|AF159117_1 thermal hysteresis protein i...    33   9.400 C 
contig08779 gi|6323274|ref|NP_013346.1| Cytidine deaminase; catalyzes the mo...    33   9.400 F 
contig05089 gi|195029375|ref|XP_001987549.1| GH19904 [Drosophila grimshawi] ...    33   9.300 E 
contig08674 gi|195337485|ref|XP_002035359.1| GM14667 [Drosophila sechellia] ...    33   9.200 C 
contig00432 gi|15239403|ref|NP_197919.1| PLDALPHA3 (PHOSPHLIPASE D ALPHA 3);...    33   7.300 I 
contig13202 gi|154335645|ref|XP_001564061.1| hypothetical protein LbrM18_V2....    33   7.300 C 
contig00831 gi|163915075|ref|NP_001106519.1| hypothetical protein LOC1001277...    33   7.200 C 
contig01235 gi|41059092|gb|AAR99079.1| xanthine dehydrogenase 2 [Arabidopsis...    33   7.200 IG 
contig01523 gi|195439294|ref|XP_002067566.1| GK16499 [Drosophila willistoni]...    33   7.200 C 
contig03390 gi|194043532|ref|XP_001926169.1| PREDICTED: chloride channel 3 [...    33   7.200 I 
contig03856 gi|194913607|ref|XP_001982736.1| GG16385 [Drosophila erecta] >gn...    33   7.200 P 
contig08408 gi|47226520|emb|CAG08536.1| unnamed protein product [Tetraodon n...    33   7.200 I 
contig09523 gi|119566859|gb|ABL84267.1| TadZ [Yersinia ruckeri]                    33   7.200 E 
contig09655 gi|149917886|ref|ZP_01906381.1| Serine/Threonine protein kinase ...    33   7.200 H 
contig10882 gi|88810943|ref|ZP_01126199.1| ribulose-bisphosphate carboxylase...    33   7.200 Q 
contig04411 gi|167388184|ref|XP_001738464.1| hypothetical protein EDI_097870...    33   7.100 E 
contig11876 gi|110189777|gb|ABG56071.1| hexokinase 2 [Monocercomonoides sp. ...    33   7.100 I 
contig13011 gi|148557627|ref|YP_001265209.1| adenosylcobyric acid synthase (...    33   7.100 G 
contig11863 gi|47211517|emb|CAF90313.1| unnamed protein product [Tetraodon n...    27   6.800 I 
contig07332 gi|169212696|ref|XP_001716936.1| PREDICTED: hypothetical protein...    33   5.600 Q 
contig01793 gi|110772525|ref|XP_625192.2| PREDICTED: similar to CG5205-PA, p...    33   5.500 P 
contig02632 gi|117959924|ref|NP_963912.1| GNAS complex locus isoform e [Mus ...    33   5.500 G 
contig03350 gi|194037217|ref|XP_001924600.1| PREDICTED: similar to phospholi...    33   5.500 C 
contig03911 gi|78211722|ref|YP_380501.1| putative glycosyl transferase, grou...    33   5.500 G 
contig06287 gi|118382431|ref|XP_001024373.1| hypothetical protein TTHERM_005...    33   5.500 I 
contig09701 gi|171322066|ref|ZP_02910938.1| Mammalian cell entry related dom...    33   5.500 C 
contig09758 gi|124001539|ref|NP_001074219.1| SRY-box containing gene 7 [Dani...    33   5.500 G 
contig01909 gi|56551058|ref|YP_161897.1| TolR biopolymer transport protein [...    33   5.400 I 
contig08109 gi|170024821|ref|YP_001721326.1| hypothetical protein YPK_2596 [...    33   5.400 F 
contig01663 gi|73953846|ref|XP_868075.1| PREDICTED: similar to delangin isof...    34   4.300 P 
contig06178 gi|195112532|ref|XP_002000826.1| GI10446 [Drosophila mojavensis]...    34   4.300 I 
contig03038 gi|149027168|gb|EDL82892.1| rCG41735, isoform CRA_a [Rattus norv...    34   4.200 I 
contig05640 gi|149493002|ref|XP_001513425.1| PREDICTED: similar to PANK2 pro...    34   4.200 I 
contig07407 gi|86608148|ref|YP_476910.1| cytochrome oxidase assembly protein...    34   4.200 Q 
contig08875 gi|89094170|ref|ZP_01167113.1| organic solvent tolerance protein...    34   4.200 Q 
contig04719 gi|170106387|ref|XP_001884405.1| predicted protein [Laccaria bic...    35   3.500 C 
contig05367 gi|162147649|ref|YP_001602110.1| putative ribosomal RNA large su...    34   3.300 E 
contig09282 gi|15230521|ref|NP_190069.1| lecithin:cholesterol acyltransferas...    34   3.200 G 
contig10179 gi|193216946|ref|YP_002000188.1| massive surface protein MspK [M...    34   3.200 C 
contig12713 gi|187956956|gb|AAI57934.1| D6Ertd527e protein [Mus musculus]          34   3.200 F 
contig12861 gi|158316180|ref|YP_001508688.1| hypothetical protein Franean1_4...    35   3.100 C 
contig00843 gi|194875784|ref|XP_001973664.1| GG16212 [Drosophila erecta] >gn...    35   2.500 C 
contig02343 gi|193209775|ref|NP_510181.3| F09A5.1 [Caenorhabditis elegans] >...    35   2.500 E 
contig04093 gi|4895195|gb|AAD32782.1|AC007661_19 putative mitochondrial carr...    35   2.500 P 
contig04235 gi|91794002|ref|YP_563653.1| hypothetical protein Sden_2651 [She...    35   2.500 C 
contig12826 gi|198145521|gb|EDY72139.1| GA22932 [Drosophila pseudoobscura ps...    35   2.500 I 




Contig BLAST result e value Class 
contig09854 gi|72393371|ref|XP_847486.1| hypothetical protein, conserved [Tr...    35   1.900 I 
contig12422 gi|6321844|ref|NP_011920.1| Metallothionein, binds copper and me...    35   1.900 P 
contig13067 gi|74004821|ref|XP_545512.2| PREDICTED: similar to ATP-binding c...    36   1.900 Q 
contig02238 gi|168039262|ref|XP_001772117.1| predicted protein [Physcomitrel...    35   1.500 F 
contig06690 gi|189523697|ref|XP_001341635.2| PREDICTED: im:6911926 [Danio re...    35   1.500 P 
contig07035 gi|50290817|ref|XP_447841.1| unnamed protein product [Candida gl...    35   1.500 G 
contig08089 gi|111020072|ref|YP_703044.1| MerR family transcriptional regula...    35   1.500 P 
contig10365 gi|156367570|ref|XP_001627489.1| predicted protein [Nematostella...    35   1.500 I 
contig12208 gi|158296537|ref|XP_316929.4| AGAP008512-PA [Anopheles gambiae s...    35   1.500 IR 
contig04848 gi|170109773|ref|XP_001886093.1| predicted protein [Laccaria bic...    35   1.400 E 
contig10181 gi|54024975|ref|YP_119217.1| acetolactate synthase 1 catalytic s...    35   1.400 E 
contig11536 gi|160941702|ref|ZP_02089029.1| hypothetical protein CLOBOL_0659...    35   1.400 C 
contig00603 gi|77553801|gb|ABA96597.1| MYB10, putative, expressed [Oryza sat...    36   1.100 G 
contig02434 gi|67043765|gb|AAY63981.1| 3-hydroxyacyl-CoA dehydrogenase [Lysi...    36   1.100 G 
contig04671 gi|125583648|gb|EAZ24579.1| hypothetical protein OsJ_008062 [Ory...    36   1.100 C 
contig07763 gi|194217761|ref|XP_001488176.2| PREDICTED: similar to serine hy...    36   1.100 C 
contig07962 gi|189238031|ref|XP_966733.2| PREDICTED: similar to T21C9.6 [Tri...    36   1.100 E 
contig09972 gi|47220907|emb|CAG03114.1| unnamed protein product [Tetraodon n...    36   1.100 P 
contig04394 gi|189240635|ref|XP_969354.2| PREDICTED: similar to AGAP009835-P...    36   0.860 I 
contig04588 gi|116788431|gb|ABK24877.1| unknown [Picea sitchensis]                 36   0.860 E 
contig09050 gi|57109426|ref|XP_549598.1| PREDICTED: hypothetical protein XP_...    36   0.860 C 
contig11461 gi|152965329|ref|YP_001361113.1| EPSP synthase (3-phosphoshikima...    36   0.850 C 
contig00359 gi|189195286|ref|XP_001933981.1| DNA polymerase alpha accessory ...    36   0.840 I 
contig04928 gi|134293884|ref|YP_001117620.1| glutamate dehydrogenase (NAD) [...    36   0.840 P 
contig04935 gi|194564602|ref|YP_002099624.1| Coenzyme F420-dependent N5,N10-...    36   0.840 F 
contig04495 gi|157134805|ref|XP_001656451.1| isocitrate dehydrogenase [Aedes...    37   0.650 E 
contig07260 gi|195037280|ref|XP_001990092.1| GH18426 [Drosophila grimshawi] ...    37   0.650 C 
contig08539 gi|193690532|ref|XP_001942614.1| PREDICTED: similar to ribosomal...    37   0.650 G 
contig02996 gi|195376021|ref|XP_002046795.1| GJ12289 [Drosophila virilis] >g...    39   0.530 Q 
contig00194 gi|169596476|ref|XP_001791662.1| hypothetical protein SNOG_01001...    37   0.520 GE 
contig09012 gi|45361643|ref|NP_989397.1| ER degradation enhancer, mannosidas...    37   0.510 P 
contig03048 gi|45384172|ref|NP_990417.1| ferritin, heavy polypeptide 1 [Gall...    37   0.500 E 
contig00135 gi|186972934|pdb|2Z9A|A Chain A, Crystal Structure Of Human Sapo...    37   0.390 I 
contig06391 gi|195118426|ref|XP_002003738.1| GI18075 [Drosophila mojavensis]...    37   0.390 C 
contig11274 gi|157356366|emb|CAO62518.1| unnamed protein product [Vitis vini...    37   0.390 C 
contig02954 gi|195396455|ref|XP_002056847.1| GJ16668 [Drosophila virilis] >g...    37   0.380 G 
contig03828 gi|86747726|ref|YP_484222.1| translation initiation factor IF-2 ...    37   0.380 C 
contig07010 gi|195384738|ref|XP_002051069.1| GJ14144 [Drosophila virilis] >g...    37   0.380 FE 
contig08736 gi|149634602|ref|XP_001513273.1| PREDICTED: similar to SNARE Vti...    37   0.380 EG 
contig09127 gi|195486210|ref|XP_002091408.1| GE12257 [Drosophila yakuba] >gn...    37   0.380 C 
contig11873 gi|196015978|ref|XP_002117844.1| hypothetical protein TRIADDRAFT...    39   0.290 F 
contig00177 gi|195457363|ref|XP_002075541.1| GK14532 [Drosophila willistoni]...    38   0.230 I 
contig02068 gi|193808552|emb|CAQ39255.1| hypothetical protein, conserved in ...    38   0.220 P 
contig02504 gi|148745279|gb|AAI42446.1| GLTP protein [Bos taurus]                  38   0.220 I 
contig01462 gi|156355189|ref|XP_001623555.1| predicted protein [Nematostella...    39   0.170 G 
contig02587 gi|114663857|ref|XP_523518.2| PREDICTED: malonyl-CoA decarboxyla...    39   0.170 G 
contig03020 gi|118777586|ref|XP_308162.3| AGAP007714-PA [Anopheles gambiae s...    39   0.130 C 
contig03369 gi|66535318|ref|XP_623221.1| PREDICTED: similar to CG31522-PA, i...    39   0.130 F 
contig03536 gi|66766200|dbj|BAD99106.1| divalent metal transporter [Mizuhope...    30   0.130 P 
contig04357 gi|11499248|ref|NP_070486.1| hypothetical protein AF1658 [Archae...    39   0.130 C 




Contig BLAST result e value Class 
contig06052 gi|88706159|ref|ZP_01103866.1| Acyl-CoA dehydrogenase, short-cha...    39   0.130 P 
contig03758 gi|194373881|dbj|BAG62253.1| unnamed protein product [Homo sapiens]    39   0.100 F 
contig04602 gi|193713559|ref|XP_001945410.1| PREDICTED: similar to transmemb...    39   0.100 G 
contig10314 gi|195486388|ref|XP_002091488.1| GE12215 [Drosophila yakuba] >gn...    39   0.100 I 
contig11270 gi|1914843|gb|AAC09470.1| lysosomal alpha-mannosidase [Mus muscu...    39   0.100 H 
contig01689 gi|194766720|ref|XP_001965472.1| GF22508 [Drosophila ananassae] ...    39   0.099 F 
contig11710 gi|169206246|ref|XP_001716022.1| PREDICTED: hypothetical protein...    39   0.099 IR 
contig03433 gi|187597787|ref|ZP_02984044.1| hypothetical protein GdiaDRAFT_2...    40   0.091 I 
contig04899 gi|194335007|ref|YP_002016867.1| cyclase family protein [Prosthe...    40   0.078 I 
contig07423 gi|193659829|ref|XP_001942654.1| PREDICTED: similar to AGAP01194...    40   0.078 C 
contig07649 gi|53791863|dbj|BAD53949.1| unknown protein [Oryza sativa Japoni...    40   0.078 C 
contig02952 gi|1345958|sp|P12276|FAS_CHICK Fatty acid synthase [Includes: [A...    40   0.077 E 
contig09134 gi|149643093|ref|NP_001092606.1| hypothetical protein LOC614494 ...    40   0.077 C 
contig05145 gi|186685256|ref|YP_001868452.1| phosphorylase kinase alphabeta ...    40   0.076 QI 
contig00012 gi|45826276|gb|AAS77782.1| NADH dehydrogenase subunit 3 [Tetrale...    40   0.059 F 
contig01454 gi|190338968|gb|AAI63342.1| Ela2l protein [Danio rerio]                40   0.059 G 
contig12058 gi|156361167|ref|XP_001625391.1| predicted protein [Nematostella...    40   0.051 E 
contig01476 gi|170097792|ref|XP_001880115.1| UTP-glucose-1-phosphate uridyly...    40   0.045 E 
contig02794 gi|149240315|ref|XP_001526033.1| hypothetical protein LELG_02591...    42   0.045 F 
contig00313 gi|50812392|gb|AAT81406.1| fatty acid elongase [Gadus morhua]          42   0.043 P 
contig00244 gi|189237128|ref|XP_972994.2| PREDICTED: similar to sodium bicar...    41   0.034 E 
contig01980 gi|158292089|ref|XP_313650.4| AGAP004367-PA [Anopheles gambiae s...    41   0.034 P 
contig08378 gi|149021392|gb|EDL78855.1| rCG59057, isoform CRA_b [Rattus norv...    41   0.034 C 
contig08810 gi|195115445|ref|XP_002002267.1| GI17291 [Drosophila mojavensis]...    41   0.027 IG 
contig05627 gi|195126769|ref|XP_002007843.1| GI12152 [Drosophila mojavensis]...    41   0.026 G 
contig12663 gi|193610823|ref|XP_001951459.1| PREDICTED: similar to CG10320 C...    42   0.024 G 
contig03292 gi|17558842|ref|NP_503846.1| CYtochrome P450 family member (cyp-...    33   0.020 G 
contig03591 gi|11878241|gb|AAG40862.1| ribonucleotide reductase [Emericella ...    42   0.020 E 
contig01785 gi|68509955|gb|AAY98350.1| acetoacyl-CoA synthetase [Amanita mus...    42   0.016 P 
contig00684 gi|192910870|gb|ACF06543.1| uridylate kinase [Elaeis guineensis]       42   0.015 G 
contig00900 gi|66521130|ref|XP_396194.2| PREDICTED: similar to ATPase type 1...    42   0.015 E 
contig02802 gi|196009740|ref|XP_002114735.1| hypothetical protein TRIADDRAFT...    42   0.015 I 
contig02852 gi|163914443|ref|NP_001106306.1| hypothetical protein LOC1001272...    42   0.015 E 
contig03204 gi|91091362|ref|XP_972603.1| PREDICTED: similar to lethal 35Di [...    43   0.009 Q 
contig03487 gi|195474149|ref|XP_002089354.1| GE19067 [Drosophila yakuba] >gn...    43   0.009 G 
contig04215 gi|119911728|ref|XP_869690.2| PREDICTED: similar to solute carri...    43   0.009 C 
contig08595 gi|191637919|ref|YP_001987085.1| Alpha-glucosidase [Lactobacillu...    43   0.009 C 
contig00967 gi|115614636|ref|XP_001199974.1| PREDICTED: similar to solute ca...    43   0.007 H 
contig05142 gi|158292101|ref|XP_313656.4| AGAP004373-PA [Anopheles gambiae s...    43   0.007 I 
contig07690 gi|147900452|ref|NP_001082222.1| pancreatic elastase 1 [Xenopus ...    43   0.007 P 
contig00412 gi|148673609|gb|EDL05556.1| mCG4140 [Mus musculus]                     44   0.005 F 
contig03328 gi|156368173|ref|XP_001627570.1| predicted protein [Nematostella...    40   0.005 C 
contig04756 gi|195587367|ref|XP_002083436.1| GD13354 [Drosophila simulans] >...    44   0.005 F 
contig05875 gi|157114275|ref|XP_001658020.1| malic enzyme [Aedes aegypti] >g...    44   0.004 G 
contig10791 gi|55736035|gb|AAV63544.1| fed tick salivary protein 10 [Ixodes ...    44   0.004 E 
contig07170 gi|47227771|emb|CAG08934.1| unnamed protein product [Tetraodon n...    44   0.003 P 
contig08624 gi|115615300|ref|XP_791028.2| PREDICTED: similar to FLJ10769 pro...    40   0.003 C 
contig08650 gi|166157941|ref|NP_001107380.1| hypothetical protein LOC1001352...    44   0.003 C 
contig03078 gi|156230054|gb|AAI52204.1| Elovl4 protein [Danio rerio] >gnl|BL...    45   0.002 C 
contig06729 gi|52355639|gb|AAU44969.1| retinal short-chain dehydrogenase/red...    45   0.002 E 




Contig BLAST result e value Class 
contig08951 gi|126337907|ref|XP_001365492.1| PREDICTED: similar to cytosolic...    45   0.002 E 
contig11309 gi|196007390|ref|XP_002113561.1| hypothetical protein TRIADDRAFT...    45   0.002 G 
contig11915 gi|68086161|gb|AAH98178.1| MGC132021 protein [Xenopus laevis]          45   0.002 C 
contig01732 gi|17506935|ref|NP_492149.1| Temporarily Assigned Gene name fami...    46   0.001 I 
contig03199 gi|115960648|ref|XP_001178059.1| PREDICTED: similar to Ubiquinol...    46   0.001 C 
contig04906 gi|114051197|ref|NP_001039492.1| thromboxane A synthase 1 (plate...    45   0.001 I 
contig06161 gi|148222486|ref|NP_001087043.1| cytochrome P450, family 2, subf...    45   0.001 H 
contig07067 gi|58384648|ref|XP_313383.2| AGAP003623-PA [Anopheles gambiae st...    45   0.001 CE 
contig08525 gi|119473973|ref|XP_001258862.1| short-chain dehydrogenase [Neos...    45   0.001 G 
contig11638 gi|157352135|emb|CAO43142.1| unnamed protein product [Vitis vini...    46   0.001 E 
contig13029 gi|188572677|ref|YP_001911141.1| hypothetical protein CBPV_s2gp3...    48   0.001 P 
contig13256 gi|196187308|gb|EDX82284.1| AMP-binding enzyme, putative [Brevun...    46   0.001 E 
contig00780 gi|157123334|ref|XP_001660121.1| oviductin [Aedes aegypti] >gnl|...    46   8E-04 P 
contig00965 gi|71066248|ref|YP_264975.1| glutathione reductase [Psychrobacte...    46   8E-04 G 
contig01131 gi|66517199|ref|XP_624588.1| PREDICTED: similar to CG31860-PA [A...    46   8E-04 P 
contig07340 gi|170062345|ref|XP_001866628.1| elongase [Culex quinquefasciatu...    46   8E-04 I 
contig11645 gi|156351329|ref|XP_001622462.1| predicted protein [Nematostella...    46   8E-04 E 
contig12824 gi|195995563|ref|XP_002107650.1| expressed hypothetical protein ...    47   7E-04 P 
contig08337 gi|386960|gb|AAA36329.1| GT mitochondrial solute carrier protein...    40   6E-04 G 
contig08970 gi|110757192|ref|XP_625219.2| PREDICTED: similar to deoxyribonuc...    47   6E-04 I 
contig11704 gi|51557673|gb|AAU06476.1| cytochrome c oxidase subunit III [Cul...    47   6E-04 GC 
contig01302 gi|148222892|ref|NP_001082410.1| similar to inosine 5'-phosphate...    47   5E-04 C 
contig07001 gi|119112640|ref|XP_317733.3| AGAP007780-PA [Anopheles gambiae s...    47   5E-04 I 
contig09509 gi|66565375|ref|XP_395198.2| PREDICTED: similar to CG1597-PA iso...    47   5E-04 G 
contig10025 gi|66772913|gb|AAY55767.1| IP10521p [Drosophila melanogaster]          47   5E-04 E 
contig10546 gi|156546442|ref|XP_001607215.1| PREDICTED: similar to ENSANGP00...    47   5E-04 E 
contig03017 gi|196014088|ref|XP_002116904.1| hypothetical protein TRIADDRAFT...    47   4E-04 F 
contig04185 gi|66555130|ref|XP_394934.2| PREDICTED: similar to SCAP CG33131-...    47   4E-04 E 
contig04427 gi|56753241|gb|AAW24830.1| SJCHGC04571 protein [Schistosoma japo...    47   4E-04 E 
contig04612 gi|197632233|gb|ACH70840.1| ubiquinol-cytochrome c reductase cor...    41   4E-04 G 
contig08425 gi|170030261|ref|XP_001843008.1| elongation of very long chain f...    47   4E-04 G 
contig08463 gi|159184758|ref|NP_354438.2| branched-chain alpha-keto acid deh...    47   4E-04 G 
contig10521 gi|189524371|ref|XP_001919145.1| PREDICTED: holocarboxylase synt...    48   4E-04 P 
contig01388 gi|126311342|ref|XP_001381718.1| PREDICTED: similar to QPS1 [Mon...    48   3E-04 C 
contig11429 gi|144899161|emb|CAM76025.1| Pyruvate carboxyltransferase [Magne...    48   3E-04 IE 
contig03513 gi|169849301|ref|XP_001831354.1| hypothetical protein CC1G_00901...    49   1E-04 I 
contig04404 gi|196181175|gb|EDX76164.1| O-methyltransferase superfamily [Mic...    49   1E-04 C 
contig04863 gi|115753229|ref|XP_001180582.1| PREDICTED: hypothetical protein...    49   1E-04 P 
contig06903 gi|145233995|ref|XP_001400370.1| hypothetical protein An02g12420...    49   1E-04 F 
contig09375 gi|195969368|gb|ACG60513.1| chitinase 1 precursor [Litopenaeus v...    49   1E-04 G 
contig02486 gi|145352581|ref|XP_001420619.1| predicted protein [Ostreococcus...    50   7E-05 I 
contig04881 gi|156369646|ref|XP_001628086.1| predicted protein [Nematostella...    50   7E-05 Q 
contig05769 gi|156548308|ref|XP_001602653.1| PREDICTED: similar to ctl2 [Nas...    50   6E-05 I 
contig08213 gi|47498070|ref|NP_998829.1| glutamic-oxaloacetic transaminase 1...    50   6E-05 G 
contig08932 gi|195055871|ref|XP_001994836.1| GH17458 [Drosophila grimshawi] ...    50   6E-05 F 
contig11620 gi|149287114|gb|ABR23456.1| cytochrome c oxidase polyprotein IV ...    50   6E-05 C 
contig02994 gi|110762638|ref|XP_624101.2| PREDICTED: similar to small wing C...    50   4E-05 H 
contig03632 gi|115683649|ref|XP_788713.2| PREDICTED: similar to MGC81887 pro...    50   4E-05 I 
contig05593 gi|156377879|ref|XP_001630873.1| predicted protein [Nematostella...    50   4E-05 Q 
contig06954 gi|170052086|ref|XP_001862062.1| multidrug resistance-associated...    50   4E-05 E 




Contig BLAST result e value Class 
contig00970 gi|198131481|gb|EAL27496.2| GA19830 [Drosophila pseudoobscura ps...    51   3E-05 F 
contig01834 gi|194754579|ref|XP_001959572.1| GF11978 [Drosophila ananassae] ...    51   3E-05 C 
contig03633 gi|116245613|ref|XP_001230565.1| AGAP012661-PA [Anopheles gambia...    51   3E-05 G 
contig06414 gi|52219050|ref|NP_001004598.1| hypothetical protein LOC447859 [...    51   3E-05 C 
contig09808 gi|195022723|ref|XP_001985629.1| GH14400 [Drosophila grimshawi] ...    51   3E-05 I 
contig00802 gi|189234287|ref|XP_970030.2| PREDICTED: similar to isocitrate d...    52   2E-05 E 
contig08182 gi|156139061|ref|NP_001095847.1| adenylosuccinate lyase [Bos tau...    40   2E-05 G 
contig09976 gi|91080223|ref|XP_972420.1| PREDICTED: similar to 1-acylglycero...    52   2E-05 G 
contig10768 gi|170596384|ref|XP_001902745.1| Dihydroorotate dehydrogenase, m...    52   2E-05 G 
contig10808 gi|91088621|ref|XP_967480.1| PREDICTED: similar to voltage-depen...    52   2E-05 G 
contig03173 gi|50540382|ref|NP_001002657.1| hypothetical protein LOC436930 [...    52   1E-05 F 
contig04527 gi|158290080|ref|XP_558852.3| AGAP003398-PA [Anopheles gambiae s...    52   1E-05 C 
contig04734 gi|90577971|ref|ZP_01233782.1| glycine dehydrogenase [Vibrio ang...    47   1E-05 G 
contig04791 gi|47227950|emb|CAF97579.1| unnamed protein product [Tetraodon n...    52   1E-05 I 
contig05114 gi|156393384|ref|XP_001636308.1| predicted protein [Nematostella...    52   1E-05 E 
contig06277 gi|197098712|ref|NP_001124971.1| phenylalanine hydroxylase [Pong...    52   1E-05 C 
contig07960 gi|193711493|ref|XP_001951913.1| PREDICTED: similar to CG18317 C...    52   1E-05 C 
contig08373 gi|118090097|ref|XP_001232415.1| PREDICTED: hypothetical protein...    52   1E-05 C 
contig00635 gi|45386071|gb|AAS59853.1| NPC1 precursor [Ornithodoros moubata]       53   9E-06 C 
contig04088 gi|194674931|ref|XP_608091.3| PREDICTED: chymotrypsinogen B1 [Bo...    53   9E-06 EG 
contig06409 gi|91090780|ref|XP_966783.1| PREDICTED: similar to calcium-trans...    53   9E-06 RP 
contig08556 gi|115689712|ref|XP_794215.2| PREDICTED: hypothetical protein, p...    53   7E-06 Q 
contig10838 gi|156551161|ref|XP_001605023.1| PREDICTED: similar to ENSANGP00...    53   7E-06 G 
contig12696 gi|170745006|ref|YP_001766464.1| hemagluttinin domain-containing...    53   7E-06 C 
contig00927 gi|195440466|ref|XP_002068063.1| GK10599 [Drosophila willistoni]...    54   5E-06 G 
contig02277 gi|195431427|ref|XP_002063743.1| GK15833 [Drosophila willistoni]...    54   5E-06 F 
contig06917 gi|156543262|ref|XP_001606750.1| PREDICTED: similar to conserved...    54   5E-06 E 
contig07160 gi|115659660|ref|XP_001199609.1| PREDICTED: similar to prosaposi...    54   5E-06 H 
contig08972 gi|162287393|ref|NP_001104713.1| hypothetical protein LOC1000030...    54   5E-06 F 
contig07836 gi|66511507|ref|XP_623995.1| PREDICTED: similar to CG9307-PA iso...    54   4E-06 H 
contig08832 gi|114051868|ref|NP_001040436.1| hydroxysteroid dehydrogenase [B...    54   4E-06 E 
contig10505 gi|94499123|ref|ZP_01305661.1| short-chain alcohol dehydrogenase...    54   4E-06 C 
contig11311 gi|56756485|gb|AAW26415.1| SJCHGC09157 protein [Schistosoma japo...    54   4E-06 F 
contig02808 gi|67083949|gb|AAY66909.1| ATP synthase H+ transporting, mitocho...    55   3E-06 C 
contig00430 gi|91081589|ref|XP_975344.1| PREDICTED: similar to AGAP011940-PA...    56   2E-06 Q 
contig00855 gi|116004575|ref|NP_001070647.1| hypothetical protein LOC570761 ...    55   2E-06 I 
contig01851 gi|193591736|ref|XP_001948381.1| PREDICTED: similar to xaa-pro a...    55   2E-06 G 
contig01883 gi|117558471|gb|AAI25766.1| LOC548740 protein [Xenopus tropicalis]     55   2E-06 E 
contig07758 gi|196012622|ref|XP_002116173.1| hypothetical protein TRIADDRAFT...    55   2E-06 F 
contig10267 gi|195161561|ref|XP_002021631.1| GL26614 [Drosophila persimilis]...    55   2E-06 I 
contig09767 gi|47222031|emb|CAG08286.1| unnamed protein product [Tetraodon n...    56   1E-06 G 
contig03474 gi|114052669|ref|NP_001040545.1| beta-1,3-galactosyltransferase ...    48   9E-07 I 
contig01989 gi|158293995|ref|XP_315341.4| AGAP005325-PA [Anopheles gambiae s...    56   8E-07 H 
contig02109 gi|115685846|ref|XP_001184955.1| PREDICTED: similar to GA15058-P...    56   8E-07 I 
contig05273 gi|114052613|ref|NP_001040544.1| transaldolase [Bombyx mori] >gn...    56   8E-07 I 
contig06770 gi|47222915|emb|CAF99071.1| unnamed protein product [Tetraodon n...    41   7E-07 E 
contig03760 gi|58268158|ref|XP_571235.1| diacylglycerol O-acyltransferase [C...    57   6E-07 C 
contig06156 gi|170043543|ref|XP_001849443.1| 1-phosphatidylinositol-4,5-bisp...    57   6E-07 E 
contig06033 gi|13162347|ref|NP_077067.1| ferredoxin reductase [Rattus norveg...    57   5E-07 P 
contig07513 gi|195571587|ref|XP_002103784.1| GD18795 [Drosophila simulans] >...    50   5E-07 I 
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contig07854 gi|156543794|ref|XP_001606411.1| PREDICTED: similar to Inositol ...    57   4E-07 I 
contig09414 gi|67083845|gb|AAY66857.1| TATA box binding protein (TBP)-associ...    57   4E-07 I 
contig01557 gi|158287182|ref|XP_560266.3| AGAP001039-PA [Anopheles gambiae s...    58   2E-07 E 
contig03084 gi|72021459|ref|XP_797239.1| PREDICTED: similar to 3 beta-hydrox...    59   2E-07 IE 
contig07860 gi|195397451|ref|XP_002057342.1| GJ16401 [Drosophila virilis] >g...    59   2E-07 I 
contig08466 gi|193676359|ref|XP_001952377.1| PREDICTED: similar to GA19958-P...    58   2E-07 G 
contig11296 gi|115639106|ref|XP_001200384.1| PREDICTED: hypothetical protein...    59   2E-07 C 
contig12543 gi|17570195|ref|NP_508868.1| VITellogenin structural genes (yolk...    60   2E-07 H 
contig04731 gi|193587209|ref|XP_001950230.1| PREDICTED: similar to NADH:ubiq...    48   1E-07 C 
contig05107 gi|110762650|ref|XP_395129.3| PREDICTED: similar to CG10413-PA [...    59   1E-07 I 
contig11211 gi|170050814|ref|XP_001861480.1| amino acid transporter [Culex q...    59   1E-07 C 
contig08281 gi|193641036|ref|XP_001948702.1| PREDICTED: similar to LN1 [Acyr...    59   9E-08 E 
contig09534 gi|156390511|ref|XP_001635314.1| predicted protein [Nematostella...    59   9E-08 C 
contig03264 gi|39577847|gb|AAR28532.1| plasma membrane calcium ATPase PMCA3 ...    60   7E-08 C 
contig08174 gi|66516122|ref|XP_393022.2| PREDICTED: similar to lethal (2) 44...    60   6E-08 G 
contig09501 gi|187608290|ref|NP_001120172.1| hypothetical protein LOC1001452...    60   5E-08 I 
contig06275 gi|6934272|gb|AAF31692.1|AF182744_1 Niemann-Pick type C1 protein...    60   4E-08 P 
contig06498 gi|149048722|gb|EDM01263.1| acyl-Coenzyme A dehydrogenase family...    60   4E-08 C 
contig05319 gi|193605977|ref|XP_001949683.1| PREDICTED: similar to AGAP00551...    61   3E-08 Q 
contig11167 gi|195999632|ref|XP_002109684.1| hypothetical protein TRIADDRAFT...    61   3E-08 C 
contig12071 gi|109118856|ref|XP_001109939.1| PREDICTED: acid alpha-glucosida...    61   3E-08 G 
contig03564 gi|91781275|ref|YP_556482.1| putative ribokinase [Burkholderia x...    61   2E-08 C 
contig05742 gi|6572446|emb|CAB63112.1| serine protease [Pacifastacus leniusc...    62   2E-08 C 
contig08270 gi|17555004|ref|NP_498363.1| T12A2.1 [Caenorhabditis elegans] >g...    61   2E-08 E 
contig10151 gi|118794464|ref|XP_321495.3| AGAP001606-PA [Anopheles gambiae s...    62   2E-08 I 
contig11879 gi|156544090|ref|XP_001605489.1| PREDICTED: similar to bicaudal-...    61   2E-08 I 
contig00278 gi|162287393|ref|NP_001104713.1| hypothetical protein LOC1000030...    63   1E-08 P 
contig01488 gi|193210674|ref|NP_497437.2| Y22D7AL.14 [Caenorhabditis elegans]      62   1E-08 E 
contig04660 gi|195122078|ref|XP_002005539.1| GI19014 [Drosophila mojavensis]...    62   1E-08 I 
contig09965 gi|47211546|emb|CAF96111.1| unnamed protein product [Tetraodon n...    62   1E-08 P 
contig12511 gi|158300633|ref|XP_552182.3| AGAP012028-PA [Anopheles gambiae s...    62   1E-08 G 
contig06164 gi|110755389|ref|XP_001121254.1| PREDICTED: similar to CG11796-P...    63   7E-09 QI 
contig05993 gi|66513180|ref|XP_623441.1| PREDICTED: similar to CG7712-PA [Ap...    63   6E-09 C 
contig06881 gi|170032877|ref|XP_001844306.1| lysosomal acid lipase [Culex qu...    63   6E-09 I 
contig11751 gi|195055751|ref|XP_001994776.1| GH17422 [Drosophila grimshawi] ...    63   6E-09 I 
contig01134 gi|17570463|ref|NP_508505.1| Y71H10A.2 [Caenorhabditis elegans] ...    64   5E-09 G 
contig01319 gi|67083923|gb|AAY66896.1| stunted-like [Ixodes scapularis]            64   5E-09 C 
contig08920 gi|195442552|ref|XP_002069018.1| GK12296 [Drosophila willistoni]...    64   5E-09 P 
contig00282 gi|18859837|ref|NP_573109.1| CG3415 CG3415-PA [Drosophila melano...    64   4E-09 E 
contig00470 gi|156353921|ref|XP_001623156.1| predicted protein [Nematostella...    66   4E-09 I 
contig03012 gi|193666972|ref|XP_001944972.1| PREDICTED: similar to AGAP00888...    64   4E-09 E 
contig06071 gi|46318071|gb|AAS87603.1| cytochrome P450 CYP331A1 [Capitella c...    64   4E-09 G 
contig05001 gi|149922588|ref|ZP_01911017.1| Acyl-CoA dehydrogenase [Plesiocy...    64   3E-09 E 
contig05125 gi|149449616|ref|XP_001519228.1| PREDICTED: similar to ELOVL fam...    64   3E-09 G 
contig08394 gi|193693010|ref|XP_001950596.1| PREDICTED: similar to zinc meta...    64   3E-09 F 
contig01141 gi|170055692|ref|XP_001863695.1| neutral and basic amino acid tr...    67   2E-09 P 
contig06262 gi|159464395|ref|XP_001690427.1| phosphoserine aminotransferase ...    65   2E-09 Q 
contig07125 gi|110761779|ref|XP_397155.3| PREDICTED: similar to lethal (2) k...    65   2E-09 E 
contig07128 gi|66547344|ref|XP_396740.2| PREDICTED: similar to CG12268-PA, i...    65   2E-09 E 
contig07463 gi|195390815|ref|XP_002054063.1| GJ22998 [Drosophila virilis] >g...    65   2E-09 H 
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contig10011 gi|156360723|ref|XP_001625175.1| predicted protein [Nematostella...    65   2E-09 P 
contig12054 gi|156408031|ref|XP_001641660.1| predicted protein [Nematostella...    54   2E-09 IQ 
contig13235 gi|189233593|ref|XP_970417.2| PREDICTED: similar to fatty acid s...    60   2E-09 F 
contig02737 gi|170062302|ref|XP_001866609.1| mitochondrial solute carrier pr...    66   1E-09 I 
contig06613 gi|91082385|ref|XP_968820.1| PREDICTED: similar to alpha-tocophe...    65   1E-09 F 
contig09114 gi|66516122|ref|XP_393022.2| PREDICTED: similar to lethal (2) 44...    65   1E-09 E 
contig04249 gi|58384648|ref|XP_313383.2| AGAP003623-PA [Anopheles gambiae st...    66   8E-10 Q 
contig04595 gi|91093016|ref|XP_969291.1| PREDICTED: similar to Glycerol kina...    66   8E-10 G 
contig08760 gi|50289223|ref|XP_447042.1| unnamed protein product [Candida gl...    66   8E-10 I 
contig10186 gi|158291516|ref|XP_313023.3| AGAP004142-PA [Anopheles gambiae s...    66   8E-10 EF 
contig06429 gi|194217344|ref|XP_001501968.2| PREDICTED: similar to Solute ca...    67   6E-10 I 
contig08439 gi|115738308|ref|XP_781908.2| PREDICTED: similar to Chain  , Avi...    67   6E-10 G 
contig05775 gi|54020920|ref|NP_001005704.1| enoyl Coenzyme A hydratase 1, pe...    67   5E-10 I 
contig11604 gi|195391400|ref|XP_002054348.1| GJ24393 [Drosophila virilis] >g...    68   4E-10 G 
contig01179 gi|193579990|ref|XP_001945355.1| PREDICTED: similar to GA10697-P...    68   3E-10 E 
contig04519 gi|41054629|ref|NP_956848.1| methylthioadenosine phosphorylase [...    68   3E-10 G 
contig04887 gi|156543509|ref|XP_001602197.1| PREDICTED: similar to GA10181-P...    68   3E-10 I 
contig07721 gi|125853302|ref|XP_689157.2| PREDICTED: similar to Mtrr protein...    68   3E-10 G 
contig02144 gi|164420731|ref|NP_001030360.2| transaldolase 1 [Bos taurus]          68   2E-10 I 
contig06950 gi|68405171|ref|XP_686778.1| PREDICTED: similar to 5-nucleotidas...    68   2E-10 G 
contig08591 gi|47523816|ref|NP_999545.1| 3-hydroxy-3-methylglutaryl-Coenzyme...    69   2E-10 H 
contig02585 gi|156549646|ref|XP_001604406.1| PREDICTED: similar to GA13300-P...    47   1E-10 C 
contig03961 gi|47224441|emb|CAG08691.1| unnamed protein product [Tetraodon n...    69   1E-10 I 
contig03499 gi|115749010|ref|XP_785115.2| PREDICTED: hypothetical protein [S...    69   9E-11 E 
contig09909 gi|198130674|gb|EDY67487.1| GA26865 [Drosophila pseudoobscura ps...    69   9E-11 C 
contig13247 gi|156551075|ref|XP_001602774.1| PREDICTED: similar to ENSANGP00...    70   8E-11 P 
contig05446 gi|37958173|gb|AAP35081.1| Der f Alt a 10 allergen [Dermatophago...    70   7E-11 C 
contig05632 gi|47216717|emb|CAG00991.1| unnamed protein product [Tetraodon n...    70   7E-11 F 
contig11760 gi|156537421|ref|XP_001606891.1| PREDICTED: similar to arsenical...    70   7E-11 G 
contig03060 gi|145546067|ref|XP_001458717.1| hypothetical protein GSPATT0002...    50   6E-11 E 
contig07122 gi|156539123|ref|XP_001599438.1| PREDICTED: similar to GA21592-P...    70   5E-11 I 
contig03001 gi|195473339|ref|XP_002088953.1| GE18859 [Drosophila yakuba] >gn...    73   4E-11 P 
contig05992 gi|194211027|ref|XP_001493619.2| PREDICTED: similar to AMP deami...    70   4E-11 P 
contig06641 gi|171695246|ref|XP_001912547.1| unnamed protein product [Podosp...    70   4E-11 H 
contig08694 gi|82658272|ref|NP_001032494.1| hypothetical protein LOC641476 [...    70   4E-11 G 
contig09438 gi|126340819|ref|XP_001373749.1| PREDICTED: hypothetical protein...    70   4E-11 I 
contig11236 gi|156545794|ref|XP_001605783.1| PREDICTED: similar to rCG31985 ...    70   4E-11 I 
contig06230 gi|195382689|ref|XP_002050062.1| GJ21930 [Drosophila virilis] >g...    71   3E-11 P 
contig07320 gi|2494071|sp|Q94688|ALDH9_POLMI Aldehyde dehydrogenase 9 (PM-AL...    71   3E-11 I 
contig00974 gi|198150738|gb|EAL29865.2| GA12151 [Drosophila pseudoobscura ps...    72   2E-11 I 
contig04655 gi|193587229|ref|XP_001951555.1| PREDICTED: similar to hydroxypy...    71   2E-11 G 
contig04853 gi|74814733|sp|Q8I913.1|SMD13_LOXLA Sphingomyelin phosphodiester...    72   2E-11 F 
contig06240 gi|197729548|ref|ZP_03182225.1| acyl-CoA synthetase [Streptomyce...    71   2E-11 Q 
contig08014 gi|93277254|gb|ABF06444.1| electrogenic NBC-like protein [Loligo...    71   2E-11 Q 
contig09800 gi|156377908|ref|XP_001630887.1| predicted protein [Nematostella...    71   2E-11 E 
contig01404 gi|194384202|dbj|BAG64874.1| unnamed protein product [Homo sapiens]    72   1E-11 C 
contig01852 gi|81158008|dbj|BAE48254.1| extracellular superoxide dismutase [...    72   1E-11 H 
contig04996 gi|91093513|ref|XP_969441.1| PREDICTED: similar to tpr repeat nu...    72   1E-11 C 
contig10052 gi|193575579|ref|XP_001951870.1| PREDICTED: similar to hemolymph...    72   1E-11 F 
contig11378 gi|195387487|ref|XP_002052427.1| GJ21736 [Drosophila virilis] >g...    66   1E-11 E 




Contig BLAST result e value Class 
contig07639 gi|50754481|ref|XP_414404.1| PREDICTED: similar to Pyruvate dehy...    73   8E-12 H 
contig00480 gi|196013916|ref|XP_002116818.1| hypothetical protein TRIADDRAFT...    73   6E-12 C 
contig03104 gi|145225845|ref|YP_001136523.1| AMP-dependent synthetase and li...    73   6E-12 C 
contig03682 gi|195126086|ref|XP_002007505.1| GI12986 [Drosophila mojavensis]...    73   6E-12 F 
contig02662 gi|195108859|ref|XP_001999010.1| GI24279 [Drosophila mojavensis]...    76   4E-12 C 
contig05545 gi|195997975|ref|XP_002108856.1| hypothetical protein TRIADDRAFT...    74   4E-12 I 
contig06536 gi|58387114|ref|XP_315337.2| AGAP005323-PB [Anopheles gambiae st...    75   4E-12 E 
contig07942 gi|170065070|ref|XP_001867789.1| conserved hypothetical protein ...    74   4E-12 Q 
contig08376 gi|167517935|ref|XP_001743308.1| predicted protein [Monosiga bre...    74   4E-12 E 
contig08995 gi|157110002|ref|XP_001650914.1| carnitine o-acyltransferase [Ae...    74   4E-12 E 
contig03072 gi|198137984|gb|EDY69913.1| GA25872 [Drosophila pseudoobscura ps...    74   3E-12 F 
contig03825 gi|110762117|ref|XP_001122114.1| PREDICTED: similar to cysteine ...    74   3E-12 G 
contig04073 gi|189240007|ref|XP_966693.2| PREDICTED: similar to vacuolar ATP...    74   3E-12 E 
contig05414 gi|194863622|ref|XP_001970531.1| GG23324 [Drosophila erecta] >gn...    74   3E-12 E 
contig10456 gi|39577847|gb|AAR28532.1| plasma membrane calcium ATPase PMCA3 ...    74   3E-12 C 
contig10657 gi|195013559|ref|XP_001983861.1| GH16129 [Drosophila grimshawi] ...    74   3E-12 C 
contig00113 gi|48101426|ref|XP_392672.1| PREDICTED: similar to CG1746-PA, is...    76   2E-12 G 
contig03600 gi|157117432|ref|XP_001658764.1| tyrosine transporter [Aedes aeg...    75   2E-12 H 
contig03644 gi|55736035|gb|AAV63544.1| fed tick salivary protein 10 [Ixodes ...    75   2E-12 E 
contig04018 gi|158302403|ref|XP_321957.3| AGAP001200-PA [Anopheles gambiae s...    75   2E-12 I 
contig05068 gi|47218158|emb|CAG10078.1| unnamed protein product [Tetraodon n...    75   2E-12 E 
contig07457 gi|147905676|ref|NP_001088580.1| hypothetical protein LOC495458 ...    75   2E-12 E 
contig09721 gi|195382312|ref|XP_002049874.1| GJ21833 [Drosophila virilis] >g...    75   2E-12 P 
contig01320 gi|163939191|ref|YP_001644075.1| aldehyde dehydrogenase [Bacillu...    76   1E-12 C 
contig05061 gi|195128215|ref|XP_002008560.1| GI11746 [Drosophila mojavensis]...    76   1E-12 FE 
contig05313 gi|156550556|ref|XP_001603294.1| PREDICTED: similar to ENSANGP00...    75   1E-12 Q 
contig10868 gi|160373115|gb|ABX38842.1| multidrug resistance-associated prot...    58   1E-12 C 
contig07263 gi|164425151|ref|XP_962376.2| hypothetical protein NCU06342 [Neu...    76   8E-13 E 
contig01746 gi|56710319|ref|NP_001008665.1| platelet coagulation factor XI [...    52   7E-13 I 
contig06907 gi|166158220|ref|NP_001107301.1| hypothetical protein LOC1001350...    76   7E-13 C 
contig09186 gi|189239301|ref|XP_971644.2| PREDICTED: similar to utp-glucose-...    76   7E-13 G 
contig09421 gi|47227107|emb|CAG00469.1| unnamed protein product [Tetraodon n...    76   7E-13 PQ 
contig01459 gi|170040775|ref|XP_001848163.1| 4-nitrophenylphosphatase [Culex...    77   6E-13 C 
contig04221 gi|156548821|ref|XP_001605394.1| PREDICTED: similar to CG9977-PA...    70   5E-13 C 
contig08282 gi|55742254|ref|NP_001006720.1| nucleoside phosphorylase [Xenopu...    77   4E-13 G 
contig09051 gi|189234287|ref|XP_970030.2| PREDICTED: similar to isocitrate d...    77   4E-13 Q 
contig05744 gi|72088537|ref|XP_780121.1| PREDICTED: similar to cytosolic NAD...    77   3E-13 H 
contig09205 gi|196476813|gb|ACG76270.1| adenosine kinase-like protein [Ambly...    77   3E-13 I 
contig09573 gi|195028104|ref|XP_001986919.1| GH20262 [Drosophila grimshawi] ...    56   3E-13 P 
contig10503 gi|158294869|ref|XP_315870.4| AGAP005845-PA [Anopheles gambiae s...    78   3E-13 QI 
contig00622 gi|157773171|ref|XP_001664650.1| hypothetical protein CBG22471 [...    78   2E-13 E 
contig02273 gi|158303308|ref|NP_062203.1| propionyl-coenzyme A carboxylase, ...    79   2E-13 I 
contig03907 gi|198130649|gb|EDY67478.1| GA26930 [Drosophila pseudoobscura ps...    79   2E-13 F 
contig04042 gi|110749750|ref|XP_624152.2| PREDICTED: similar to CG9977-PA [A...    78   2E-13 E 
contig04558 gi|5921919|sp|O42563|CP3AR_ONCMY Cytochrome P450 3A27 (CYPIIIA27...    78   2E-13 C 
contig04722 gi|115758805|ref|XP_001203713.1| PREDICTED: similar to cytochrom...    66   2E-13 P 
contig09379 gi|57098467|ref|XP_540100.1| PREDICTED: similar to CG9413-PA, is...    78   2E-13 Q 
contig10124 gi|115722514|ref|XP_001198640.1| PREDICTED: similar to CG9990-PB...    78   2E-13 P 
contig12434 gi|170059729|ref|XP_001865488.1| NADH:ubiquinone dehydrogenase [...    79   2E-13 I 
contig05650 gi|148224038|ref|NP_001089730.1| hypothetical protein LOC734793 ...    79   1E-13 F 




Contig BLAST result e value Class 
contig09650 gi|156407402|ref|XP_001641533.1| predicted protein [Nematostella...    72   1E-13 C 
contig10145 gi|126311408|ref|XP_001381865.1| PREDICTED: similar to glycogen ...    79   1E-13 E 
contig10146 gi|91094733|ref|XP_975938.1| PREDICTED: similar to AGAP002830-PA...    79   1E-13 I 
contig06732 gi|160872768|ref|ZP_02062900.1| fructose-bisphosphate aldolase c...    79   9E-14 PQ 
contig08767 gi|193659690|ref|XP_001950251.1| PREDICTED: similar to AGAP00764...    79   9E-14 E 
contig02949 gi|195575821|ref|XP_002077775.1| GD23108 [Drosophila simulans] >...    80   7E-14 I 
contig04506 gi|195436172|ref|XP_002066043.1| GK22142 [Drosophila willistoni]...    80   5E-14 I 
contig00091 gi|51011612|gb|AAT92215.1| cytochrome oxidase subunit VIIc [Ixod...    82   4E-14 G 
contig04436 gi|156542993|ref|XP_001603137.1| PREDICTED: similar to ENSANGP00...    80   4E-14 I 
contig11736 gi|170744118|ref|YP_001772773.1| phosphoribosylamine--glycine li...    80   4E-14 G 
contig06032 gi|194219975|ref|XP_001504536.2| PREDICTED: similar to Alpha-ami...    81   3E-14 F 
contig03968 gi|48101936|ref|XP_392725.1| PREDICTED: similar to CG18815-PA, i...    82   2E-14 P 
contig05891 gi|195997821|ref|XP_002108779.1| hypothetical protein TRIADDRAFT...    82   2E-14 IE 
contig06070 gi|166979753|sp|Q8BX37.2|PAPL_MOUSE Iron/zinc purple acid phosph...    82   2E-14 E 
contig06084 gi|194383054|dbj|BAG59083.1| unnamed protein product [Homo sapiens]    81   2E-14 C 
contig09842 gi|91082037|ref|XP_970725.1| PREDICTED: similar to AGAP004744-PA...    81   2E-14 G 
contig02219 gi|157136674|ref|XP_001663817.1| sugar transporter [Aedes aegypt...    82   1E-14 E 
contig03920 gi|193809405|emb|CAQ40107.1| aquaglyceroporin, putative [Plasmod...    67   1E-14 I 
contig08867 gi|91091770|ref|XP_966678.1| PREDICTED: similar to S-adenosylmet...    82   1E-14 I 
contig09745 gi|50344854|ref|NP_001002099.1| hypothetical protein LOC415189 [...    82   1E-14 Q 
contig10706 gi|195570253|ref|XP_002103123.1| GD20259 [Drosophila simulans] >...    82   1E-14 G 
contig03590 gi|56118640|ref|NP_001008120.1| pigm protein [Xenopus tropicalis...    83   8E-15 F 
contig06694 gi|115772601|ref|XP_001183409.1| PREDICTED: hypothetical protein...    83   8E-15 P 
contig07410 gi|212491|gb|AAA48996.1| ORF                                           83   8E-15 E 
contig00348 gi|149699396|ref|XP_001501853.1| PREDICTED: similar to WW domain...    83   6E-15 G 
contig06463 gi|193613296|ref|XP_001946535.1| PREDICTED: similar to CG6950 CG...    77   6E-15 C 
contig02132 gi|42491539|gb|AAS16911.1| 71 kDa salivary protein [Lutzomyia lo...    55   5E-15 C 
contig03778 gi|189546543|ref|XP_001919592.1| PREDICTED: similar to Solute ca...    84   5E-15 I 
contig05228 gi|167522755|ref|XP_001745715.1| predicted protein [Monosiga bre...    84   5E-15 F 
contig05680 gi|189537626|ref|XP_684074.3| PREDICTED: aminoadipate-semialdehy...    84   5E-15 G 
contig10258 gi|115911562|ref|XP_793074.2| PREDICTED: hypothetical protein [S...    84   5E-15 C 
contig04532 gi|193587221|ref|XP_001951102.1| PREDICTED: similar to lethal (2...    84   4E-15 E 
contig08890 gi|154300406|ref|XP_001550619.1| hypothetical protein BC1G_11392...    77   4E-15 P 
contig09427 gi|189238926|ref|XP_001811313.1| PREDICTED: similar to CG8814 CG...    84   4E-15 E 
contig00934 gi|67083961|gb|AAY66915.1| ubiquinol-cytochrome C reductase comp...    86   3E-15 G 
contig02494 gi|170032335|ref|XP_001844037.1| vacuolar ATP synthase subunit H...    84   3E-15 G 
contig02846 gi|115666557|ref|XP_797442.2| PREDICTED: similar to Ppox-prov pr...    84   3E-15 I 
contig01884 gi|187829489|ref|NP_001120706.1| ornithine decarboxylase antizym...    87   2E-15 H 
contig03757 gi|194760099|ref|XP_001962279.1| GF15389 [Drosophila ananassae] ...    85   2E-15 Q 
contig04496 gi|195426310|ref|XP_002061281.1| GK20832 [Drosophila willistoni]...    85   2E-15 G 
contig08369 gi|156717370|ref|NP_001096225.1| SEC14-like 1 [Xenopus (Silurana...    85   2E-15 C 
contig10349 gi|198131524|gb|EAL27542.2| GA21221 [Drosophila pseudoobscura ps...    85   2E-15 E 
contig05570 gi|194862154|ref|XP_001969934.1| GG23666 [Drosophila erecta] >gn...    86   1E-15 P 
contig09242 gi|194226528|ref|XP_001491279.2| PREDICTED: similar to ADP/ATP t...    86   1E-15 E 
contig09484 gi|71895769|ref|NP_001026203.1| ChaC, cation transport regulator...    86   1E-15 C 
contig01603 gi|73982759|ref|XP_864136.1| PREDICTED: similar to NADH-ubiquino...    86   9E-16 I 
contig01880 gi|195431523|ref|XP_002063787.1| GK15853 [Drosophila willistoni]...    86   9E-16 I 
contig05029 gi|156354255|ref|XP_001623314.1| predicted protein [Nematostella...    86   9E-16 F 
contig01421 gi|193078240|gb|ABO13201.2| putative metallopeptidase [Acinetoba...    86   7E-16 C 
contig02658 gi|195494019|ref|XP_002094662.1| GE20080 [Drosophila yakuba] >gn...    87   5E-16 P 




Contig BLAST result e value Class 
contig10567 gi|170068294|ref|XP_001868812.1| glutamine-dependent NAD(+) synt...    87   5E-16 C 
contig00857 gi|149618312|ref|XP_001510407.1| PREDICTED: similar to cytochrom...    89   4E-16 F 
contig03083 gi|66547760|ref|XP_392684.2| PREDICTED: similar to Dihydropterid...    87   4E-16 F 
contig06223 gi|1839194|gb|AAC47636.1| enolase [Dugesia cf. dorotocephala]          87   3E-16 C 
contig10562 gi|195122754|ref|XP_002005876.1| GI20717 [Drosophila mojavensis]...    82   3E-16 C 
contig00880 gi|91091346|ref|XP_972193.1| PREDICTED: similar to predicted pro...    88   2E-16 F 
contig11097 gi|148231141|ref|NP_001083508.1| hypothetical protein LOC398964 ...    89   2E-16 I 
contig11920 gi|156554132|ref|XP_001604231.1| PREDICTED: similar to ubiquinol...    88   2E-16 C 
contig09092 gi|195148434|ref|XP_002015179.1| GL18556 [Drosophila persimilis]...    90   1E-16 G 
contig01481 gi|194224697|ref|XP_001495027.2| PREDICTED: similar to fructose-...    89   9E-17 Q 
contig04550 gi|189241870|ref|XP_971717.2| PREDICTED: similar to saccharopine...    55   9E-17 I 
contig10515 gi|195033324|ref|XP_001988662.1| GH11286 [Drosophila grimshawi] ...    89   9E-17 F 
contig09821 gi|170039628|ref|XP_001847631.1| acyl-CoA oxidase [Culex quinque...    89   8E-17 H 
contig02270 gi|189525113|ref|XP_695050.3| PREDICTED: sulfite oxidase [Danio ...    90   7E-17 I 
contig02795 gi|66517758|ref|XP_623474.1| PREDICTED: similar to Carbonyl redu...    91   6E-17 Q 
contig03175 gi|194745602|ref|XP_001955276.1| GF18677 [Drosophila ananassae] ...    91   3E-17 E 
contig11436 gi|77461455|ref|YP_350962.1| gamma-butyrobetaine hydroxylase [Ps...    92   3E-17 E 
contig04721 gi|198151525|gb|EAL30569.2| GA19849 [Drosophila pseudoobscura ps...    91   2E-17 P 
contig06116 gi|197245693|gb|AAI68641.1| Unknown (protein for MGC:186503) [Xe...    92   2E-17 F 
contig06900 gi|149706173|ref|XP_001502362.1| PREDICTED: similar to NADH dehy...    92   2E-17 P 
contig07626 gi|148235999|ref|NP_001085057.1| hypothetical protein LOC432127 ...    91   2E-17 F 
contig03079 gi|156553614|ref|XP_001599996.1| PREDICTED: similar to CG31522-P...    92   1E-17 G 
contig07804 gi|91084189|ref|XP_967176.1| PREDICTED: similar to AGAP002647-PA...    92   1E-17 E 
contig08750 gi|124295296|gb|ABN04118.1| ATP/ADP translocase [Marsupenaeus ja...    92   1E-17 I 
contig08899 gi|193662234|ref|XP_001948711.1| PREDICTED: similar to alanine a...    92   1E-17 HE 
contig09038 gi|170057714|ref|XP_001864604.1| conserved hypothetical protein ...    67   1E-17 I 
contig02410 gi|17507759|ref|NP_491464.1| F57C9.1b [Caenorhabditis elegans] >...    93   8E-18 E 
contig03752 gi|55736029|gb|AAV63541.1| fed tick salivary protein 7 [Ixodes s...    94   8E-18 GC 
contig04868 gi|195972843|ref|NP_001124421.1| hypothetical protein LOC1001748...    93   8E-18 I 
contig06179 gi|163915469|gb|AAI57302.1| LOC548390 protein [Xenopus tropicalis]     93   6E-18 C 
contig09855 gi|148230290|ref|NP_001080419.1| solute carrier family 25 (carni...    93   6E-18 F 
contig06919 gi|16197889|gb|AAL13694.1| GH26644p [Drosophila melanogaster]          94   4E-18 P 
contig09825 gi|158286795|ref|XP_308929.4| AGAP006817-PA [Anopheles gambiae s...    94   4E-18 C 
contig01200 gi|66515272|ref|XP_623495.1| PREDICTED: similar to Vacuolar ATP ...    78   3E-18 I 
contig07706 gi|115720214|ref|XP_789770.2| PREDICTED: similar to aquaporin 9 ...    94   3E-18 P 
contig08050 gi|195058786|ref|XP_001995500.1| GH17781 [Drosophila grimshawi] ...    94   3E-18 E 
contig08919 gi|195503375|ref|XP_002098625.1| GE23836 [Drosophila yakuba] >gn...    94   3E-18 I 
contig11615 gi|195474885|ref|XP_002089720.1| GE22674 [Drosophila yakuba] >gn...    94   3E-18 E 
contig12284 gi|119352607|gb|ABL63906.1| Na,K,Cl-cotransporter [Amblyomma ame...    94   3E-18 E 
contig13294 gi|195954016|ref|YP_002122317.1| cytochrome c oxidase subunit II...    94   3E-18 P 
contig00011 gi|32481105|gb|AAP83944.1| ATPase subunit 6 [Rhipicephalus haema...    96   2E-18 C 
contig00651 gi|194332534|ref|NP_001123756.1| hypothetical protein LOC1001705...    75   2E-18 C 
contig01773 gi|195124843|ref|XP_002006893.1| GI21317 [Drosophila mojavensis]...    96   2E-18 I 
contig02575 gi|119925522|ref|XP_001253431.1| PREDICTED: similar to Monoacylg...    95   2E-18 C 
contig02857 gi|158301606|ref|XP_321277.4| AGAP001791-PA [Anopheles gambiae s...    95   2E-18 G 
contig03918 gi|26337211|dbj|BAC32290.1| unnamed protein product [Mus musculus]     95   2E-18 F 
contig04691 gi|194226282|ref|XP_001491158.2| PREDICTED: similar to ECHOS1 [E...    95   2E-18 RP 
contig04973 gi|14485281|ref|NP_058968.14| aldehyde dehydrogenase family 1, s...    95   2E-18 I 
contig08359 gi|65332146|gb|AAY42207.1| short chain dehydrogenase-like protei...    58   2E-18 E 
contig00295 gi|166219081|gb|ABY85409.1| chitinase [Scylla serrata]                 96   1E-18 Q 




Contig BLAST result e value Class 
contig00709 gi|6179898|gb|AAF05702.1|AF190129_1 Na+/K+/2Cl- cotransporter [C...    96   9E-19 G 
contig02844 gi|38570373|gb|AAR24625.1| tryptophan oxygenase [Plodia interpun...    96   9E-19 Q 
contig04483 gi|74096077|ref|NP_001027723.1| ATP sulfurylase/APS kinase [Cion...    96   9E-19 C 
contig04999 gi|156547798|ref|XP_001606202.1| PREDICTED: similar to organic a...    96   9E-19 C 
contig01778 gi|158293496|ref|XP_314839.4| AGAP008727-PA [Anopheles gambiae s...    98   8E-19 G 
contig01055 gi|156380971|ref|XP_001632040.1| predicted protein [Nematostella...    97   5E-19 P 
contig10742 gi|195389915|ref|XP_002053617.1| GJ23253 [Drosophila virilis] >g...    97   5E-19 I 
contig12600 gi|195328533|ref|XP_002030969.1| GM24286 [Drosophila sechellia] ...    98   5E-19 P 
contig01342 gi|66553147|ref|XP_624346.1| PREDICTED: similar to Vacuolar ATP ...    97   3E-19 C 
contig01037 gi|76156087|gb|AAX27321.2| SJCHGC02398 protein [Schistosoma japo...    98   2E-19 H 
contig04609 gi|47218833|emb|CAG02818.1| unnamed protein product [Tetraodon n...    99   1E-19 Q 
contig07380 gi|196002753|ref|XP_002111244.1| hypothetical protein TRIADDRAFT...    99   1E-19 E 
contig03334 gi|157132079|ref|XP_001662452.1| coupling factor, putative [Aede...    99   8E-20 P 
contig04559 gi|118794426|ref|XP_321470.3| AGAP001627-PA [Anopheles gambiae s...    85   8E-20 C 
contig08673 gi|126320626|ref|XP_001368242.1| PREDICTED: similar to Chain B, ...    99   8E-20 F 
contig01291 gi|156553749|ref|XP_001601392.1| PREDICTED: similar to gamma-glu...    89   7E-20 Q 
contig01730 gi|91091864|ref|XP_968949.1| PREDICTED: similar to NADH-ubiquino...   101   6E-20 F 
contig02848 gi|12644305|sp|P52307.2|5NTD_BOOMI Protein 5NUC precursor [Inclu...   100   6E-20 C 
contig08379 gi|157132046|ref|XP_001662436.1| potassium/chloride symporter, p...   100   6E-20 PQ 
contig03126 gi|156408908|ref|XP_001642098.1| predicted protein [Nematostella...   101   4E-20 H 
contig11494 gi|91088121|ref|XP_970262.1| PREDICTED: similar to nudix hydrola...   100   4E-20 E 
contig03553 gi|157134166|ref|XP_001656319.1| glycine cleavage system h prote...    66   3E-20 I 
contig05716 gi|189237128|ref|XP_972994.2| PREDICTED: similar to sodium bicar...   100   3E-20 G 
contig01355 gi|156408582|ref|XP_001641935.1| predicted protein [Nematostella...   101   2E-20 C 
contig02484 gi|193636681|ref|XP_001947434.1| PREDICTED: similar to multidrug...   101   2E-20 C 
contig01125 gi|156555239|ref|XP_001604130.1| PREDICTED: similar to MGC52653 ...   102   1E-20 I 
contig02714 gi|156555760|ref|XP_001602610.1| PREDICTED: similar to CG7430-PA...   102   1E-20 IG 
contig02970 gi|70887737|ref|NP_001020716.1| hypothetical protein LOC566769 [...   102   1E-20 P 
contig06193 gi|110764096|ref|XP_624260.2| PREDICTED: similar to hoepel1 CG12...   102   1E-20 C 
contig07567 gi|91076040|ref|XP_972204.1| PREDICTED: similar to CG1814 CG1814...   102   1E-20 I 
contig11077 gi|26000552|gb|AAN75454.1| Na-dependent Cl/HCO3 exchanger [Lolig...   102   1E-20 I 
contig04710 gi|156543124|ref|XP_001605583.1| PREDICTED: similar to tpr repea...   102   7E-21 C 
contig05417 gi|47086263|ref|NP_998051.1| phosphoglucomutase 2 [Danio rerio] ...    86   7E-21 C 
contig05671 gi|193659714|ref|XP_001943295.1| PREDICTED: similar to AGAP00609...    73   7E-21 C 
contig10003 gi|26420454|gb|AAN78224.1| factor D-like protein [Dermacentor va...   102   7E-21 C 
contig00405 gi|149721010|ref|XP_001492275.1| PREDICTED: similar to Thymidyla...   103   6E-21 P 
contig00046 gi|74186440|dbj|BAE42978.1| unnamed protein product [Mus musculus]    105   4E-21 I 
contig04277 gi|88853843|ref|NP_001034691.1| solute carrier family 27, member...    62   4E-21 Q 
contig12094 gi|33286942|gb|AAH55383.1| Echs1 protein [Danio rerio]                103   4E-21 C 
contig06733 gi|94692224|gb|ABF46831.1| multidrug resistance protein MRP2 [Ma...   104   3E-21 I 
contig07465 gi|170049513|ref|XP_001857207.1| serine protease [Culex quinquef...   103   3E-21 C 
contig10702 gi|91076782|ref|XP_967792.1| PREDICTED: similar to sphingosine p...   104   3E-21 I 
contig11252 gi|69933293|ref|ZP_00628495.1| Deoxyribose-phosphate aldolase [P...   104   3E-21 G 
contig06884 gi|36938566|gb|AAQ86831.1| chloride channel [Ixodes scapularis]       104   2E-21 C 
contig05402 gi|195503929|ref|XP_002098862.1| GE10606 [Drosophila yakuba] >gn...   105   1E-21 EF 
contig05512 gi|49474815|ref|YP_032857.1| succinyl-CoA synthetase subunit alp...    72   1E-21 E 
contig01770 gi|189240738|ref|XP_968166.2| PREDICTED: similar to AGAP007574-P...   107   9E-22 G 
contig03137 gi|195583780|ref|XP_002081694.1| GD25577 [Drosophila simulans] >...   105   9E-22 C 
contig01727 gi|195380171|ref|XP_002048844.1| GJ21093 [Drosophila virilis] >g...    73   7E-22 C 
contig04271 gi|187026108|emb|CAP34759.2| C. briggsae CBR-TAT-5 protein [Caen...   106   7E-22 F 




Contig BLAST result e value Class 
contig02919 gi|147904583|ref|NP_001090373.1| electron transfer flavoprotein,...   107   4E-22 C 
contig03185 gi|47217590|emb|CAG02517.1| unnamed protein product [Tetraodon n...   107   4E-22 Q 
contig05160 gi|169768148|ref|XP_001818545.1| hypothetical protein [Aspergill...   107   4E-22 E 
contig06718 gi|156547213|ref|XP_001604483.1| PREDICTED: similar to homogenti...   107   3E-22 I 
contig08291 gi|158286683|ref|XP_308864.3| AGAP006891-PA [Anopheles gambiae s...   107   3E-22 E 
contig01710 gi|156405693|ref|XP_001640866.1| predicted protein [Nematostella...   107   2E-22 G 
contig01745 gi|195113251|ref|XP_002001181.1| GI10642 [Drosophila mojavensis]...   108   2E-22 C 
contig03910 gi|91094297|ref|XP_971720.1| PREDICTED: similar to steroid dehyd...   108   2E-22 I 
contig01873 gi|189237972|ref|XP_001812042.1| PREDICTED: similar to AGAP00927...   108   1E-22 E 
contig03288 gi|66533950|ref|XP_623800.1| PREDICTED: similar to Succinyl coen...   108   1E-22 G 
contig03345 gi|195429930|ref|XP_002063010.1| GK21608 [Drosophila willistoni]...   108   1E-22 G 
contig04746 gi|156546442|ref|XP_001607215.1| PREDICTED: similar to ENSANGP00...   108   1E-22 C 
contig06406 gi|149023839|gb|EDL80336.1| rCG30713, isoform CRA_a [Rattus norv...   108   1E-22 F 
contig07331 gi|109097119|ref|XP_001098147.1| PREDICTED: similar to citrate s...   108   1E-22 G 
contig02312 gi|50753071|ref|XP_413855.1| PREDICTED: similar to Fumarylacetoa...   109   8E-23 F 
contig06138 gi|115440181|ref|NP_001044370.1| Os01g0769100 [Oryza sativa (jap...   109   8E-23 C 
contig02694 gi|195454346|ref|XP_002074200.1| GK12747 [Drosophila willistoni]...   110   5E-23 P 
contig11269 gi|17561328|ref|NP_506376.1| F53F4.10 [Caenorhabditis elegans] >...   110   5E-23 C 
contig08317 gi|170095097|ref|XP_001878769.1| predicted protein [Laccaria bic...   110   4E-23 H 
contig06551 gi|47217700|emb|CAG13331.1| unnamed protein product [Tetraodon n...   110   2E-23 C 
contig06753 gi|157105391|ref|XP_001648848.1| ATP-citrate synthase [Aedes aeg...   111   2E-23 P 
contig08052 gi|193215860|ref|YP_001997059.1| isocitrate dehydrogenase, NAD-d...   111   2E-23 I 
contig11019 gi|156547848|ref|XP_001604320.1| PREDICTED: similar to ENSANGP00...   111   2E-23 G 
contig05000 gi|195052348|ref|XP_001993284.1| GH13153 [Drosophila grimshawi] ...    91   1E-23 E 
contig05174 gi|113681577|ref|NP_001038619.1| hypothetical protein LOC568160 ...   112   1E-23 I 
contig07679 gi|157113072|ref|XP_001651879.1| acetyl-coa carboxylase [Aedes a...   112   1E-23 G 
contig08352 gi|157110450|ref|XP_001651107.1| plasma membrane calcium-transpo...   112   1E-23 C 
contig05215 gi|148227451|ref|NP_001089298.1| hypothetical protein LOC734347 ...   112   7E-24 F 
contig01305 gi|91090998|ref|XP_974932.1| PREDICTED: similar to AGAP003680-PA...   113   6E-24 I 
contig10588 gi|71896949|ref|NP_001026492.1| major facilitator superfamily do...   113   4E-24 F 
contig12295 gi|115741846|ref|XP_001198932.1| PREDICTED: similar to CG9990-PB...    96   4E-24 E 
contig03332 gi|62955483|ref|NP_001017755.1| NADH dehydrogenase (ubiquinone) ...   114   2E-24 FQ 
contig07351 gi|108744354|gb|ABG02425.1| glutathione reductase [Tigriopus jap...   114   2E-24 I 
contig08142 gi|66531425|ref|XP_623450.1| PREDICTED: similar to CG7920-PA, is...   114   2E-24 F 
contig08770 gi|156390853|ref|XP_001635484.1| predicted protein [Nematostella...   114   2E-24 E 
contig10437 gi|195486942|ref|XP_002091716.1| GE12096 [Drosophila yakuba] >gn...   114   2E-24 C 
contig01321 gi|109128739|ref|XP_001103601.1| PREDICTED: aspartate aminotrans...   115   1E-24 E 
contig12876 gi|157929880|gb|ABW04128.1| endozepine [Epinephelus coioides]         116   6E-25 PQ 
contig05017 gi|152207621|gb|ABS30897.1| 5'-nucleotidase/putative apyrase iso...   116   5E-25 C 
contig05648 gi|60302696|ref|NP_001012540.1| ATP-binding cassette, sub-family...   116   5E-25 C 
contig11305 gi|170582233|ref|XP_001896037.1| N-myristoyltransferase 2 [Brugi...   116   5E-25 P 
contig00940 gi|50752839|ref|XP_413770.1| PREDICTED: hypothetical protein [Ga...   117   4E-25 I 
contig04449 gi|170034336|ref|XP_001845030.1| isocitrate dehydrogenase [Culex...   117   4E-25 I 
contig02899 gi|53933295|ref|NP_990229.1| thymidine kinase 1, soluble [Gallus...   117   3E-25 H 
contig04330 gi|115640689|ref|XP_780760.2| PREDICTED: hypothetical protein [S...   117   3E-25 C 
contig02788 gi|157114716|ref|XP_001652386.1| methylmalonate-semialdehyde deh...   118   2E-25 E 
contig03235 gi|114707413|ref|ZP_01440309.1| probable enolase protein [Fulvim...   117   2E-25 P 
contig04150 gi|195392792|ref|XP_002055038.1| GJ19157 [Drosophila virilis] >g...   117   2E-25 E 
contig01676 gi|62857761|ref|NP_001017234.1| steroid dehydrogenase-like [Xeno...   121   1E-25 P 
contig10898 gi|193783653|dbj|BAG53564.1| unnamed protein product [Homo sapiens]   119   1E-25 I 




Contig BLAST result e value Class 
contig11001 gi|170054407|ref|XP_001863115.1| cytosolic purine 5-nucleotidase...   119   6E-26 I 
contig02329 gi|72042689|ref|XP_794417.1| PREDICTED: similar to Retinol dehyd...   120   5E-26 H 
contig03180 gi|156547719|ref|XP_001605273.1| PREDICTED: similar to MGC97830 ...   120   5E-26 G 
contig02302 gi|45382681|ref|NP_990806.1| Na,K-ATPase alpha-3-subunit [Gallus...   120   4E-26 C 
contig07528 gi|38194439|gb|AAR13229.1| glycerol-3-phosphate dehydrogenase [C...   115   4E-26 I 
contig00584 gi|156396842|ref|XP_001637601.1| predicted protein [Nematostella...   120   3E-26 Q 
contig05945 gi|194034149|ref|XP_001924714.1| PREDICTED: similar to adenylate...   120   3E-26 P 
contig11030 gi|156551900|ref|XP_001606799.1| PREDICTED: similar to ENSANGP00...   121   2E-26 QI 
contig12273 gi|67084103|gb|AAY66986.1| F1F0-type ATP synthase subunit g [Ixo...   121   2E-26 I 
contig13318 gi|156548537|ref|XP_001602077.1| PREDICTED: similar to ENSANGP00...   121   2E-26 G 
contig04932 gi|156393904|ref|XP_001636567.1| predicted protein [Nematostella...   113   6E-27 G 
contig01284 gi|45219771|gb|AAH66902.1| Myo-inositol 1-phosphate synthase A1 ...   108   2E-27 I 
contig01688 gi|115942978|ref|XP_787078.2| PREDICTED: hypothetical protein [S...   108   2E-27 G 
contig07429 gi|156542905|ref|XP_001601219.1| PREDICTED: similar to adenosine...   126   2E-27 E 
contig09760 gi|157813368|gb|ABV81429.1| putative hypothetical 44.9 kDa prote...   125   1E-27 C 
contig07527 gi|157776283|ref|XP_001666207.1| hypothetical protein CBG09180 [...   126   6E-28 C 
contig00596 gi|186920389|gb|ACC95446.1| glutamate dehydrogenase [Litopenaeus...   112   5E-28 C 
contig05404 gi|156551734|ref|XP_001599719.1| PREDICTED: similar to conserved...   126   5E-28 Q 
contig07048 gi|193591861|ref|XP_001945864.1| PREDICTED: similar to serine pr...   127   4E-28 G 
contig00009 gi|156547609|ref|XP_001603441.1| PREDICTED: similar to CG8680-PA...   128   3E-28 I 
contig02821 gi|157110519|ref|XP_001651137.1| utp-glucose-1-phosphate uridyly...   128   2E-28 F 
contig01306 gi|23308625|ref|NP_694493.1| fatty acid binding protein 3, muscl...   130   1E-28 P 
contig01538 gi|47522760|ref|NP_999131.1| long-chain 3-ketoacyl-CoA thiolase ...   129   1E-28 QI 
contig03485 gi|195126843|ref|XP_002007878.1| GI13181 [Drosophila mojavensis]...   128   1E-28 C 
contig08289 gi|91084231|ref|XP_969408.1| PREDICTED: similar to pyrroline-5-c...   128   1E-28 I 
contig00926 gi|110757125|ref|XP_625036.2| PREDICTED: similar to Phosphoribos...   129   7E-29 H 
contig08152 gi|156406811|ref|XP_001641238.1| predicted protein [Nematostella...   129   7E-29 G 
contig00981 gi|94421562|gb|ABF18888.1| delta-9 desaturase [Lygus lineolaris]      131   4E-29 G 
contig02432 gi|194881310|ref|XP_001974791.1| GG21959 [Drosophila erecta] >gn...   130   3E-29 C 
contig04152 gi|156548342|ref|XP_001603387.1| PREDICTED: similar to CG3297-PB...   130   3E-29 E 
contig10378 gi|189095482|ref|YP_001936641.1| NADH dehydrogenase subunit 4 [L...   130   3E-29 C 
contig04130 gi|158288815|ref|XP_310644.4| AGAP000448-PA [Anopheles gambiae s...   131   2E-29 C 
contig05489 gi|47199333|emb|CAF87694.1| unnamed protein product [Tetraodon n...   131   2E-29 G 
contig12884 gi|30102420|gb|AAP03985.1| cytochrome c oxidase subunit 1 [Strat...   131   2E-29 C 
contig06384 gi|156390853|ref|XP_001635484.1| predicted protein [Nematostella...   132   1E-29 F 
contig02590 gi|51949802|gb|AAU14833.1| adenosine kinase isoform 2S [Nicotian...   132   7E-30 E 
contig07069 gi|66511322|ref|XP_623076.1| PREDICTED: similar to CG9520-PB, is...   132   7E-30 I 
contig11343 gi|74003677|ref|XP_545253.2| PREDICTED: similar to major facilit...   134   7E-30 G 
contig11909 gi|67083995|gb|AAY66932.1| cytochrome c oxidase polypeptide Vb [...   135   7E-30 E 
contig07666 gi|198151502|gb|EAL30537.2| GA13420 [Drosophila pseudoobscura ps...   133   5E-30 P 
contig01696 gi|31202411|ref|XP_310154.1| AGAP009537-PA [Anopheles gambiae st...   133   4E-30 E 
contig03525 gi|91082435|ref|XP_970856.1| PREDICTED: similar to AGAP010039-PA...    94   4E-30 C 
contig12978 gi|3970893|dbj|BAA34806.1| serin proteinase 2 [Haemaphysalis lon...   135   3E-30 I 
contig05815 gi|167519412|ref|XP_001744046.1| predicted protein [Monosiga bre...   134   2E-30 I 
contig05937 gi|195131189|ref|XP_002010033.1| GI14910 [Drosophila mojavensis]...   134   2E-30 I 
contig05468 gi|147906027|ref|NP_001088098.1| hypothetical protein LOC494796 ...   135   1E-30 G 
contig10510 gi|47218252|emb|CAF96289.1| unnamed protein product [Tetraodon n...   135   1E-30 G 
contig11535 gi|27311161|ref|NP_758881.1| NADH dehydrogenase subunit 4 [Varro...   139   5E-31 C 
contig01308 gi|195578891|ref|XP_002079297.1| GD23872 [Drosophila simulans] >...   138   2E-31 G 
contig02961 gi|156542476|ref|XP_001599672.1| PREDICTED: similar to ENSANGP00...   137   2E-31 I 




Contig BLAST result e value Class 
contig11045 gi|22164298|gb|AAM93654.1|AF483732_1 putative secreted NADH-ubiq...   138   2E-31 E 
contig11385 gi|91090684|ref|XP_974597.1| PREDICTED: similar to AGAP005222-PB...   140   2E-31 F 
contig06171 gi|196006812|ref|XP_002113272.1| hypothetical protein TRIADDRAFT...   120   1E-31 I 
contig08433 gi|72088438|ref|XP_792502.1| PREDICTED: similar to high density ...   138   1E-31 I 
contig06968 gi|193678979|ref|XP_001951009.1| PREDICTED: similar to predicted...   139   9E-32 G 
contig02304 gi|110757125|ref|XP_625036.2| PREDICTED: similar to Phosphoribos...   140   4E-32 G 
contig07207 gi|158289559|ref|XP_311260.4| AGAP000721-PA [Anopheles gambiae s...   141   2E-32 P 
contig00526 gi|56756378|gb|AAW26362.1| SJCHGC08585 protein [Schistosoma japo...   142   1E-32 I 
contig06194 gi|78190715|gb|ABB29679.1| methylthioadenosine phosphorylase MTA...   105   9E-33 G 
contig11889 gi|114153138|gb|ABI52735.1| mitochondrial ATP synthase F chain [...   143   6E-33 PQ 
contig02588 gi|195156388|ref|XP_002019082.1| GL25621 [Drosophila persimilis]...   143   4E-33 G 
contig04675 gi|157127160|ref|XP_001661062.1| cysteine desulfurylase [Aedes a...   144   2E-33 G 
contig08304 gi|189241870|ref|XP_971717.2| PREDICTED: similar to saccharopine...    93   2E-33 E 
contig02843 gi|66508366|ref|XP_623071.1| PREDICTED: similar to Inosine-5-mon...   145   8E-34 G 
contig00201 gi|149695380|ref|XP_001489937.1| PREDICTED: similar to Elastase-...    93   5E-34 H 
contig11578 gi|198150845|gb|EAL29946.2| GA21583 [Drosophila pseudoobscura ps...   149   5E-34 P 
contig10159 gi|110757127|ref|XP_001121693.1| PREDICTED: similar to CG5731-PA...   146   4E-34 E 
contig04593 gi|156543929|ref|XP_001607212.1| PREDICTED: similar to ENSANGP00...   149   5E-35 I 
contig06036 gi|91091714|ref|XP_966527.1| PREDICTED: similar to elongation of...   151   5E-35 C 
contig07300 gi|91087539|ref|XP_970257.1| PREDICTED: similar to electron-tran...   150   4E-35 G 
contig00369 gi|157167424|ref|XP_001660686.1| NADH:ubiquinone dehydrogenase, ...   151   3E-35 H 
contig00702 gi|194749219|ref|XP_001957037.1| GF10225 [Drosophila ananassae] ...    91   3E-35 I 
contig06578 gi|195026936|ref|XP_001986371.1| GH21324 [Drosophila grimshawi] ...   152   6E-36 I 
contig00212 gi|193594270|ref|XP_001942800.1| PREDICTED: similar to S-adenosy...   154   2E-36 I 
contig11959 gi|51011610|gb|AAT92214.1| cytochrome c oxidase subunit Va [Ixod...   157   8E-37 I 
contig00375 gi|115665420|ref|XP_786125.2| PREDICTED: similar to putative gly...   107   6E-37 E 
contig02327 gi|82878755|gb|AAW78557.2| vitellogenin [Dermacentor variabilis]      158   5E-37 I 
contig00690 gi|56684769|gb|AAW22505.1| ferritin heavy chain-1b [Carcinoscorp...   160   1E-37 C 
contig13356 gi|30692450|gb|AAP33409.1| cytochrome c oxidase subunit I [Myrmi...   162   1E-38 G 
contig00072 gi|109463918|ref|XP_001056911.1| PREDICTED: similar to stearoyl-...   136   7E-39 C 
contig01152 gi|194224071|ref|XP_001490939.2| PREDICTED: succinate dehydrogen...   162   6E-39 G 
contig02729 gi|67083875|gb|AAY66872.1| ATP synthase D chain [Ixodes scapularis]   165   6E-39 PQ 
contig01769 gi|110755373|ref|XP_396540.3| PREDICTED: similar to spinster CG8...   140   4E-39 RP 
contig03462 gi|77955974|gb|ABB05539.1| mitochondrial manganese superoxide di...   165   2E-39 Q 
contig05269 gi|161088766|gb|ABX57442.1| cytosolic malate dehydrogenase [Apor...   165   9E-40 I 
contig11496 gi|170064241|ref|XP_001867443.1| 2-oxoglutarate dehydrogenase E1...   167   3E-40 E 
contig11567 gi|157123148|ref|XP_001660031.1| hexokinase [Aedes aegypti] >gnl...   167   2E-40 E 
contig02986 gi|66511507|ref|XP_623995.1| PREDICTED: similar to CG9307-PA iso...   168   1E-40 E 
contig11865 gi|157073915|ref|NP_001096672.1| elastase 1, pancreatic [Gallus ...   148   1E-40 E 
contig03924 gi|156538693|ref|XP_001607780.1| PREDICTED: similar to spermidin...   170   5E-41 IR 
contig06418 gi|189524083|ref|XP_001918523.1| PREDICTED: hypothetical protein...   169   5E-41 G 
contig04107 gi|91082287|ref|XP_973816.1| PREDICTED: similar to sodium/solute...   122   4E-41 H 
contig02479 gi|194217822|ref|XP_001497298.2| PREDICTED: similar to Excitator...   108   1E-41 E 
contig05025 gi|91083531|ref|XP_973193.1| PREDICTED: similar to predicted pro...   172   1E-41 G 
contig00519 gi|168824098|gb|ACA30403.1| hexokinase [Crassostrea gigas]            172   7E-42 G 
contig11199 gi|126338475|ref|XP_001364598.1| PREDICTED: similar to high dens...   173   6E-42 E 
contig01171 gi|162462458|ref|NP_001105881.1| UMP synthase [Zea mays] >gnl|BL...   175   1E-42 E 
contig01735 gi|2829707|sp|P81023|HBA_MELGA Hemoglobin subunit alpha-A (Hemog...   175   9E-43 I 
contig03443 gi|47228564|emb|CAG05384.1| unnamed protein product [Tetraodon n...   175   9E-43 I 
contig11637 gi|49257190|gb|AAH72658.1| Enoyl Coenzyme A hydratase, short cha...   137   4E-43 C 




Contig BLAST result e value Class 
contig05359 gi|163916462|gb|AAI57294.1| Hydroxyacyl-Coenzyme A dehydrogenase...   180   6E-44 G 
contig07915 gi|119590785|gb|EAW70379.1| NADH dehydrogenase (ubiquinone) Fe-S...   152   3E-45 C 
contig12306 gi|39653771|ref|NP_945222.1| NADH dehydrogenase subunit 5 [Haema...   125   3E-45 I 
contig00816 gi|91088235|ref|XP_973797.1| PREDICTED: similar to NADH-ubiquino...   150   9E-46 P 
contig12639 gi|124076983|sp|P00040|CYC_SCHGR Cytochrome c                         190   4E-47 C 
contig13193 gi|27311165|ref|NP_758885.1| NADH dehydrogenase subunit 1 [Varro...   194   6E-48 QR 
contig11544 gi|91092948|ref|XP_972400.1| PREDICTED: similar to Rieske iron-s...   201   5E-50 I 
contig11525 gi|156397107|ref|XP_001637733.1| predicted protein [Nematostella...   160   3E-50 C 
contig01007 gi|291866|gb|AAA35578.1| ATPase                                       201   2E-50 H 
contig01937 gi|126338475|ref|XP_001364598.1| PREDICTED: similar to high dens...   203   2E-50 I 
contig03555 gi|156537219|ref|XP_001605059.1| PREDICTED: similar to fatty aci...   205   1E-51 P 
contig00381 gi|145579797|pdb|2JDI|G Chain G, Ground State Structure Of F1-At...   209   4E-52 HR 
contig03238 gi|54887356|gb|AAH37009.1| Hydroxyacyl-Coenzyme A dehydrogenase/...   208   3E-52 G 
contig00171 gi|194319795|gb|ABW82681.2| vitellogenin-2 precursor [Dermacento...   212   1E-52 C 
contig11060 gi|66557932|ref|XP_623386.1| PREDICTED: similar to Glycogen phos...   208   1E-52 I 
contig12032 gi|82878755|gb|AAW78557.2| vitellogenin [Dermacentor variabilis]      209   9E-53 P 
contig04137 gi|187608195|ref|NP_001120566.1| hypothetical protein LOC1001457...   209   7E-53 E 
contig00385 gi|195969366|gb|ACG60512.1| chitinase 1 precursor [Scylla serrata]    209   6E-53 F 
contig05283 gi|158301525|ref|XP_321196.4| AGAP001870-PA [Anopheles gambiae s...   211   6E-53 H 
contig04205 gi|157690439|gb|ABV65906.1| sodium/potassium-transporting ATPase...   154   3E-53 F 
contig13158 gi|5835683|ref|NP_008499.1|COX2_15044 cytochrome c oxidase subun...   215   2E-54 E 
contig05503 gi|109461932|ref|XP_001079287.1| PREDICTED: similar to glycogen ...   216   1E-54 P 
contig08309 gi|151427590|tpd|FAA00352.1| TPA: predicted dual oxidase [Apis m...   217   3E-55 I 
contig01709 gi|89271291|emb|CAJ82653.1| dihydropyrimidine dehydrogenase [Xen...   181   1E-55 C 
contig11811 gi|195156303|ref|XP_002019040.1| GL26145 [Drosophila persimilis]...   220   6E-56 Q 
contig08786 gi|156548615|ref|XP_001608103.1| PREDICTED: similar to CuZn supe...   222   3E-56 P 
contig02897 gi|121543963|gb|ABM55646.1| putative vacuolar ATP synthase prote...   223   1E-56 I 
contig11896 gi|91077486|ref|XP_968733.1| PREDICTED: similar to H+ transporti...   224   9E-57 F 
contig00363 gi|2499486|sp|Q27543|K6PF_CALFI 6-phosphofructokinase (Phosphofr...   222   8E-57 C 
contig01111 gi|170038460|ref|XP_001847068.1| deoxyuridine 5'-triphosphate nu...   225   4E-57 G 
contig01510 gi|170172430|dbj|BAG12983.1| kynurenine aminotransferase [Haemap...   225   2E-57 C 
contig01743 gi|91084123|ref|XP_967224.1| PREDICTED: similar to aspartate ami...   206   2E-57 G 
contig12228 gi|189095643|ref|YP_001936484.1| cytochrome c oxidase subunit I ...   228   4E-58 P 
contig02614 gi|47219329|emb|CAG10958.1| unnamed protein product [Tetraodon n...   227   3E-58 G 
contig08892 gi|1213460|gb|AAB51350.1| C subunit of V-ATPase                       229   7E-59 Q 
contig01951 gi|67083945|gb|AAY66907.1| putative ATP synthase-like protein [I...   232   6E-59 C 
contig03556 gi|158298125|ref|XP_318298.4| AGAP001065-PA [Anopheles gambiae s...   231   1E-59 I 
contig00660 gi|126313584|ref|XP_001363206.1| PREDICTED: similar to flavin-co...   236   8E-61 E 
contig00022 gi|161669226|gb|ABX75465.1| nucleoside diphosphate kinase [Lycos...   237   4E-61 E 
contig00774 gi|193620315|ref|XP_001945213.1| PREDICTED: similar to AGAP00263...   146   4E-61 F 
contig06731 gi|156537608|ref|XP_001607735.1| PREDICTED: similar to ENSANGP00...   236   3E-61 C 
contig03297 gi|170042855|ref|XP_001849126.1| vacuolar ATP synthase subunit e...   241   2E-61 G 
contig12646 gi|38707983|ref|NP_944590.1| aconitase 2, mitochondrial [Danio r...   238   1E-61 C 
contig00610 gi|115898441|ref|XP_786111.2| PREDICTED: similar to fumarase [St...   239   5E-62 C 
contig01532 gi|189525926|ref|XP_694336.3| PREDICTED: wu:fb81h03 [Danio rerio]     239   5E-62 E 
contig01841 gi|34484219|gb|AAQ72744.1| sodium/potassium ATPase alpha subunit...   241   2E-62 Q 
contig01974 gi|66535629|ref|XP_392950.2| PREDICTED: similar to CG3376-PA, is...   243   9E-63 I 
contig04038 gi|50512854|gb|AAS93901.1| glycogen phosphorylase [Crassostrea g...   133   7E-63 G 
contig01446 gi|45479211|gb|AAS66655.1| ferritin [Hyalomma asiaticum asiaticum]    247   4E-64 I 
contig04670 gi|66523390|ref|XP_392776.2| PREDICTED: similar to Glutamate deh...   247   2E-64 G 




Contig BLAST result e value Class 
contig00394 gi|189233821|ref|XP_971721.2| PREDICTED: similar to conserved hy...   256   2E-65 C 
contig12831 gi|91088621|ref|XP_967480.1| PREDICTED: similar to voltage-depen...   254   2E-65 CE 
contig05135 gi|183448416|gb|ACC62887.1| glucose 6-phosphate dehydrogenase is...   251   1E-65 I 
contig11892 gi|91077504|ref|XP_966852.1| PREDICTED: similar to saposin isofo...   230   5E-68 G 
contig11295 gi|84095074|dbj|BAE66652.1| phenylalanine hydroxylase [Papilio x...   260   3E-68 G 
contig06749 gi|156402676|ref|XP_001639716.1| predicted protein [Nematostella...   268   4E-70 P 
contig06936 gi|195385958|ref|XP_002051671.1| GJ11069 [Drosophila virilis] >g...   266   3E-70 G 
contig12538 gi|72053243|ref|XP_783757.1| PREDICTED: similar to GMPS protein ...   273   2E-71 C 
contig04500 gi|198149572|gb|EDY73335.1| GA29299 [Drosophila pseudoobscura ps...   274   2E-72 C 
contig13138 gi|66547465|ref|XP_392938.2| PREDICTED: similar to Glucose trans...   281   1E-73 IR 
contig12246 gi|194226870|ref|XP_001917242.1| PREDICTED: similar to adenylosu...   263   5E-75 C 
contig04596 gi|186920389|gb|ACC95446.1| glutamate dehydrogenase [Litopenaeus...   154   2E-75 G 
contig01139 gi|46849491|dbj|BAD17955.1| glycinamide ribonucleotide synthetas...   291   1E-76 G 
contig12226 gi|38564419|ref|NP_942572.1| choline transporter-like protein 2 ...   179   2E-77 G 
contig11813 gi|156547189|ref|XP_001604156.1| PREDICTED: similar to sodium/po...   300   2E-79 I 
contig02330 gi|194754279|ref|XP_001959423.1| GF12060 [Drosophila ananassae] ...   306   1E-81 CIQ 
contig01232 gi|156552794|ref|XP_001600967.1| PREDICTED: similar to GA17603-P...   307   4E-82 P 
contig01617 gi|156550600|ref|XP_001604166.1| PREDICTED: similar to inorganic...   281   4E-82 C 
contig00570 gi|71895387|ref|NP_001025772.1| inosine monophosphate dehydrogen...   310   2E-82 E 
contig02283 gi|189525094|ref|XP_001923821.1| PREDICTED: succinate-CoA ligase...   312   2E-83 E 
contig01006 gi|189235816|ref|XP_972044.2| PREDICTED: similar to AGAP006936-P...   315   4E-84 C 
contig02069 gi|126330256|ref|XP_001366956.1| PREDICTED: hypothetical protein...   249   4E-84 C 
contig12613 gi|27311164|ref|NP_758884.1| cytochrome b [Varroa destructor] >g...   319   3E-85 I 
contig12059 gi|2570843|gb|AAB82290.1| sarco/endoplasmic reticulum Ca2+-ATPas...   322   7E-86 E 
contig11085 gi|167536447|ref|XP_001749895.1| predicted protein [Monosiga bre...   324   3E-87 C 
contig12733 gi|118404104|ref|NP_001072376.1| 4-hydroxyphenylpyruvate dioxyge...   194   3E-88 C 
contig01343 gi|5230695|gb|AAD40966.1|AF081807_1 cytochrome P450 4W1 [Boophil...   332   5E-89 G 
contig02388 gi|157111333|ref|XP_001651490.1| cytosolic purine 5-nucleotidase...   332   3E-89 F 
contig03685 gi|193706886|ref|XP_001950623.1| PREDICTED: similar to GA10597-P...   333   1E-89 H 
contig02154 gi|114319091|gb|ABI63547.1| triosephosphate isomerase [Blattella...   337   1E-90 P 
contig01207 gi|91086519|ref|XP_971755.1| PREDICTED: similar to vesicle amine...   337   9E-91 C 
contig01461 gi|170032167|ref|XP_001843954.1| conserved hypothetical protein ...   231   3E-91 P 
contig01818 gi|91078838|ref|XP_971511.1| PREDICTED: similar to AGAP007285-PA...   338   1E-91 H 
contig00502 gi|73979739|ref|XP_856678.1| PREDICTED: similar to Ornithine dec...   345   8E-93 E 
contig00484 gi|115495787|ref|NP_001070100.1| solute carrier family 25 (mitoc...   355   9E-96 I 
contig05520 gi|110769804|ref|XP_624006.2| PREDICTED: similar to dre4 CG1828-...   338   6E-96 Q 
contig03159 gi|197632181|gb|ACH70814.1| S-adenosylhomocysteine hydrolase [Sa...   356   1E-96 I 
contig04951 gi|114052783|ref|NP_001040279.1| serine hydroxymethyltransferase...   361   8E-98 C 
contig00435 gi|66509679|ref|XP_395764.2| PREDICTED: similar to CTP:phosphoch...   369   1E-100 IG 
contig00890 gi|437279|gb|AAB86499.1| stearoyl-CoA desaturase [Amblyomma amer...   369   1E-100 C 
contig02767 gi|148223856|ref|NP_001087698.1| MGC83352 protein [Xenopus laevi...   368   1E-100 I 
contig01715 gi|194765671|ref|XP_001964950.1| GF22842 [Drosophila ananassae] ...   379   1E-103 C 
contig01584 gi|189239301|ref|XP_971644.2| PREDICTED: similar to utp-glucose-...   392   1E-107 I 
contig04889 gi|114052230|ref|NP_001040132.1| hydroxyacyl-coenzyme A dehydrog...   354   1E-108 F 
contig11916 gi|72053243|ref|XP_783757.1| PREDICTED: similar to GMPS protein ...   394   1E-108 C 
contig00877 gi|41054619|ref|NP_955871.1| phosphoglycerate dehydrogenase [Dan...   397   1E-109 C 
contig01427 gi|25090938|sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosi...   252   1E-114 C 
contig12001 gi|50758110|ref|XP_415765.1| PREDICTED: similar to Malate dehydr...   326   1E-114 I 
contig13207 gi|194241600|gb|ACF35055.1| hemelipoglycoprotein precursor 2 [De...   159   1E-116 I 
contig00376 gi|21450129|ref|NP_659033.1| acetyl-Coenzyme A acetyltransferase...   266   1E-120 F 




Contig BLAST result e value Class 
contig02591 gi|157106042|ref|XP_001649141.1| transketolase [Aedes aegypti] >...   454   1E-126 P 
contig00067 gi|158631166|ref|NP_001037072.1| ADP/ATP translocase [Bombyx mor...   391   1E-127 G 
contig11557 gi|74950265|sp|Q4U3L0|G3P_GLOMM Glyceraldehyde-3-phosphate dehyd...   406   1E-128 I 
contig11619 gi|72010168|ref|XP_783048.1| PREDICTED: similar to Slc25a3-prov ...   464   1E-128 QI 
contig01072 gi|158292977|ref|XP_314288.4| AGAP004890-PB [Anopheles gambiae s...   480   1E-133 I 
contig13306 gi|195114014|ref|XP_002001562.1| GI16461 [Drosophila mojavensis]...   275   1E-133 C 
contig00578 gi|92090585|sp|Q27238|ADT1_ANOGA ADP,ATP carrier protein 1 (ADP/...   501   1E-140 F 
contig00885 gi|25453072|sp|Q95V58|KARG_ARTSF Arginine kinase (AK) >gnl|BL_OR...   516   1E-144 C 
contig11570 gi|195430072|ref|XP_002063081.1| GK21733 [Drosophila willistoni]...   287   1E-145 P 
contig00631 gi|115948338|ref|XP_001175657.1| PREDICTED: similar to 5-aminoim...   521   1E-146 IR 
contig11550 gi|110748949|ref|XP_623342.2| PREDICTED: similar to Aldolase CG6...   532   1E-149 C 
contig01932 gi|58390364|ref|XP_317672.2| AGAP007827-PA [Anopheles gambiae st...   548   1E-154 P 
contig11287 gi|157133341|ref|XP_001656210.1| citrate synthase [Aedes aegypti...   574   1E-161 F 
contig01083 gi|91092172|ref|XP_968236.1| PREDICTED: similar to Type III alco...   352   1E-166 C 
contig01267 gi|148237376|ref|NP_001086928.1| phosphoglycerate kinase 2 [Xeno...   588   1E-166 F 
contig02408 gi|157111261|ref|XP_001651458.1| ATP synthase subunit beta vacuo...   399   1E-167 P 
contig01077 gi|158290905|ref|XP_312441.4| AGAP002499-PA [Anopheles gambiae s...   595   1E-168 F 
contig11592 gi|169260101|gb|ACA51932.1| arginine kinase [Metapenaeus ensis]       396   1E-170 I 
contig12598 gi|157690439|gb|ABV65906.1| sodium/potassium-transporting ATPase...   612   1E-173 P 
contig00859 gi|170064276|ref|XP_001867458.1| glutamate carboxypeptidase [Cul...   615   1E-174 E 
contig01816 gi|157137937|ref|XP_001664086.1| aconitase, mitochondrial [Aedes...   464   1E-178 C 
contig11897 gi|194319795|gb|ABW82681.2| vitellogenin-2 precursor [Dermacento...   636   1E-180 C 
contig00165 gi|149413032|ref|XP_001506958.1| PREDICTED: similar to ATP synth...   863   0 CE 
contig00870 gi|158866359|gb|ABW82155.1| catalase [Fenneropenaeus chinensis]       681   0 C 
contig02962 gi|157133637|ref|XP_001662952.1| bifunctional purine biosynthesi...   276   0 G 
contig03582 gi|160898730|ref|YP_001564312.1| hypothetical protein Daci_3289 ...    21   0 G 
contig09482 gi|196011112|ref|XP_002115420.1| hypothetical protein TRIADDRAFT...    40   0 E 
contig12013 gi|82878755|gb|AAW78557.2| vitellogenin [Dermacentor variabilis]      831   0 G 
contig13231 gi|134143225|gb|ABO61883.1| phosphoenolpyruvate carboxykinase [R...   884   0 P 
contig13317 gi|194319795|gb|ABW82681.2| vitellogenin-2 precursor [Dermacento...   759   0 H 
contig13348 gi|147905995|ref|NP_001083034.1| hypothetical protein LOC1000387...   781   0 P 
contig00751 No hits found 
 
IR 
contig01516 No hits found 
 
E 
contig01547 No hits found 
 
I 
contig01950 No hits found 
 
C 
contig03479 No hits found 
 
IR 
contig04021 No hits found 
 
E 
contig04371 No hits found 
 
C 
contig04512 No hits found 
 
Q 
contig06567 No hits found 
 
Q 
contig06596 No hits found 
 
G 
contig08015 No hits found 
 
C 
contig08406 No hits found 
 
C 
contig09560 No hits found 
 
I 
contig09833 No hits found 
 
I 
contig09912 No hits found 
 
C 
contig10647 No hits found 
 
I 
contig10694 No hits found 
 
H 
contig10832 No hits found 
 
I 
contig11583 No hits found 
 
C 
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contig12439 No hits found 
 
I 
contig12811 No hits found 
 
C 
contig12857 No hits found 
 
C 
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Table showing all the contigs that had count data in each sample and had a significant fold change of more than three.  
Probe p-value Fold change 
 Fed vs Unfed 
Gene F1 F2 F3 S1 S2 S3 
contig12543 2.6E-04 110.853 gi|17570195|ref|NP_508868.1| VITellogenin structural genes (yolk...    60 28738 99606 52525 561 361 545 
contig12032 0.00511 69.317 gi|82878755|gb|AAW78557.2| vitellogenin [Dermacentor variabilis]      209 7916 2465 2294 150 16 56 
contig12020 0.00587 58.038 No hits found 11528 3657 8541 473 66 59 
contig12579 6.5E-05 55.864 gi|169215918|ref|XP_001718712.1| PREDICTED: hypothetical protein...    42 11859 7087 10710 191 124 218 
contig11532 0.02143 51.208 gi|125524395|gb|EAY72509.1| hypothetical protein OsI_000356 [Ory...    33 8313 36848 39333 2757 115 283 
contig00712 0.00012 39.675 gi|167035216|ref|YP_001670447.1| hypothetical protein PputGB1_42...    35 9327 11563 15466 225 271 438 
contig00149 1.7E-05 38.910 No hits found 6404 7744 8025 224 145 208 
contig13089 0.03095 37.151 gi|119628581|gb|EAX08176.1| hCG2038677 [Homo sapiens]                  38 23667 1231 2065 332 38 93 
contig12724 0.00204 36.924 gi|74267388|dbj|BAE44191.1| cuticular protein [Tachypleus triden...    50 1071 1231 2291 25 25 96 
contig01395 8.2E-04 35.517 gi|119715610|ref|YP_922575.1| hypothetical protein Noca_1374 [No...    35 1471 1353 1569 24 88 33 
contig12891 0.02325 29.318 gi|153829295|ref|ZP_01981962.1| MshQ [Vibrio cholerae 623-39] >g...    36 14901 51336 50954 6080 365 697 
contig13001 0.02963 27.656 No hits found 734 1562 1750 304 24 13 
contig12013 0.00267 26.812 gi|82878755|gb|AAW78557.2| vitellogenin [Dermacentor variabilis]      831 127950 71499 50643 5890 1400 2915 
contig00171 0.01360 24.596 gi|194319795|gb|ABW82681.2| vitellogenin-2 precursor [Dermacento...   212 101586 20153 17416 3380 583 1216 
contig12861 0.00126 21.875 gi|158316180|ref|YP_001508688.1| hypothetical protein Franean1_4...    35 648 1276 1940 43 44 81 
contig12148 1.5E-04 21.540 gi|170696288|ref|ZP_02887419.1| transcriptional regulator, winge...    34 2905 1962 3000 85 136 148 
contig01907 0.01108 19.885 gi|114153294|gb|ABI52813.1| GGY domain protein [Argas monolakensis]    39 109 540 778 13 32 14 
contig07410 0.01253 19.579 gi|212491|gb|AAA48996.1| ORF                                           83 561 735 3128 133 38 34 
contig04772 0.00521 17.297 No hits found 1530 1486 4942 85 103 248 
contig01984 0.01228 16.398 No hits found 1460 1124 2336 50 322 54 
contig12559 0.04277 15.478 gi|195567675|ref|XP_002107384.1| GD17434 [Drosophila simulans] >...    44 607 830 1281 344 22 23 
contig04119 0.01044 13.771 No hits found 348 1370 948 104 64 26 
contig00317 0.00433 13.486 No hits found 369 532 1417 45 36 70 
contig00690 9.2E-04 12.945 gi|56684769|gb|AAW22505.1| ferritin heavy chain-1b [Carcinoscorp...   160 462 270 378 19 44 26 
contig05591 0.02280 12.219 No hits found 556 612 605 14 155 52 











Probe p-value Fold change 
 Fed vs Unfed 
Gene F1 F2 F3 S1 S2 S3 
contig02256 0.02389 11.114 gi|189202442|ref|XP_001937557.1| conserved hypothetical protein ...    38 869 297 782 35 168 25 
contig06158 0.04003 10.235 No hits found 302 870 474 15 44 176 
contig12606 0.00500 10.089 gi|109506318|ref|XP_226158.4| PREDICTED: similar to Mucin-2 prec...    57 2532 753 2552 158 153 196 
contig12810 0.00184 9.969 gi|114675653|ref|XP_001170388.1| PREDICTED: deoxyribonuclease II...   119 1910 833 1827 172 104 164 
contig00670 0.00127 9.900 gi|72008176|ref|XP_780713.1| PREDICTED: similar to cathepsin L [...   377 3956 4789 8377 741 541 408 
contig12371 0.03655 9.828 gi|149723703|ref|XP_001489791.1| PREDICTED: granulin [Equus caba...    45 468 59 363 16 15 44 
contig13131 0.00447 9.699 gi|91081217|ref|XP_975622.1| PREDICTED: similar to ecdysteroid r...   116 823 1202 2413 89 200 147 
contig13200 0.03687 9.619 gi|111220888|ref|YP_711682.1| 1-hydroxy-2-methyl-2-(E)-butenyl 4...    43 3675 6429 36634 1589 878 697 
contig13074 0.01140 9.557 gi|47230018|emb|CAG10432.1| unnamed protein product [Tetraodon n...   169 951 534 1164 50 215 63 
contig11938 0.04833 8.563 gi|161788938|dbj|BAF95090.1| 2nd tick legumain [Haemaphysalis lo...    77 586 140 225 99 11 27 
contig11417 4.1E-04 8.536 gi|91080885|ref|XP_972748.1| PREDICTED: similar to GA14321-PA [T...    37 97 73 137 12 10 13 
contig11374 0.04441 8.515 No hits found 689 126 98 13 53 20 
contig11787 3.5E-04 8.513 gi|15219757|ref|NP_176856.1| unknown protein [Arabidopsis thalia...    42 74679 140492 100406 12198 12937 10821 
contig00726 0.03861 8.411 gi|45386073|gb|AAS59854.1| NADH-ubiquinone oxidoreductase [Ornit...    53 681 233 408 39 155 18 
contig05927 0.02458 8.041 No hits found 639 102 131 23 34 21 
contig11836 0.00187 7.939 gi|40548304|ref|NP_954972.1| carboxypeptidase, vitellogenic-like...   303 4773 1846 2783 321 376 406 
contig12768 6.5E-04 7.628 gi|196236958|ref|ZP_03135749.1| conserved hypothetical protein [...    49 4136 3918 7235 698 550 688 
contig05241 0.02602 7.582 gi|169170573|ref|XP_001716045.1| PREDICTED: hypothetical protein...    34 727 308 147 31 28 87 
contig12017 0.00561 7.522 No hits found 2824 1319 2093 350 145 361 
contig12038 0.03652 7.274 gi|1236646|gb|AAC48775.1| ch4 and secrete domains of swine IgM [...    34 491 126 75 41 21 14 
contig08739 0.03324 7.252 gi|186686156|ref|YP_001869352.1| hypothetical protein Npun_F6121...    33 2117 401 483 138 147 53 
contig13173 6.3E-05 7.215 gi|1389604|gb|AAC59905.1| acetylcholinesterase                        186 13321 12603 16570 2172 2027 1682 
contig02590 0.04679 7.086 gi|51949802|gb|AAU14833.1| adenosine kinase isoform 2S [Nicotian...   132 201 380 598 15 107 80 
contig01314 0.03827 7.082 gi|157108382|ref|XP_001650201.1| seryl-tRNA synthetase [Aedes ae...   105 532 133 64 25 30 17 
contig12549 0.04210 7.079 No hits found 1237 254 271 127 63 30 
contig01853 0.01540 6.994 gi|66508914|ref|XP_623207.1| PREDICTED: similar to CG10527-PA is...   100 948 234 671 49 107 83 











Probe p-value Fold change 
 Fed vs Unfed 
Gene F1 F2 F3 S1 S2 S3 
contig00304 0.00764 6.641 gi|153832046|ref|ZP_01984713.1| pyruvate/2-oxoglutarate dehydrog...    43 371 189 275 55 21 57 
contig00102 0.04250 6.509 gi|187598503|ref|ZP_02984755.1| hypothetical protein GdiaDRAFT_3...    52 557 593 206 74 145 23 
contig12507 0.03377 6.448 gi|81096421|ref|ZP_00874766.1| hypothetical protein SsuiDRAFT_16...    49 3037 853 456 122 230 157 
contig05426 0.00816 6.422 gi|157676771|emb|CAP08020.1| unnamed protein product [Danio rerio]     36 678 420 730 150 48 109 
contig11590 5.7E-04 6.225 gi|149287022|gb|ABR23410.1| p8 nuclear protein [Ornithodoros par...    80 7885 6337 6074 776 1263 1284 
contig00207 0.02356 6.088 gi|46111825|ref|XP_382970.1| hypothetical protein FG02794.1 [Gib...    38 148 180 247 81 20 18 
contig04973 0.01136 6.008 gi|14485281|ref|NP_058968.14| aldehyde dehydrogenase family 1, s...    95 135 66 184 30 21 12 
contig00873 0.01953 5.856 gi|2665388|dbj|BAA23764.1| cyclophilin G [Tachypleus tridentatus]     251 446 148 511 34 81 61 
contig13129 0.00650 5.688 gi|118429511|gb|ABK91803.1| aspartic protease precursor [Clonorc...   177 1625 666 1574 226 266 154 
contig00052 0.01387 5.632 gi|111022465|ref|YP_705437.1| chaperone protein [Rhodococcus sp....    35 135 246 377 32 30 73 
contig02996 0.01838 5.549 gi|195376021|ref|XP_002046795.1| GJ12289 [Drosophila virilis] >g...    39 148 167 132 62 22 14 
contig01412 0.01832 5.453 No hits found 807 776 858 62 244 219 
contig11508 0.04393 5.440 gi|157748651|ref|XP_001669420.1| Hypothetical protein CBG19758 [...    35 2352 355 797 122 143 237 
contig01148 0.04266 5.427 No hits found 588 261 309 27 67 164 
contig11293 0.00662 5.372 gi|148717315|dbj|BAF63671.1| protein disulfide isomerase-2 [Haem...   385 1079 991 1433 118 261 321 
contig07771 0.01428 5.339 No hits found 179 110 113 42 29 12 
contig01438 0.03987 5.321 gi|150864759|ref|XP_001383727.2| hypothetical protein PICST_4371...    35 1259 347 305 53 162 103 
contig12246 0.00141 5.285 gi|194226870|ref|XP_001917242.1| PREDICTED: similar to adenylosu...   263 800 656 796 102 136 204 
contig00176 0.03015 5.179 gi|67083759|gb|AAY66814.1| selenium dependent salivary glutathio...   188 2194 617 599 156 126 297 
contig02485 0.01107 5.175 gi|66524917|ref|XP_393112.2| PREDICTED: similar to 26S proteasom...   219 475 260 152 37 60 61 
contig02881 0.04351 5.157 gi|67920250|ref|ZP_00513770.1| conserved hypothetical protein [C...    33 4562 929 1127 296 530 222 
contig12224 0.03416 5.132 gi|115655582|ref|XP_780679.2| PREDICTED: similar to granulin [St...   106 2004 375 843 202 200 116 
contig07518 0.02419 5.075 gi|196001653|ref|XP_002110694.1| hypothetical protein TRIADDRAFT...    45 491 139 121 32 47 42 
contig12061 0.03293 5.044 gi|8050849|gb|AAF71775.1|AF263912_14 NysB [Streptomyces noursei]       38 1419 368 1076 91 228 211 
contig13159 0.02917 5.006 No hits found 87 274 78 15 38 26 
contig13068 0.00303 4.948 gi|27733415|gb|AAO21505.1|AF413064_1 serpin 3a [Manduca sexta] >...    35 86 141 113 26 29 15 
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Gene F1 F2 F3 S1 S2 S3 
contig12705 0.02520 4.922 gi|189208430|ref|XP_001940548.1| laccase-1 precursor [Pyrenophor...    26 7114 1846 2340 846 686 444 
contig01538 0.00647 4.922 gi|47522760|ref|NP_999131.1| long-chain 3-ketoacyl-CoA thiolase ...   129 236 261 262 36 94 40 
contig00466 0.01495 4.879 gi|74096057|ref|NP_001027676.1| sec61 protein [Ciona intestinali...    64 480 257 337 37 118 82 
contig06291 0.02386 4.875 gi|171689310|ref|XP_001909595.1| unnamed protein product [Podosp...    34 123 173 172 14 37 61 
contig12253 0.01082 4.862 gi|123959678|gb|AAI28967.1| LOC100037110 protein [Xenopus laevis]      65 595 237 301 47 81 97 
contig02168 0.04722 4.862 gi|169218160|ref|XP_001719783.1| PREDICTED: similar to KLHL23 pr...    30 576 157 113 27 54 61 
contig08063 0.03875 4.841 gi|196000721|ref|XP_002110228.1| expressed hypothetical protein ...    45 227 45 179 20 31 26 
contig01772 0.00507 4.839 gi|169217278|ref|XP_001732938.1| PREDICTED: hypothetical protein...    34 1855 924 873 316 209 200 
contig12894 0.00395 4.807 gi|114153234|gb|ABI52783.1| mucin peritrophin salivary protein [...    70 10902 25028 18318 3651 2948 4181 
contig02157 7.2E-04 4.781 gi|67083785|gb|AAY66827.1| secreted salivary protein [Ixodes sca...    48 2033 2647 2771 406 517 650 
contig02767 0.01405 4.778 gi|148223856|ref|NP_001087698.1| MGC83352 protein [Xenopus laevi...   368 395 317 609 134 111 47 
contig00262 0.00972 4.754 gi|153791210|ref|NP_001014420.2| taste receptor protein 1 [Mus m...    36 11438 3970 9425 1483 1872 1435 
contig03656 0.04663 4.731 gi|195108637|ref|XP_001998899.1| GI24219 [Drosophila mojavensis]...    43 423 417 774 55 80 293 
contig11681 0.00141 4.723 No hits found 270 184 294 55 63 40 
contig12243 0.02839 4.668 gi|39725977|gb|AAR29940.1| calreticulin [Boophilus microplus]         323 652 205 441 45 116 111 
contig00022 0.01571 4.648 gi|161669226|gb|ABX75465.1| nucleoside diphosphate kinase [Lycos...   237 2017 723 1252 165 365 302 
contig07116 0.00447 4.637 No hits found 318 384 429 54 128 76 
contig00916 0.03627 4.637 gi|50251506|dbj|BAD28867.1| aminotransferase-like [Oryza sativa ...    36 240 123 107 15 32 66 
contig03414 0.04484 4.554 gi|149898803|gb|ABR27863.1| Sec61 protein translocation complex ...    87 655 183 124 49 73 44 
contig05486 0.04412 4.530 gi|194765045|ref|XP_001964638.1| GF23289 [Drosophila ananassae] ...    57 1200 249 713 194 85 139 
contig02324 0.00413 4.524 gi|41617918|tpg|DAA02898.1| TPA: TPA_inf: HDC09484 [Drosophila m...    33 236 544 385 70 93 82 
contig12045 0.04927 4.516 gi|149031098|gb|EDL86125.1| rCG37365 [Rattus norvegicus]               35 552 705 1264 101 456 116 
contig11943 0.00374 4.511 gi|171912587|ref|ZP_02928057.1| hypothetical protein VspiD_15445...    33 752 516 833 102 194 178 
contig03269 0.00197 4.501 No hits found 2036 3587 2760 784 530 532 
contig02067 0.02818 4.486 gi|145340986|ref|XP_001415597.1| predicted protein [Ostreococcus...    33 1376 428 742 109 294 151 
contig11625 0.03843 4.485 gi|170030742|ref|XP_001843247.1| proteasome subunit alpha type 6...   384 1431 288 500 100 136 168 
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contig00556 0.03373 4.415 gi|195396577|ref|XP_002056907.1| GJ16636 [Drosophila virilis] >g...    33 875 253 280 57 95 133 
contig00188 0.02877 4.408 gi|196476807|gb|ACG76267.1| histone 2B [Amblyomma americanum]         182 267 307 451 109 120 33 
contig00212 0.00561 4.364 gi|193594270|ref|XP_001942800.1| PREDICTED: similar to S-adenosy...   154 357 180 268 85 46 53 
contig00498 0.00261 4.352 gi|88602953|ref|YP_503131.1| HNH endonuclease [Methanospirillum ...    36 4921 2929 3131 793 1072 644 
contig06286 0.02872 4.290 gi|169640128|gb|ACA61137.1| cellulase [uncultured microorganism]       36 108 180 327 24 61 55 
contig12692 0.01634 4.257 No hits found 181 103 139 20 28 60 
contig12538 0.04258 4.165 gi|72053243|ref|XP_783757.1| PREDICTED: similar to GMPS protein ...   273 251 315 472 35 90 164 
contig02748 0.01514 4.097 gi|194218564|ref|XP_001917008.1| PREDICTED: low density lipoprot...    87 694 365 905 97 179 192 
contig01006 0.02642 4.051 gi|189235816|ref|XP_972044.2| PREDICTED: similar to AGAP006936-P...   315 1677 546 583 248 233 139 
contig04737 0.00861 4.042 No hits found 63 62 102 13 16 29 
contig07176 0.00381 3.996 gi|28422163|gb|AAH46839.1| Plk-prov protein [Xenopus laevis]          147 885 1163 1322 209 405 252 
contig10262 0.00272 3.991 gi|74318688|ref|YP_316428.1| metal dependent phosphohydrolase, H...    36 176 117 129 25 44 38 
contig00165 0.00930 3.978 gi|149413032|ref|XP_001506958.1| PREDICTED: similar to ATP synth...   863 6398 2898 3364 1381 886 810 
contig13261 3.4E-04 3.972 gi|157776976|ref|XP_001666554.1| hypothetical protein CBG15153 [...    65 630 597 700 181 180 129 
contig04318 0.01009 3.965 gi|194225289|ref|XP_001494645.2| PREDICTED: similar to Fibulin 5...    60 2454 2237 5055 950 825 568 
contig13273 0.01583 3.954 No hits found 513 473 719 152 235 79 
contig00156 0.01187 3.900 gi|118104159|ref|XP_425038.2| PREDICTED: similar to cathepsin L ...    96 2397 1044 2790 447 543 485 
contig01743 0.03107 3.891 gi|91084123|ref|XP_967224.1| PREDICTED: similar to aspartate ami...   206 339 124 128 45 29 70 
contig02329 0.04537 3.888 gi|72042689|ref|XP_794417.1| PREDICTED: similar to Retinol dehyd...   120 62 119 182 17 24 56 
contig00859 0.01226 3.867 gi|170064276|ref|XP_001867458.1| glutamate carboxypeptidase [Cul...   615 364 191 377 115 73 54 
contig13232 0.03540 3.848 gi|66506394|ref|XP_624700.1| PREDICTED: similar to CG31618-PA [A...   160 40471 14587 10732 5116 6103 3562 
contig07208 0.00411 3.846 gi|118462588|ref|YP_882079.1| CDP-alcohol phosphatidyltransferas...    37 499 331 460 84 100 159 
contig11796 0.00432 3.842 gi|82705844|ref|XP_727137.1| hypothetical protein PY06477 [Plasm...    39 1376 1865 1151 278 359 522 
contig11910 0.01826 3.837 gi|156372710|ref|XP_001629179.1| predicted protein [Nematostella...   379 1023 1344 3089 366 520 395 
contig06536 0.03600 3.803 gi|58387114|ref|XP_315337.2| AGAP005323-PB [Anopheles gambiae st...    75 126 32 55 16 12 21 
contig13080 0.01102 3.773 gi|45269081|gb|AAS55945.1| actin [Ornithodoros moubata]               742 16230 7077 9123 1932 3114 3244 
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contig13130 0.02822 3.743 gi|115931821|ref|XP_001180548.1| PREDICTED: hypothetical protein...    44 1502 450 756 225 283 153 
contig04085 4.2E-04 3.688 gi|170094979|ref|XP_001878710.1| predicted protein [Laccaria bic...    33 421 449 326 97 123 103 
contig12240 0.04692 3.685 gi|33348836|gb|AAQ16118.1| cathepsin L-like cysteine proteinase ...   123 1944 2014 3268 286 723 1237 
contig03700 0.00426 3.684 gi|191171858|ref|ZP_03033404.1| Cps2D [Escherichia coli F11] >gn...    33 767 464 416 141 178 118 
contig06739 0.02577 3.669 gi|169206246|ref|XP_001716022.1| PREDICTED: hypothetical protein...    48 191 145 78 60 27 27 
contig13043 0.04933 3.654 No hits found 1925 652 815 170 514 240 
contig09987 0.02739 3.598 gi|114153104|gb|ABI52718.1| metalloprotease [Argas monolakensis]       34 105 66 71 44 16 15 
contig11620 0.00665 3.591 gi|149287114|gb|ABR23456.1| cytochrome c oxidase polyprotein IV ...    50 237 202 392 65 99 63 
contig00224 0.01188 3.585 gi|39725965|gb|AAR29934.1| calreticulin [Amblyomma cooperi]           546 1562 1271 2518 725 396 378 
contig04408 0.03623 3.580 gi|169213506|ref|XP_001719061.1| PREDICTED: hypothetical protein...    42 1699 1004 1237 173 422 630 
contig12001 0.00722 3.529 gi|50758110|ref|XP_415765.1| PREDICTED: similar to Malate dehydr...   326 769 1149 1243 436 246 233 
contig09563 0.00459 3.514 gi|169213190|ref|XP_001714612.1| PREDICTED: hypothetical protein...    34 74 48 61 24 13 16 
contig00950 0.01114 3.508 gi|170062080|ref|XP_001866514.1| conserved hypothetical protein ...    33 3812 3698 2929 576 1310 1268 
contig05646 0.02734 3.490 gi|194227065|ref|XP_001915913.1| PREDICTED: similar to Zinc fing...    33 119 112 252 62 49 26 
contig13208 0.03647 3.476 No hits found 2862 7833 7447 1181 2518 1337 
contig01639 0.03029 3.475 No hits found 155 162 360 64 37 91 
contig04310 0.00134 3.443 gi|158287073|ref|XP_309120.3| AGAP000935-PA [Anopheles gambiae s...   305 409 371 600 127 122 144 
contig07136 0.02224 3.442 gi|86355535|ref|YP_473203.1| P49 [Hyphantria cunea nucleopolyhed...    33 279 178 142 32 74 73 
contig12842 0.01013 3.435 gi|148709239|gb|EDL41185.1| Max dimerization protein 3, isoform ...    29 1119 2370 2533 612 547 495 
contig12071 0.00253 3.434 gi|109118856|ref|XP_001109939.1| PREDICTED: acid alpha-glucosida...    61 1354 1749 1891 370 628 476 
contig11842 0.02746 3.419 gi|98986297|dbj|BAE94536.1| hypothetical protein [Colletotrichum...    35 94 79 135 16 49 32 
contig04095 0.03214 3.409 No hits found 100 136 164 19 52 57 
contig01211 0.02643 3.390 gi|125586705|gb|EAZ27369.1| hypothetical protein OsJ_010852 [Ory...    40 1261 655 928 491 212 189 
contig00921 0.02573 3.389 gi|68171402|ref|ZP_00544794.1| Glyceraldehyde-3-phosphate dehydr...    35 565 228 261 103 131 64 
contig12736 0.02998 3.388 gi|167534260|ref|XP_001748808.1| predicted protein [Monosiga bre...    72 1492 3054 4511 571 897 1032 
contig12241 0.04574 3.364 gi|91084417|ref|XP_967827.1| PREDICTED: similar to chromobox-lik...   104 160 339 348 76 145 45 
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contig12206 0.01696 3.345 No hits found 763 364 304 146 150 103 
contig11867 0.02125 3.323 No hits found 60 37 100 14 18 24 
contig03781 0.04544 3.323 gi|94733117|emb|CAK04429.1| novel protein similar to vertebrate ...    50 239 188 238 31 74 127 
contig10333 0.04019 3.316 gi|119577990|gb|EAW57586.1| chromosome 17 open reading frame 78,...    33 554 235 243 56 149 104 
contig00470 7.9E-05 3.313 gi|156353921|ref|XP_001623156.1| predicted protein [Nematostella...    66 5270 5577 4710 1466 1497 1735 
contig11441 0.00473 3.293 gi|148657070|ref|YP_001277275.1| putative endoribonuclease L-PSP...   143 1935 3275 3082 647 1005 841 
contig00543 0.00725 3.287 gi|170596615|ref|XP_001902831.1| FKBP-type peptidyl-prolyl cis-t...   103 1640 1074 1284 276 418 552 
contig00938 0.00913 3.282 gi|169175412|ref|ZP_02837264.1| putative serine protease, subtil...    35 1950 3101 3538 620 859 1136 
contig10397 0.03888 3.277 gi|195444800|ref|XP_002070035.1| GK11242 [Drosophila willistoni]...    33 208 479 716 102 167 119 
contig00223 9.1E-04 3.269 No hits found 3822 3836 5632 1437 1264 1301 
contig03105 0.01566 3.265 gi|84570464|dbj|BAE72662.1| mucin [Haemaphysalis longicornis]          54 6450 4716 3554 964 1468 2194 
contig11550 0.01678 3.262 gi|110748949|ref|XP_623342.2| PREDICTED: similar to Aldolase CG6...   532 631 244 406 139 135 96 
contig05201 0.00871 3.260 No hits found 1050 2297 1241 412 503 417 
contig13340 0.00959 3.259 gi|157757981|ref|XP_001671334.1| Hypothetical protein CBG01569 [...    37 904 1778 1528 367 557 347 
contig11595 0.01944 3.258 gi|193608341|ref|XP_001948728.1| PREDICTED: similar to conserved...    45 6616 7146 12819 1641 3071 3478 
contig11535 0.02715 3.253 gi|27311161|ref|NP_758881.1| NADH dehydrogenase subunit 4 [Varro...   139 316953 461095 444976 67028 202999 13888
2 
contig01111 0.01937 3.235 gi|170038460|ref|XP_001847068.1| deoxyuridine 5'-triphosphate nu...   225 1299 1044 1227 200 477 515 
contig01770 0.00166 3.234 gi|189240738|ref|XP_968166.2| PREDICTED: similar to AGAP007574-P...   107 586 461 712 209 152 179 
contig13293 0.02813 3.229 gi|159470549|ref|XP_001693419.1| predicted protein [Chlamydomona...    39 65 92 136 21 50 23 
contig00629 0.01278 3.216 gi|167536992|ref|XP_001750166.1| predicted protein [Monosiga bre...    30 2859 1319 1307 620 512 467 
contig09309 0.04289 3.205 No hits found 427 201 348 168 100 54 
contig03108 0.02505 3.200 gi|149287082|gb|ABR23440.1| RNA binding protein [Ornithodoros pa...    75 906 1067 1032 239 601 212 
contig07552 0.03152 3.180 gi|168062615|ref|XP_001783274.1| predicted protein [Physcomitrel...   139 158 72 58 38 27 20 
contig03260 0.04405 3.156 gi|195153445|ref|XP_002017636.1| GL17205 [Drosophila persimilis]...   153 128 78 120 59 17 38 
contig10131 0.03695 3.150 gi|170064624|ref|XP_001867602.1| mitochondrial GTPase 1 [Culex q...    50 245 402 493 86 215 84 
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contig00345 0.00595 3.125 No hits found 837 1438 1569 357 467 371 
contig04735 0.01886 3.123 gi|197342428|ref|ZP_03180248.1| acetyltransferase [Streptomyces ...    34 1048 1249 1738 264 646 438 
contig02417 0.02132 3.119 gi|47206961|emb|CAF90782.1| unnamed protein product [Tetraodon n...    88 664 300 250 106 113 137 
contig13047 0.00494 3.100 No hits found 3254 1913 1743 778 721 649 
contig13158 0.04495 3.097 gi|5835683|ref|NP_008499.1|COX2_15044 cytochrome c oxidase subun...   215 55535 28781 41236 6610 19898 16874 
contig08115 0.03025 3.095 gi|21307827|gb|AAL47188.1| putative odorant receptor Or5 [Anophe...    33 150 157 161 26 82 60 
contig03384 4.1E-04 3.089 No hits found 178 212 200 69 53 70 
contig01481 0.02657 3.081 gi|194224697|ref|XP_001495027.2| PREDICTED: similar to fructose-...    89 350 479 1031 173 207 165 
contig11204 0.04833 3.080 No hits found 873 426 452 331 161 108 
contig00725 0.04163 3.075 gi|195396001|ref|XP_002056621.1| GJ11045 [Drosophila virilis] >g...    99 193 244 532 61 113 125 
contig11786 0.04683 3.075 gi|67517927|ref|XP_658738.1| QUTA_EMENI QUINIC ACID UTILIZATION ...    
33 
1610 526 675 192 388 264 
contig03915 0.04789 3.061 No hits found 154 246 208 32 113 76 
contig12655 0.02816 3.051 gi|171688916|ref|XP_001909398.1| unnamed protein product [Podosp...    42 553 439 385 131 270 93 
contig12306 0.00259 3.043 gi|39653771|ref|NP_945222.1| NADH dehydrogenase subunit 5 [Haema...   125 30010 22941 36701 7970 10556 10662 
contig11947 0.00953 3.035 No hits found 179 237 236 53 109 62 
contig13316 0.03218 3.006 gi|170089261|ref|XP_001875853.1| predicted protein [Laccaria bic...    35 209 371 592 111 162 94 
contig06979 0.03059 -3.056 No hits found 806 1402 1309 1938 4714 4621 
contig07485 0.04292 -3.249 No hits found 180 183 123 250 614 905 
contig06768 0.03542 -3.262 gi|70909867|emb|CAJ17420.1| ribosomal protein L35Ae [Carabus gra...   164 46 27 28 209 75 77 
contig11750 0.03351 -3.499 gi|124487974|gb|ABN12070.1| putative RNA-dependent helicase p68 ...   139 1675 2180 2432 3517 8590 12593 
contig12184 0.04160 -3.505 gi|149921489|ref|ZP_01909941.1| hypothetical protein PPSIR1_3079...    33 35 23 12 100 42 99 
contig13133 0.04525 -3.529 gi|67083339|gb|AAY66605.1| putative salivary protein [Ixodes sca...    41 2490 2121 4154 4541 15004 14154 
contig00109 0.02191 -3.552 gi|194222651|ref|XP_001497265.2| PREDICTED: eIF4GI protein [Equu...    48 14 13 36 71 53 78 
contig13213 0.04280 -3.692 gi|195112951|ref|XP_002001035.1| GI22201 [Drosophila mojavensis]...    37 86 71 35 110 342 286 
contig13166 0.01018 -3.708 No hits found 1375 831 662 2556 3125 4828 











Probe p-value Fold change 
 Fed vs Unfed 
Gene F1 F2 F3 S1 S2 S3 
contig13326 0.01507 -4.307 gi|148255061|ref|YP_001239646.1| putative ABC transporter (perme...    35 538 667 1024 1694 4528 3828 
contig13325 0.02267 -4.322 No hits found 442 261 173 1743 1427 648 
contig00150 0.03440 -4.391 gi|91081773|ref|XP_973360.1| PREDICTED: similar to GA13521-PA [T...    82 106 259 213 378 960 1364 
contig00603 0.00303 -4.429 gi|77553801|gb|ABA96597.1| MYB10, putative, expressed [Oryza sat...    36 849 921 954 2547 4826 5273 
contig00416 0.01391 -4.673 gi|67603978|ref|XP_666583.1| hypothetical protein Chro.70593 [Cr...    39 2990 5869 3816 10185 25123 26701 
contig13119 0.00935 -4.703 gi|116059360|emb|CAL55067.1| unnamed protein product [Ostreococc...    35 23 11 9 51 86 54 
contig07154 0.00301 -4.765 No hits found 36 49 42 193 138 301 
contig04870 0.00218 -5.137 gi|183979376|dbj|BAG30740.1| muscle myosin heavy chain [Papilio ...   244 19 37 31 181 120 136 
contig13174 0.01353 -5.251 gi|171678553|ref|XP_001904226.1| unnamed protein product [Podosp...    35 705 297 428 1306 2765 3594 
contig13310 0.02038 -6.204 gi|16877407|gb|AAH16950.1| KLHL23 protein [Homo sapiens]               27 1846 451 461 3360 5534 4930 
contig13245 0.02973 -6.666 gi|30023940|ref|NP_835282.1| polymerase [Indian peanut clump virus]    39 47 16 28 89 458 153 
contig13337 0.01148 -6.932 No hits found 1546 541 406 3575 5072 6239 
contig13361 0.01738 -7.228 gi|145598291|ref|YP_001162367.1| hypothetical protein YPDSF_0994...    33 1558 1869 1275 4171 18438 18228 
contig00606 7.1E-04 -32.170 gi|189242145|ref|XP_001813277.1| PREDICTED: similar to polyprote...    70 3212 19
15 
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